Design and synthesis of farnesyl diphosphate analogues for modulating the chemistry of aristolochene synthase by Yu, Fanglei
DESIGN AND SYNTHESIS OF FARNESYL DIPHOSPHATE 
ANALOGUES FOR MODULATING THE CHEMISTRY OF 
ARISTOLOCHENE SYNTHASE
by
Fanglei Yu
A thesis submitted to 
Cardiff University 
for the degree of
DOCTOR OF PHILOSOPHY
School of Chemistry 
Cardiff University 
December 2007
i
UMI Number: U585075
All rights reserved
INFORMATION TO ALL USERS  
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com plete manuscript 
and there are missing pages, th ese  will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U585075
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
DECLARATION
This work has not previously been accepted in substance for any degree and is not concurrently 
submitted in candidature for any degree.
STATEMENT 1
This thesis is being submitted in partial fulfillment of the requirements for the degree of 
 .........  ..(insert MCh, MD, MPhil, PhD etc, as appropriate)
Signed .. .........................(candidate) Date .. ......
STATEMENT 2
This thesis is the result of my own independent work/investigation, except where otherwise stated. 
Other sources are acknowledged by explicit references.
Signed ....................... (candidate) Date ............
STATEMENT 3
I hereby give consent for my thesis, if accepted, to be available for photocopying and for inter- 
library loan, and for the title and summary to be made available to outside organisations.
Signed........ (candidate) Date
n
vsm&rtSD 10 tmi prfzsm s
E S f r J f c * b * C J U t
ABSTRACT
A variety of famesyl pyrophosphate (FPP) analogues were prepared by both published protocols and 
novel methodology, which was developed by modification and improvement of the traditional 
Suzuki-Miyaura coupling. These compounds were incubated with aristolochene synthase in order to 
probe its mechanism of action and resulted in many interesting results.
The synthesis 12,13-difluoro famesyl pyrophosphate was achieved in 13 steps using Suzuki- 
Miyaura chemistry. It proved to be a potent inhibitor of aristolochene synthase (AS), which revealed 
that the initial cyclisation to germaciyl cation occurs in a concerted fashion.
Analogue 2-fluoro FPP was synthesized and upon incubation with aristolochene synthase was 
converted to a single pentane extractable product according to GC/MS analysis. On the basis of 
NMR-analyses and GC-MS experiments this product was identified as 2-fluorogermacrene A. This 
work suggests that after an initial concerted cyclisation of FPP to germacryl cation, deprotonation 
leads to the formation of germacrene A and provides compelling evidence that germacrene A is 
indeed an on-pathway product of catalysis by aristolochene synthase.
Analogue 6-fluoro FPP was prepared using the Weiler’s chain extension method in 10 steps, and has 
been postulated to be give 6-fluoro germacrene A as product, which is consistent with published 
results on Epi-aristolochene synthase.
10-Fluoro FPP was made with sulfonylation-alkylation-desulfonylation methodology and it was 
found not to act as substrates of the AS. This result is fully consistent with the conclusions drawn 
from the results with 12,13-difluoro FPP.
FPP analogues with one fluoro substituent at position C14 and C l5 were made using methodology 
employing the Homer-Emmons Wittig condensation as a key step. These two compounds were 
tested with AS and both gave one major extractable terpene product according to GC/MS analysis. 
These two products are postulated as two different compounds - 14-fluoro aristolochene and 15- 
fluoro germacrene A respectively, because of the destabilizing effect of the (3-substituted fluorine 
atom on the carbocation in their vicinity.
Analogues of famesyl pyrophosphate containing phenyl substituents in place of methyl groups have 
been prepared in syntheses that feature use of Suzuki-Miyaura reactions as key steps. These 
analogues were found not to act as substrates of the aristolochene synthase. However, they were 
potent competitive inhibitors of AS, which indicate that the active sites of terpene synthases are 
sufficiently flexible to accommodate even substrate analogues with large substituents suggesting a 
potential way for the generation of non-natural terpenoids.
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CHAPTER 1 
INTRODUCTION
1.1 General introduction to terpenes
The name “terpene” derives from the word “turpentine”, which is a fluid obtained by the 
distillation of resin obtained from trees, mainly pine trees. Terpenes are a large and varied class of 
hydrocarbons which are widespread in nature. They are small organic molecules that have an 
immense diversity of structure. So far more than 30,000 terpenoids have been identified, and 
plants produce more than half of them.1
The majority of terpenoids synthesised by plants are produced by secondary metabolism. 
Although for most of these compounds, the exact functions are unidentified, it has been known 
that they are not essential for viability of the organism. Instead, they play important roles, for 
instance, in communication or defence. There is also a small group of terpenoids which are used 
in primary metabolism, such as the phytol side chain of chlorophyll.
1.2 Importance and ecological role of terpenes
Apart from their huge array of structural diversity, terpenoids also have varied biological activity. 
In nature, their uses encompass employment as scents, oils, pheromones, phytoalexins.4 For 
example, there are different groups of terpenoid molecules produced by plants that act in different 
roles to help them survive in nature. Some may be produced by plants under attack. Gossypol (1) 
from cotton,5 which is toxic to the attacking organism is a good example. Some plants give out 
small volatile molecules as scents to attract insects that can help distribute pollen for reproduction 
and other compounds act as inhibitors to prevent the growth of competitor plants in a
A 7resource-limited area. ’ The varied usage of terpenes in nature will become apparent in the
following sections.
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Figure 1.1: Structure o f gossypol (1).
Terpenes can be divided into groups according to the number of five-carbon units they contain. 
The group of compounds with 10 carbons is named monoterpenes, sesquiterpenes contain 15
o
carbons, diterpenes contain 20 carbons, and so on.
Monoterpenoids are produced from geranyl pyrophosphate (GPP) (2).4 They are nonnutritive 
dietary components and usually found in the essential oils of citrus and other plants.9 They are 
largely responsible for the distinctive fragrance of many plants. However, recently, more medical 
and ecological functions have been allocated to this group of terpenoid compounds. p-Pinene (3) 
is a flavour and fragrance material10 which has a structural isomer in nature, a-pinene (4). The 
latter compound has been proven as a sex pheromone attracting the female cotton boll weevil.9 Its 
primary oxidation product is verbenone (5), which plays an important role in the control of the 
southern pine bark beetle. Recent publications have noted that verbenone may also have 
antimicrobial properties.11 Another example of medicinal use of a monoterpene is 8-limonene (6). 
It is extracted from orange peel oil and has chemopreventive activity against some cancers.9 
Some other dietary monoterpenes have been found to have similar anti-cancer property when fed
to rat during the initiation phase.9 Other monoterpenes are also used as antimicrobial agents such 
as camphor (7), which is found in wood of the Camphor laurel, a large evergreen tree found in 
Asia, and thymol (8), which is a monoterpene phenol derivative of cymene (9), isomeric with 
carvacrol (10), and is present in the oil of thyme, oregano and sage.12
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Figure 1.2: Structures o f geranyl pyrophosphate (2), fi-pinene (3), 
a-pinene (4), verbenone (5), S-limonene (6), camphor (7), thymol (8), 
cymene (9) and carvacrol (10).
All sesquiterpenes, of which more than 300 are known, are derived from the same starting 
material - famesyl pyrophosphate (FPP) ( l l) .13 Sesquiterpenoids or rather natural extracts 
containing sesquiterpenoids have been used as traditional medicines for thousands of years. More 
recently, along with such natural products, modified natural products have been used as 
therapeutic agents.14 For example, artemisinin (12), an endoperoxide-containing sesquiterpenoid 
lactone from the Chinese-Vietnamese plant - artemisia annua L. (sweet wormwood) has been 
used in China (where it is known as Qing Hao Su) as a traditional antimalarial and antipyretic 
drug for hundreds of years.15 Recent research has found that the characteristic peroxide lactone
structure is indispensable for anti-malarial activity, but other modifications of the parent structure 
have been found to retain or improve its pharmacological properties.16 For example, 
dihydroartemisinin (13) is more potent than the parent material.17 Sesquiterpenoids have also 
been found to have antibacterial properties - a good example is pentalenolactone (14), which is a
• • ISmember of the pentalenene-derived family of antibiotics.
iPP
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13
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14
Figure 13: Structures o f famesyl pyrophosphate (11), artemisinin (12), 
dihydroartemisinin (13) and pentalenolactone (14).
As with monoterpenes, sesquiterpenoids are widespread in nature and exhibit the full range of 
biological properties illustrated above. For example, S-cadinene (15) is the precursor of gossypol 
(1) which is a plant defensive phytoalexin in cotton.5,19
In contrast to phytoalexins that are defensive compounds, some sesquiterpenoids are mycotoxins
that are used to attack competing organisms. Aristolochene (16) from Penicillium roqueforti can
8
be derivatised to several fungal toxins that can seriously damage crop plantations with
*yr\
world-wide economic consequences.
15 16
Figure 1.4: Structure o f S-cadinene (15) and (+)-aristolochene (16).
As with other groups of terpenoids, diterpenoids have quite a few different uses both in nature 
and in medicine. When castor bean plants are under attack, much higher levels of casbene (17) 
have been observed in the seedlings.21 With both antibacterial and antifungal properties, this 
diterpene has been considered as a phytoalexin 21 As to the therapeutical properties of diterpenes, 
paclitaxel (taxol) (18) is a multi million dollar anti-cancer drug. Taxol is extracted from the 
pacific yew tree and has remarkable antitumour and antileukemic activity. One common 
characteristic of most cancer cells is their rapid rate of cell division. In order to accommodate this, 
the cytoskeleton of a cell undergoes extensive restructuring. Paclitaxel is an effective treatment 
for aggressive cancers because it adversely affects the process of cell division by preventing this 
restructuring by binding to tubulin. It is most commonly used to treat ovarian, breast and 
non-small cell lung cancer.
9
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Figure 1.5: Structures ofcasbene (17) and paclitaxel (18).
Cholesterol (19) and other steroids are considered as triterpenes even though they possess 
C27-C30 skeletons. This is because they are derived from the C30 linear precursor, squalene (20), 
which is derived from two molecules of FPP (11) (Scheme l.l).23 Oxidation by squalene 
monooxygenase of one of the terminal double bonds of squalene yields 2,3-squalene oxide (21) 
which undergoes enzyme-catalyzed cyclization to afford lanosterol (22), and is then elaborated 
into cholesterol and other steroids. Cholesterol is the source of sexual homones, bile acid and 
vitamin D in animals as well as having functions in controlling calcium and phosphorus 
metabolism. Another important function is the maintenance of membrane fluidity and 
permeability.24
10
NADPH NADP
OPP squalene synthase
-OPP
11 squalene
monooxygenase
HoO/NADP
lanosterol synthase
HO1
19 steps
HO1
19
Scheme 1.1: Generation o f cholesterol (19) from FPP (11).
Phytoene (23), the C40 terpene precursor, is the parent molecule of carotenoids, the family of 
naturally occurring pigments. Members of this group of molecules are deeply coloured 
compounds and are present in all photosynthetic organisms, in fungi and even in some animals. 
Due to their conjugated structures, carotenoids are central for the absorption of light in 
photosynthetic organisms. They can absorb the light at lower wavelengths than chlorophyll and
*)f\this increases the range of wavelength of light that may be used in photosynthesis. In this case,
11
the terpenoids are primary metabolites, as they are essential for survival. Phytoene can also be 
converted to vitamin A (24), which is an important compound in the vision process, for resistance 
to infectious disease and bone remodelling.27'29
OH
Figure 1.6: Structures o f Phytoene (23) and vitamin A (24).
1.3 The isoprene rule
The initially postulated “isoprene rule” by Wallach stated that most terpenoids could be
hypothetically constructed by a repetitive joining of isoprene (2-methyl-1,3-butadiene) (25) units
and have formula of CsHg or (CsHg^.30 In 1953, the “biogenetic isoprene rule” postulated by
Leopold Ruzicka, which ignores the precise character of biological precursors and assumes only
that they are “isoprenoid” in structure. The carbon skeleton of terpenes is composed of isoprene
units linked in a regular (head to tail) or an irregular arrangement. In most cases, the initially
formed structure assembled from C5 units is enzymatically modified in a number of ways to
generate the known terpenoid skeletal types. This indicates that all terpenes are related, regardless
of their apparent structural differences. Terpenes can be thought of as arising from the five-carbon
building block “isoprene” and oligomerisation of this motif, followed by cyclisation,
12
rearrangement and further oxidation of the carbon skeleton, which makes for an enormous 
diversity of structure.
Hef  Tail
4 2
25
Figure 1.7: Structure o f isoprene (25).
1.4 Biosynthesis of IPP and DMAPP
Isoprene is not the biological precursor of terpenes, even though the isoprene unit is the structural 
component of the terpenes. Rather, two biological equivalents of isoprene, isopentenyl 
pyrophosphate (IPP) (26) and dimethylallyl pyrophosphate (DMAPP) (27), are the building 
blocks of isoprenoids.31
26 27
Figure 1.8: Structures o f isopentenyl pyrophosphate (26) and 
dimethylallyl pyrophosphate (27).
There are two pathways used to produce the IPP and DMAPP in nature. They are the so-called
• 'l')mevalonic acid pathway and non-mevalonate pathway. The mevalonic acid pathway takes place 
in the cytosol and is responsible for the formation of sesquiterpenes and triterpenes. The 
non-mevalonate pathway takes place in plastids and is responsible for the formation of 
monoterpenes, diterpenes and tetraterpenes.
1.4.1 Mevalonic acid (MVA) pathway
The mevalonic acid pathway is usually used by mammals, higher plants, fungi and even some 
bacteria to produce IPP and DMAPP.33 This pathway starts with three units of acetyl-CoA (28). 
The first two units of acetyl-CoA react in a Claisen condensation catalysed by acetoacetyl-CoA 
synthase with the release of coenzyme A to afford the acetoacetyl-CoA (29). A third molecule of 
acetyl-CoA is added in an aldol-like reaction with the help of p-hydroxy-P-methylglutaryl-CoA 
(HMG-CoA) synthase to afford the product, HMG-CoA (30).33
+H
30
HMG-CoA
NADPH
^»N A D P +
2 x ADP 2 x ATP NADP+ NADPH
33 32 31
(3.R)-mevalonic acid
^  ATP 
ADP
34 26 27
IPP DMAPP
Scheme 1.2: Mevalonic acid pathway to IPP and DMAPP.
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HMG-CoA reductase is the enzyme which catalyses the reduction of the thioester group of 
HMG-CoA to the primary alcohol 32. The cofactors used in this reaction are two equivalents of 
NADPH. The first NADPH reduces the HMG-CoA to mevaldic acid (31), and the second 
performs a reduction to make (Ji?)-mevalonic acid (MVA) (32).34
The two hydroxy groups of (i^)-mevalonic acid are phosphorylated and pyrophosphorylated by 
three molecules of ATP to yield mevalonic acid triphosphate (34). The final product IPP (26) 
comes from the decarboxylation of mevalonic acid triphosphate. IPP (26) and DMAPP (27) are 
interconvertible by stereospecific isomerisation. It was shown by tritium-labelling experiment 
that only the pro-/? proton on C2 of 26 is involved in the isomerisation process.35
1.4.2 Non-mevalonate (non-MVA) pathway
The non-MVA pathway (Scheme 1.3) was discovered at the end of the last century by Rohmer 
and coworkers.36’ 37 It is found in the chloroplasts of algae, cyanobacteria, eubacteria and 
apicomplexa. This pathway is also named as the pyruvate/glyceraldehyde-3-phosphate pathway 
or sometime as MEP pathway, due to the fact that pyruvate (35) and 
D-glyceraldehyde-3-phosphate (36) are the starting compound of this pathway and that 
2-C-methyl-D-erythritol-4-phosphate (MEP) (39) is an important intermediate in the pathway.
15
° ” + H '  Y  "OP 
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35 36
pyruvate glyceraldehyde- 
3-phosphate NADPH
OH
o- o-
OH OH
40ATP
ADP
NADP
PPi CTP
OH OH
OH OH
OH
r \\
'O
N
CMP Q or
,^ V °iT X ^O '"' ^OH 
I H* OH
42
NADP NADPH
IPP DMAPP
Scheme 1.3: The non-mevalonate pathway to IPP and DMAPP.
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Thiamine pyrophosphate (TPP) mediated decarboxylation of pyruvate (35) affords an enamine 
that reacts with glyceraldehyde-3-phosphate (36) to generate l-deoxy-D-xylulose-5-phosphate 
(DXP) (37). After a pinacol-like rearrangement of DXP, it is reduced by NADPH in 
DXP-reductoisomerase, giving 2-C-methyl-D-erythritol-4-phosphate (MEP) (39) as the 
product. MEP reacts with cytidine triphosphate (CTP) and is then phosphorylated by one 
equivalent of ATP to yield 2-phospho-4-cytidinediphosphate-2-C-methylerythritol (41), which is 
converted to 2-C-methyl-D-erythritol-2,4-cyclodiphosphate (42).38 Following this, there are a 
reduction and a dehydration that are not yet precisely identified leading to the formation of IPP 
(26) and DMAPP (27).
1.5 Biosynthesis of linear polyisoprenoid precursors
Condensation of IPP and DMAPP in a head to tail fashion is catalysed by isoprenyl 
pyrophosphate synthase leading to the formation of geranyl pyrophosphate (2) - the universal 
precursor of monoterpenes. Poulter and co-workers proposed the reaction mechanism, which 
comprises the ionisation of DMAPP (27), condensation of the isopentenyl cation with IPP (26), 
and then proton elimination (Scheme 1.4).39
17
Scheme 1.4: Formation o f geranyl pyrophosphate (2) through 
condensation o f IPP and DMAPP
This reaction can be extended in the same manner with specific isoprenyl pyrophosphate 
synthases to produce further linear precursors of terpenes, as shown in Scheme 1.6. For example, 
the precursor of sesquiterpenes is famesyl pyrophosphate (FPP) (11), and the precursor of 
diterpenes is geranyl geranyl pyrophosphate (GGPP) (46). There are even longer terpene 
precursors, such as squalene made from two molecules of FPP, which is the precursor of 
triterpenes, and phytoene, which is the precursor of tetraterpenes. Note that all double bonds in 
these linear precursor have specifically ^-stereochemistry.40
OPP OPP
ipp
IOC
PP
15 C
-OPP
20 C
Monoterpenes
2 x
2 x
Sesquiterpenes
Squalene
Triterpenes
Diterpenes
Phytoene
V
Tetraterpenes
Scheme 1.6: Biosynthesis o f the linear precursor o f terpenes.
1.6 Introduction to terpene synthases
1.6.1 General introduction
Terpene cyclases are enzymes that chaperone the conversion of a universal polyisoprenoid 
precursor to one or more, complex cyclic terpene products. Terpene synthases are divalent metal 
cation dependent enzymes and have often two specific binding motifs for the metal ions. These 
metal ions are believed to coordinate to the pyrophosphate group and trigger what is proposed to 
be the first step in most cyclisation reactions - the loss of the pyrophosphate group.41 A series of 
cyclizations, eliminations, methyl and hydride shifts and other rearrangements then occur to
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produce the final products. The divalent metals are usually Mg2+ or Mn2+, with Mg2+ being used 
most often.42,43 The levels of enzyme activities with different metals are variable and enzyme 
dependent. For example, activity of (£)-(3-famesene synthase is much higher in the presence of 
Mn than Mg , however, humulene synthase is less effective in the presence of Mn , and 
even can be inhibitory when the concentration of Mn2+ is higher than 3 mM 45
Terpene synthases exhibit impressive accuracy in terms of stereo- and regio-specificity. A 
number of carbon-carbon bonds are formed during the catalytic reaction, and when this kind of 
reaction occurs around a prochiral centre, the terpene synthase displays very good ability to 
discriminate bond formation on one or another side of the prochiral centre.46 A good example in 
nature is that of lanosterol (22) (Figure 1.9), which has seven chiral centres. In theory, it has 128 
(2 ) possible steroisomers. However, in the biosynthesis of lanosterol only one steroisomer is 
produced.47
HO’
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Figure 1.9: Structure o f lanosterol (22).
Terpene synthases, especially the synthases from bacterial, fungal and plant sources, share little 
sequence similarity typically below 25-35%.48 For example, the aristolochene synthase (AS) from 
Pemcillium roqueforti and epi-aristolochene synthase (TEAS) from nicotiana tabacum only share
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16% sequence similarity (Figure 1.10).49 However, there is an interesting observation to be seen
from all the crystal structures of sesquiterpene synthase up to date - they share a common fold, an
a-barrel usually containing ten to twelve a-helices arranged in anti-parallel fashion. The active
site is always nested deep within the a-barrel, and the contour o f the active site varies between the
different cyclases. This forms a template that stabilises the unique conformation of the substrate
required to form the product.x Usually, the active site is surrounded by about 5 helices, which are
connected by loops.^' The loops are relatively short at the bottom of the active site and relatively
•  •  •long at the top, which makes the shape of the active site conical.
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Figure 1.10: Sequence alignment o f  AS from P. roqueforti and A. terreus and TEAS 
from N. tabacum. Identical residues are highlighted.
There are several other interesting facts regarding the active sites of terpene synthases. 
Usually,the active site cleft is lined with mainly hydrophobic residues that can help to sequester 
the substrate from the solvent.53,54 This formation also stabilizes the unique conformation of the 
substrate needed to make the required product. During the formation of terpenoids in the 
enzyme’s active site, it is proposed that the various intermediates, such as carbocations, are 
stabilized by specific amino acid residues in the vicinity of reacting parts of the substrate and 
intermediates.55 These direct the cyclisation of the substrate towards the specific product required 
and prevent alternative cyclisations that otherwise would be of very similar energy. For example, 
aromatic amino acid residues can be found quite often in the active site. These aromatic residues 
can be very useful in electrostatic stabilization of carbocation intermediate in the pathway (see 
section 1.6.4 for more details).56*59
Compared to the insignificant sequence homology across the different kingdoms of life, the plant 
synthases show great similarity among themselves. For example, the 5-selinene synthase and 
y-humulene synthase both from the gymnosperm abies grandis show 83% sequence similarity.60 
And even different groups of terpene synthases from plants have high degree of sequence 
homology: casbene synthase (diterpene cyclase) has 65% of sequence similarity with
5-epi-aristolochene synthase (sesquiterpene cyclase) and 53% of sequence similarity with 
limonene synthase (monoterpene cyclase).61
Substrate specificity varies among plant terpene synthases. Geranyl pyrophosphate (GPP) is the 
exclusive substrate accepted by monoterpene synthases, just as the geranylgeranyl pyrophosphate
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(GGPP) is the major substrate for diterpene synthase. However, this rule is not suitable for 
triterpene synthases and sesquiterpene synthases. For example, sesquiterpene (£)-p-famesene 
synthase can use the monoterpene linear precursor GPP to synthesis monoterpenes limonene (6), 
terpinolene (47) and myrcene (48) .62
47 48
Figure 1.11: Structure o f terpinolene (47) 
and myrcene (48).
Some terpene synthases produce only one major product, for instance, 5-cadinene synthase makes
6-cadinene (15) as its sole product.63 However, some other terpene synthases produce more than 
one product, aristolochene synthase from P. roqueforti produces three products for example. In 
addition to the major product aristolochene (16), there are two side products, valencene (49) and 
germacrene A (50).64 y-Humulene synthase from Grand Fir produces fifty-two different 
products.60
5049
Figure 1.12: Structure o f valencene (49) and 
germacrene A (50).
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According to the tertiary structure and the general reaction mechanism, terpene synthases can be 
divided into two groups - class I terpene synthases and class II terpene synthases. Class I terpene 
synthases are more common and are predominantly helical.65 Several residues conserved amongst 
terpene cyclases have been identified by sequence alignment, the most prominent of which are the 
amino acids of the metal binding motif, the specific DDXX(D/E) metal binding motif that is at the 
entrance of the active site, and another metal binding motif, (D/N)DXX(S/T)XXXE, on the 
opposite site.41, 66 The metal ions attached to the metal-binding motifs coordinate the 
pyrophosphate group and trigger the first step in the cyclisation cascade, which is the loss of the 
pyrophosphate group from the substrate. Class I terpene synthases have a conical active site that 
contains about five helices.51 However, class II terpene synthases initiate the whole reaction from 
protonation of a C-C double bond or the corresponding epoxide and contain a DXDD metal 
binding motif.67 The squalene-hopene synthase from alicyclobacillus belongs to this class. It 
consists of a major and a minor domain, comprising six a-helices each, in regular barrel 
conformation.51 Some terpene synthases have both the class I and class II characters. For example, 
the C-terminal catalytic domain of 5-epi-aristolochene synthase belongs to the class I terpenoid 
fold which consists of 281 residues, whilst the 240-residue N-terminal domain belongs to class II 
terpenoid fold but has unknown function.51,68 Another interesting example is an enzyme that is 
encoded by the SCO6073 gene in Streptomyces coelicolor A3(2), which can catalyses the 
cyclization of FPP to geosmin. Its C-terminal and N-terminal domains each have independently 
functioning active site. It has been demonstrated that the N-terminal protein catalyse the
^ I
Mg -dependent cyclization of FPP to germacradienol and germacrene D, and the C-terminal 
domain of SCO6073 converts germacradienol produced by N-terminal domain to geosmin.69
1.6.2 Crystal structures of terpene synthases
Recently, the 3D structures of the several terpene synthases have been solved, and half of these 
are sesquiterpene synthases. They are aristolochene synthase from Penicillium roqueforti9 and 
Aspergillus terreus,50 5-epi-aristolochene synthase from Nicotiana tabacum,68 bomyl diphosphate 
synthase from Salvia officinalis,70 famesyl pyrophosphate synthase from Staphylococcus
71aureus, recombinant human squalene synthase, pentalenene synthase from Streptomyces
m  7 7UC5319, trichodiene synthase from Fusarium sporotrichioides and limonene synthase from
7^
Mentha spicata (Figure 1.13).
The 2.5-A resolution crystal structure of aristolochene synthase (AS) from Penicillium roqueforti 
was the first of a fungal terpenoid cyclase. Until now, only the apo-enzyme has been crystallised. 
It shows that the enzyme has 11 a-helices in its structure, 6 of which form the hydrophobic active 
site cavity. The cone shape active site has been measured as 15 A wide and 20 A deep.49 
Aristolochene synthase from Aspergillus terreus has also been crystallized recently. The 2.2 A 
resolution X-ray crystal structure of aristolochene synthase reveals a tetrameric quaternary 
structure. There are a total of 13 a-helices, 6 of which form the 20 A active site cleft. At the same 
time, the 2.15 A resolution crystal structure of the complex with Mg2+3-PPi indicates that ligand 
binding only occurs in tetramer subunit D.50 More details of aristolochene synthase will be 
discussed in the next section (1.7).
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Figure 1.13: Ribbon diagram representations o f the 
crystal structures o f various terpene synthases.
The crystal structure of 5-epi-aristolochene synthase (EPS, from Nicotiana tabacum) alone as 
well as the crystal structure of 5-epi-aristolochene synthase complexed with two substrate 
analogues (famesyl hydroxyphosphonate and trifluoro-famesyl pyrophosphate) and two Mg2+ in 
the active site was analysed in 1997 by Starks et al. at 2.2 to 2.8 A resolution.68 It showed that
5-epi-aristolochene synthase consisted entirely of a-helices with connecting loops and turns, and 
was organized into two structural domains (Figure 1.14). The active site was identified in the 
hydrophobic pocket of the C-terminal domain by the location of two Mg2+ coordination sites at
/o
its opening and the location of bound substrate analogues.
Figure 1.14: Two domains o f 5-epi-aristolochene synthase (lEAS.pdb); 
the C-terminal domain is in green and N-terminal domain is in red.
The X-ray crystal structures of bomyl pyrophosphate synthase (BPPS), a metal-requiring 
monoterpene cyclase from Salvia officinalis was resolved to 2.0-A resolution.70 As with 
5-epi-aristolochene synthase, it contains two a-helical domains; the C-terminal domain catalyzes 
the cyclization of geranyl pyrophosphate, orienting and stabilizing multiple reactive carbocation 
intermediates; however the N-terminal a-barrel domain has no established catalytic function. The 
C-terminal domain of BPPS contains 12 a-helices, 6 of which largely define a hydrophobic active 
site cleft. The crystal structure of the enzyme-1 igand complexes with pyrophosphate (PPi) and 
three Mg2+ ions has also been solved.70
The crystal structures of trichodiene synthase in both unliganded and complexed form were
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♦ 77obtained by Rynkiewicz et al in 2001. The native trichodiene synthase structure is formed by 17 
a-helices, 6 of which define a conical and hydrophobic active site cleft. The complexed crystal 
structure is similar to BPPS, which contains three bound Mg2+ ions and one molecule of 
inorganic pyrophosphate. The three Mg2+ ions are located in two metal-binding regions in the 
active site.72
The X-ray structure of pentalenene synthase (PS) reveals a tertiary structure defined by 
aggregation of 11 a-helices, 5 of which surround an active site cavity approximately 15 A deep 
and 9 A wide. A similar, but not identical fold to that of pentalenene synthase is also discovered 
in famesyl pyrophosphate synthase (FPPS), which catalyses the synthesis of famesyl 
pyrophosphate from IPP and DMAPP despite only 15% sequence identity between the two 
enzymes. It is found that the bottom of this cavity is hydrophobic and contains quite a few 
aromatic and aliphatic residues that confer a shape to the cavity that serves as a template for the 
binding of FPP in the correct conformation for cyclization to the product.52
Another enzyme that does not belong to sesquiterpene synthases is human squalene synthase 
(SQS). Squalene synthase catalyses the reductive dimerization of two molecules of FPP in a 
two-step reaction to form squalene, which is a key cholesterol precursor. The structure of SQS is 
entirely a-helical, with the helices arranged in three layers. Squalene synthase has a very similar 
core structure to famesyl pyrophosphate synthase, pentalenene synthase and 5-epi-aristolochene 
synthase. The conserved feature in all the structures is an a-helical core surrounding a central 
active site cavity, of which one end is predominantly hydrophobic, and the other end is more
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hydrophilic and contains polar and charged residues.23
1.7 Aristolochene synthase (AS) and aristolochene.
1.7.1 Aristolochene synthase
Aristolochene synthase (AS) is a Mg2+ dependent sesquiterpene cyclase enzyme that catalyses the 
formation of aristolochene from FPP. Aristolochene may be further transformed to produce a 
family of toxins that includes PR toxin.74
Aristolochene synthase was first isolated and purified from the fungus, Penicillium roqueforti in 
198975 and the X-ray crystal structure of the apo-enzyme was solved in 2000.49 Aristolochene 
synthase from P. roqueforti is a monomeric sesquiterpene cyclase consisting of 342 amino acid 
residues and has a molecular weight of 38000.49 Like other sesquiterpene synthases, both Mg2+
7*+* 7+and Mn can be the cofactors of this reaction. However, Mn also can act as inhibitor when it is 
in high concentration.75 According to its tertiary structure and the catalytic reaction mechanism, P. 
roqueforti AS is a class I terpene synthase.49 Even though no Mg2+ ions were identified in the 
crystal structure, one Sm ion was cocrystallised and located near D115, which indicates that one 
metal binding motif is located between D115 and El 19. The enzyme’s structure consists of 11 
a-helices, 6 of which form the hydrophobic active site cavity. All a-helices are connected by 
loops. The loops close to the entrance of the active site are on average 12 residues long. However, 
the loops which connect the other side of these helices are only 5 residues long, which makes the 
active site adopt a conical shape (Figure 1.15)49 In order to infer the residues within the active 
site that may be involved in the catalytic mechanism, Caruthers et al. docked the substrate and
intermediates into the active site pocket manually and optimised the geometries of the complexes 
with energy minimization.49 Because of the lack of metal ions in this manually docking, the 
pyrophosphate group was put in a particular position by fixing the substrate orientation manually. 
So that the pyrophosphate leaving group could interact with metal ions bound to the 
aspartate-rich sequence (as indicated by Sm3^  binding in the SmCh derivative). According to the 
modelling result, it was identified that some of amino acid residues (Phe-178, Phe-112 and 
Trp-333) in the active site were involved in stabilising various cationic intermediates, and thus 
involved in the catalytic mechanism.3609
Figure 1.15: Ribbon diagram representation o f the crystal structure oj 
aristolochene synthase from R roqueforti (lDGP.pdb). The six a-helices with 
different colours (from gray) form the hydrophobic active site cavity.
Aristolochene synthase from Aspergillus terreus also catalyses the cyclization of famesyl
diphosphate to form (+)-aristolochene as a single sesquiterpene product.76 Its molecular weight is
36000, which is less than aristolochene synthase from Penicillium roqueforti (Mw = 38000).
Apart from that, the amino acid sequence of the aristolochene synthase from A. terreus is 61%
identical with the enzyme from P. roqueforti.49 The recent work of Christianson et al.
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demonstrated a tetrameric quaternary structure from the crystallized aristolochene synthase from 
A. terreus,50 in which each subunit adopts the a-helical class I terpene synthase fold with the 
active site in a solvent-exposed conformation. However, from the 2.15 A resolution crystal
^ I
structure of its complex with inorganic pyrophosphate and three Mg ions indicates the 
Mg2+3-PPi cluster binds only to subunit D of the tetramer, which is stabilized in the “closed” 
conformation required for catalysis. There are two metal binding motifs in the enzyme - the 
DDLLE motif beginning with D90 and the NSE/DTE motif beginning with N219.50 Because of 
the similar active site contours of aristolochene synthases from A. terreus and P. roqueforti, these 
two enzymes have directly relevancy in structural analysis and mechanistic implications.49,50,56
1.7.2 Aristolochene
Aristolochene is a bicyclic eremophilane-type sesquiterpene.77 Interestingly, it has been isolated 
from several sources in different enantiomeric forms. The (-)-enantiomer has been found in the 
hexane extract of the root of Aristolochia indica, in the leaf oil of Bixa orellana, in the liverwort
11 70 onof Dumortiera hirsute and in defensive secretions of termites. ’ ' Fungal sources such as 
Penicillium roqueforti and Aspergillus terreus, and the liverwort Porella arhorisvitae give
a 1 T C  0 1 O ')(+)-aristolochene. ’ ’ ’ The diastereomeric sesquiterpene 5-epi-aristolochene (51) has been 
identified in tobacco (Nicotiana tabacum) and results from the cyclization of famesyl 
pyrophosphate by 5-epi-aristolochene synthase by a similar mechanism to aristolochene 
synthase 49
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Figure 1.16: Structures o f (+)-aristolochene (16) and its 
diastereomeric isomer 5- epi-aristolochene (51).
(+)-Aristolochene formation is thought to be the first committed step in the biosynthesis of a 
large group of sesquiterpenoid fungal toxins, the most poisonous of which is the bis-epoxide 
PR-toxin 52 (Figure 1.17).74
16 (+)-aristolochene
O O H  HO*'"tr\AcO1
54 gigantenone53 phaseolimone52 PR-toxin
OH HO1
OH
57 bipolaroxin56 phomenone
HO'""'
55 sporogen-AOl
Figure 1.17: Structures o f fungal toxins thought to be derived from 
aristolochene (blue colour indicates the mother molecule - aristolochene).
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1.73 Description of the proposed catalytic mechanism of AS
The general cyclisation mechanism of sesquiterpene cyclases involves the ionization of FPP, 
followed by nucleophilic attack of one of the double bonds present in the FPP structure to yield a 
cyclic intermediate. The starting geometry of the substrate and its orientation within the active 
site is a critical determinant of the ultimate cyclisation product. The terpene cyclase active site 
plays a critical role as a template in binding the flexible polyisoprenoid substrate in the proper 
conformation for catalysis.50 A cascade of reactions including hydride shifts, and 
Wagner-Meerwein rearrangements that relocate a positive charge over different atoms of the 
reaction intermediates will then take place. Final deprotonation or capture of an exogenous 
nucleophile such as water leads to product formation.83
The most common mechanism for the initial ionization of the substrate in sesquiterpene cyclases 
is through the coordination of the diphosphate group to metal cations bound to the active site 
through specific residues, leaving behind a polyisoprenyl cation. In addition, the diphosphate 
moiety, that most likely remains bound throughout the cyclisation reaction, may play an 
important role in the stabilization of the positively charged intermediates.52 However, it has been 
reported that other terpene cyclases achieve ionisation by the enzymatic protonation of a double 
bond of the substrate with an acidic residue or by epoxide opening.51
Wagner-Meerwein-like rearrangements are often thought to proceed through carbocations that
• 0*1would be considered less favourable. 5 The amino acid residues in the vicinity of reacting parts 
of the substrate and intermediates stabilise intermediate species such as carbocations.55 Many
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aromatic residues can be found in the active site. The electrostatic component arises from 
interactions of the quadrupole moments of the aromatic rings, which are produced by the uneven 
distribution of charge. Greater electron density concentrates on the face of the ring, resulting in 
reduced electron density on the edge of the ring, giving rise to the quadrupole moment. Several 
geometries of interaction between aromatic rings have been proposed.85,86 Cation-71 interactions 
involve the quadrupole moment of the aromatic ring, suggesting that aromatic residues within the 
active site of proteins may bind cationic substrates.87 These aromatic residues are an ideal source 
for electrostatic stabilisation of carbocations in the reaction pathway.47,56'58,87
Based on mechanistic studies with labeled substrates and through the analysis of the reaction 
products obtained with mutant aristolochene synthase, a reaction mechanism was proposed, in 
which the initial cleavage of the alkyl diphosphate bond leads to famesyl cation (58) prior to 
cyclization (Scheme 1.6).64,76,77,88 This cation is stabilised by residues FI78 and FI 12.57,58 The 
PPi leaving group is believed to be coordinated to metal ions bound to the highly conserved Mg 
binding motifs, which are at the opposite side at the entrance of active site cavity. Attack by the 
C10-C11 double bond to produce germacryl cation (59) followed by proton loss from C12 has
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been proposed to lead to germacrene A (50). Residue Y92 was initially suggested to act as an 
acid in the formation of the eudesmane cation (60).59 However, after Felicetti & Cane removed 
the hydroxyl group, creating a Y92F mutant, this still produced aristolochene, but in lower
7 f\quantity. Alternatively, protonation of germacrene A has been proposed to be carried out by a 
water molecule trapped in the active site.76 After the protonation of the C6-C7 double bond and a 
further cyclisation by intramolecular attack of the resulting carbocation by the C2-C3 7t-bond, the
uncharged germacrene A is converted to the bicyclic eudesmane cation (60).90, 49,59, 64 The 
positive charge on the eudesmane cation is thought to be stabilised by the 7i-system of W334.56 
Successive 1,2 hydride shift and methyl migration followed by the deprotonation of Hsi on C8 
results in the generation of the product (+)-aristolochene 16.89
5
OPPy
Scheme 1.6: Proposed mechanism for AS catalysed cyclization o f FPP.
Site directed mutagenesis of key amino acid residues has generated a lot of useful evidence 
supporting the above mentioned stepwise reaction mechanism and identifying important amino 
acid residues. Residue FI78 of AS from P. roqueforti was identified as a residue that is involved 
in the stabilisation of transition states preceding germacrene A and following eudesmane cation, 
because a mutant of AS, in which residue phenylalanine 178 (FI78) was replaced by valine, 
produced significant amounts of a-famesene (63) and P-famesene (64) as well as a-selinene (65), 
p-selinene (66) and selina-4,ll-diene (67).57 The residue FI78 is also postulated to be involved in
preventing erroneous deprotonation in the last step of synthesis of aristolochene, as the F178C 
mutant of AS produced increased proportions of valencene (68).
When residue 112 was replaced by alanine, the presence of famesenes 63 and 64 suggested that 
famesyl cation accumulated during catalysis by F112A mutant of AS, leading to deprotonation 
from C4 and C l5. Residue 112, therefore, most likely contributes significantly to the stabilisation 
of the transition state following famesyl cation formation. Changing FI 12 to alanine, terminated 
the reaction at germacrene A (50), indicating that production of eudesmane cation can not be 
induced in the absence of the side chain of F112.58
65 66 67 68
Figure 1.18: Structures o f (E,E)-a-farnesene (63), (E)-f-farnesene (64), 
a-selinene (65), f-selinene (66), selina-4,ll-diene (67), valencene (68).
The positive charge of the eudesmane cation (60) also seems to be stabilised by the 71-system of 
W334, because only small amounts of aristolochene (16) were produced and the main reaction 
product was germacrene A (50) when this aromatic residue was replaced with an aliphatic amino 
acid.56
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Even though there is not enough evidence to prove that residue Y92 acts as the proton donor in 
the protonation of germacrene A, its size and position (in the bottom of active site) have been 
shown to enforce a quasi-cyclic conformation on the substrate, thus helping to form of the 
10-membered ring. When this amino acid was replaced by alanine, cysteine, valine and 
phenylalanine, it was shown that a decrease in the size of residue 92 produces an increase in the 
production of linear compounds.59,91 Perturbation of the active site by site directed mutagenesis 
of these residues has led to mutant AS enzymes that are considerably more promiscuous than the 
wild type enzyme. As mentioned above, the finding that the Y92F mutant of AS from P. 
roqueforti produced significant amounts of (+)-aristolochene, disfavours the possibility that the 
hydroxyl group of Y92 was involved in proton donation to the double bond of germacrene A as 
the active site acid. Felicetti et al. therefore proposed that a water molecule in the active site 
might act as the acid although there was no evidence from the crystal structure.76
AV334
Figure 1.19: Ribbon diagram representation o f the crystal 
structure o f aristolochene synthase from P. roqueforti 
(lDGPpdb). Aromatic residues in the active site are shown.
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However, Shishova et al. modelled the product - aristolochene into the active site of A. terreus 
AS, and found the aristolochene was precisely and tightly packed into the active site cavity in the 
“closed” conformation, so it is unlikely that a water molecule could trapped in the enclosed active 
site to perform a general acid/base function. The authors therefore propose that the pyrophosphate 
moiety is the most likely candidate for the general acid/base in the active site.50
FPP analogues have also been employed to study the catalytic mechanism of AS. In order to 
determine which methyl group of FPP undergoes deprotonation in the generation of germacrene 
A and which hydrogen atom is lost in the formation of the C7-C8 double bond of aristolochene, 
Cane and co-workers made four 2H labelled FPP analogues at position Cl2, C l3 and C8 and 
incubated them with aristolochene synthase. After analysis of the products by H NMR, it was 
concluded that the C12 methyl and H-8Si were deprotonated during the synthesis of 
aristolochene.89
The observation of (-)-germacrene A as a minor by-product of the reaction indicates that 
(-)-germacrene A is either an intermediate or side product during the cyclisation.64 Cane et al. 
found good evidence for the intermediacy of germacrene A. They tested the 6,7-dihydro-analogue 
of FPP (69) as a substrate of AS, and the structure of the abortive cyclisation product, 
dihydrogermacrene A, was confirmed by a direct GC/MS comparison with a synthetic sample of 
this compound.90 According to the proposed catalytic mechanism of AS (Scheme 1.6), after the 
generation of germacrene A, this uncharged intermediate is then postulated to undergo 
protonation of the C6-C7 double bond and undergo a further cyclisation by intramolecular attack
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of the resulting carbocation by the C2-C3 rc-bond to form the bicyclic eudesmane cation (60). 
However this cyclisation would be prevented because of the lack of C6-C7 double bond in this
on6,7-dihydro-analogue of FPP, and dihydro-germacrene A (72) was then generated (Scheme 1.7).
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Scheme 1.7: Proposed sequence o f reactions leading to 6,7-dihydrogermacrene A 
(72) from 6,7-dihydro FPP (69) catalysed by P roqueforti AS.
The vinyl analogue of FPP, 1,2-methylidenefamesyl pyrophosphate, (VFPP) (73), was shown to 
act as a mechanism-based inhibitor to AS (Scheme 1.8). The initial ionisation and cyclization of 
the VFPP by aristolochene synthase possibly gives rise to the allylic cation species 74. This 
cation could react with the active site base of a nearby nucleophilic amino acid side chain to form 
a covalent bond, which results in permanent inactivation of the enzyme.92
B-Enz
7574
OPP
73
Scheme 1.8: Proposed inactivation process o f AS 
byl,2-methylidenefarnesylpyrophosphate (73).
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1.8 Approaches for studying the catalytic mechanism of sesquiterpene 
synthases
Sesquiterpenes are all formed from FPP alone yet they are a family of compounds comprising 
thousands of known members possessing more than 300 known carbon skeletal arrangements.13 
Understanding of how this one compound may be transformed by a family of structurally related 
enzymes into myriad derivatives would be a great step forward in modem enzymology. There are 
two main approaches to the study of this problem. One is site directed mutagenesis of key amino 
acid residues. Another approach is turnover of modified FPP analogues.
1.8.1 Site directed mutagensis
Site directed mutagenesis of a protein allows a residue to be replaced and the effects on function 
to be probed. A mutant sesquiterpene synthase may give a different distribution of products to the 
wild type enzyme. Structure activity relationships in sesquiterpene cyclases have been widely 
studied through site directed mutagenesis to identify residues in the active site which are involved 
in the catalytic mechanism.46,93
Trichodiene synthase (TS) from Fusarium sporotrichioides catalyzes the cyclization of famesyl 
diphosphate (11) to trichodiene (76) in the presence of Mg (Scheme 1.9). It has a conserved 
aspartate rich domain, from residue 100 to 104 (DDSKD). In order to demonstrate the use the of 
aspartate residues in mediating substrate binding by chelation of the divalent metal ion, the three 
aspartate residues in the aspartate rich region were individually replaced by glutamate.94'96 The 
D100E and D101E mutants of TS showed an increase in Km and a reduction in compared to
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the wild type. At the same time, all three mutants produced anomalous sesquiterpene products in 
addition to trichodiene when incubated with famesyl diphosphate. With regard to the 
arginine-rich region of TS, 302-306 (DRRYR), site-directed mutagenesis study also gave
Q*7important information. The R304K mutant showed an obvious increase in Km, as well as a 
200-fold reduction in kcat, mutant Y305T exhibited a 80-fold increase in Km and and 120 fold 
reduction in Acat- Both of these two mutants converted FPP to a mixture of trichodiene and other 
sesquiterpene hydrocarbons.97 The above evidence established the importance of the 
aspartate-rich domain and arginine-rich domain in catalysis of the trichodiene synthase reaction.
Cane et al. also showed that two cysteine residues (Cl46 and C l90) were important at the active 
site of TS by generation of C146A and C190A mutants. The CD spectra of each of the mutant 
proteins showed negligible differences compaired with that of native enzyme. However, the 
C190A mutant displayed significantly reduced activity, with a reduction in kcJKm of 3000 
compared to the wild-type TS, while the C146A mutant was essentially inactive. 98
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Scheme 1.9: Proposed mechanism for TS catalysed cyclization o f FPP.
Another sesquiterpene synthase is pentalenene synthase (PS) from Streptomyces UC5319. This 
enzyme catalyzes the cyclization of famesyl diphosphate (11) to the sesquiterpene hydrocarbon 
pentalenene (83).53 In order to find out the functional active site base in the active site of 
pentalenene synthase that mediates the postulated series of deprotonations and reprotonations, 
incruding the final deprotonation that generates pentalenene (Scheme 1.10), the only basic 
residues in the active site cavity - histidine-309 and the possible Lewis base tryptophan (W308)
were both tested by site directed mutagenesis 53
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Scheme 1.10: Proposed mechanism for PS catalysed cyclization o f FPP
Mutants H309F, W308F and double mutant W308F/H309F all retained substantial pentalenene 
synthase activity. In addition, incubation of FPP with the W308F or W308F/H309F mutants of 
pentalenene synthase yielded pentalenene, accompanied by varying proportions of 
(+)-germacrene A. By contrast, single H309 mutants gave rise to both (+)-germacrene A (87) and 
protoilludene (88) in addition to pentalenene. Both anomalous cyclization products result from 
derailment of the normal cyclization cascade, presumably due to relaxed control over the 
conformation of the substrate FPP and derived intermediates in the active sites of H309 mutant. 
From this result, three possibilities also can be considered: the possible active site base could be 
enzyme-bound water(s), a carbonyl oxygen atom of the peptide backbone or the bound 
pyrophosphate ion.
8887
Figure 1.20: Structures o f (+)-germacrene A (87) and protoilludene (88).
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To explore the role of the aspartate-rich domain (80DDLFD) of pentalenene synthase, each of the 
three aspartate residues was separately replaced by glutamate.53 Both the D80E and D81E 
mutants of PS suffered a significant decrease in Acat and a significant increase in Km compared to 
wild type. By contrast, the D84E mutant displayed relative minor changes in the steady-state 
kinetic parameters (2.5-fold increase in measured kc* offset by a 7-fold increase in Km). 
Asparagine 219 of pentalenene synthase is part of the DXX(S/T)XXXE motif in the active site, 
and it is thought to be chelated to a Mg2+ ion. Consistent with the expected role of N219 in 
binding Mg2+, the corresponding N219L mutant of pentalenene synthase is completely inactive 
despite the observation from its crystal structure that nominally isosteric amino acid substitution 
does not result in any significant conformational changes for neighboring residues in the enzyme 
active site.
Both theoretical and experimental studies have proved support for the importance of aromatic 
amino acid residues in stabilizing carbocations at enzyme active sites.87 Among the many 
aromatic residues that can be seen within the active site of pentalenene synthase, F76 and F77 
appear to be well placed and can interact with positive charge at C-l, C2 and C-3 of the famesyl 
residue and derived intermediates. Replacement of either F76 or F77 by alanine led to a more 
than 10-fold reduction in catalytic activity. Mutant F77Y, in which the phenylalanine is replaced 
by a more electron-rich tyrosine residue, also produced pentalenene, with essentially no change in 
Km compared to the value for the wild type but with k^t reduced by a factor of 20, suggesting that 
the precise geometry of interaction of the aromatic residues with the intermediate carbocations is
c'icritical to enhancement of the rate of the reaction.
Based upon the three-dimensional structure of tobacco 5-epi-aristolochene synthase (TEAS), a
1 ^  ACdetailed mechanism has been proposed for TEAS catalysis (Scheme 1.12). ’ (+)-Germacrene A 
(87) is proposed as an intermediate during the cyclization. In order to demonstrate the formation 
of this postulated intermediate, site directed mutagenesis was undertaken to alter residue Y520 to 
Phe." This residue is proposed to be responsible for the activation of germacrene A (87) to a 
eudesmane cation (89) with proton donation.68 The identity of the hexane-extractable material 
produced from FPP by TEAS-Y520F was elucidated through GC-MS analysis. The results 
indicate the introduction of the Y520F mutation into the TEAS active site results in formation of 
germacrene A as the final product. This observation supports the intermediacy of germacrene A in 
TEAS catalysis and strongly supports the proposal that the hydroxyl group of Y520 is indeed the 
proton donor initiating transformation of germacrene A to the eudesmane cation.
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Scheme 1.11: Proposed mechanism for TEAS catalysed cyclization o f FPP.
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The role that terpene synthases play as templates for their substrates and intermediates can be 
probed by the site-directed mutagenesis within the active site not only by insertions and/or 
deletions, but also by swapping entire domains between proteins to create chimeric cyclases that 
will generate a mixture of products.47,55,100 To identify not just the role played by a single residue, 
but complete functional domains of sesquiterpene cyclases, a domain-swapping strategy has been 
carried out. For example, swapping exons between both enzymes identified functional domains of 
epi-aristolochene synthase from Nicotiana tabacum and vetispiradiene synthase from 
Hyoscyamus muticus. The resulting chimeric protein produced both epi-aristolochene and 
vetispiradiene.101,102 Above example indicated that domain swapping between structurally related 
terpene synthases is a useful tool to express functional terpene synthases without interrupting 
enzyme integrity. Combining two functional domains from different proteins resulted in a novel 
enzyme able to synthesise reaction products of both parent enzymes.
1.8.2 Substrate analogues
Another powerful technique for studying the catalytic mechanism of sesquiterpene synthases is 
the use of substrate analogues. The preparation of a series of FPP analogues and the analysis of 
how they bind to and are transformed by the chosen enzymes may lead to a deeper understanding 
of the processes at work. In other words, modification of FPP at appropriate positions with 
functional groups capable of stabilising or destabilising cations in their vicinity will perturb the 
mechanism in a predictable and testable fashion. Several studies on aristolochene synthase with 
different FPP analogues have shown insight into its mechanism (See section 1.7.3). The method
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of anomalous substrates is also widely used in other sesquiterpene synthase studies.
With regard to the mechanism of TS catalysed cyclization of FPP to trichodiene, Cane et al. 
proposed that the substrate FPP underwent initial syn isomerization to the tertiary allylic isomer, 
nerolidyl diphosphate (NPP) (78) (See Scheme 1.10).13,103 In order to support above postulation, 
two enantiomeric analogues of FPP, (7S)-6,7-dihydrofamesyl diphosphate (93) and 
(7i?)-6,7-dihydrofamesyl diphosphate (94), were tested as anomalous substrates of trichodiene 
synthase.103,104
OPPOPP
Figure 1.21: Structures o f (7S)-6,7-dihydrofarnesyl diphosphate (93) and 
(7R)-6,7-dihydrofarnesyl diphosphate (94).
In principle, the enzyme should be able to isomerize each of these substrate analogues to the 
corresponding tertiary allylic diphosphate, 6,7-dihydronerolidyl diphosphate (95), but further 
cyclization would be blocked due to the absence of 6,7-double bond. Unfortunately, in neither 
case was any of the tertiary allylic pryophosphate 95 directly observed. However, the observed 
formation of 6,7-dihydronerolidol (97) can be accounted for by backside attack of water on an 
allylic cation-pyrophosphate anion pair generated by syn allylic rearrangement of dihydrofamesyl 
diphosphate and ionization of the resulting 6,7-dihydronerolidyl diphosphate (95). So this 
analogue study provided further support for the proposed isomerization of FPP to (3R)-nerolidyl
diphosphate (78) in the enzymatic formation o f  trichodiene.104
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Scheme 1.12: Proposed sequence o f reactions leading to 6,7-dihydronerolidol (97) 
from 6,7-dihydrofarnesyl diphosphate (93) catalysed by recombinant TS.
FPP analogues also can act as inhibitors of sesquiterpene cyclase enzymes. This also can help to 
probe the factors affecting substrate recognition and indicate the catalytic mechanism of enzymes. 
For example, Cane et al. designed the 10-cyclopropylidene famesyl diphosphate (98) as a 
mechanism-based inhibitor of TS.105 As an analogue of FPP, diphosphate 98 was expected to bind 
well to the active site and undergo the usual ionisation, isomerization and cyclization to yield the 
cation 102 (Scheme 1.13). Further cyclization of 102 would yield the cyclopropylcarbinyl 
intermediate 103. This type of cation is known to undergo extensive rearrangement through a 
cyclobutyl cation intermediate. Alternatively, cation 103 could undergo the normal hydride shift 
and methyl migration to give species 105 that would be subject to a similar rearrangement. These 
rearrangements would put the positive charge to regions of the active site which do not normally 
encounter carbocations, and the derailment intermediates are intercepted by nearby nucleophilic 
amino acid residues, leading to alkylation of the enzyme.
103 102 -OPP
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Scheme 1.13: Proposed inactivation process o f TS by 
10-cyclopropylidenefarnesyl diphosphate (98).
The inductive electron-withdrawing effect of the fluoro-substituent on 6-fluorogeranylgeranyl 
diphosphate (GGPP) (107) was also demonstrated in the study of taxadiene synthase, which 
converts GGPP (46) to taxadiene (108). A mechanism involving a transannular proton transfer 
that converts a verticillen-12-yl carbocation (109) to verticillen-8-yl carbocation (110) (Scheme
1.14).106
109
H
108 110
Scheme 1.14: Proposed mechanism for taxadiene 
synthase catalysed cyclization o f GGPP.
The fluoro-substituent was expected to prevent this specific proton transfer and thereby derail the 
reaction at the bicyclic stage. Three fluorinated verticillene products (111, 112 and 113) were 
found and analysed by GC-MS and NMR (Scheme 1.15). The products provided support for the 
contention that the reaction proceeds via an H-l 1 to H-7 proton transfer.107
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Scheme 1.15: Products from incubation o f 6-fluoroGGPP 
and recombinant taxadiene synthase.
Isotopically labeled FPP analogues have been useful in determining the regio and stereochemical 
selectivity during the FPP cyclization to sesquiterpenes. For example, in order to explore the 
stereochemistry of the deprotonation step in cyclization of FPP (11) to pentalenene (82) by 
pentalenene synthase from Streptomyces UC5319. Both (9i?)-[9-3H,4,8-14C]FPP (114) and 
(95)-[9-3H,4,8-14C]FPP (115) were incubated with PS separately. It was thereby established that 
H-9re (Ha) of FPP become H-8 of pentalenene while H-9s/ (Hb) of the substrate undergoes 
intramolecular transfer to C-l of pentalenene (See Scheme 1.10).108
114 115
Figure 1.22: Structures o f (9R)-[9-3H,4,8-14C]FPP (114) and 
(9S)-[9-3H,4,8-14CJFPP (115).
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1.9 Synthetic preparation of FPP analogues
From the above discussion, it is clear that FPP analogues have been widely used for the 
mechanistic study of these enzymes. In the following sections, synthetic methods for the 
preparation of FPP analogues will be discussed.
1.9.1 Preparation of pyrophosphate salts
The first reaction used routinely to prepare allylic pyrophosphates was published by Cramer and 
Bohm in 1959.109 This procedure involves treatment of an alcohol with inorganic phosphate and 
trichloroacetonitrile. Whereupon, the desired product is then isolated from a complex mixture of 
organic and inorganic mono-, di-, and triphosphates by ion-exchange chromatography. This 
method is difficult to manage on a big scale and the yield is poor. So far, the most successful 
method for diphosphate preparation is that described by Poulter et al. (Scheme 1.16).110
116
Cl
117
ii
11
Scheme 1.16: Synthesis o f FPP (11) from farnesol (116).
Reagents and conditions: i) NCS, DMS, -30 °C to RT, 2 h; ii) 
(Bu4N)3HP20 7, MeCN, RT, 2 h, 72%.
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Generation of the pyrophosphate ester from the allylic alcohol, is a two steps process. The allylic 
alcohol 116 can be first transformed into an allylic chloride 117 by treatment with dimethyl 
sulfide (DMS) and N-chlorosuccinimide (NCS) at low temperature in anhydrous 
dichloromethane,110 or into an allylic bromide by treatment with methane sulfonyl chloride and 
lithium bromide in anhydrous tetrahydrofuran,111 or into a tosylate by treatment with 
p-toluenesulfonyl chloride and 4-(AyV-dimethylamino)pyridine in anhydrous dichloromethane.110 
Treatment with the tris-tetrabutylammonium salt of pyrophosphoric acid in anhydrous acetonitrile 
followed by ion exchange chromatography gives the tris-ammonium salt 11 of the target 
substance. Purification by reverse phase HPLC then yields the required pure product.112
1.9.2 Sulfonylation-alkylation-desulfonylation methodology
The sulfonylation-alkylation-desulfonylation methodology was first developed by Biellmann and 
Ducep in 1969.113 This sequence of reactions is then widely used in the preparation of isoprenoid 
diphosphate analogues. For example, [12,12,12-2H3]FPP and [13,13,13-2Hs]FPP have both been 
synthesized using this methodology (Scheme 1.17).89
53
OBn
119
OBn
120
IV
Ph02S
OBn
121
122
S02Ph j24
V I , V II
118
^ 'V V
Scheme 1.17: Synthesis o f diphosphate 111.
Reagents and conditions: i) PBr3, DCM ii) PhS02Na, DMF, 3 h, 76%; iii) PBr3, THF, 
15 h, 81%; iv) n-BuLi, HMPA, THF, -78 °C, 6 h, 56%; v) Li, EtNH2, THF; vi) CC14, 
PPh3, vii) (Bu4N)3HP20 7, CH3CN, 2 h.
It can be concluded that the forward synthetic steps of this methodology include synthesis of two 
major units. One unit is the bromide 123, which is made by bromination of the corresponding 
alcohol 122 as described above.114 The other unit is the sulfone 121, which can be made by 
successive halogenation of the alcohol 119 and then treatment of the resulting halide with 
benzenesulfmic acid, sodium salt.115 These two species are coupled together in the presence of an 
appropriate base, which is followed by a reductive desulfonylation process. The desulfonylation
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process is the most critical step as it can potentially lead to double bond migration in the product, 
and there are many reagents available that can achieve the desired result. For example, lithium in 
EtNH2,116 lithium with ter/-butyl alcohol,116 LiBHEt3 in the presence of palladium catalyst.117
1.9.3 Weiler and Sum chain extension methodology
The Weiler and Sum chain extension methodology was first introduced in 1981118 and its utility 
has been much extended by Gibbs et al.u9 This elegant and robust chain extension methodology 
was extensively employed in the synthesis of isoprenoids. For example, this methodology was 
successfully used by Cane etal. for the synthesis of 6,7-dihydrofamesol (126) (Scheme 1.18).103
O Li ONa
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Scheme 1.18: Synthesis o f 6,7-dihydrofarnesol (126).
Reagents and conditions: i) NaH, n-BuLi, THF, 0 °C, 30 min; ii) MsCl, TEA, 
Nal, DCM, 0 °C, 22 h, 79%; iii) 128, THF, 0 °C, 55% for two steps; iv) Diethyl 
chlorophosphate, NaH, Et20 , 0 °C, 12 h, 76%; v) Cul, MeLi, Et20, -78 °C, 3.5 h, 
84%; vi) LiAlH4, EtOH, Et20 , 0 °C, 27 h, 63%.
The main synthetic steps of Weiler and Sum chain extension comprise the bromination of the 
starting alcohol 129, alkylation of lithio-sodio acetoacetate dianion 128 (derived from methyl 
acetoacetate 127) with the resulting bromide to give the P-keto ester 131. This was then treated 
with diethyl chlorophosphate and sodium hydride to give the Z-enol phosphate 132, which was 
followed by coupling with lithium dimethylcuprate to give ester 133. Derivatisation of this 
compound to the famesol analogues 126 was achieved by the reduction with LiAlFL*.
This method was modified by Poulter and Gibbs to allow the introduction of a wide range of 
modifications to FPP.119 Their vinyl triflate-mediated route has proven to be suitable for the 
synthesis of a wide variety of FPP and GGPP analogues. It differs from the classic Weiler chain 
extension, by use of an enol triflate as a more reactive leaving group before the coupling instead 
of using phosphate. This improvement allowed the introduction of a different functional group 
into the 3 position of the famesyl structure rather than the methyl group. For example, 
13-methylidenefamesyl diphosphate (134) was made through this improved methodology 
(Scheme 1.19)."9-120
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Scheme 1.19: Synthesis o f diphosphate 134.
Reagents and conditions: i) (Me3Si)2NK, THF, -78 °C; (CF3S02)2NPh,
THF, -78 °C to RT, over night, 52%; ii) CH2=CHSnBu3, Pd(AsPh3)2, Cul,
N-methylpyrrolidone, 15 h, 69%; DCM, 0 °C, 22 h, 79%; iii) DIBAL-H,
PhMe, -78 °C, 1 h, 43%; iv) NCS, Me2S, DCM, -40 °C to 0 °C, 2.5 h, 76%; 
v) (Bu4N)3HP20 7, CH3CN, 2.5 h, 20%.
By using potassium bis(trimethylsilyl)amide as the base to react with the P-keto ester 135 to 
generate the potassium enolate, followed by quenching the reaction with (CF3S02)2NPh or 
2-(5-chloropyridyl)N(S02CF3)2,121 the substitution is stereoselective and primarily the desired Z 
isomer of the vinyl triflate 136 was obtained. The coupling of the resulting triflate 136 with 
organostannane reagent with Pd(0)/Cul catalyst in jV-methylpyrrolidone ensures the coupling 
proceeds with high ratio of the desired Z isomer 137.119 This stereoselective coupling also can be 
performed with Grignard reagent in the presence of CuCN in diethyl ether.121,122
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1.9.4 Wittig reaction and Horner-Emmons reaction
Witting and Homer-Emmons condensations are also useful for the construction of the isoprenoid 
chain and allow the addition of key functional groups. For instance, Poulter successfully made the 
13-desmethylfamesyl diphosphate 139 through a synthetic route based on a Homer-Emmons 
Wittig condensation (Scheme 1.20).123 The ester 140 was reduced to alcohol 141 using lithium 
aluminium hydride, and the alcohol was oxidized to aldehyde 142 with tetrapropylammonium 
perruthenate (TPAP) and 4-methylmorpholine A-oxide (NMO). Treatment of aldehyde 142 with 
triethyl phosphonoacetate and sodium hydride gave ester 143 as a single isomer. Reduction of the 
conjugated ester provided alcohol 144. Derivatisation of this alcohol to diphosphate analogue 139 
was achieved by the diphosphorylation methodology of Poulter et al.no
144 139
Scheme 1.20: Synthesis o f diphosphate 139.
Reagents and conditions: i) LiAlH4, Et20, -78 °C, 45 min, 94%; ii) NMO,
TPAP, DCM, overnight, 91%; iii) triethyl phosphonoacetate, NaH, THF, 
overnight, 49%; iv) DIBAL-H, DCM, -78 °C to -50 °C, 1.5 h, 93%; v) CBr4,
PPh3, DCM, 2 h; vi) (Bu4N)3HP20 7, CH3CN, 2 h, 76% over two steps.
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In addition to the simple condensation to make carbon-carbon double bonds, Wittig or 
Homer-Emmons reactions can also be used to put the functional groups onto the vinyl positions 
in the isoprenyl chain. For example, the Homer-Emmon condensation was successfully used by 
Coates et al. to produce 6-fluoro (£,£^E)-geranylgeranyl diphosphate 145 (Scheme 1.21). In 
addition to the overall Weiler’s isoprenoid chain extension, they used the triethyl 
fluorophosphonoacetate 146 as a Homer-Emmons reagent to put the fluorine in the C6 vinyl 
position.107
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Scheme 1.21: Synthesis o f 6-fluoro (E,E,E)-geranylgeranyl diphosphate (145).
Reagents and conditions: i) NaH, THF, 16 h, 98%; ii) LiAlH4, THF, overnight, 51%.
1.10 Development of new Suzuki coupling methodology
It was one of the intentions of this project to develop a novel Suzuki-Miyaura coupling
methodology to perform the synthesis of the compounds with changes to the methyl groups of
FPP. It seemed an appropriate method for constructing isoprenoid chains and would ensure no
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problems with double bond geometry were possible. The Suzuki coupling is a 
palladium-catalysed cross coupling between an organoboronic acid and a halide. Recent catalyst 
and method developments have broadened the possible applications of this reaction enormously, 
so that the scope of the reaction partners is not restricted to aryls, but includes alkyls, alkenyls 
and alkynyls.124,125 The reaction mechanism is illustrated in Scheme 1.22.
Ar-Ar*
Pd(0) ArX
Ar‘-Pd(ll)-Ar 
B(OH)4~
Ar*— B— OH
NaOH
Ar,B(OH)2
Ar-Pd(ll)-OH
Ar-Pd(ll)-X
NaOH
NaX
X = Br or I
Scheme 1.22: The catalytic cycle o f Suzuki coupling.
From the retrosynthesis Scheme 1.23, it seemed that a disconnection that exploited the oligomeric 
nature of FPP would be both appropriate and efficient. Hence a series of monomers was 
envisaged with one group being 1,3-dienes 151 representing the C-terminal end of the famesyl 
group and the other set being various £-crotonyl iodides 152 and 153. The key forward reaction 
to connect these two monomers would involve transformation of the dienyl group with a hindered 
borane such as 9-BBN followed by Suzuki-Miyaura coupling with the appropriate iodide.124.
126-129
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Scheme 1.23: Retrosynthesis o f FPP analogues using the 
planned Suzuki-Miyaura coupling.
1.11 Aim of the project
The aim of this project was to design and synthesize famesyl diphosphate analogues for 
modulating the chemistry of aristolochene synthase. In other words, one part of this project was 
to produce libraries of FPP analogues with different methodologies as those indicated in Scheme 
1.18, Scheme 1.20 and Scheme 1.23. It was anticipated that the methodologies developed in this 
project would be feasible (rapid, efficient and low cost) and extendable to the preparation of 
precursor-analogues of other terpene classes.
Another part of this project was to test the developed FPP analogues as substrates or inhibitors of 
aristolochene synthase. The study of their transformation by aristolochene synthase should further 
our understanding of the mechanism of action of this enzyme and provide generic insights 
applicable to other enzyme systems.
The following chapters will describe the successful synthesis of some of the required FPP 
derivatives using such methodology and their testing as mechanistic probes of aristolochene 
synthase.
k
CHAPTER 2 
SYNTHESIS OF FPP ANALOGUES
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2.1 Target molecules
From the previous introduction, it was concluded there were two important approaches for 
studying the catalytic mechanism of sesquiterpene synthase, site directed mutagenesis of key 
amino acid residues and turnover of modified FPP analogues. However, the interpretation of 
results from site-specific mutants of terpene cyclases requires some caution, since there is a 
possibility that the change of only a single amino acid in their active site can alter their 
templating potential. Such local geometrical changes may be inherently difficult to detect since 
they may not affect the global fold of the proteins but nevertheless lead to the synthesis of novel 
products through subtle alterations of the reaction pathway. So in this case, the method of turn 
over of modified FPP analogues has its advantage. It is one of the intentions of this project to 
synthesize a wide range of analogues of FPP, which can be used to explore more deeply the 
mechanism of the reaction catalysed by aristolochene synthase.
As stated in Chapter one (see section 1.7.4), the cationic intermediates generated during the 
enzyme catalysed reaction can be stabilised or destabilised by functional groups in their vicinity. 
So different functional groups in different positions have predictable and testable effects on the 
cations, which might be helpful for understanding the reaction mechanisms. Nine FPP analogues 
with phenyl and fluoro substituents have been made through different methodologies (Figure 
2 .1).
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Figure 2.1 Structures o f target FPP analogues.
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The phenyl group is a bulky aromatic group capable of stabilising cationic intermediates, both its
size and the affinity to cation will be the interesting points that require to be investigated. Fluoro
substituents do not greatly affect the binding affinities to the enzyme as a consequence of size and
shape but at the same time exert a strong influence on the electronic environment at the site of
replacement107, 130 in that they stabilize cations on the a-carbon by 7c-donation but exert a
destabilizing inductive effect on cations located on the p-carbon (Figure 2.2). The strong
influence on the reactivity exerted by fluoro substituents without significantly affecting size and
shape may make these reagents more suitable than mutagenesis experiments to decipher the
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intricate details of terpene synthase chemistry. Fluoro-substituent analogues of 
prenyldiphosphates recently were successfully used as powerful reagents to study the mechanism 
of the enzyme-catalysed cyclisations to terpenoids products.107,123,130
F F+
X ~  X
Stabilised cation Destabilised cation
Figure 2.2: Fluoro substituent’s influence on the 
carbon cation in its vicinity.
2.2 Synthesis of 12,13-difluoro farnesyl diphosphate (154)
The first trial synthesis of an FPP analogue was 12,13-difluoro farnesyl pyrophosphate 154. 
Several different synthetic methodologies were tried to produce this analogue; the key 
methodologies used included Suzuki-Miyaura coupling, Wittig reaction, Weiler chain extension 
and the use of iron tricarbonyl protecting groups.
2.2.1 Suzuki coupling methodology
As introduced in Chapter 1 (see section 1.10), our newly developed Suzuki coupling 
methodology for the synthesis of FPP analogues starts from two groups of monomers; one group 
was dienes representing the C-terminal end of the farnesyl group and the other set was various 
F-crotonyl iodides (Scheme 2.1). In this case, the diene 164 possesses two fluorine substituents 
and the £-crotonyl iodide is a simple iodide 165 with a methyl group. The retrosynthesis leading 
to diene 164 is shown in Scheme 2.1.
'0P20 6'
154
OH
163
+ , A ^ c ° 2Et + | / k ^ / C 0 2Et
164 165 165
Scheme 2.1. Retrosynthesis o f 12,13-difluoro FPP 154.
Reaction of the tris(hydroxymethyl)aminomethane hydrochloride (166) with 
2,2-dimethoxypropane in the presence of acid catalyst p-toluenesulfonic acid in anhydrous DMF
111 119 •gave 5-amino-5-hydroxymethyl-2,2-dimethyl-1,3-dioxane (167). ’ As purification after
vacuum distillation gave only a 23% yield, the crude product 167 was directly treated with a 
solution of sodium periodate at pW 6 to give 2,2-dimethy 1-5-oxo-1,3-dioxane (168) as a colorless 
oil in 68% overall yield.132 Wittig reaction of ketone 168 with 
(carbethoxymethyl)triphenyl-phosphonium bromide in dry ethanol afforded the ester 169 in 77% 
yield after purification by silica column chromatography.
67
Scheme 2.2: Synthesis o f Ester 169.
Reagents and conditions: i) 2,2-dimethoxypropane, PTSA, DMF, RT, 15 h, 28%; 
ii) NaI04, KH2P04, 0 °C to RT, 15 h, 68% for two steps; iii) (carbethoxymethyl)- 
triphenyl phosphonium bromide, Na, EtOH, RT, 15 h, 77%.
Attempts to convert the ester 169 to the diol 170 with TFA in ethanol 134 failed probably due to 
lactone formation (Scheme 2.3).
169 170
Scheme 2.3: Proposed mechanism o f generation o f the lactone 171. 
Consequently, a new retrosynthetic plan was formulated leading to diene 172 (Scheme 2.4).
154
OP 2^6
HO-
£
-COoEt
173
+ C02Et + C02Et
172 165 165
Scheme 2.4: Alternative retrosynthesis o f 12,13-difluoro FPP 154.
In this case, diene 172 would be coupled with an appropriate iodide using a Suzuki-Miyaura 
coupling reaction. The protective acetal group could be removed and the resulting diol then 
fluorinated with diethylaminosulfur trifluoride (DAST) before transformation to the target 
pyrophosphate.
Reduction of ester 169 with DIBAL-H gave alcohol 175 in 97% yield. Pyridinium 
chlorochromate oxidation135, 136 in anhydrous DCM then gave aldehyde 176 in 55% yield 
(Scheme 2.5).137 Wittig reaction of aldehyde 176 with the ylid of methyl phosphonium bromide 
then afforded the diene 172 in 62% yield after purification by silica flash column 
chromatography.133
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Scheme 2.5: Synthesis o f ester 177.
Reagents and conditions: i) DIBAL-H, THF, 0 °C, 2 h, 97%; ii) PCC, DCM, RT, 4 h,
55%; iii) methyl triphenyl phosphonium bromide, BuLi, THF, RT, 18 h, 62%; 
iv) 9-BBN, PdCl2dppf, AsPh3, 165, NaOH, THF, 50 °C, 15 h, 62%.
The other compound of the Suzuki-Miyaura coupling, ^-iodide 165 was synthesised in two steps 
from ethyl 2-butynoate (178) (Scheme 2.6). Reaction of ester 178 with sodium iodide and glacial 
acetic acid at 115 °C gave the Z-iodide 179 in 98% yield. 138' 140 This was then converted to the 
more stable £-isomer 165 by heating the Z-isomer in a sealed tube for 4 hours under argon. 
Separation of the resulting isomeric mixture by flash column chromatography then gave the pure 
is-isomer in 47% yield. 139
i \  P  ii \  /C°2Et
— -C02E* ------  ^ M  ------~ H
I C02Et I H
178 179 165
Scheme 2.6: Synthesis o f iodide 165.
Reagents and conditions: i) Nal, CH3COOH, 115 °C, 1.5 h, 98%; ii) sealed tube 
under argon, 220 °C, 2 h, 47%.
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Suzuki-Miyaura coupling of diene 172 with iodide 165 using triphenyl arsine, PdCbdppf and 6  M 
NaOH afforded ester 177 in 62% yield (Scheme 2.5) . 1 2 4 ,126
Reduction of ester 177 with DIBAL-H in anhydrous THF gave alcohol 180 in 8 8 % yield 
(Scheme 2.7).141, 142 Oxidation of alcohol 180 with pyridinium chlorochromate (PCC) led 
isomerisation, probably due to the slightly acidic nature of the reagent. The *H NMR spectrum 
showed two doublet resonances around 1 0  ppm indicating two distinct aldehyde protons, i.e. the 
E and Z isomers 181 and 182. However, when the oxidation was carried out using 
tetra-n-propylammonium perruthenate (TPAP), N-methylmorpholine-N-oxide (NMO) and ground 
4 A molecular sieves, the desired ^-aldehyde 181 was obtained exclusively in 78% yield. 143
OH
180177
181181
182
Scheme 2.7: Synthesis o f aldehyde 181.
Reagents and conditions: i) DIBAL-H, THF, -78 °C, 2 h, 8 8 %; ii) PCC, DCM, RT, 
4 h; iii) NMO, TPAP, CH3CN, RT, 15h, 78%;.
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The ^-aldehyde was then subjected to a Wittig reaction with methyl triphenyl phosphonium 
bromide to give 1,3-diene 183 in 82% yield (Scheme 2.8). Suzuki coupling of this with iodide 
165 in the same manner as for the preparation of 177 (see above) afforded ester 184 in 35% yield. 
Removal of the diol protecting group using TFA in ethanol then gave diol 185 in 79% yield. 144
181 183
HO.
HO. C02Et
185 184
Scheme 2.8: Synthesis o f diol 185.
Reagents and conditions: i) CH3P+Ph3Br’, BuLi, THF, RT, 18 h, 82%; ii) 9-BBN, 
PdCl2dppf, AsPh3, 165, NaOH, THF, 50 °C, 15 h, 35%; iii) TFA, EtOH, RT, 3 h, 79%.
2.2.2 Introduction of fluoro groups
In order to test the methodology of fluorination with DAST, ester 177 was used as it was 
available in larger quantities than 184 and simpler to prepare. The ester 177 was converted to the 
diol 186 by treatment with TFA in ethanol. 144 Diol 186 was recovered in 90% yield after 
purification by flash chromatography on silica gel. Treatment of the diol 186 with DAST in dry 
DCM at -78 °C gave a mixture of products, difluoride 187 and the undesired product 188 in 19% 
and 48% yield respectively (Scheme 2.9) . 1 4 5 ,146
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HO-
HO.
186
188187
Scheme 2.9: Synthesis o f difluoride 187.
Reagents and conditions: i) TFA, EtOH, RT, 2 h, 98%; ii) DAST, DCM, -78 °C to 
RT, 5 h.
The 19F NMR spectrum of difluoride 187 had two doublets with similar chemical shifts (5f = 
-212.84 and -217.05 ppm), suggesting that the two fluorine atoms in this molecule are in similar 
magnetic environments. However, the 19F NMR spectrum of difluoride 188 had two doublet at 
very different chemical shifts (8f = -182.64 and -216.76 ppm) due to them being in different 
molecular environments. A possible mechanism leading to the formation of 187 and 188 is shown 
in Scheme 2.10.
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Scheme 2.10 Possible mechanism for the formation of 187 and 188.
2.2.3 Investigation of diene protection with iron tricarbonyl group
Although the initial approach towards difluoride 187 looked positive, low yields due to double
bond migration were observed when the fluorination was carried out on the allylic alcohol. This
was not ideal and therefore an alternative method was sought. As it was noticed that the allylic
double bond was involved in the fluorinations, how to ‘lock’ the double bond was the key issue.
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When the allylic double bond is a part of 1,3-diene, allylic fluorinations have been shown to be 
regiospecific when iron tricarbonyl is used to coordinate the diene group and therefore this was 
investigated (Scheme 2.11) . 147
HCL Fe(CO)3
192 164 165 165
Scheme 2.11. Methology with using of iron tribcarbonyl coordination.
To test the fesibility of the iron tricarbonyl methodology, diene 193 was used as it was available 
in larger quantities than 172 and simpler to prepare. Acrolein 194 was treated with 
carbethoxyethylidene triphenyl phosphorane in DCM to afford ester 193 in 79% yield (Scheme 
2.12) ; 148 This ester then was reduced to the alcohol using DIBAL-H. A mixture of diiron 
nonacarbonyl and diene 195 was heated to 50 °C for 15 h under argon atmosphere to afford 
complex 196 in 81% yield. 149 Fluorination of complex 196 using DAST1 4 5 ,146 in DCM at -78 °C 
yielded the expected fluoride 197 in 56% yield. Unfortunately, the cleavage of the iron 
tricarbonyl group proved difficult. After several attempts (e.g. FeCL in CH3CN, 
4-methylmorpholine N-oxide in DCM) , 150 there were no separable products from the reaction 
mixture, presumably because the product was highly volatile (estimate of its boiling point is 
below 80 °C) and therefore lost during reaction work up.
Scheme 1.12: Investigation o f diene protection with iron tricarbonyl.
Reagents and conditions: i) carbethoxyethylidiene triphenyl phosphorane, DCM,
RT, 5 h, 79%; ii) DIBAL-H, THF, -78 °C to 0 °C, 3 h, 76%; iii) Fe2(CO)9, THF, 
reflux, 15 h, 81%; iv) DAST, DCM, -78 °C, 6  h, 56%.
2.2.4 Use of Horner-Emmons chemistry
As the previous approach to synthesise 12,13-difluoro FPP was unsuccessful, a new methodology 
had to be developed. Because of the difficulty of converting the allylic diols to difluorides, it was 
decided to introduce this functionality using Horner-Emmons chemistry. The retrosynthesis 
scheme is shown below (Scheme 2.13).
F>
187
201 199 200
Scheme 1.13: Retrosynthesis o f difluoride 187.
The forward reaction starts with a-acetyl butyrolactone (201), which was treated with 
hydrobromic acid in the presence of sulfuric acid to give bromoketone 202 in 92% yield (Scheme 
2.14).151, 152 This was then initially subjected to a Horner-Emmons reaction with triethyl 
phosphonoacetate to generate the bromoester 203 with good stereoselectivity (E:Z = 11:1) . 153 An 
Arbuzov reaction using triethyl phosphite then gave phosphonoacetate 199 in 81% yield after 
purification by silica flash column chromatography. 1 5 4 ,155
Scheme 2.14: Synthesis o f phosphonoacetate 199.
Reagents and conditions: i) HBr, H2 S04, toluene, 70 °C, 18 h, 92%; ii) Triethyl 
-phosphonoacetate, NaH, THF, 0 °C, 14 h, 6 8 %; iii) Triethyl phosphite, 130 °C,
3.5 h, 81%.
A Horner-Emmons reaction on this phosphonoacetate with 1,3-difluoroacetone 200156 using 
different bases (t-BuOK, KHMDS, NaH, LDA) proved unsuccessful due to possible six 
membered ring formed in a Dieckmann-like condensation (Scheme 2.15). In order to prevent this 
problem, the ester functionality was removed, and the use of alternative protecting groups was 
explored.
Scheme 2.15: Proposed mechanism of ring formation 
from phosphonoacetate 199.
At the same time, we decided to use Wittig reaction rather than the Horner-Emmons reaction, 
because the reagent 1,3-difluoroacetone is a symmetrical molecule and the Horner-Emmons 
reagent is less reactive than the Wittig reagent despite its ^-selectivity in stereochemistry. The 
benzyl-protecting group was tried as the first alternative group (Scheme 2.16). Reduction of the 
ester 203 with DIBAL-H in THF gave alcohol 206 in 98% yield. Treatment with benzyl bromide 
and NaH in THF then gave bromo benzyl ether 207 in 73% yield. 157 This was then initially 
converted to the triphenyl phosphonium bromide 208 by heating with triphenyl phosphine 
overnight in acetonitrile, 158 and then treatment with 1,3-difluoro acetone in a Wittig reaction to 
give the desired difluoro benzyl ether 209 in 93% yield. 156
Br\ ^ \ ^ k ^ / C 0 2Et  !—
203 206
ii
Br-
208 207
209
Scheme 2.16: Synthesis o f difluoro benzyl ether 209.
Reagents and conditions: i) DIBAL-H, THF, -78 °C to 0 °C, 2 h, 98%; ii) Benzyl 
bromide, NaH, THF, 0 °C to RT, 3 h, 73%; iii) Ph3P, CH3CN, reflux, 14 h, 87%; 
iv) 1,3-difluoro acetone, LiHMDS, THF, -78 °C to RT, 1 h, 93%.
Several attempts were made to remove the benzyl protecting group. Dissolving metal reduction 
using sodium liquid ammonia was unsuccessful because the fluorine group was removed. The 
resultant compound did not show any peaks in the 19F NMR spectrum. The difluoro benzyl ether 
was inert to treatment with methanesulfonic acid. Attempted hydrogenolysis with H2 on Pd was 
successful but the double bonds were also reduced. 157 So another, more readily removable 
protecting group was required.
2.2.5 Weiler and Sum chain extension methodology
The THP protecting group was then selected as it could be introduced in high yield and removed 
readily. 159 The THP protected difluoride 210 was made in the same manner as difluoro benzyl
79
ether 209 in 60% overall yield for the four steps following reduction of the ester 203 with 
DIBAL-H (Scheme 2.17).159’160
After successful preparation of difluoride 210, the THP protecting group was easily removed by 
heating the compound with pyridinium p-toluenesulfonate in ethanol, 1 6 0 ,161 and the alcohol 156 
was isolated in 97% yield (Scheme 2.17). To extend the geraniol analogue to famesol analogue, 
the chain extension methodology first published by Weiler and Sum (see section 1.8.3) was 
attempted. 1 18 ,162 Alcohol 211 was converted to a bromide 212 by reaction with methanesulfonyl 
chloride and lithium bromide. 163
206
O "O'
210
OH
211
O O
213
214
212
Scheme 2.17: Synthesis o f difluoro bromide 212.
Reagents and conditions: i) 3,4-DHP, p-TsOH, DCM, 0 °C to RT, 16 h, 93%; 
ii) Ph3P, CH3 CN, reflux, 14 h; iii) 1,3-difluoro acetone, LiHMDS, THF, -78 °C 
to -20 °C, 2 h, 6 6 % for 2 steps; iv) PPTS, EtOH, 55 °C, 2 h, 97%; v) MsCl, 
Et3N, LiBr, THF, -55 °C to 0 °C, 2 h.
Alkylation of bromide 212 with three equivalents of lithio-sodio acetoacetate dianion (215) gave
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the p-keto ester 216 in 8 8 % yield after purification by silica flash column chromatography. 
Reaction with diethyl chlorophosphate then gave the enol phosphate 217 as a single isomer in 
8 8 % yield (Scheme 2.18).162 The proposed final step, a Michael addition with lithium 
dimethylcuprate, 162 however, resulted in loss of fluorine atoms, as indicated by the absence of 
resonance in the 19F spectrum, most likely due to elimination of hydrogen fluoride.
218
O Li ONa
215 216
C02Et
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217219
Scheme 2.18: Attempted synthesis o f difluoro ester 219.
Reagents and conditions: i) NaH, n-BuLi, THF, 0 °C, 20 min; ii) 212, THF, 0 °C, 
89% for two steps; iii) Diethyl chlorophosphate, NaH, Et20, 0 °C, 1 h, 8 8 %; iv) Cul, 
MeLi, Et2Q, -78 °C, 3h.
2.2.6 Reuse of Suzuki coupling methodology
As the chain extension methodology of Weiler and Sum was unsuccessful for our purpose, the 
Suzuki coupling methodology was revived since this route had been abandoned due to problems 
of regioselective fluorination, a problem now solved. The alcohol 211 was converted to the
1,3-diene 220 by successive TPAP oxidation143 and Wittig reaction in 83% overall yield (Scheme 
2.19).133 A Suzuki-Miyaura coupling124’ 126 with the crotonyl iodide 165 resulted in the production
of ester 219 in 29% yield in the same manner as the described procedure for ester 177 (see 
Scheme 2.5).
211
C02Et
219
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Scheme 2.19: Synthesis o f difluoro ester 219.
Reagents and conditions: i) TPAP, NMO, CH3CN, RT, 16 h, 82%; 
ii) CH3PPh3Br, n-BuLi, THF, RT, 16 h, 92%; iii) 9-BBN, PdCl2dppf, 
AsPh3, 165, NaOH, THF, 50 °C, 15 h, 29%.
Reduction of ester 219 with DIBAL-H gave the alcohol 222 in 6 8 % yield. 142 This was then 
converted to bromide 223 by treating with methanesulfonyl chloride and lithium bromide. 163 
Treatment of the bromide with freshly recrystallized tris(tetra-n-butylammonium) 
hydrogenpyrophosphate in anhydrous acetonitrile generated the desired difluoro farnesyl 
pyrophosphate analogue 154 in 10% yield for the last two steps. 110 This tetra-butyl ammonium 
salt had to be converted to the ammonium salt via cation exchange chromatography prior to 
purification by reverse phase HPLC, as the original tetra-butylammonium salt caused serious 
separation problem in the HPLC step because of its long tail.
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Scheme 2.20: Synthesis o f diphosphate 154.
Reagents and conditions: i) DIBAL-H, THF, -78 °C, 2 h, 6 8 %; ii) MsCl, NEt3,
LiBr, THF, -45 °C, 2 h; iii) (Bu4N)3HP2 0 7, CH3CN, 2 h, then DOWEX ion exchange 
Bu4N+/NH4+, 10% for two steps.
2.2.7 Summary
After trying different methodologies, the synthesis of 12,13-difluoro farnesyl pyrophosphate was 
finally achieved in 13 steps using Wittig reaction and Suzuki-Miyaura coupling as key steps. The 
overall yield is 0.8%. The summary scheme is shown below (Scheme 2.21).
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Scheme 2.21: Synthesis o f diphosphate 154. (Summary)
Reagents and conditions: i) HBr, H2S04, toluene, 70 °C, 18 h, 92%; ii) Triethyl 
-phosphonoacetate, NaH, THF, 0 °C, 14 h, 68%; iii) i) DIBAL-H, THF, -78 °C 
to 0 °C, 2 h, 98%; iv) 3,4-DHP, p-TsOH, DCM, 0 °C to RT, 16 h, 93%; v) Ph3P, 
CH3CN, reflux, 14 h; vi) 1,3-difluoro acetone, LiHMDS, THF, -78 °C to -20 °C, 2 h, 
66% for 2 steps; vii) PPTS, EtOH, 55 °C, 2 h, 97%; viii) TPAP, NMO, CH3CN, RT, 16 
h, 82%; ix) CH3PPh3Br, n-BuLi, THF, RT, 16 h, 92%; x) 9-BBN, PdCl2dppf, AsPh3, 
165, NaOH, THF, 50 °C, 15 h, 29%; xi) DIBAL-H, THF, -78 °C, 2 h, 68%; xii) MsCl, 
NEt3, LiBr, THF, -45 °C, 2 h; xiii) (Bu4N)3HP20 7, CH3CN, 2 h, then DOWEX ion 
exchange Bu4N+/NH4+, 10% for two steps.
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2.3 Vinyl fluoro analogues of farnesyl pyrophosphate
The double bonds in FPP play a very important role in the formation of aristolochene according 
to the proposed mechanism shown in Scheme 1.7. For example, in the formation of germacryl
oncation and subsequent eudesmane cation all three double bonds of FPP are involved. Vinyl 
fluoro analogues of FPP were therefore considered to be powerful tools to study the mechanism 
of the enzyme-catalysed cyclisations of sesquiterpenoids, reactions that are inherently difficult to 
study spectrometrically. We therefore decided to synthesize vinyl fluoro FPP analogues using the 
Weiler and Sum chain extension and sulfonylation-alkylation-desulfonylation methodologies (see 
section 1.8).
2.3.1 Synthesis of 2-fluoro farnesyl pyrophosphate (155)
The synthesis of 2-fluoro farnesyl pyrophosphate was achieved using a modification of a 
published procedure.164 Geranyl acetone (224) was treated with triethyl 
2-fluoro-2-phosphonoacetate and sodium hydride to give the fluoro ester 225 and its £-isomer in 
96% yield after purification by silica flash column chromatography (Scheme 2.22). DIBAL-H 
reduction of the resulting ester mixture gave E and Z fluoro alcohols 226 and 227 in a ratio of 
approximately 1:1. Purification by silica column chromatography afforded the pure Z-isomer in 
46% yield. Bromination followed by diphosphorylation110 and purification by reverse phase 
HPLC in the same manner as for the difluorinated analogue 154 (see page 65) gave 2-fluoro FPP 
155 in 36% yield over the two steps.
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Scheme 2.22: Synthesis o f diphosphate 155.
Reagents and conditions: i) Triethyl 2-fluoro-2-phosphonoacetate, NaH, THF, 0 °C, 
14 h, 96% including E isomer; ii) DIBAL-H, THF, -78 °C, 2 h, 46%; iii) MsCl, TEA, 
LiBr, THF, -45 °C to 0 °C, 2 h; iv) (Bu4N)3HP20 7, CH3CN, 2 h, then DOWEX 
ion exchange Bu4N+/NH4+, 36% for two steps.
2.3.2 Synthesis of 6-fluoro farnesyl pyrophosphate (156)
Synthesis of 6-fluoro farnesyl pyrophosphate was also achieved using a modification of a 
published procedure.107 Condensation of 6-methyl-5-hepten-2-one (229) with triethyl 
fluorophosphonacetate gave fluoro ester 230 as a mixture of isomers (Scheme 2.23).165 As 
separation of these by silica column chromatography proved difficult, the mixture was reduced 
directly using DIBAL-H to afford chromatographically separable 2-fluorogeraniol isomers, 
£-isomer 231 and Z-isomer 232 in approximately 1:1 ratio. The Z isomer was separated and then
163transformed into bromide 233 using methanesulfonyl chloride and lithium bromide.
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Scheme 2.23: Synthesis o f fluoro bromide 233.
Reagents and conditions: i) Triethyl 2-fluoro-2-phosphonoacetate, NaH, THF, 
0 °C, 14 h; ii) DIBAL-H, THF, -78 °C, 2 h, 46%; iii) MsCl, TEA, LiBr, THF, 
-45 °C to 0 °C, 2 h, used directly in next step.
Alkylation of lithio-sodio acetoacetate dianion 215 with bromide 233 provided fluoro P-keto ester 
234 in 98% yield. This was then converted to the E enol phosphate 235 using diethyl 
chlorophosphate and sodium hydride in 95% yield.162 Treatment with lithium dimethyl cuprate at 
-78°C gave fluoro ester 236 in 95% yield.162 Reduction with DIBAL-H then gave fluoro famesol 
237 in 91% yield. Activation of the alcohol as the allylic bromide 238, followed by reaction with 
tris tetrabutyl ammonium hydrogen pyrophosphate gave 6-fluoro farnesyl pyrophosphate 
tetra-n-butylammonium salt. Cation-exchange chromatography followed by reverse phase HPLC 
purification finally gave the 6-fluoro farnesyl pyrophosphate ammonium salt 156 in 44% yield 
for the last two steps.110
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Scheme 2.24: Synthesis o f diphosphate 156.
Reagents and conditions: i) NaH, n-BuLi, THF, 0 °C, 20 min; ii) 233, THF, 0 °C,
98% for two steps; iii) Diethyl chlorophosphate, NaH, Et20 , 0 °C, 1 h, 97%; iv)
Cul, MeLi, Et20, -78 °C, 3.5 h, 95%; v) DIBAL-H, THF, -78 °C, 91%; vi) MsCl,
Et3N, then LiBr, THF, -45 °C to 0 °C, 2 h; vii) (Bu4N)3HP20 7,CH3CN, 2 h, then 
DOWEX ion exchange Bu4N+/NH4+, 48% for two steps.
2.3.3 Synthesis of 10-fluoro farnesyl pyrophosphate (157)
10-Fluoro farnesyl pyrophosphate was synthesized using a modification of the procedure of Cane 
et a/.,116 who tested it as an effective competitive inhibitor for trichodiene synthase. The key steps 
in this synthetic route were a coupling reaction between a sulfone and a bromide followed by a 
reductive desulfonylation.
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Acetone (239) was treated with triethyl 2-fluoro-2-phosphonoacetate and sodium hydride to give 
ethyl 2-fluoro-3-methylbut-2-enoate (240) as a colorless oil in 47% yield (Scheme 2.25).116 
DIBAL-H reduction followed by treatment with methane sulfonyl chloride and lithium bromide 
gave bromide 241. The bromide was not purified and was coupled directly with sulfone 242 (see 
Scheme 2.26).
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Scheme 2.25: Synthesis o f bromide 241.
Reagents and conditions: i) Triethyl 2-fluoro-2-phosphonoacetate, NaH, THF, 
RT, 14 h, 47%; ii) DIBAL-H, THF, -78 °C, 2 h; iii) MsCl, TEA, LiBr, THF, 
-45 °C to 0 °C, 2 h;
Geraniol (244) was treated with benzyl bromide and sodium hydride to afford the benzyl ether
245 in 94% yield.157 Oxidation of the terminal methyl group in the presence of selenium dioxide,
tert-butyl hydroperoxide and acetic acid gave alcohol 246 in 32% yield after purification by silica
column chromatography. The poor yield was attributed to over oxidation with the aldehyde being
isolated in 30% yield.166,167 The alcohol 246 was then treated with methanesulfonyl chloride and
lithium bromide and the resulting crude bromide 247 was directly reacted with benzenesulfinic
acid sodium salt to afford the sulfone 242 in 82% yield over the two steps. Sulfone 242 was
coupled to bromide 241 using «-BuLi at -78 °C to afford the fluoro sulfone 245 in 76% yield.
Reductive desulfonylation in the presence of lithium and tert-butyl alcohol also lead to
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debenzylation to afford the alcohol 249 in 28% yield.116 Bromination and then diphosphorylation 
in the same manner as described previous gave diphosphate 157 in 56% yield.
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Scheme 2.26: Synthesis o f diphosphate 157.
Reagents and conditions: i) Benzyl bromide, NaH, THF, 0 °C to RT, 3 h, 94%; ii) 
t-BuOOH, Se02, CH3COOH, DCM, RT, 16 h, 32%; iii) MsCl, TEA, LiBr, THF, -45 
°C to 0 °C, 2 h; iv) Benzensulfinic acid sodium salt, DMF, RT, 20 h, 82% for two 
steps; v) 241, n-BuLi, THF, -78 °C to 0 °C, 3 h, 76%; vi) t-BuOH, Li, THF, RT, 20 
h, 28%; vii) MsCl, TEA, LiBr, THF, -45 °C to 0 °C, 2 h; viii) (Bu4N)3HP20 7, 
CH3CN, 2 h, then DOWEX ion exchange Bu4N+/NH4+, 56% for two steps.
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2.4 14-Fluoro farnesyl diphosphate (158) and 15-fluoro farnesyl diphosphate 
(159)
The 14-F and 15-F FPP analogues were synthesized using similar metholodgy. The key steps 
involved the introduction of fluorine with TBAF and a Wittig or Homer-Wadsworth-Emmons 
reaction with the resulting fluorinated ketone.
2.4.1 Synthesis of 14-fluoro farnesyl pyrophosphate (158)
14-Fluoro FPP was synthesized using a modification of the method of Poulter et al.m  Treatment 
of ethyl 4-chloroacetoacetate (251) with benzyl alcohol in the presence of sodium hydride gave 
the benzyl protected compound 252 in 82% yield.169 Cleavage of the benzyl group was achieved 
by reductive hydrogenolysis using H2 and 10% Pd/C catalyst gave the pure alcohol 253 in 95% 
yield after purification by silica column chromatography.157 Treatment with
3,4-dihydro-2//-pyran and catalytic amount of p-toluenesulfonic acid then gave the THP ether
254. 159
o o
Cl
251
CT°'TYa
252
ii
254
HO
O O 
253
Scheme 2.27: Synthesis o f THP ether 254.
Reagents and conditions: i) Benzyl alcohol, NaH, toluene, 0 °C to RT, 18 h, 
82%; ii)H2, Pd/C (10% w/w), EtOH, 16 h, 95%; iii) 3,4-DHP, p-TsOH, 
DCM, 0 °C to RT, 16 h.
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Alkylation of the THP ether 254 with l-bromo-3-methylbut-2-ene (256) (derived from the 
reaction of 3-methyl-2-butene-l-ol (255) with methane sulfonyl chloride and lithium bromide) in 
the presence of sodium hydride gave ester 257 in 53% yield (Scheme 2.28). Base-mediated 
decarboxylation using KOH in ethanol afforded THP protected ketone 258 in 52% yield.159
The THP protecting group was then removed using pyridinium p-toluenesulfonate (PPTS) to 
afford keto alcohol 259 in 95% yield.161 Fluorination was achieved using TBAF in the presence 
of triflic anhydride and 2,6-lutidine.170 Due to the highly volatility of the resulting fluoride 260, 
eluents from silica column chromatography were not concentrated completely under reduced 
pressure.
Fluoro ketone 260 (with residual solvent) was then subjected to a Wittig reaction with 
phosphonium salt 214 (see Scheme 2.17) to afford the THP ether 261 as major product in 30% 
yield over the three steps. Removal of the THP protecting group using PPTS gave alcohol 262 in 
91% yield after purification by silica column chromatography.161 Bromination and then 
diphosphorylation were carried out using the same method described previously. 14-Fluoro FPP 
(158) was eventually obtained in 45% yield (from 262) after HPLC purification.
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Scheme 2.28: Synthesis o f diphosphate 158.
Reagents and conditions: i) MsCl, TEA, LiBr, THF, -45 °C to 0 °C, 2 h; 
ii) NaH, 256, THF, 0 °C to RT, 16 h, 53%; iii) KOH, EtOH, RT, 24 h, 52%; i) 
PPTS, EtOH, RT to 50 °C, 18 h, 95%; ii) 2,6-Lutidine, triflic anhydride, then 
TBAF, THF, 0 °C to RT, 2.5 h; iii) LiHMDS, 214, THF, -78 °C to -20 °C, 3 h, 
30% for 3 steps; iv) PPTS, EtOH, 55 °C, 2 h, 91%; v) MsCl, TEA, LiBr, THF, 
-45 °C to 0 °C, 2 h; vi) (Bu4N)3HP2 0 7 , CH3CN, 2 h, then DOWEX ion 
exchange Bu4N+/NH4+, 45% for two steps.
2.4.2 Synthesis of 15-fluoro farnesyl pyrophosphate (159)
15-Fluoro farnesyl pyrophosphate was also synthesized using a modification of a literature 
procedure.123 The main steps similar to those described above for 14-fluoro FPP (158). Bromide 
264, required for alkylation with THP ether 254, was synthesized from geraniol by treatment with 
methanesulfonyl chloride and lithium bromide (Scheme 2.29). Alkylation of THP ether 254 with 
bromide 264 using sodium hydride afforded keto ether 265 in 46% yield after purification by 
silica column chromatography.123 Decarboxylation with KOH followed by treatment with PPTS 
gave the keto alcohol 267 in 60% yield over the two steps.123
Conversion of alcohol 267 to fluoride 268 was carried in the same manner as described for the 
preparation of fluoride 260. However in this case, due to the larger molecular weight of fluoride 
268 (compaired with fluoride 260), this compound was less volatile and therefore isolated for full 
characterization. The fluoride 268 was then treated with triethyl phosphonoacetate and sodium 
hydride to give fluoro ester 269 as a mixture of E and Z isomers in a ratio of 1 : 10.130 The two 
isomers had very similar chromatographic properties; the Rf values for Z isomer and E isomer 
were 0.18 and 0.17 for 60:1 hexane-ethylacetate, so medium performance liquid chromatography 
(MPLC) was used to perform the separation. After four rounds of MPLC, the Z isomer of 269 
was isolated in 64% yield. The ester was finally converted to 15-fluoro FPP 159 using the usual 
sequence of reduction, bromination and diphosphorylation steps. Cation exchange followed by 
HPLC purification gave the desired compound in 34% yield over the last three steps.
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Scheme 2.29: Synthesis o f diphosphate 159.
Reagents and conditions: i) MsCl, TEA, LiBr, THF, -45 °C to 0 °C, 2 h; ii) NaH, 
264, THF, 0 °C to RT, 16 h, 46%; iii) KOH, EtOH, 75%; iv) PPTS, EtOH, RT 
to 50 °C, 18 h, 81%; v) 2,6-lutidine, triflic anhydride, then TBAF, THF, 0 °C to 
RT, 2.5 h, 69%; vi) NaH, triethyl- phosphonoacetate, THF, 0 °C, 16 h, 64%; vii) 
DIBAL-H, THF, -78 °C, 2 h, 80%; viii) MsCl, TEA, LiBr, THF, -45 °C to 0 °C, 
2 h; ix) (Bu4N)3HP20 7, CH3CN, 2 h, then DOWEX ion exchange Bu4N+/NH4+, 
43% for two steps.
2.5 Phenyl substituted FPP analogues
Three phenyl substituted FPP analogues were prepared using the novel Suzuki-Miyaura 
cross-coupling methodology in the key step (see section 1.10).
2.5.1 Synthesis of E- and Z-ll-phenyl farnesyl diphosphate analogues 160 and 161
The synthesis of the E-W-phenyl FPP analogue 160 is shown in Schemes 2.30 and 2.31. 
Reaction of acetophenone (272) with triethyl phosphonoacetate under Homer-Emmons 
condensation lead to ester 273 in good stereoselectivity {E : Z = 12 : 1) (Scheme 2.30).171
179 17TDIBAL-H reduction followed by oxidation of the resulting alcohol 274 using PCC ’ and then 
a Wittig reaction with methyltriphenylphosphonium bromide gave the required £-phenyl diene 
275 in 34% overall yield over the four steps.
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Scheme 2.30: Synthesis o f diene 275.
Reagents and conditions: i) NaH, triethylphosphonoacetate, DME, 3 h, 61%; ii) 
DIBAL-H, THF, -78 °C, 2 h, 96%; iii) PCC, DCM, 4 h, 57%; iv) CH3PPh3Br, 
n-BuLi, THF, 78%.
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£-Phenyl diene 275 was then hydroborated using crystalline 9-BBN as described before (see 
section 2.2.1) and immediately coupled to iodide 165 using PdCbdppf as catalyst, triphenylarsine 
as co-ligand and aqueous sodium hydroxide as base124, 126~129 to give E-phenyl geranyl ester 
product 277 in 59% yield (Scheme 2.31). Homologation to the 1,3-diene derivative 278 was 
carried in a manner similar to that described above (Scheme 2.30). A second Suzuki coupling 
with iodide 165 then gave the farnesyl ester analogue 279 in 28% yield over the four steps. Ester 
279 was transformed into the desired £-11 phenyl FPP analogue 160 in 27% yield following the 
normal sequence of reduction, bromination and diphosphorylation (Scheme 2.31).
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Scheme 2.31: Synthesis o f diphosphate 160.
Reagents and conditions: i) 9-BBN, THF, then iodide 165, PdCl2dppf, NaOH, AsPh3, 
THF, 50 °C, 16 h, 59%; ii) DIBAL-H, THF, -78 °C, 2 h, 96%; iii) TPAP, NMO, CH3CN, 
RT, 16 h, 89%; iv) CH3PPh3Br, n-BuLi, THF, 16 h, 81%; v) 9-BBN, THF, then 165, 
PdCljdppf, NaOH, AsPh3, THF, 50 °C, 16 h, 54%; vi) DIBAL-H, THF, -78 °C, 2 h, 86%; 
vii) MsCl, NEt3, then LiBr, THF, -45 °C to 0 °C, 2 h; viii) (Bu4N)3HP20 7, CH3CN, 2 h, 
then DO WEX ion exchange Bu4N+/NH4+, 31 % for two steps.
Preparation of the Z-11-phenyl FPP analogue 161 was achieved in much the same fashion as
shown in Schemes 2.32 and Scheme 2.33. Preparation of the initial Z-l,3-diene 284 was a little
more complex because Homer-Emmons or Wittig modification of acetophenone (272) only
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yielded a small amount of the Z-ester 285. A Suzuki-Miyaura coupling of phenylboronic acid to 
Z-crotonyl iodide 179 (an intermediate in the preparation of 165)140 however, gave ester 285 in 
85% yield after purification by silica column chromatography (Scheme 2.32).174
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Scheme 2.32: Synthesis o f diene 284.
Reagents and conditions: i) PhB(OH)2, Pd(OAc)2, AsPh3, K3P04, toluene, 90 °C, 
6 h, 85%; ii) DIBAL-H, THF, -78 °C, 2 h, 99%; iii) oxalyl chloride, DMSO, 
DCM, -78 °C, then NEt3, 30 min, 88%; iv) CH3PPh3Br, n-BuLi, THF, 16 h, 76%.
Using DIBAL-H ester 285 was transformed into alcohol 286 and then to aldehyde 287 by Swem 
oxidation175 and followed by a Wittig reaction to generate 1,3-diene 284. Diene 2284 was then 
converted to the Z-11-phenyl FPP analogue 161 using almost identical chemistry described above 
for the preparation of the E-W-phenyl FPP analogue 160 (Scheme 2.30 and 2.31). The two 
crucial Suzuki-Miyaura coupling steps took place in approximately 40% yield.
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Scheme 2.33: Synthesis o f diphosphate 161.
Reagents and conditions: i) 9-BBN, THF, then 165, PdCl2dppf, NaOH, AsPh3, THF, 
50 °C, 16 h, 41%; ii) DIBAL-H, THF, -78 °C, 2 h, 91%; iii) TPAP, NMO, CH3CN, 
16 h, 87%; iv) CH3PPh3Br, n-BuLi, THF, 16 h, 86%; v) 9-BBN, THF, then 165, 
PdCl2dppf, NaOH, AsPh3, THF, 50 °C, 16 h, 40%, vi) DIBAL-H, THF, -78 °C, 2 h, 
77%; vii) MsCl, NEt3, then LiBr, THF, -45 °C to 0 °C, 2 h; viii) (Bu4N)3HP20 7, 
CH3CN, 2 h, then DOWEX ion exchange Bu4N+/NH4+, 36% for two steps.
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2.5.2 Synthesis of 3-phenyl farnesyl diphosphate (162)
We envisaged synthesis of the 3-phenyl farnesyl diphosphate 162 starting from Z-crotonyl triene 
295 and iodide 296 (Scheme 2.34).
OH
297162
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Scheme 2.34: Retrosynthesis o f diphosphate 162.
£-Crotonyl iodide (296) was prepared in two steps from ethyl phenylpropiolate (298) as 
described previously for iodide 165 (Scheme 2.35).138, 139 However, as the separation of the 
isomeric mixture of iodides 296 and 299 by flash silica column chromatography proved difficult 
(due to very similar Rf values),139 the mixture was used directly in the next step.
To synthesize the other component of the Suzuki coupling, geraniol (244) was subjected to TPAP 
oxidation143 followed by a Wittig reaction with methylphosphonium bromide (Scheme 2.35). The 
resulting 1,3-diene 300 which was obtained in 64% yield, was subjected to our new Suzuki 
coupling methodology with iodide 296, as described previously (vide supra). However, when the 
reaction was carried out even at a higher temperature (65 °C), no coupling occurred, presumably
because the bulky phenyl ring hindered attack of the iodide.
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Scheme 2.35: Attempted synthesis o f ester 302.
Reagents and conditions: i) Nal, CH3COOH, 115 °C, 1.5 h, 87%; ii) sealed 
tube under argon, 220 °C, 3 h; iii) TPAP, NMO, CH3CN, RT, 16 h, 82%;
iv) CH3PPh3Br, n-BuLi, THF, 16 h, 80%; v) 9-BBN, THF, then 296, 
PdCl2dppf, NaOH, AsPh3, THF, 65 °C, 16 h.
In order to resolve the above problem, we used the chain extension methodology of Weiler and
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Sum. Geraniol (244) was converted into geranyl bromide (264) and then treated with dienolate 
215 (see Section 2.2.5) to give P-ketoester 303 in 92% yield.118, 162 Treatment with triflic 
anhydride and KHMDS gave the Z-enol triflate 304 in 51% yield.176, 177 Suzuki-Miyaura 
cross-coupling with phenylboronic acid resulted in the formation of 3-phenyl ester 302 in 66%
178 170yield. ’ Reduction followed by derivatisation in the usual manner gave 3-phenyl FPP 
analogue 162 in 26% yield over three steps.
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Scheme 2.36: Synthesis o f diphosphate 162.
Reagents and conditions: i) MsCl, TEA, LiBr, THF, -45 °C to 0 °C, 2 h; ii) 215, 
THF, 0 °C to RT, 2 h, 92%; iii) KHMDS, (CF3S02)20, THF, -78 °C to RT,
16 h, 51%; iv) PhB(OH)2, Pd(OAc)2, AsPh3, Ag20, THF, reflux, 15 h, 66%;
v) DIBAL-H, THF, -78 °C, 2 h, 85%; vi) MsCl, NEt3, then LiBr, THF, -45 °C 
to 0 °C, 2 h; vii) (Bu4N)3HP20 7, CH3CN, 2 h, then DOWEX ion exchange 
Bu4N+/NH4+, 31% for two steps.
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CHAPTER 3
INCUBATION OF FPP ANALOGUES
WITH AS
104
I3.1 Introduction
After obtaining the novel FPP analogues, the following task of this project was testing them with 
sesquiterpene synthase. As an analogue of FPP, they were expected to bind well to the active site, 
and there are two likely results from the incubation of FPP analogues and sesquiterpene 
synthases.
First, the FPP analogues are accepted as substrates by enzymes. This is an effective strategy for 
the investigation of sesquiterpene synthases catalysing multistep transformations in which the 
intermediates are sequestered by the enzyme. Substrate analogues are suitable designed so as to 
prevent completion of the normal catalytic cycle, ether by stabilization of an otherwise reactive 
intermediate or by the absence of a critical reactive centre.90, 103,104 The abortive cyclization 
products thus generated are released from the enzyme and are diagnostic of the structure and 
stereochemistry of the normal enzyme bound intermediates.107,121
Second, the FPP analogues can act as an inhibitor to the enzymes. The development of 
mechanism-based inhibitors for sesquiterpene synthases is particularly challenging since these 
enzymes have evolved to handle highly reactive electrophilic species-cationic intermediates.92 
However, one strategy to overcome this problem is to use substrate analogues, which upon 
cyclization, could undergo rearrangement or delocalisation to place positive charge in a region of 
the protein that does not normally encounter reactive electrophilic centers and that therefore 
would be susceptible to alkylation.92,105, 116,119, 120
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rAs introduced in the first chapter, it is known that the mechanistic details of the cyclisation of 
FPP by aristolochene synthase from P. roqueforti have only recently begun to emerge, mainly 
through the analysis of the reaction products generated by AS-mutants.58 However, there is still 
some details that need further investigation, for example, little is known about the reaction 
mechanism of the formation of the decalin ring system. This could be formed by several
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mechanistically distinct pathways (see Scheme 3.1). ’ ’ ’ ’ In order to explore more deeply the 
mechanism of the reaction catalysed by AS, the nine FPP analogues were incubated with AS and 
the results were analysed using a combination of mass spectrometry and NMR.
3.2 Preparation of wild-type aristolochene synthase
In order to understand how aristolochene synthase catalyses the cyclisation of FPP analogues, and 
also the effects of the substituent functional groups, the preparation of AS is necessary. Therefore, 
the cDNA that codes for aristolochene synthase, Aril, was expressed, and the protein purified 
according to a the published method.49,59 The whole procedure is described in Experimental.
3.3 Incubation results for 12,13-difluoro FPP (154)
Incubation of 12,13-difluoro FPP (154) with purified recombinant aristolochene synthase from 
Penicillium roqueforti in pH 7.5 Tris buffer in the presence of Mg2+ at room temperature58 did not 
lead to any hexane extractable products as judged by GC-MS analysis even after prolonged 
incubation up to seven days. Since 12,13-difluoro FPP clearly did not act as a substrate for AS, it 
was tested as an inhibitor of AS. The steady-state kinetic parameters of purified recombinant AS 
were measured in the presence of varying amounts of 12,13-difluoro FPP by incubation with
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[1-3H]-FPP and monitoring the formation of tritiated, hexane extractable products by Dr. David J. 
Miller, a co-worker on the project. A double reciprocal plot indicated that 12,13-difluoro FPP was 
a reversible competitive inhibitor of AS (Figure 3.1). The measured Ki of 0.8 ± 0.2 mM was 
comparable to the Michaelis constant for AS catalysis (K m = 2.3 mM) reported previously 
indicating that the fluoro substituents do not have a negative effect on the affinity of the enzyme 
for this compound.180
16i
10-
o
1/[S] / pM
Figure 3.1: Double reciprocal plot for inhibition of AS catalysed 
turnover o f FPP (11) by 12,13-difluoro FPP (154) at 0 (•), 0.4 pM (A), 
0.6pM (JL)and 1 pM (o) o f 154.
From the results of incubation of 12,13-difluoro FPP (154) with purified recombinant AS, one 
can gain deeper insight into the mechanism of action of this enzyme. The results obtained with 
site-specific mutants of AS, in which Phe 178 was replaced by valine and which gave relatively 
large amount of (£)-p-famesene (9.2%) and (F^-a-famesene (2.7%) suggested that diphosphate 
ionisation led to the formation of farnesyl cation which was then attacked by the C10-C11 7i-bond 
to generate germacryl cation (path I, Scheme 3.1).57 Alternatively, the formation of germacryl
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cation could take place in a concerted reaction in which famesyl-diphosphate ionisation is 
accompanied by electrophilic attack of Cl of FPP by the CIO, C ll 7i-system (path II).50 This 
mechanism is in agreement with the observation that the reaction of stereospeciflcally deuterated 
FPP occurred with inversion of configuration at Cl.77 In path III, cyclisation is initiated by 
deprotonation from C12 and concurrent bond formation between CIO and Cl.89
58 farnesyl cation
Path I
Path II
OPP,
11 FPP 59 germacryl cationPath III
50 germacrene A 16 aristolochene
Scheme 3.1: Possible pathways for initial cyclisation during 
catalysis by aristolochene synthase.
Due to the electronic effects of fluoro substituents on carbocations described above, incubation of
12,13-difluorofamesyl diphosphate with AS would be expected to generate different outcomes for 
the three cyclisation pathways shown in Scheme 3.2.
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Path I
Path II
Path III12,13-difluoro FPP
12,13-difluoro (£,£)-a-fam esene
12,13-difluoro-(£)-P-famesene
12,13-difluoro farnesyl cation
12,13-difluoro germacryl cation
Q D , r ,
311 nf 312 \ F
12,13-difluoro germacrene A 12,13-difluoro aristolochene
Scheme 3.2: Possible outcomes for 12,13-difluoro FPP during 
catalysis by aristolochene synthase.
For path I, the destabilizing effect of the two fluoro substituents on the putative carbocation on 
Cll should lead to the accumulation of the 12,13-difluorofamesyl cation (307) and the formation 
of 12,13-difluoro (£,£)-a-famesene (308) and 12,13-difluoro-(£)-|3-famesene (309) through 
deprotonation from C4 or C l5. For a reaction where pyrophosphate departure occurs 
simultaneously with electron flow from the CIO, C ll double bond, 12,13-difluoro farnesyl 
diphosphate (path II) would be expected to act as a competitive inhibitor. In pathway III, the 
acidifying effect of the fluoro substituents on the protons on C12 and C l3 should allow the 
reaction to proceed, ultimately generating 12,13-difluoro aristolochene (312).
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The observation that 12,13-difluoro FPP (154) acts as an inhibitor of AS suggests that the 
cyclisation of FPP occurs along path II in which farnesyl diphosphate ionisation is accompanied 
by electrophilic attack of Cl by the CIO, C ll 7i-bond with inversion of configuration at Cl 
resulting in the formation of germacryl cation. However, in previous publication, it was indicated 
that the farnesyl cation was an intermediate during the cyclization of FPP to aristolochene.58 This 
latter conclusion was reached from experiments with a site-specific AS mutant, in which Phe 112 
was replaced with alanine, leading to the production of 34.3% (£)-P-famesene (64) and 53.1% 
(£,ii)-a-famesene (63) in addition to a small amount of germacrene A.58 It was postulated that the 
presence of these linear sesquiterpenoids occurred because of the accumulation of farnesyl cation 
during catalysis in the mutant enzyme due to the lack of stabilization of germacryl cation through 
interaction with the aromatic ring of Phe 112. It was concluded that the aromatic ring of residue 
Phe 112 in addition to stablizing the germacryl carbocation might also play an important role in 
aligning the rc-orbital of the CIO, Cll double bond with the breaking Cl-O bond of the 
diphosphate group due to its steric bulk. When the size of this side chain is reduced by replacing 
the benzyl group with the smaller methyl group this alignment may no longer be optimal thereby 
preventing the immediate quenching of the developing positive charge on Cl and leading to the 
accumulation of farnesyl cation and the production of the linear famesenes (Figure 3.3).
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Figure 3.3: Phe 112 may promote the formation o f the 
reactive conformation.
According to this argument, 154 should act as a substrate of the mutant enzyme AS-F112A since 
the less hindered rotation around the C l-0  bond of 154 in the mutant should lead to the 
formation of 12,13-difluorofamesyl cation (307) and hence of the difluorinated famesenes, 308 
and 309. One major and two side products with the molecular ion peaks of m/z of 240 expected 
for difluorinated sesquiterpenoids were detected in the gas chromatogram of the hexane 
extractable products of incubations of the AS-F112A with 154. While the low activity of 
AS-F112A even with FPP58 allowed for the production of only a small amount of fluorinated 
products and prevented the detailed molecular characterization of the products, this experiment 
nevertheless confirmed that AS-F112A could indeed turnover 154. This result strongly supported 
the proposal that AS catalyses the breaking of the ester bond in FPP and the formation of the 
cyclic germacryl cation (59), at least in part, by facilitating optimal orbital overlap between the 
C10-C11 and Cl-O bonds in FPP through the templating effect of bulky active site residues such
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as Phe 112.
3.4 Incubation results for 2-fluoro FPP (155)
Small scale incubation of 2-fluoro FPP (155) with purified recombinant aristolochene synthase 
for 48 h under the reaction conditions previously used for the incubation of FPP with AS64 gave a 
single pentane extractable product as judged by GC-MS analysis, that showed the molecular mass 
expected for a monofluorinated sesquiterpenoid (Figure 3.2).
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Scheme 3.2: GC-MS analysis o f the pentane extractable 
product o f 2-fluoro FPP (155) utilisation by AS.
As the small scale incubation result was promising, the incubation was repeated on a preparative 
scale. Quantities were increased 50 fold (incubation of 25 mg of diphosphate 155 with AS gave 4 
mg of product). GC mass spectral analysis of the pentane extractable material gave the same 
result.
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IScheme 3.4 shows the outcome expected for the reaction of 2-fluoro FPP (155) when incubated 
with AS. Concurrent loss of pyrophosphate and cyclisation via attack by the C10-C11 double 
bond gives the 2-fluoro germacryl cation (313). Loss of the C12 proton should generate 2-fluoro 
germacrene A (314). The next cyclisation step should be disfavoured because of the inductive 
effect of the fluoride group reducing the nucleophilicity of the C2-C3 double bond and the 
destabilising effect of the positive charge on C3 in eudesmane cation 315. These effects lead to an 
increase of the height of the energy barrier of the step following formation of compound 314.
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313 H B:
2 -fluoro germacryl cation
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Scheme 3.4: Prediction o f the outcome from incubation o f 2-fluoro FPP with AS.
’H-NMR spectroscopic analysis of the product at room temperature gave a rather poorly resolved 
NMR spectrum which was similar to the literature reference spectrum of germacrene A without
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full assignment. 181 The 19F NMR spectrum of the product showed two resonances (§f = -88.8 and 
-90.9 ppm) at room temperature. Because of the known flexibility of cyclodecadienes a variable 
temperature NMR study was carried out in d8-toluene between -80 °C and 90 °C at 10 °C 
intervals. The compound proved to be stable over the whole temperature range as evidenced by 
the reversibility of the temperature dependent spectral changes. Significant line sharpening was 
observed both on lowering and increasing the temperature from 25 °C (Figure 2.5). The 
compound existed as two resolvable conformers at temperatures below 0 °C while at elevated 
temperatures the position of the sharp resonance signals indicated a fast equilibrium between the 
two conformers resulting in a weighted average of the NMR-resonances. A coalescence 
temperature of approximately 30 °C was observed.
COSY and HSQC NMR spectra were obtained both at -60 °C and 90 °C, which made it possible 
to assign the ^-resonance of the compound (see Chapter 3). Together with the room temperature 
HMBC spectrum these data also allowed us to assign the 13C NMR spectrum of this compound. 
Based on these assignments the spectrum at room temperature could also be assigned and all 
were fully consistent with structure of compound 314. As evident from the variable temperature 
NMR spectrum, ]H-NMR signals of 314 were temperature dependent. According to the NMR 
peaks assignment, it was found that the change of resonances for the protons on C4, C6 , C14 and 
the olefinic proton on C12 were most obvious, and which clearly indicated the slow exchange of 
the two major conformations (Figure 3.3). CH3-I4  for instance gives rise to two singlets at 1.67 
and 1.78 ppm at -60 °C while at 90 °C only one singlet is observed at 1.65 ppm. H- 6  presented 
two well-resolved signals at 5.05 and 5.36 ppm at -60 °C while at high temperature only a poorly
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resolved double doublet is observed at 5.18 ppm. At low temperature, the proton on C6  in the two 
conformers showed two different splitting patterns; in the predominant conformer a relatively 
broad doublet is observed as its coupling to one of protons on C5 is presumably minimal due to 
the dihedral angle being close to 90°, however, in the minor conformer coupling to both protons 
on C5 is evident. Similarly, the patterns of the H4 resonances change with temperature as well. 
One of the two protons which leads to a complex multiplet at 90 °C is well resolved at low 
temperature to indicate a double double triplet splitting pattern due to its coupling with the 
geminal proton, the vicinal protons on C5 and the fluoro-substituent. The two resonances for the 
olefinic protons on C12 at 90 °C were resolved into an AB-system when temperature was lowed 
down to -60 °C.
Conformational isomerism of the germacradiene family of natural products, in particular the 
(E, £)-germacranes, has been studied previously both by NMR-spectroscopy and
•  189computationally. The 10-membered ring can adopt four distinct conformations with up-up, 
down-down, up-down and down-up orientations of the methyl groups on C3 and C7 (Figure
1893.4). These conformations are interconvertible by rotation of each of the double bonds through 
the ring and inversion of the C9-C10 unit, the conformation of which is largely determined by the 
exocyclic subsistent on CIO which favors a pseudo-equatorial orientation.
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Figure 3.3. 500 MHz !H NMR spectra of 314 at -60, 25 and 90 °C with assignments shown. Insets show the temperature 
dependent change in the resonances for H6, one of the H4 protons and CH3-I4 . Clearly two conformational isomers 
exist in a ratio o f approximate 3:1 at the lower temperatures (integrals not shown) and the signals for the two coalesce at 
approximately 30 °C. The conformation o f the down-down isomer o/314 is also shown.
up-up up-down
down-up down-down
Figure 3.4. Four distinct conformations o f (+)-germacrene A.
From the recent publication of the conformational analysis of (+)-germacrene A, it can be seen
183that the up-up conformer was predominant according to NMR studies (52% at -20°C). As the
co
AS from Penicillium roqueforti only produces (-)-germacrene A and the relatively large 
isopropylidene substituent will predominately adopt the pseudo-equatorial position, it is 
reasonable to suggest that the mirror image of above illustrated up-up conformer is most stable 
and populated in compound 314. And the minor conformer is expected to be one of the down-up 
or up-down conformers according to the published (+)-germacrene A structure. 183 The analysis of 
the relative intensities of the resonances for the proton on C6  in the -60 °C lU NMR spectrum 
indicate that the ratio between the major and the minor conformer of compound 314 was 3.22 : 1 , 
which is closed to what had been observed for (+)-germacrene A.
3.4.1 Thermal rearrangement of 2-fluoro germacrene A
Germacrene A is known to undergo a Cope rearrangement to generate |3-elemene181 and it was
117
partly, as a result of the temperature induced Cope rearrangement in GC-MS experiments that 
germacrene A was first identified as a minor product of FPP turnover by AS.64 Hence a GC-MS 
analysis with varying injector temperatures but under otherwise identical conditions was applied 
to the product as another experiment to further characterize compound 314 (Figure 3.5).
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Figure 3.5: GC analysis o f the temperature induced reaction products o f the pentane 
extractable products o f 2-fluoroFPP (155) from the cyclization by AS. (A) GC analysis 
of the compound produced by AS from 155 at an injection port temperature o f 50 °C. 
(B) GC analysis o f the same compound at an injection port temperature o f250 °C; (C) 
GC analysis o f the same compound at an injector port temperature o f300 °C.
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Germacrene A undergoes significant Cope rearrangement when the injector temperature is set to 
200 °C.64 In contrast, no thermal rearrangement of compound 314 was observed at this 
temperature. When higher injection temperatures were used, injection at 250 °C gave a small 
amount of rearranged product, and at 300 °C thermal rearrangement of compound 314 was 
dominant (Figure 3.6) and high-resolution mass spectrometry indicated that the two compounds 
had an identical elemental composition (C15H23F).
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Figure 3.6: Mass spectral analysis o f the two isomers produced by thermal rearrangement 
o f 314 in the GC injector. (A) E f  mass spectrum o f the material eluting at 26.24 min, 
this is the presumed 2-fluoro-germacrene A derivative 314; (B) E f  Mass spectrum o f the 
material eluting at 23.72 min, this is the presumed f-elemene analogue 319.
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From the above results, it can be concluded that the presence of the fluoro-substituent in 314 
appears to slow the Cope rearrangement down relative to germacrene A. The effects of fluorine 
substituents on six electron electrocylic processes is unclear since steric and electronic effects 
often compete leading to unpredictable effects on the reaction kinetics, 184 hence a rationalization 
of the reduced reactivity of 314 is difficult.
The fragmentation patterns of both compounds were indicative of a loss of CH3 (-15 m/z), HF 
(-20 m/z) and loss of both CH3 and HF (-35 m/z). The parent molecular ion of compound 314 has 
greater intensity than that of the presumed fluoro-p-elemene (319), which is most likely because 
of facilitated loss of hydrogen fluoride from Cl and C2 of 319 to generate a conjugated diene, 
when compared to elimination of HF from 314.
3.4.2 Discussion on 2-fluoro farnesyl pyrophosphate
As germacrene A does not act as a substrate for AS, it can be argued that germacrene A is not an 
on-path reaction product but a minor side product from a separate reaction pathway catalysed by 
AS.64 However, the above results illustrated that the 2-fluorofamesyl diphosphate 155 is a 
substrate of aristolochene synthase and is converted exclusively to 2F-germacrene A 314, which 
provides strong evidence that germacrene A is generated as an on-path reaction product of the 
conversion of FPP to aristolochene. If germacrene A was produced in a minor, but separate 
pathway by AS, more than one product would be expected from the incubation with 2F-FPP. The 
observation that germacrene A doesn’t act as a substrate for AS is most likely the consequence of 
its very poor solubility in aqueous reaction buffer.
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3.5 Incubation results for 6-fluoro FPP
Incubation of 6 -fluoro FPP (156) with purified recombinant aristolochene synthase under the 
standard reaction conditions (see Section 3.2) for 48 h led to two major hexane extractable 
products as judged by GC-MS analysis, and which showed the molecular mass expected for 
monofluorinated sesquiterpenoid (m/z = 222) (Figure 3.7). The mass spectrum of these two 
products have similar fragmentation pattern, so that we can assume these two molecules have 
similar structures.
In order to make clear what exactly these two products are, preparative scale (50 times scale up) 
incubation of 6 -fluoro FPP (156) with recombinant AS (pH 7.5, 25 °C, 48 hrs) was also done with 
same GC-MS results.
As there were two major products from the incubation of 6 -fluoro FPP (156) and AS, the 
separation of them was necessary before characterization. Two different methods of separation 
were tried. Firstly chromatography using silver nitrate coated silica gel as the stationary phase 
was attempted. This relies upon the coordination between silver and different double bonds, 3% 
(w/w) silver nitrate coated silica gel was made by suspending silica gel in aqueous silver nitrate 
solution and lyophilization, however the two products were not separable by this method. 
Analytical scale HPLC was also attempted, but also failed.
100
%
26.81
(A)
oJ
i27.48
Vi1 rnf|
min
"5o10 15 20 25 30
68.1100 (B)
93.1 179.179.1
159.1 207.2 222 2139. 187.199.1 173.1
190170 210130 150110
100 68.1
(C)
93.1
107.1 1191 179.179.
159.1139.
i 173. m/z
230110 130 190 210170150
Figure 3.7: GC-MS analysis o f the pentane extractable products o f 6-fluoroFPP (156) 
utilisation by AS, (A) GC analysis o f the compounds produced by AS from 156 at an 
injection port temperature o f 50 °C; (B) E f  mass spectrum o f the material eluting at 
26.81 min; (C) E f  mass spectrum o f the material eluting at 27.48 min.
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As these two products were not separable using the above methods, another explanation is 
possible. It is possible the fluorine substituent reduces the basicity of C6-C7 double bond in 
6 -fluoro germacrene A, therefore further cyclization cannot carry on as it cannot easily protonate. 
There is probably only one major product from this incubation, which is 6 -fluoro germacrene A 
(321) (Scheme 3.5). The two peaks observed in GC analysis are probably 6 -fluoro germacrene A 
(321) and its Cope rearrangement product. 6 -Fluoro germacrene A has been observed as a product 
when 6 -fluoro FPP was incubated with epi-aristolochene synthase. 185
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156 320
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Scheme 3.5: Prediction o f the incubation o f 6-fluoro FPP with AS.
3.6 Incubation results for 10-fluoro FPP (157)
Incubation of 10-fluoro FPP (157) with purified recombinant AS under the standard reaction 
conditions used throughout this work led to no hexane extractable product as judged by GC-MS 
analysis.
This result can be compared to that obtained for 12,13-difluoro FPP (Scheme 3.2). In the first
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step of the cyclisation of 10-fluoro FPP 157, for path I, 57 the destabilizing effect of the CIO fluoro 
substituent on carbocation on Cll should lead to the accumulation of the 10-fluorofamesyl cation 
323 and the formation of 10-fluoro (£,£)-a-famesene 324 and 10-fluoro-(£)-p-famesene 325
O Q  %
through deprotonation from C4 or C l5 since 326 is destabilised. Path III will lead to the 
production of 10-fluoro aristolochene 327. From our incubation results, there was no haxane 
extractable product, so path I and path III are not in agreement with the experimental results.
Even though the kinetic study of this analogue as an inhibitor of AS has not yet been done, the 
GC-MS result is also strong evidence for path II, which is a concerted reaction, in which 
diphosphate ionisation is accompanied by electrophilic attack of Cl by the 10, 11 7i-system, 50 in 
this case, the result 1 0 -fluoro germacryl cation is strongly destablised, which should make this 
analogue a competitive inhibitor of AS. All above results and discussion give further support for 
the reaction mechanism of the formation of the decalin ring system (Scheme 3.6).
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10-fluoro FPP
10-fluoro (£,iT)-a-famesene
1 0 -fluoro-(£)-p-famesene
1 0 -fluoro famesyl cation
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1 0 -fluoro germacryl cation
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10-fluoro germacrene A 10-fluoro aristolochene
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Scheme 3.6: Possible products for 10-fluoro FPP during catalysis by AS.
3.7 Incubation results for 14-fluoro FPP (158) and 15-fluoro FPP (159).
Incubation of 14-fluoro FPP (158) with purified recombinant AS under the standard reaction 
conditions used earlier for 48 hours led to 3 major hexane extractable products as judged by 
GC-MS analysis (Figure 3.8). One of those had the required mass (m/z = 222).
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Figure 3.8: GC-MS analysis o f the pentane extractable products o f 14-fluoroFPP 
(157) utilisation by AS, (A) GC analysis o f the compounds produced by ASfrom 157 at 
an injection port temperature o f 50 °C; (B) GC trace containing m/z=222; (C) E f  
mass spectrum o f the material eluting at 29.2 min.
Similar incubation of 15-fluoro FPP (159) with purified recombinant AS led to four major hexane
extractable products as judged by GC-MS analysis (Figure 3.9). One of the four products had the
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required mass (m/z = 222).
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Figure 3.9: GC-MS analysis o f the pentane extractable products o f 15-fluoroFPP (158) 
utilisation by AS, (A) GC analysis o f the compounds produced by AS from 158 at an 
injection port temperature o f 50 °C; (B) GC trace containing m/z=222; (C) E f  mass 
spectrum o f the material eluting at 28.8 min.
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The above two results clearly show that these two analogues were substrates of AS. They both 
have one peak which containing the right molecular weight for a monofluoro sesquiterpenoid 
compound {m/z = 222). Scheme 3.7 and Scheme 3.8 shows the possible outcomes from the AS 
cyclization of 14-fluoro FPP (158) and 15-fluoro FPP (159).
For 14-fluoro FPP (158), there is no build up of positive charge in the vicinity of fluorine atom 
through the entire proposed AS catalytic mechanism, and so the fluorine atom may have no effect 
on the reaction, and the cyclization would go in its normal route and then generate 14-fluoro 
aristolochene (334) as final product. However, the situation is different for the other FPP 
analogue 159. The fluorine substituent should destabilize the cation 337. This effect increases the 
height of the energy barrier, so that, 15-fluoro germacrene A (336) should accumulate and hence 
become the major product from the cyclization.
5
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Scheme 3.7: Prediction o f the incubation o f 14-fluoro FPP with AS.
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Scheme 3.8: Prediction o f the incubation o f 15-fluoro FPP with AS.
3.8 Incubation results for Phenyl substituted FPP analogues
Each of the famesyl diphosphate analogues prepared 160, 161 and 162 was tested as a substrate 
for aristolochene synthase as previously described. None of the compounds tested in this study 
produced any hydrocarbon products of the correct mass as judged by GC-MS analysis. Each 
compound was therefore examined as an inhibitor of AS using a radiolabelled assay by Dr. David 
J. Miller. Double reciprocal plots indicated that all compounds were reversible competitive 
inhibitors of AS and hence are bound at the enzyme’s active site in a way similar to that of the 
natural substrate (Figure 3.10). The Xi-values were determined as 0.8 ± 0.2, 1.2 ± 0.2 and 1.2 ± 
0.1 pM for 160,161, and 162, respectively.
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Figure 3.10: Double reciprocal plots o f initial rates versus the concentration o f substrate 
for AS catalysed turnover o f FPP in the presence of 160, 161 and 162 are shown on 
panels A, B and C for increasing concentrations o f inhibitor (0 pM (•), 1 juM (A), 2 pM 
(4)  and 3 pM (a)). Intersection o f the lines on the y-axis indicate that each compound is a 
competitive inhibitor o f AS. All assays were carried out at 37 °C and pH 7.5.
The three phenyl derivatives 160, 161 and 162 prepared in this study were initially envisaged as
proof of concept synthetic targets in order to test the Suzuki-Miyaura cross-coupling
methodology and were not expected to bind with any great affinity to the enzyme. It was
expected that the bulky phenyl groups would make the whole molecule too large to fit in the
active site. It was therefore quite surprising when each of these compounds -  although not a
substrate for AS -  were nevertheless binding to the active site with barely reduced affinity
compared to natural substrate. Each inhibitor was therefore docked to the active site of AS using
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the existing molecular model of FPP bound to AS49 as a starting point by Neil J. Young. Energy
186minimisations of the docked structures were performed using the MMFF94 forcefield. Amino 
acids within 6 .5 A of the inhibitor molecule were allowed to move while the coordinates of all 
other residues were fixed. Each inhibitor appeared to fit well into the active site of AS and only 
minor reorganizations of active site residues were necessary to avoid steric clashes through the 
introduction of the bulky phenyl substituents (Figure 3.11).
W334
W334
Figure 3.11: Sketches from molecular mechanics simulations o f  the active sites o f AS 
complexed with E-l 1-phenyl FPP (160) (A), Z-ll-phenyl FPP (161) (B) and 3-phenyl 
FPP (162) (C). The substrate and the inhibitors as well as key amino acid residues are 
shown in purple for the original structure and in green for the energy minimised 
structures o f the inhibitor complexes o f  AS.
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Particularly noteworthy is the case of the 3-phenyl FPP analogue 162 which binds to AS with Ki 
= 1.2 pM. Previous work has shown that a large tryptophan residue (W334) is positioned in the 
active site of AS to stabilise a positive charge build up on C-3 during formation of the eudesmane 
cation and so one would expect this residue to sterically hinder the approach of a phenyl group on 
C3 49 ,56 Clearly this does not occur although the enzyme does not produce any product from this 
compound. From this result and the fact that the other two phenyl derivatives bind effectively to 
the enzyme one can draw the conclusion that the active site is impressively flexible and able to 
bind FPP analogues even with very large pendant groups. The vast majority of the binding 
energy of FPP is hence unsurprisingly provided by the diphosphate group and the alkyl chain 
contributes little to this such that large substituents and concomitant rearrangement of amino acid 
residues in and around the active site can be accommodated with little effect on the affinity of 
such compounds for the enzyme. However, such alterations in the binding fold clearly prevent 
functionality.
3.8 Overall conclusions and future work
A variety of famesyl pyrophosphate (FPP) analogues were prepared using both published
protocol and novel methodologies. The latter consisting of modification and improvement of the
traditional Suzuki-Miyaura coupling. These coupling reactions proceed in moderate to good
yield. It should be possible to use this technology to prepare combinatorial libraries of FPP
analogues in the future. Some members of such libraries may act as substrates for AS and other
terpene cyclases thereby opening up the possibility of short economical routes to complex,
synthetic unnatural analogues of terpenoids. These compounds were incubated with aristolochene
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synthase (AS) in order to probe its mechanism of action and resulted in many interesting results.
The mechanisms of the enzyme-catalysed cyclisations of sesquiterpenoids are inherently difficult 
to study spectrometrically and their elucidation has been largely dependent on the use of substrate 
mimics and site directed enzyme mutants. Mechanistic studies with substrate analogues suggested 
that AS converts FPP into the bicyclic sesquiterpene aristolochene (16) through an initial 
cyclisation to generate the intermediate (-)-germacrene A (50) followed by protonation, 1,2 
hydride and methyl shifts and stereospecific deprotonation from C8  (Scheme 1.6). Surprisingly 
little is known about the reaction mechanism of the formation of the decalin ring system that could 
be formed by several mechanistically distinct pathways (Scheme 3.1). First, the diphosphate 
ionisation led to the formation of famesyl cation (58) which was attacked by the C10-C117c-bond 
to generate germacryl cation (59). Alternatively, the formation of 59 could take place in a concerted 
reaction in which famesyl diphosphate ionisation is accompanied by electrophilic attack of Cl of 
FPP by the CIO, Cl 1 7r-bond. Also, cyclisation can be initiated by deprotonation from C12 and 
concurrent bond formation between CIO and Cl. Since it has become increasingly apparent that 
only a few amino acid substitutions can be sufficient to remodel the active site template provided 
by terpene synthases, thereby often dramatically altering the reaction products, a detailed 
mechanistic understanding of the reaction catalysed by these enzymes is central to their further 
evolution in vitro or in vivo for the generation of novel products. The synthesis of 12,13-difluoro 
famesyl pyrophosphate (154) was achieved in 13 steps using Suzuki-Miyaura chemistry. This 
compound proved to be potent inhibitor of aristolochene synthase (AS), which revealed that the 
initial cyclisation to germacryl cation occurs in a concerted fashion, in which famesyl diphosphate
ionisation is accompanied by electrophilic attack of Cl by the CIO, Cl 1 rc-bond with inversion of 
configuration at Cl resulting in the formation of germacryl cation.
As described above, it is known the mechanism of the conversion of FPP (11) to aristolochene 
(16) catalyzed by aristolochene synthase from Pemcillium roqueforti has been proposed to 
proceed through the neutral intermediate germacrene A (50). However, much of the experimental 
evidence is also in agreement with a mechanism in which germacrene A is not an intermediate in 
the predominant mechanism that leads to the formation of aristolochene, but rather an 
off-pathway product that is formed in a side reaction. Hence, to elucidate the mechanism of FPP 
cyclisation the substrate analogue 2-fluoro FPP (155) was synthesized, and upon incubation with 
aristolochene synthase was converted to a single pentane extractable product according to 
GC-MS analysis. On the basis of NMR analyses this product was identified as 
2-fluorogermacrene A (314). Variable temperature *H NMR spectroscopy indicated the existence 
of two conformers of 314 that were in slow exchange at -60 °C, while at 90 °C the two isomers 
gave rise to averaged NMR signals. In the major isomer (-75%) the methyl groups on C3 and C7 
were most likely in the down - down orientation as had been observed for other 
(£,£)-germacranes. This work suggests that after an initial concerted cyclisation of FPP to 
germacryl cation deprotonation leads to the formation of germacrene A, and provides compelling 
evidence that germacrene A is indeed an on-pathway product of catalysis by aristolochene 
synthase.
6 -Fluoro FPP (156) was prepared using the Weiler’s chain extension method in 10 steps, and was
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identified as substrate of AS. The inductive electron-withdrawing effect of the fluoro group 
decreases the tz system basicity of the 6,7-double bond resulting in blockage of the subsequent 
proton-induced cyclization to the bicyclic eudesmane cation 322. The product was postulated as 
6 -fluoro germacrene A, which is consistent with published results on epi-aristolochene 
synthase185.
10-Fluoro FPP (157) was synthesized using the sulfonylation-alkylation-desulfonylation 
methodology and it was found not to act as substrates of the AS. This result is fully consistent 
with the conclusions drawn from the results with 12,13-difluoro FPP (154). Work is ongoing in 
the group to support this hypothesis. FPP analogues with one fluoro substituent at position C14 
158 and C l5 159 were made using methodology employing the Homer-Emmons Wittig 
condensation as a key step. These two compounds were tested with AS and both gave one major 
extractable terpene product according to GC/MS analysis. These two products are postulated as 
two different compounds - 14-fluoro aristolochene and 15-fluoro germacrene A respectively, 
because of the destabilizing effect of the ^-substituted fluorine atom on the carbocation in their 
vicinity. Again, work to support this hypothesis is ongoing within the group.
From above mentioned work, it seems the strong influence on the reactivity exerted by fluoro 
substituents without significantly affecting size and shape may make fluorinated FPP analogues a 
very powerful method to explore the chemistry of terpene synthases. 187 However, only through a 
combination of experimental approaches will the intricate details of this masterpiece in 
combinatorial chemistry be deciphered.
135
Analogues of famesyl pyrophosphate containing phenyl substituents in place of methyl groups 
were synthesized using the Suzuki-Miyaura reaction as the key step. These analogues were found 
not to act as substrates of the aristolochene synthase. However, they were potent competitive 
inhibitors of AS, which indicate that the active sites of AS is sufficiently flexible to accommodate 
even substrate analogues with large substituents. The plasticity of the terpene cyclases appears 
not only to provide the framework for the combinatorial production of many natural terpenoids 
through subtle alterations in the composition of the active site during evolution but may also 
allow modifications of the active site residues by site directed or random mutagenesis in vitro or 
in vivo for the production of functional enzymes that convert FPP analogues to unnatural 
“terpenoids”.
In the future, it should be possible to make use of new Suzuki coupling technology to prepare 
combinatorial libraries of FPP analogues. Some of these compounds will no doubt act as 
substrates for AS and other terpene cyclase enzymes and thus open up the possibility of short 
economical routes to complex, synthetic modified terpenoids.
136
CHAPTER 4 
EXPERIMENTAL
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4.1 General experimental
All chemicals were purchased from Sigma-Aldrich unless otherwise stated. Tetrahydrofuran 
(THF) and diethyl ether were distilled from sodium/benzophenone ketyl under nitrogen. 
Acetonitrile, dichloromethane, toluene and triethylamine were distilled from calcium hydride 
under nitrogen. 9-BBN was used as the commercially available crystalline form as solutions were 
not found to work adequately in hydroboration reactions employed in this study. Ecoscint 
scintillation fluid was purchased from National Diagnostics. All other chemicals were of analar 
quality and used as received unless otherwise stated. Reactions were stirred at room 
temperature in air unless otherwise stated. All glassware was clean and dry before use.
!H NMR spectra were measured at 500 MHz on a Bruker Avance 500 NMR spectrometer or a 
Bruker Avance DPX400 NMR spectrometer and are reported as chemical shifts in parts per 
million downfield from tetramethylsilane, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet), coupling constant (to the nearest 0.5 Hz) and assignment respectively. 
13C NMR spectra were measured at 125 MHz on a Bruker Avance 500 NMR spectrometer and 
are reported as chemical shift downfield from tetramethylsilane, coupling constant where 
appropriate and assignment. Assignments are made to the limitations of COSY, DEPT 90/135, 
gradient HSQC and gradient HMBC spectra. 19F and 31P NMR spectra were recorded on a Jeol 
Eclipse +300 NMR spectrometer and are reported in chemical shift downfield from CFCI3 and 
85% H3PO4 respectively followed by multiplicity and coupling constant (to the nearest 0.5 Hz) if 
appropriate. IR spectra were recorded on a Perkin ELMER 1600 series FTIR spectrometer and 
samples were prepared as thin films of neat liquid on sodium chloride discs for oils and as KBr
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disks for solids. EI+ mass spectra were measured on a Micromass LCT premiere XE mass 
spectrometer. ES' mass spectra were provided by the UK EPSRC mass spectrometry service, 
Swansea UK. Reverse phase HPLC was performed on a system comprising of a Dionex P680 
pump and a Dionex UVD170U detector unit.
4.2 Experimental
(£)-3-Iodo-but-2-enoic acid ethyl ester (165)
^CQ2Et 
I H
The (Z)-3-iodo-but-2-enoic acid ethyl ester (4.63g, 19.3 mmol) was heated at 220 °C under argon 
in a sealed tube for 4 h, purification of the resulting brown oil by flash column chromatography 
directly to give the title compound as a pale yellow oil (2.16 g, 46%, recover 47%); Rf 0.21 
(Hexane : EtOAc = 9:1) ;  xwfthin filmycm' 1 2980.1, 1718.3, 1617.3, 1424.7, 1366.3, 1330.1,
1264.7, 1185.7, 1074.4, 1036.2, and 861.2; 5H (300 MHz; C2HC13) 1.26 (3 H, t, J  7.0, C773CH20), 
2.97 (3 H, d, J  1.5, CH3CI), 4.13 (2 H, q, J  7.0, CH3C7/20) and 6.61 (1 H, J  1.5, ICCH); 8C(75.4 
MHz; C2HC13) 12.61 (CH3CH20), 29.42 (CH3CI), 58.80 (CH3CH20), 118.69 (quaternary C) and 
129.94 (1CCH); m/z (El*) 240.1 (100%, M*).
5-Ammo-5-hydroxymethyI-2,2-dimethyl-l,3-dioxane (167)
O H
, N H 2
O .
To a stirred solution of tris(hydroxymethyl)aminomethane hydrochloride (7.9 g, 50 mmol) in dry
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DMF (40 cm3) was added p-toluenesulfonic acid (0.5g, 2.5mmol) monohydrate followed by
2.2-dimethoxypropane (6 . 8  cm3, 55mmol). The resulting clear and colourless solution was 
allowed to stir overnight. Triethylamine (0.42 cm3, 3mmol) was added and stirring continued for 
a further 10 min. The mixture was concentrated under reduced pressure and then treated with 
triethylamine (6.3 cm3, 45 mmol) and ethyl acetate (150 cm3). The white precipitate which was 
formed upon addition of base was removed via filtration and the fitrate purified by bulb-to-bulb 
distillation (85 °C/ 0.7 Torr) to afford a white solid (1.83 g, 23%); Dmax (KBr disk)/cm_1 3324.0,
3270.2, 1993.0, 2863.1, 2361.5, 1611.6, 1454.4, 1369.3, 1153.6, 1052.1 and 826.8; 5H(300 MHz; 
C2HC13) 1.38, 1.41 [ 6  H, 2  x s, (CH3)2C02], 2.36 (3 H, br, OH and NH2), 3.45 (2 H, s, HOC/^C) 
and 3.53 and 3.78 [4 H, 2 x d, J  12.0 and J  12.0, (CH2)2C]; 5C(75.4 MHz; C2HC13) 22.88 and 
25.56 [(CH3)2C02], 50.89 (HOCH2), 65.43 and 67.85 (CH2CCH2) and 99.21 [(CH3)2C02]; m/z 
(El*) 161.7 (8 %, M*), 145.7 (43, [M -  NH2]+), 72.8 (100).
2.2-Dimethyl-5-oxo-l,3-dioxane (168)
To a stirred solution of 5-amino-5-hydroxymethyll-2,2-dimethyl- 1,3-dioxane (crude) and
potassium dihydrogenphosphate (6 . 8  g, 50 mmol) in water (100 cm3) at 5 °C was added dropwise,
over 3 h a solution of sodium periodate (10.7 g, 50 mmol) in water (100 cm3). The mixture was
allowed to stir for an additional hour at 5 °C and then for 15 h at R.T. before being extracted with
DCM (10 x 1 5  cm ). The combined organic extractions were dried (MgS0 4 ), filtered, and
concentrated under reduced pressure. The crude ketone was then purified by bulb-to-bulb
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distillation (85 °C/ 20 Torr) to give the title compound as a colorless liquid (4.4g, 6 8 % over two 
steps); Rf 0.25 (Hexane : EtOAc = 4: 1) ;  \)max(thin film)/cm_1 2993.1, 2937.3, 1751.4, 1679.5,
1381.3, 1232.6, 1088.6, 1047.9 and 831.5; 6H(300 MHz; C2HCI3) 1.29 ( 6  H, s, 2 x CH3) and 3.97 
(4 H, s, 2  x CH2); 6c (75.4 MHz; C2HC13) 25.05 (2 x CH3), 68.38 (2 x CH2), 101.88 [(CH3)2q  
and 209.72 [(CH ^CO ]; m/z (El*) 130 (17 %, M*), 115 (35, [M -  CH3]+), 100 (30, [M -  
(CH3)2]+)and43(100).
2-(2,2-Dimethyl-l,3-dioxan-5-ylidene)-acetic acid ethyl ester (169)
Fleshly cut sodium (0.68 g, 29 mmol) was dissolved in dry ethanol (50 cm3). 
(Carbethoxymethyl)triphenyl-phosphonium bromide (12.7 g, 29 mmol) was added and the 
reaction mixture allowed to stir for 1 h. The ketone 168 (2.21 g, 17 mmol) was added and after 15 
h, the mixture was extracted with DCM (3 x 15 cm3), dried (MgSCU) and concentrated under 
reduced pressure. Purification by flash column chromatography on silica gel with hexane and 
ethyl acetate (4 : 1) as eluent gave the title compound as a light yellow oil (2.6 g, 77%); Rf 0.36 
(Hexane : EtOAc = 4:1) ;  umax(KBr disk)/cm_1 2984.1, 2939.8, 1778.9, 1736.7, 1639.8, 1443.0,
1375.3, 1225.0, 1022.8 and 890.8; 5H(500 MHz; C2HC13) 1.29 (3 H, t, J 7.0, OCH2C//3), 1.41 [ 6  
H, s, (CH3)2C], 4.16 (2 H, q, J7.0, OCi72CH3), 4.28 and 4.87 (4 H, 2 x s, OCH2C) and 5.62 (1 H, 
s, C=CHC=0); 5C (75.4 MHz; C2HC13) 14.42 (OCH2CH3), 24.13 [(CH3)2C], 60.32 (OCH2CH3), 
61.83 and 63.04 [(CH2)2C], 100.31 [(CH3)2q , 112.49 (C=CHC=0), 158.04 (C=CHC=0) and 
166.02 (C=CHC=0); m/z (EI+) 185 (28%, [M -  CH3]+) and 97 (100).
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5-Allylidene-2,2-dimethyl-l,3-dioxane (172)
Methyl triphenylphosphonium bromide (20.9g, 58.7 mmol) was dissolved in dry THF (100 cm3), 
then BuLi (29.4 cm3, 58.7 mmol) was added dropwise to the stirred solution under an argon 
atmosphere. After stirring under argon for about 30 min at room temperature, the aldehyde 176 
(3.05g, 19.6 mmol) was added dropwise in the deep yellow solution and the reaction mixture was 
stirred under argon for 18h. The result mixture was extracted with diethyl ether (3 x 30 cm3), and 
the organic phases were combined, washed with brine (30 cm3) and dried (MgSCU), filtered and 
then concentrated under reduced pressure. Purification by flash column chromatography on silica 
gel with hexane and ethyl acetate (9 : 1) as eluent gave the title compound as a pale yellow oil 
(1.85 g, 61.5 % yield); Rf 0.36 (Hexane : EtOAc = 9: 1) ;  umax(thin film)/cm_1 2988.3, 2849.6,
1596.6, 1447.7, 1380.9, 1221.7, 1154.9, 1083.0, 1047.1, 903.3 and 831.4; 5H(500 MHz; C2HC13) 
1.37 [ 6  H, s, (CH3)2C], 4.22 and 4.45 (4 H, 2 x s, OCH2), 5.06 (1 H, d, J  10.0 CHCHCHtranstfas),
5.12 ( 1  H, d, J  16.5, CHCHCi/transHcis), 5.75 (1  H, d, J  11.0, CtfCHCH2) and 6.31 ( 1  H, dt, J  10.5, 
J  16.5, CHC//CH2); Sc (75.4 MHz; C2HC13) 25.07 [(CH3)2C], 60.91 and 65.18 [(CH2)2C], 100.30 
[(CH3)2q ,  119.32 (C=CHCtf2), 123.92 and 131.59 (2 x CH), 135.83 (C=CHCH2); m/z (El*) 154 
(5%, M*) and 67 (100).
2-(2,2-Dimethyl-l,3-dioxan-5-ylidene)-l-ol (175)
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To a stirred solution of ester 169 (2.11 g, 10.6 mmol) in dry THF (50 cm3) at 0 °C (ice bath), was 
added dropwise (over 3 min) diisobutylaluminum hydride (1.5 M, 17.7 mL, 26.5 mmol). The 
reaction mixture was allowed to stir at 0 °C for 1 h, quenched with sat. sodium potassium tartrate 
(30 cm3), and then extracted with diethyl ether (3x15 cm3). The combined organic extracts were 
dried (MgSCU), and then concentrated under reduced pressure. Purification by flash column 
chromatography on silica gel with hexane and ethyl acetate ( 1  : 2 ) as eluent gave the title 
compound as a pale yellow oil (1.63 g, 97%); Rf 0.27 (Hexane : EtOAc = 1  : 2); omax (thin 
film)/cm_1 3357.3, 2935.8, 2882.3, 1720.7, 1652.2, 1411.6, 1215.5, 1167.6, 1090.2 and 1002.5; 
8 h (300 MHz; C2HC13) 1.49 ( 6  H, s, (CH3)2C), 2.32 (1  H, br, CHCH20//)> 4.06 ( 2  H, d, J6.5, 
CHCtf2OH), 4.22 and 4.38 (2 H, s, OCH2C) and 5.42 (1 H, t, J  6.5, C=CtfCH2OH); 5C(75.4 
MHz; C2HC13) 25.59 [(CH3)2C], 59.33 and 61.15 [(CH2)2C], 65.69 (CHCH2OH), 100.98 
[(CH3)2q ,  123.62 (C=CHCH2OH) and 136.93 (CCHCH2OH); m/z (EI+) 143 (40%, [M -  C H ^  
and 83 (100).
(2,2-Dimethyl-l,3-dioxan-5-ylidene)-acetaldehyde (176)
To a stirred suspension of pyridinium chlorochromate (9.2g, 42.5mmol) in anhydrous DCM was 
added a solution of alcohol 175 (5.6g, 35.4 mmol) in DCM (100 cm3) in one portion. After 4 h, 
dry diethyl ether ( 1 0 0  cm3) was added and the supernatant liquid was decanted from the black 
gum. The insoluble residue was washed with dry diethyl ether (100 cm3) and became a black 
granular solid. The organic phases were combined, washed with brine (30 cm3) and then dried
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(MgSCU), filtered and then concentrated under reduced pressure. Purification by flash column 
chromatography on silica gel with hexane and ethyl acetate ( 2  : 1 ) as eluent gave the title 
compound as a yellow oil (3.05 g, 55% yield); Rf 0.30 (Hexane : EtOAc = 2 : 1 ) ;  ^w^liin 
film)/cm_1 2988.3, 2844.5, 1678.7, 1611.9, 1442.5, 1375.8, 1216.6, 1077.9 and 831.4; 8H(300 
MHz; C2HC13) 1.35 [ 6  H, s, (CH3)2C], 4.28 and 4.77 (4 H, 2 x s, OCH2) and 5.79 (1 H, m, 
C=CHCHO) and 9.71 (1 H, d, J6.0, CHO); 8C(75.4 MHz; C2HC13) 22.17 [(CH3)2C], 58.58 and
61.16 [(CH2)2C], 98.79 [(CH3)2q ,  119.33 (C=CHCHO), 158.45 (C=CHCHO) and 187.50 
(CHCHO); m/z (Ef) 156.1 (33%, M+ ) and 43.0 (100).
(£)-6-(2^2-Dimethyl-lr3-dioxan-5-ylidene)-3-methyl-hex-2-enoic acid ethyl ester (177)
A mixture of the diene 172 (0.144g, 1.00 mmol) and 9-BBN solution (6.0 cm3, 3.0 mmol) in dry 
THF (10 cm3) was stirred at room temperature until all the starting material had been consumed. 
Following this the iodide 165 (0.22g, 0.9 mmol), triphenyl arsine (0.03 lg, 0.1 mmol), PdCl2dppf 
(0.04lg, 0.05 mmol) and 6  M NaOH (0.67 cm3, 4 mmol) were added, the complete solution was 
then stirred under a inert atmosphere for 15 h at 50 °C. TLC (eluting with Hexane:EtOAC, 9:1) 
after this time showed that the iodide had been consumed. H20 2 (8.0 cm , 8  mmol) was then 
added to quench the reaction. The result mixture was extracted with diethyl ether (3 x 30 cm ), 
and the organic phases were combined, washed with brine (30 cm3) and dried (MgS0 4 ), filtered 
and then concentrated under reduced pressure. Purification by flash column chromatography on 
silica gel with hexane and ethyl acetate (9 : 1) as eluent gave the title compound as a pale yellow
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oil (0.16g, 62 % yield); Rf 0.18 (Hexane : EtOAc = 9 : 1 ) ;  HRMS (ES+, [M + Na]4) found 
291.1578. Ci5H240 4Na requires 291.1572; omax(thin filmycm" 1 2978.0, 2849.6, 1709.8, 1642.8,
1442.5, 1365.5, 1216.6, 1139.5, 1072.8 and 831.4; 6H(300 MHz; C2 HC13) 1.25 (3 H, t, J  7.0, 
OCH2 C//3), 1.40 [ 6  H, s, (CH3)2 C], 2.12 (3 H, d, J  1.0, Ctf3OCHC=0), 2.15 (4 H, b, CH2CH2), 
4.11 (2 H, q, J  7.0, OC//2 CH3), 4.20 and 4.36 (4 H, 2 x s, OCH2), 5.17 (1 H, m, C=CHCH2CH2) 
and 5.62 (1 H, d, J  1.0, C=CHC=0); Sc (75.4 MHz; C2 HC13) 12.35 (OCH2 CH3), 16.73 
(CH3C=CH), 22.06 [(CH3)2 C], 22.59 and 38.34 (CH2CH2), 57.60 and 57.79 [(CH2)2 C], 62.43 
(OCH2 CH3), 97.14 [(CH3)2 q ,  114.18 and 119.74 (2 x CH), 131.00, 156.51 and 165.00 
(quaternary C); m/z (ES4) 291.1 (100%, [M + Na]+ ).
(Z)-3-Iodo-but-2-enoic acid ethyl ester (179)
I C02Et
An oil bath was preheated at 115 °C for 15 min, a flask containing a mixture of ethyl 2-butynoate
(2.33 cm3, 20.0 mmol), sodium iodide (4.80 g, 3.0 mmol) and glacial acetic acid (7.70 cm3, 134
mmol) was placed in the oil bath and the mixture was stirred at 115 °C for 90 min. the bath was
removed and the brown mixture was transferred while hot to a separatory funnel containing water.
The phases were separated and the aqueous phase was washed with diethyl ether (3 x 30 cm3),
the combined organic phase was washed sequentially with saturated aqueous sodium bicarbonate
(30 cm3), satd. sodium metabisulfite (30 cm3) and brine (30 cm3). Then dried (MgS04) and
concentrated under reduced pressure to give the title compound as a yellow oil (4.75 g, 98%); Rf
0.26 (Hexane : EtOAc = 9 : 1 ) ;  omax(thin filmVcm’ 1 2979.1, 1727.2, 1628.3, 1431.8, 1365.8,
1308.2, 1275.2, 1180.1, 1094.7, 1046.1, 948.4 and 846.3; 8H(300 MHz; C2HC13) 1.27 (3 H, t, J
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7.0, C//3CH20), 2.71 (3 H, d, J  1.5, C//3CI), 4.18 (2 H, q, J  7.0, CH3C//2O) and 6.26 (1 H, J 1.5, 
ICC//); 8 c (75.4 MHz; C2HC13) 13.55 (CH3CH2O), 35.85 (CH3CI), 59.83 (CH3CH2O), 112.48 
and 163.50 (quaternary C) and 124.95 (ICCH); m/z (EI+) 240.1 (100%, M+).
(£)-6-(2,2-Dimethyl-lv5-dioxan-5-ylidene)-3-methyl-hex-2-en-l-ol (180)
This compound was prepared from 177 in a manner similar to that for the alcohol 175; 
purification by silica column chromatography using hexane and ethyl acetate (1 : 2 ) as eluent gave 
alcohol 180 as a pale yellow oil (0.76 g, 91 % yield); Rf 0.32 (Hexane : EtOAc = 1:2);  HRMS 
(ES+, [M + Na]*) found 249.1478. C o^C ^N a requires 249.1467; umax(thin filmVcm' 1 3416.0,
2987.2, 2934.7, 2852.2, 1666.9, 1449.4, -1370.4, 1222.6, 1194.5, 1155.8, 1063.8, 1015.1 and 
831.2; 8 h (300 MHz; C2HC13) 1.36 [ 6  H, s, (C/f&C], 1.60 (3H, s, C//3C=CHCH2OH), 2.00 (4H, 
b, CH2CH2), 2.32 (1H, b, OH), 3.94 (2 H, d, J  7.0, C=CHC/f2OH), 4.16 and 4.30 (4 H, 2 * s, 2 x 
OCH2), 5.16 ( 1 H, m, C=C//CH2CH2) and 5.33 (1  H, dt, J  7.0, C=C77CH2OH); 5C(75.4 MHz; 
C2HC13) 18.46 (CH3C=CHCH2OH), 26.16 [(CH3)2C], 27.01 and 40.96 (CH2CH2), 59.15
(C=CHCH2OH), 61.25 and 62.00 [(OCH2)2C], 101.24 [(CH3)2q ,  124.99 and 126.61 (2 * CH),
134.16 and 140.23 (quaternary C); m/z (ES+) 249.1 (15%, [M + Naf), 133.1 (100).
(£)-6-(2,2-Dimethyl-l,3-dioxan-5-ylidene)-3-methyI-hex-2-enal (181)
A mixture of alcohol 180 (0.76 g, 3.36 mmol), A-methylmorpholine-jV-oxide (0.56 g, 4.70 mmol)
and freshly activated powdered 4 A molecular sieves (0.30 g) in anhydrous acetonitrile (40 cm3) 
was stirred for 10 min whereupon tetra-«-propyl perruthenete (0.06 g, 0.17 mmol) was added. 
The reaction became warm and was then stirred at room temperature for 16 h. The mixture was 
filtered through Celite® and the solvent was concentrated under reduced pressure. Purification by 
flash column chromatography on silica gel with hexane and ethyl acetate (3 : 2) as eluent gave 
181 as a pale yellow oil (0.59 g, 78%); Rf 0.33 (Hexane : EtOAc = 3 : 2); HRMS (ES+, [M + Na]+) 
found 247.1316. Ci3H2o0 3 Na requires 247.1310; umax(thin film)/cm_1 2990.1, 1672.3, 1448.2,
1370.2, 1 2 2 2 .1 , 1194.1, 1066.5 and 831.6; 6H(500 MHz, C2HC13) 1.50 [ 6  H, s, (Cfl&C], 1.58 (3 
H, s, Ci/3), 1.73 (4 H, b, CHCH2CH2C), 4.20 and 4.30 [4 H, 2 x s , (Ctf2)2C], 4.83 (1 H, b, 
C=CtfCH2CH2), 5.82 (1 H, d, J  7.5, CtfCHO) and 9.95 (1 H, d, J7.5, CHCtfO); 5C(125 MHz, 
C2HC13) 16.60 (CH3), 23.94 and 39.47 (CH2CH2C), 24.04 and 24.08 [(CH3)2C], 59.41 and 64.04 
[(CH2)2C], 98.98 [(CH3)2q ,  120.39 (C=CHCH2CH2), 127.51 (CHCHO), 134.21 (quaternary C) 
and 189.59 (CHCHO); m/z (ES+) 247.1 (20%, [M + Naf) and 131.1 (100).
(E)-2^-Dimethyl-5-(4-methyl-hepta-4,6-dienylidene)-13-dioxane (183)
This compound was prepared from 181 in a manner similar to that for the triene 172; purification
by silica column chromatography using hexane and ethyl acetate (9: 1) as eluent gave triene 183
as a light yellow oil (0.89 g, 91%); Rf 0.36 (Hexane : EtOAc = 9:1) ;  HRMS (EI+, M+) found
222.1624. CmH220 2 requires 222.1620; umax (thin film)/cm_1 2987.4, 2847.0, 1649.2, 1448.9,
1369.7, 1222.4, 1194.1, 1156.2, 1067.6, 898.3 and 832.5; 6H(500 MHz, C2HC13) 1.45 [ 6  H, s,
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(CH3)2C], 1.73 (3 H, s, CH3), 2.10 (4 H, m, C=CUCH2CH2), 4.23 and 4.41 [4 H, 2 x s, (CH2)2C],
5.01 (1 H, dd ,J 10.0,71.5, CHCH=CHJram.flcis), 5.11 (1 H, dd, J  17.0, J 1.5, CHCH=C//M„Hcls), 
5.24 (1 H, m, C=CtfCH2CH2), 5.85 (1 H, d, Ctf=CHCH2) and 6.58 (1 H, dt, J  17.0, J  10.0, 
CHCff=CH2); 8 c (125 MHz, C2HC13) 16.60 (CH3), 24.05 [(CH3)2C], 25.00 and 39.28 
(C=CCH2CH2), 59.87 and 64.56 [CH3]2C], 99.02 [(CH3)2q ,  115.12 (CHCH=CH2), 122.84 
(C=CHCH2CH2), 125.97 (CHCH=CH2), 131.96 and 138.42 (quaternary C) and 133.18 
(CHCH=CH2); m/z (EI+) 222.2 (1%, M+) and 177.1 (100).
(2£',6£)-10-(2,2-Dimethyl-13-dioxan-5-ylidene)-3,7-dimethyl-deca-2,6-dienoic acid ethyl 
ester (184)
This compound was prepared from 183 in a manner similar to that for the ester 177; purification 
by silica column chromatography using hexane and ethyl acetate (9: 1) as eluent gave ester 184 as 
a light yellow oil (0.48g, 38%); Rf 0.26 (Hexane : EtOAc = 9 : 1) ;  HRMS (ES+, [M + NHLtf) 
found 354.2638. C20H36O4N requires 354.2639; iw(thin film)/cnf' 2933.9, 2849.1, 1715.0,
1647.5, 1448.4, 1368.7, 1222.0, 1145.1, 1089.8, 1055.7 and 833.0; 8H(500 MHz; C2HC13) 1.21 (3 
H, t, J  7.0, OCH2C7/3), 1.36 [ 6  H, s, (CH3)2C], 1.52 (3 H, s, CH3), 1.93 [4 H, m, 
(OCH2)2C=CHC7/2C7/2], 2.04 (7 H, m, CH2 and C/f2C772CCHC=0), 4.06 (2 H, q, J  7.0, 
OC/72CH3), 4.15 and 4.32 (4 H, 2 x s, 2 x OCH2), 5.01 (1 H, m, CH3C=C//CH2CH2), 5.14 [1 H, t, 
J  7.0, (OCH2)2C=C//CH2CH2] and 5.59 (1 H, s, C=C#C=0); 8 C (125 MHz; C2HC13) 14.34 
(OCH2CH3), 15.95 and 18.79 (CH3C=CH), 24.07 [(CH3)2C], 25.15, 25.81, 39.12 and 40.80 (2 x
148
CH2CH2), 59.48 (OCH2CH3), 59.90 and 64.54 [(CH2)2C], 99.01 [(CH3)2q ,  115.73, 123.02 and
123.61 (3 x CH), 131.82, 135.27, 159.54 and 166.85 (quaternary C); m/z (CI+) 353.3 (20%, [M + 
NH4]+ ) and 279.2 (100).
(22s,6£)-12-Hydroxy-ll-hydroxymethyl-3,7-dimethyl-dodeca-2,6,10-trienoic acid ethyl ester 
(185)
The ester 184 (0.53 g, 1.58 mmol) was dissolved in ethanol (30 cm3), then 3 drops of TFA was 
added and the mixture was stirred at room temperature for 3h. The reaction mixture was diluted 
with diethyl ether (30 cm3), then washed with sodium bicarbonate (20 cm3) and brine (20 cm3), 
the aqueous layer was extracted with diethyl ether, The organic phases were combined, washed 
with brine and dried (MgS0 4 ), filtered and then concentrated under reduced pressure. Purification 
by flash column chromatography on silica gel with hexane and ethyl acetate (1 : 9) as eluent gave 
the title compound 185 as a pale yellow oil (0.37g, 79%); Rf 0.34 (Hexane : EtOAc = 1 : 9 ) ;  
HRMS (ES+, [M + H]*) found 297.2059. C17H29O4 requires 297.2060; umax(thin film)/cm_1
3348.4, 2931.1, 1714.2, 1645.9, 1445.9, 1382.8, 1223.4, 1446.5, 1011.9 and 864.9; 5H(500 MHz; 
C2HC13) 1.21 (3 H, t, J  7 .0 , OCH2C//3), 1.53 (3 H, s, CH3), 1.96-2.14 ( 1 1  H, m, CH3 and 2 x 
CH2CH2), 2.27 (2 H, b, 2  x OH), 4.06 (2 H, q, J7.0, OCH2CH}), 4.14 and 4.24 (4 H, 2 x s, 2 x 
HOCtf2), 5.02 (1 H, m, CH3C=CtfCH2CH2), 5.44 [1  H, t, J  7.0, (HOCH2)2C=CtfCH2CH2] and 
5.59 (1 H, s, C=CHC=0); 8 C (125 MHz; C2HC13) 14.33 (OCH2CH3), 16.01 and 18.80 
(CH3C=CH), 24.89, 25.81, 39.23 and 40.81 (2 x CH2CH2), 59.58 (OCH2CH3), 60.03 and 67.53 
(2 x CH2OH), 115.79, 123.66 and 130.41 (3 x CH), 135.28, 137.28, 159.58 and 166.99
(quaternary C); m/z (Cl*) 314.2 (50%, [M + NR,]*) and 297.2 (100, [M + H]*).
(£)-8-Hydroxy-7-hydroxymethyl-3-methyl-octa-2,6-dienoic acid ethyl ester (186)
H O O'
This compound was prepared from 177 in a manner identical to that for the diol 185; purification
by silica column chromatography using hexane and ethyl acetate (1: 9) as eluent gave 186 as a
light yellow oil (0.20g, 97%); Rf 0.31 (Hexane : EtOAc = 1 : 9 ) ;  HRMS (ES*, [M + H]*) found
C=CHC=0); 5c (125 MHz; C2HC13) 14.31 (OCH2C//3), 15.27 (CH}CCH), 25.24 and 40.42 
(CH2CH2), 59.71 (OCH2CH3), 59.83 and 67.28 [(CH2)2C], 116.18 (C=C7/CH2CH2), 129.02 
(C=CHC=0), 138.16, 158.48 and 166.85 (quaternary C). m/z (Cl*) 246.2 (100%, [M + NR,]*) 
and 229.1 (30, [M + H]*).
(£)-8-Fluoro-7-fluoromethyl-3-methyl-octa-2,6-dienoic acid ethyl ester (187)
To a stirred solution of DAST (0.23 cm3, 1.76 mmol) in anhydrous DCM (30 cm3) at -78 °C 
under argon was added a solution of the diol 186 (0.20 g, 0.88 mmol) in anhydrous DCM (2 cm3), 
this solution was stirred for lh at -78 °C, then 4h at room temperature. Water was carefully added
229.1433. C12H21O4 requires 229.1434; omax(thin film)/cm-1  3357.6, 2934.1, 1713.0, 1647.2,
1368.5, 1224.4, 1146.5, 1010.0 and 865.2; 8H(500 MHz; C2HC13) 1.21 (3 H, t, J7.0, OCH2Ctf3),
2.08 (3 H, d, J  1.0, C7/3C=CHC=0), 2.13-2.24 (4 H, m, CH2CH2), 4.07 (2 H, t, J7.0, OCtf2CH3),
4.13 and 4.23 (4 H, 2 x s, 2 x HOCtf2), 5.44 (1 H, t, J7.0, C=CHCH2CH2) and 5.59 (1 H, q, J  1.0,
F>
to quench the reaction, and the separated aqueous layer was extracted with DCM ( 3x 10  cm3). 
The organic phases were combined, washed with brine and dried (MgSCU) and then concentrated 
under reduced pressure. Purification by flash column chromatography on silica gel with hexane 
and ethyl acetate (4 : 1) as eluent gave the title compound as a pale yellow oil (39 mg, 19%); Rf 
0.36 (Hexane : EtOAc = 4:1);  HRMS (ES+, [M + N tU t) found 250.1614. C12H22O2NF2 requires 
250.1613; \w (th in  film)/cm_1 2982.3, 1713.8, 1649.1, 1445.7, 1369.4, 1223.6, 1146.7, 1060.3,
969.1 and 864.8; 6H(500 MHz; C2HC13) 1.21 (3 H, t, J  7.5, OCH2C//3), 2.11 (3 H, d, J  1.0, 
Ctf3CCHCO), 2.16-2.33 (4H, m, CH2CH2), 4.08 (2H, t, J  7.5, OGtf2CH3), 4.76 and 4.88 (4 H, 2 
x d, JH.F 47.5, 2 x FCH2), 5.60 ( 1  H, q, J  1.0, C=CHCO) and 5.59 (1 H, m, C=C//CH2CH2); 5C 
(125 MHz; C2HC13) 14.31 (OCH2CH3), 18.67 (C//3C=CH), 25.43 and 40.04 (CH2CH2), 59.67 
(OCH2CH3), 78.05 (d, Jc.f 165.0, CH2F), 85.09 (d, JC-F 165.0, CH2F), 116.44 (C=CHC=0), 
131.67 (t, Jc-f 14.5, FCH2C), 135.77 (dd, JC-F 9.0, JC.F 10.0, C=C//CH2CH2), 157.73 and 166.58 
(quaternary C); 8f (250 MHz, proton decoupled, C2HC13) -217.07 (d, Jf-f 7.5) and -212.87 (d, 
Jf-f 7.5); m/z (ES*) 250.2 (100%, [M + NH4]+).
(£)-2-MethyI-penta-2,4-dienoic acid ethyl ester (193)
o
Acrolein (3.28 cm3, 50 mmol) and carbethoxyethylidene triphenyl phosphorane (27.2 g, 75 mmol)
were dissolved in DCM (150 cm3), the reaction mixture was stirred at room temperature for 5h,
then the water was added to quench the reaction, the organic phase was separated. The aqueous
layer was extracted with diethyl ether (3 x 1 0  cm3). The combined organic phases were washed
with brine ( 1 0  cm3) and dried (MgS0 4 ), filtered and then concentrated under reduced pressure.
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Purification by flash column chromatography on silica gel with hexane and ethyl acetate (9 : 1) as 
eluent gave the title compound as a yellow oil (5.5lg, 79%); Rf 0.34 (Hexane : EtOAc = 9:1) ;  
HRMS (EI+, M*) found 140.0836. C8H12O2 requires 140.0837; Oma t^hin film)/cm_1 2981.3,
1708.8, 1632.6, 1596.1, 1366.6, 1246.9, 1176.1, 1101.9, 990.5, 928.1 and 757.5; 6H(500 MHz; 
tfHCb) 1.24 ( 3 H , U  7.0, C//3CH2O), 1.88 (3 H, d, J  0.5, C//3C=CHCH), 4.14 (2 H, t , J  7.0, 
CH3CH2O), 5.37 (1 H, dd, J  10.0, J  0.5, CHCHCH//cls), 5.48 (1 H, dd, J  17.0, J  0.5, 
CHCHCflmnsH), 6.55 (1 H, ddd, J  10.0, J  11.0, J  17.0, CHC#CH2) and 7.09 (1 H, dd, J  11.0, J  
0.5, C#CHCH2); 6c (125 MHz; C2HC13) 12.66 (CH3C=CH), 14.29 (CH3CH20), 60.63 
(CH3CH20), 124.01 (CHCHCH2), 128.19 (C=0), 132.24 and 138.21 (CH), 168.36 (quaternary 
C); m/z (El*) 140.1 (65%, M*) and 67.1 (100).
(2s)-2-Methyl-penta-2,4-dien-l-oI (195)
H
To a stirred solution of ester 193 (1.63 g, 11.6 mmol) in dry THF (80 cm3) at -78 °C, was added
dropwise (over 3 min) diisobutylaluminum hydride (1.0 M, 25.6 mL, 25.6 mmol). The reaction
mixture was allowed to stir at -78 °C for 1 h, then 0 °C for lh, quenched with sat. sodium
potassium tartrate (30 cm3), and then extracted with diethyl ether (3 x 20 cm3). The combined
organic extracts were dried (MgSCU), filtered and then concentrated under reduced pressure.
Purification by flash column chromatography on silica gel with hexane and ethyl acetate (2 : 1) as
eluent gave the title compound as a pale yellow oil (0.86 g, 76%); Rf 0.33 (Hexane : EtOAc = 2 :
1); HRMS (EI+, M*) found 98.0729. C6Hl0O requires 98.0732; i w  (thin film)/cm'' 3333.9,
2915.7,1658.4, 1601.1, 1421.2,1144.2, 989.3, 901.5 and 650.0; 6H(500 MHz; C2HC13) 1.80 (3 H,
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s, C / / 3 C C H C H ) ,  4.08 (2 H ,  s, H O C / / 2 C ) ,  5.13 (2 H ,  dd, J  10.0, J  1.0, C H C H C H / / cis) ,  5.21 (2 H ,  
dd, J  17.0, J  1.0, C H C H C Z / t r a n s H ) ,  6.11 (1 H ,  dd, J  10.0, J  1.0, C t f C H C H 2)  and 6.61 ( 1  H ,  dt, J
17.0, 10.0, C H C / / C H 2) ;  5 C (125 MHz; C 2 H C 1 3)  14.08 ( C H 3 C C H C H C H 2) ,  68.21 ( C H 2 O H ) ,
117.02 ( C H C H C H 2) ,  125.35 ( C H C H C H 2) ,  132.56 ( C H C H C H 2)  and 137.83 (quaternary C ) ;  m/z 
(E f) 98.1 (80%, M+) and 83.1 (100).
[(£)-2-Methyl-penta-2,4-dien-l-ol]tricarbonyliroii (196)
Fe(CO)3
Diiron nonacarbonyl (1.17 g, 3.21 mmol) was added to a solution of the diene 195 ( 0.21 g, 2.14 
mmol) in degassed THF (20 cm3) and the mixture was refluxed under argon for 15h until the 
solid carbonyl had disappeared. The resulting mixture was concentrated under reduced pressure 
and column chromatography of the residue on silica separated the required complex form any 
inorganic species. Further purification by flash column chromatography on silica gel with hexane 
and ethyl acetate (2 : 1) as eluent gave the title compound as a yellow oil (0.41 g, 81%); R f  0.30 
(Hexane : EtOAc = 2 : 1 ) ;  HRMS (E f, M+) found 237.9917. C9Hi0O456Fe requires 237.9928; 
tw (th in  film)/cm"‘ 3327,3, 2931.8, 2043.4, 1961.2, 1411.7, 995.7 and 610.6; 5H(500 MHz; 
C2HC13) 1.19 (3 H, br, CftC=CHCH), 1.68 and 1.89 (2 H, br, CHCHCft), 3.64 (2 H, br, C//2OH) 
and 5.36 (2 H, br, 2 x CH); 8C(125 MHz; C2HC13) 15.79 (CH3), 41.52 (CHCHCHj), 73.37 
(CH2OH), 86.51 and 91.14 (2 * CH) and 211.10 (C=0); m/z (E f) 238.0 (2%, M"), 210.0 (10, [M 
-  CO]*), 182.0 (10, [ M - 2  x CO]*), 154.0 (12, [ M - 3 x COf) and 134.0 (100).
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[(£)-5-Fluoro-4-methyl-penta-1,3-diene] tricar bony li ron (197)
Fe(CO)3
To a stirred solution of DAST (0.45 cm3, 3.40 mmol) in dry DCM (50 cm3) at -78°C under argon 
atmosphere was added a solution of the alcohol 196 (0.67 g, 2.84 mmol) in dry DCM (2 cm3), 
this solution was stirred for lh at -78°C, then 4h at room temperature. Water was carefully added 
to quench the reaction, and the separated aqueous layer was extracted with DCM ( 3 x 1 0  cm3). 
The organic phases were combined, washed with brine (10 cm3) and dried (MgS0 4 ), filtered and 
then concentrated under reduced pressure. Purification by flash column chromatography on silica 
gel with hexane and ethyl acetate (9 : 1) as eluent gave the title compound as a pale yellow oil 
(0.38g, 56 %); Rf 0.33 (Hexane : EtOAc = 9 : 1 ) ;  n o th in  film)/cm_1 2895.6, 2044.7, 1963.8,
1446.3, 1386.0, 1111.8, 1056.2 and 607.0; 6H(500 MHz; dH C h) 0.38 (2 H, d, JH-f 687.0, CH2F), 
0.79 (1 H, br, CHC//CH2), 2.08 (3 H, s, C/f3C=CHCH), 3.31 (1 H, br d, J 42.5, CHCHCtftransH), 
3.52 (1 H, br d, J  33.0, CHCHCH//cls) and 5.17 (1 H, br, C//CHCH2); 6 c (125 MHz; C2HC13) 
22.68 (CH3), 43.53 (d, JC-f 10.0, CH2F), 55.16 (d, JC-f 24.0, CHCHCH2), 72.23 (d, J C-f 12.5, 
CHCHCH2), 87.04 (d, J C-f 27.5, CHCHCH2), 100.48 (d, JC-f 12.5, quaternary C) and 211.31 
(C=0); 6 f (250 MHz, proton decoupled, C2HC13) -158.03; m/z (EF") 240.1 (1%, M+), 212.1 (12, 
[M -C O f), 184.1 (13, [M - 2  x CO]*), 156.1 (10, [M - 3  x CO]*) and 136.0(100).
5-Bromopentan-2-one (202).
A solution of a-acetylbutyrolactone (6.46 cm , 60.0 mmol) in toluene (40 cm ) was stirred and
hydrobromic acid (48% in H2O, 10.2 cm3, 90.0 mmol) was added. The whole reaction mixture 
was heated at 80 °C for 14 h under N2 . Water (30 cm3) and diethyl ether (30 cm3) were added, 
and the organic layer was separated. The aqueous layer was extracted with diethyl ether (2 * 20 
cm3). The combined ethereal extracts were washed with water (2 x 20 cm3) and brine (20cm3), 
dried over MgSC>4, filtered and then concentrated under reduced pressure. Purification by flash 
column chromatography on silica gel with hexane and ethyl acetate (4 : 1) as eluent gave 
bromoketone 202 as a pale yellow oil (1.83 g, 23%); Rf 0.25 (Hexane : EtOAc = 4 : 1) ;  HRMS 
(El*, [M^Br)]4) found 163.9829. CsH9 0 79Br requires 163.9831; Umax (thin film)/cm_1 2963.8,
1714.7, 1434.6, 1367.2, 1301.3, 1247.1, 1179.0, 908.6 and 735.0; 5H (500 MHz, C2HC13) 2.12 (2 
H, quintet, J  7.0, CH2C ^ 2CH2), 2.17 (3 H, s, CH3), 2.65 (2 H, t, J7.0, CH2C) and 3.45 (2 H, t, J
6.5, BrCH2); 5c (125 MHz, CDC13) 26.37 (CH2CH2CH2), 30.07 (CH3), 33.28 (BrCH2), 41.43 
(CH2C) and 207.30 (quaternary C); m/z (El4) 165.9 (40%, [M^Br)]4), 164.0 (40, [M^Br)]4) and
92.8 (100).
(£)-Ethyl 6-bromo-3-methylhex-2-enoate (203)
Br
To a suspension of sodium hydride (0.12 g, 4.80 mmol) in anhydrous THF (10 cm3) at 0 °C,
triethyl phosphonoacetate (0.95 cm3, 4.80 mmol) and a solution of bromo ketone 202 (0.66 g,
4.00 mmol) in anhydrous THF (5 cm3) were sequentially added dropwise and with stirring. The
reaction mixture was stirred for 14 h under N2 . Water (20 cm3) and diethyl ether (20 cm3) were
added, and the organic layer was separated. The aqueous layer was extracted with diethyl ether (2
x 15 cm3). The combined ethereal extracts were washed with water (2 x 10 cm3) and brine (10
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cm ), dried over MgS0 4 , filtered and then concentrated under reduced pressure. Purification by 
flash column chromatography on silica gel with hexane and ethyl acetate (9 : 1) as eluent gave 
the Z isomer of 203 as a minor by-product (56 mg, 6 %) followed by E isomer as a pale yellow 
oil (640 mg, 69%).
E isomer; Rf 0.27 (Hexane : EtOAc = 9 : 1 ) ;  HRMS (ES+, [M + H f) found 235.0327. 
C9 H|6()2™Br requires 235.0328; Umax (thin film)/cm_l 2977.6, 1713.6, 1648.9, 1438.4, 1368.1,
1272.6, 1217.4, 1147.1, 1041.7,951.3, 865.9 and 810.7; 6H(500 MHz, C2HCI3) 1.30 (3 H, t, J7.0, 
CH2CH3), 2.06 (2 H, m, BrCH2C7/2), 2.18 (3 H, d, J  1.0, CCH3), 2.32 (2 H, t, J  8.0, 
B1CH2CH2C//2), 3.42 (2 H, t, J  7.5, BrCH2), 4.16 (2 H, q, J7.0, CH2CH3) and 5.72 (1 H, m, 
CCH); 5c (125 MHz, C2HC13) 14.30 (CH2CH3), 18.67 (CH3), 30.25 (BrCH2CH2), 32.61 (BrCH2), 
38.99 (BrCH2CH2CH2), 59.61 (CH2CH3), 116.65 (CH), 157.51 (quaternary C) and 166.57 (C=0); 
m/z (C f) 252.0 (100%, [M(79Br) + N H ,f) and 254.0 (100, [M(81Br) + NHt]4).
Z-isomer; Rf 0.35 (Hexane : EtOAc = 9 : 1 ) ;  HRMS (ES+, [M + H f) found 235.0328. 
C9Hi602” Br requires 235.0328; w  (thin film)/cm"‘ 2978.7, 1713.4, 1649.9, 1439.6, 1366.7,
1349.0, 1222.7, 1149.6, 1044.4 and 868.0; 5H(500 MHz, C2HC13) 1.28 (3 H, t, J  7.0, CH2Ctf3), 
1.91 (3 H, d, J 1.5, CCH3), 2.05 (2 H, m, BrCH2Ctf2), 2.74 (2 H, t, J  8.0, BrCH2CH2C//2), 3.44 (2 
H, t, J  7.0, BrCH2), 4.15 (2 H, q, J7.0, C//2CH3) and 5.71 (1 H, d, J  1.5, CCH); 8c(125 MHz, 
C2HC13) 14.30 (CH2CH3), 18.65 (CH3), 31.39 (BrCH2CH2), 32.24 (BrCH2CH2CH2), 33.24 
(BrCH2), 59.58 (CH2CH3), 117.19 (CCH), 158.22 (quaternary C) and 166.16 (C=0); m/z (CI+)
254.0 (60, [M(81Br) + NH,]"), 252.0 (60%, [M(79Br) + NHJ^and 174.0 (100).
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(E)-6-(Diethoxy-phosphoryI)-3-methyl-hex-2-enoic acid ethyl ester (199)
The bromo ester 203 (1.18 g, 5.0 mmol) was added to fresh distilled triethyl phosphite (1.03 cm3, 
6  mmol) and the mixture was stirred and heated to 130 °C for 3.5 h under N2 . The resulting 
material was purified by flash column chromatography on silica gel with hexane and ethyl acetate 
(1 :9) as eluent gave the title compound as light yellow oil (1.19 mg, 81%).
£-isomer: Rf 0.17 (Hexane : EtOAc =1 : 9 ) ;  HRMS (ES+, [M + H f)  found 293.1514. C13H26O5P 
requires 293.1512; iw (th in  film)/cm_1 2980.8, 2360.6, 1714.6, 1648.4, 1444.7, 1391.8, 1368.1,
1223.8, 1151.7, 1096.9, 1029.1, 959.7, 851.1 and 810.5; 5H (500 MHz, C2HC13) 1.29 (3 H, t, J 7.0, 
CO2CH2C/73), 1.34 (6 H, J  7.0, 2 x POCH2C//3), 1.70-1.83 (4 H, m, ?CH2CH2CH2), 2.16 (3 H, d, 
J1.0, CCH3), 2.24 (2 H, t, J7.5, PCH2CH2C//2), 4.08-4.18 (6 H, m, 3 x C//2CH3) and 5.68 (1 H, 
d ,y  1.0, CH); 5c (125 MHz, C2HC13) 14.31 (CO2CH2CH3), 16.45 and 16.50 (2 x POCH2CH3), 
18.50 (CCH3), 20.25 (d, JC-p5.0, PCH2CH2CH2), 24.50 (d, JC-? 140.0, PCH2CH2CH2), 41.19 (d, 
Jc-p 16.0, PCH2CH2CH2), 59.57, 61.51 and 61.56 (3 x OCH2CH3), 116.54 (CH), 158.04 
(quaternary C) and 166.60 (C=0); 5P (500 MHz, C2HC13) 31.50; m/z (Cl4) 310.2 (25%, [M + 
m uT )  and 293.2 (100, [M + Hf) .
Z-isomer: R f  0.14 (Hexane : EtOAc =1 : 9); HRMS (ES+, [M + H]4) found 293.1511. C13H26O5P 
requires 293.1512; n o t h in  film)/cm_1 2982.4, 2908.5, 1713.3, 1649.8, 1443.9, 1391.9, 1368.6,
1225.8, 1150.6, 1096.6, 1024.8, 963.3, 811.9 and 701.9; 5H (500 MHz, C2HC13) 1.21 (3 H, t, J 7.0, 
CO2CH2C/73), 1.26 (6 H, J  7.0, 3 x POCH2C//3), 1.61 (4 H, m, ?CH2CH2CH2\  2.08 (3H, d, J  1.0, 
CCH3), 2.16 (2H, t, J  7.5, PCH2CH2CH2), 4.01-4.10 (6H, m, 3 x OCi/2CH3) and 5.60 (1H, d, J
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1.0, CH); 8 c (125 MHz, C2HC13) 14.30 (CO2CH2CH3), 16.44 and 16.49 (3 x POCH2CH3), 18.49 
(CCH3), 20.24 (d, JC-p 5.0, PCH2CH2CH2), 24.49 (d, Jc.p 140.0, PCH2CH2CH2), 41.17 (d, JC-p
17.5, PCH2CH2CH2), 59.56, 61.51 and 61.56 (3 x C//2CH3), 116.54 (CH), 158.01 (quaternary C) 
and 166.58 (C=0); SP (500 MHz, C2HC13>) 31.66; m/z (C f) 293.2 310.2 (25%, [M + NH4]+) and 
(100, [M + H]*).
(£)-6-Bromo-3-methyl-hex-2-en-l-ol (206)
-j
A solution of 203 (1.50 g, 6.40 mmol) in anhydrous THF (60 cm ) was stirred under N2 and
cooled to -78 °C and then diisobutylaluminium hydride (1 M solution in hexane, 15.4 cm3, 15.4
mmol) was added dropwise. The resulting mixture was stirred at -78 °C for 2 h and then allowed
to warm to 0 °C at which time the reaction was judged complete by TLC analysis. Saturated
potassium sodium tartrate solution (50 cm3) and diethyl ether (50 cm3) were added. The mixture
was stirred at room temperature for another 30 min, and the organic layer was separated. The
aqueous layer was extracted with diethyl ether (2 * 30 cm3). The combined ethereal extracts were
washed with brine (30 cm3), dried over MgSC>4 , filtered and then concentrated under reduced
pressure. Purification by flash column chromatography on silica gel with hexane and ethyl acetate
(2 : 1) as eluent gave 206 as a light yellow oil (1.20 g, 98%); Rf 0.29 (Hexane : EtOAc = 2:1) ;
Umax (thin filmVcnf1 3327.9, 2936.0, 1668.1, 1437.5, 1382.1, 1284.6, 1244.0, 1202.3, 1092.2,
1000.9 and 865.9; 5H(500 MHz, C2HC13) 8  1.40 (1 H, b, OH), 1.61 (3H, s, CCH3), 1.92 (2 H,
quintet, J 7.0, BrCH2C//2), 2.11 (2 H, t, J7.0, BrCH2CH2OT2), 3.33 (2 H, t, J7.0, BrCtf2), 4.10
(2 H, d, J  7.0, CH2OH) and 5.39 (1 H, m, CH); 5C(125 MHz, C2HC13) 16.19 (CCH3), 30.63
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(BiCH2CH2), 33.18 (BrCH2), 37.71 (BrCH2CH2CH2), 59.29 (CH2OH), 124.61 (CH) and 137.76 
(quaternary C); m/z (EC) 194.0 (100%, [M(8 lBr)]+) and 192.0 (100%, [M(wBr)]^).
l-{[(£)-6-bromo-3-methylhex-2-enyloxy]methyl}benzene (207)
To a suspension of sodium hydride (1.02 g, 25.5 mol) in anhydrous THF (80 cm3) at 0 °C, benzyl 
bromide (3.03 cm3, 25.5 mmol) and a solution of alcohol 206 (3.28 g, 17.0 mmol) in anhydrous 
THF (10 cm3) were sequentially added dropwise and with stirring. The whole reaction mixture 
was allowed to warm to RT and stirred for 3 h under N2 . Water (40 cm3) and diethyl ether (40 cm3) 
were added, and the organic layer was separated. The aqueous layer was extracted with diethyl 
ether (2 * 30 cm3). The combined ethereal extracts were washed with water (2 x 30 cm3) and satd. 
NaCl (1 x 40 cm3), dried over MgSC>4 and then concentrated under reduced pressure. Purification 
of the crude product by flash column chromatography on silica gel with hexane and ethyl acetate 
(9 : 1) as eluent gave the title benzyl ether as a pale yellow oil (3.51 g, 73%); R f  0.36 (Hexane : 
EtOAc = 9 : 1 ) ;  HRMS (C f, [M + NFL*]*) found 300.0956. Ci4H23ON79Br requires 300.0958; 
Umax (thin film)/cm_1 2925.0, 2845.1, 1668.9, 1495.6, 1452.7, 1363.2, 1245.3, 1203.8, 1069.1,
1027.7, 736.2 and 697.6; SH (500 MHz, C2HC13) 1.69 (3H, s, CH3), 2.02 (2 H, quintet, J  7.0, 
CH2C//2CH2), 2.22 (2 H, t, J  7.0, CH2C), 3.43 (2H, t, J  6.5, BrCH2), 4.07 (2H, d, J  6.5, 
CHC//2O), 4.55 (2 H, s, OCH2Ph), 5.50 (1 H, m, CC//CH2) and 7.34 (5 H, m, Ar-H); 5C (125 
MHz, C2HC13) 16.49 (CH3), 30.66 (CH2CH2CH2), 33.38 (BrCH2), 37.80 (CH2C), 66.53 
(CCHCH2), 72.21 (OCH2Ph), 122.15 (CCHCH2), 123.23 (quaternary C), 127.65, 127.88 and
128.44 (Ar-CH) and 138.48 (quaternary C); m/z (Cl*) 302.1 (95%, [M(8 lBr) + NR,]*) and 301.1 
(100, [M(TOBr) + N H 4 ] * ) .
(fsH6-(benzyloxy)-4-methyl-4-hexen-l-yl]triphenyIphosphonium bromide (208)
A mixture of bromo benzyl ether 207 (3.51 g, 12.4 mmol) and triphenyl phosphine (4.88 g, 18.6 
mmol) in acetonitrile (100 cm3) under a nitrogen atmosphere was refluxed for 14 h and cooled to 
25 °C. The solvent was evaporated to afford an oily mixture. Excess triphenyl phosphine was 
removed by continuously washing the mixture with anhydrous diethyl ether (3 x 20 cm3) and 
triturating the mixture until a solid precipitated. Diethyl ether (20 cm3) was added to the solid, 
and mixture was kept reffigetated overnight. The phosphonium salt was collect and washed with 
diethyl ether (2 x 20 mL) to afford the title product as a white solid (5.81 g, 87%); HRMS (ES+, 
M*) found 465.2338. C32H34OP requires 465.2347; Umax (thin film)/cm_1 3386.2, 3030.1, 2859.8,
2356.8, 1652.0, 1585.2, 1483.6, 1437.3, 1111.6, 1066.6, 995.5, 922.1, 733.9 and 691.0; 6 H (500 
MHz, C2HC13) 1.46 (3 H, s, CH3), 1.72 (2 H, m, CH2CH2CH2), 2.31 (2 H, t, J  7.0, CH2C), 3.69 (2 
H, br, PCH2), 3.89 (2 H, d, J6 .5 , CHCH20), 4.38 (2 H, s, OCH2Ph), 5.27 (1 H, dt, J6 .5 , J  1.0, 
C=C//CH2), 7.18-7.25 (5 H, m, Ar-H) and 7.60-7.77 (15H, m, Ar-H); 6 C (125 MHz, C2HC13)
16.61 (CH3), 20.32 (d, JC-p 4.0, CH2CH2CH2), 21.86 (d, JC-p 51.5, PCH2), 39.13 (d, Jc.p 15.0, 
CH2CH2C), 66.50 (C=CHCH2), 72.35 (OCH2Ph), 117.87 (d, Jc.? 86.5, Ar-CH), 122.41 
(CCHCH2), 127.60, 127.82 and 128.35 (Ar-CH), 130.49 (d, JC-p 12.5, Ar-CH), 133.60 (d, Jc .p
10.0, Ar-CH), 135.06 (d, JC-p 2.5, Ar-CH) and 138.31 (quaternary C); m/z (ES+) 465.2 (100%,
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l-{[(£)-8-fluoro-7-(fluoromethyl)-3-methylocta-2,6-dienyloxy]methyl}benzene (209)
To a suspension of triphenylphosphonium bromide 208 (5.45 g, 10.0 mol) in anhydrous THF (50 
cm3) at -78 °C, LiHMDS (1 M, 11.0 cm3, 11.0 mmol) was added dropwise and with stirring. The 
reaction mixture was allowed to warm to -20 °C for 30 min before it was cooled to -78 °C again. 
Difluoro acetone (0.82 cm3, 10.0 mmol) was then added dropwise. The whole reaction mixture 
was then allowed to warm to RT over 1 h. Water (20 cm3) and diethyl ether (20 cm3) were added, 
and the organic layer was separated. The aqueous layer was extracted with diethyl ether (2^15 
cm ). The combined ethereal extracts were washed with satd. NaCl (1 x 20 cm ), dried over 
MgSC>4 and then concentrated under reduced pressure. Purification of the crude product by flash 
column chromatography on silica gel with hexane and ethyl acetate (9 : 1) as eluent gave the 
difluoride as a colorless oil (2.67 g, 93%); R f  0.28 (Hexane : EtOAc = 9 : 1); HRMS (ES+, [M + 
N H t ] * )  found 298.1978. Ci7H26ONF2 requires 298.1977; Umax (thin film)/cm_1 2925.4, 2855.4,
1617.7, 1495.9, 1453.7, 1371.6, 1237.5, 1202.1, 1068.6, 969.6, 737.9 and 698.4; 5H(500 MHz, 
C^HCh) 1.50 (3 H, s, CH3), 1.89 (2 H,t, J8.0, CH2CH2C), 2.16 (2 H, m, C/72CH2C), 3.87 (2 H, d, 
J  7.5, CH20), 4.35 (2 H, s, OCH2Ph), 4.66 (2 H, d, Jh-f 47.5, CH2F), 4.80 (2 H, d, JH-f 48.0, 
CH2F), 5.27 (1 H, dt, J  7.0, J 1.0, C//CH20), 5.70 (1 H, m, CCtfCH2CH2) and 7.10-7.20 (5 H, m, 
Ar-H); 5C (125 MHz, C2HC13) 16.44 (CH3), 25.77 (CHCH2CH2C), 38.78 (t, Jc-f 2.5, CH2CH2C), 
66.49 (CH20), 72.18 (CH2Ph), 76.87 (d, JC-f161.5, CH2F), 83.94 (d, Jc-f 163.5, CH2F), 121.98
(CHCHiO), 127.59, 127.81 and 128.39 (Ar-CH), 131.05 (t, JC.F 15.0, CCH2F), 137.11 (t, JC.F 9.0, 
CH2FCCH), 138.48 and 138.74 (quaternary C); SF (282 MHz, C2HC13) -210.37 (t, Jh-f 48.0) and 
-215.10 (t, Jh-f 48.5); m/z (Cl*) 298.3 (100%, [M + NFL,]*).
2-((£)-6-bromo-3-methylhex-2-enyloxy)-tetrahydro-2//-pyran (213)
3
To a stirred solution o f206 (2.82 g, 14.6 mmol) and 3,4-dihydro-2 //-pyran (2.68 cm3, 29.2 mmol) 
in CH2CI2 (80 cm3) under N2 at 0 °C was added /?-toluenesulfonic acid (0.14 g, 0.74 mmol), and 
the mixture stirred for 16 h whilst warming to room temperature. The solution was then diluted
- j 2with diethyl ether (80 cm ) and washed with a saturated NaHCC>3 solution (50 cm ). The aqueous 
layer was extracted with diethyl ether ( 2  x 50 cm3) and the combined ethereal extracts were 
washed with water (50 cm3) and brine (50 cm3), dried over MgSC>4, filtered and then concentrated 
under reduced pressure. Purification by flash column chromatography on silica gel with hexane 
and ethyl acetate (9 : 1) as eluent to gave 158 as a yellow oil (3.72 g, 93%); R f  0.23 (Hexane : 
EtOAc = 9 : 1) ;  HRMS ( E S * ,  [M + NR,]*) found 294.1065. C,2H250 2N79Br requires 294.1063; 
Unax (thin film)/cm“' 2940.1, 2865.2, 1669.3, 1439.8, 1383.6, 1353.0, 1245.5, 1199.8, 1116.8,
1076.2, 1023.2, 905.6, 8 6 8 . 8  and 813.8; 5H(500 MHz, C2HC13) 1.60-1.85 [ 6  H, m, CH(CR2)3],
1.69 (3 H, s, CCH3), 2.00 (2 H, quintet, J  7.0, BrCH2CR2), 2.19 (2 H, t, J7 .0 , BrCH2CH2CR2), 
3.40 (2 H, t, J  7.0, BrCH2), 3.51 and 3.88 [2 H, m, (CH&OftO], 4.01 and 4.23 (2 H, m, 
CHCftO), 4.62 (1 H, m, 'CRCH2CH2CH2) and 5.42 (1 H, m, GHCH20); Sc (125 MHz, C2HC13)
16.34 (CCH3), 19.61,25.49, and 30.66 [(CH2)3CH20], 30.71 (BrCH2CH2), 33.25 (BrCH2), 37.80
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(BrCH2CH2CH2), 62.32 [(CH2)3CH20], 63.58 (CHCH20), 97.95 (OCHO), 121.98 (CHCH20) 
and 138.13 (CH3C=CH); m/z (E f) 296.2 (50, [M(81Br) + NH^*), 294.2 (50%, [M(79Br) + NH4]+) 
and 1 0 2 . 1  ( 1 0 0 ).
(£)-2-(8-Fluoro-7-fluoromethyl-3-methyI-octa-2,6-dienyloxy)-tetrahydro-2Jyr-pyran (210)
A mixture of 213 (1.10 g, 3.97 mmol) and triphenylphosphine (1.57 g, 5.99 mmol) in anhydrous
acetonitrile (20 cm3), under a nitrogen atmosphere, was heated under reflux for 14 h. After
cooling, the solvent was concentrated under reduced pressure to afford an oily mixture. Excess
triphenyl phosphine was removed by triturating the mixture with anhydrous diethyl ether, and the
sticky residue was dried in vacuo for 5 h to afford the intermediate phosphonium salt 214 as a
viscous oil, which was used directly without further purification. To a stirred solution of crude
214 (1.96 g, 3.63 mmol) in anhydrous THF (40 cm3) under N2 at -78 °C, was added lithium
hexamethyldisilazide (1.0 M solution in THF, 4.00 cm ,4.00 mmol), the mixture was stirred for
30 min at -78 °C, and then 1,3-difluoro acetone (0.30 cm3, 3.64 mmol) was added dropwise. The
whole reaction mixture was allowed to warm to -20 °C over 1 h, and maintained at -20 °C for a
further 2 h. The reaction was then quenched by addition of diethyl ether (40 cm ) and water (40
cm ). The aqueous layer was extracted with diethyl ether (3 * 30 cm ) and the combined ethereal
extracts were washed brine (30 cm3), dried over MgSC>4 , filtered and then concentrated under
reduced pressure. Purification by flash column chromatography on silica gel with hexane and
ethyl acetate ( 6  : 1) as eluent gave 210 as a yellow oil (0.66 g, 6 6 %); Rf 0.27 (Hexane : EtOAc =
6  : 1); HRMS (C f, [M + m u t )  found 292.2081. Ci5H280 2NF2 requires 292.2083; tw (th in
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filmycm'1 2942.1,2364.1, 1672.0, 1441.6,1317.6, 1261.0, 1200.1, 1117.4,1076.4,1203.8,970.8, 
904.9, 8 6 8 . 8  and 813.9; 5H(500 MHz, C2HC13) 1.39-1.68 [ 6  H, m, (Ctf2)3CH20], 1.53 (3 H, s, 
CCHi), 1.98 (2 H, t, J7 .5 , FCH2CCHCH2C//2), 2.14 (2 H, m, FCH2CCHC//2), 3.35 and 3.71 [2 
H, m, (CH2)3Ctf20], 3.85 and 4.07 (2 H, m, CHCH20), 4.47 (1 H, m, OCHO), 4.67 (2 H, d, J h f
47.5, CH2F), 4.80 (2 H, d, J hf 47.5, CH2F), 5.23 (1 H, dt, J7.S, J  1.0, C=C//CH20) and 5.70 (1 H, 
m, CH2FC=CF0: Sc (125 MHz, C2HC13) 16.35 (CH3), 19.61, 25.48 and 30.70 [(CH2)3CH20], 
25.76 (FCH2C=CHCH2), 38.77 (t, J cf 2.5, CH2FCCHCH2CH2), 62.32 [(CH2)3CH20], 63.54 
(CHCH20), 76.86 (d, JCF = 161, CH2F), 83.92 (d, JCF = 164, CH2F), 97.95 (OCHO), 121.81 
(CHCH20), 130.89 (t, JcF = 14.0, CCH2F), 137.12 (t, Jc? = 9, CH2FCCH) and 138.49 
(CH2CCH3); Sf (283 MHz, C2HC13) -210.13 (t, Jhf 47.0) and -214.88 (t, Jhf 48.5); m/z (Cl*)
292.3 (100%, [M + NFL,]*) and 1 0 2 . 2  (95).
(£)-8-FIuoro-7-fluoromethyl-3-methylocta-2,6-dien-l-ol (211).
OH
A solution of 210 (0.48 g, 1.75 mmol) and pyridinium /Moluenesulfonate (0.04 g, 0.17 mmol) in 
ethanol (20 cm3) was stirred at 55 °C for 3 h. The solvent was concentrated under reduced 
pressure to give a yellow oil. Water (20 cm3) and diethyl ether (20 cm3) were added, and the 
organic layer was separated. The aqueous layer was extracted with diethyl ether (2 x 10 cm ). 
The combined oiganic layers were washed with brine (10 cm3), dried over MgSC>4 , filtered and 
then concentrated under reduced pressure. Purification by flash column chromatography on silica 
gel with hexane and ethyl acetate (2 : 1) as eluent gave 211 as a pale yellow oil (0.30 g, 91%); R f  
0.24 (hexane : EtOAc = 2:1) ;  HRMS (C f, [M + m u t )  found 208.1508. CioH2oONF2 requires
208.1507; i w  (thin film)/cm“' 3364.5,2932.0, 2361.2, 1670.5, 1443.4, 1373.6, 1236.9 and 987.1; 
5h (500 MHz, C2HC13) 1.65 (1 H, s, OH), 1.69 (3 H, s, CH3), 2.14 (2 H, t, J 7.5, C=CHCH2Ci/2), 
2.32 (2 H, m, C=CHC//2CH2), 4.16 (2 H, d, J  7.0, CftOH), 4.84 (2 H, d, J H-f 47.5, Ctf2F), 4.96 
(2 H, d, J h-f 47.5, CH2F), 5.43 (1 H, dt, J  7.0, J 1.0, C77CH2OH) and 5.86 (1 H, m, CCtfCH2CH2); 
5c (125 MHz, C2HC13) 16.19 (CH3), 25.76 (C=CHCH2CH2), 38.63 (C=CHCH2CH2), 59.22 
(CH2OH), 76.88 (d, JCF 161.0, CH2F), 83.94 (d, JCF 164.0, CH2F), 124.54 (CHCH2OH), 131.08 (t, 
J cf 15.0, CCH2F), 137.09 (t, J c-f 9.0, CH2FC=CH) and 137.92 (CH2CCH3); 5 F (283 MHz, 
C^HCU) -209.94 (t, J hf 47.5) and -214.59 (t, J hf 47.5); m/z (Cl*) 208.2 (100, [M + NFL,]*) and
190.2 (90%, M*).
(E)-ethyl 12-fluoro-ll-(fluoromethyl)-7-methyl-3-oxododeca-6,10-dienoate (216)
A solution of alcohol 211 (0.24 g, 1.26 mmol) and triethylamine (0.35 cm3, 2.53 mmol) in 
anhydrous THF (15 mL) was stirred and cooled at -45 °C as MsCl (0.13 cm3, 1.64 mmol) was 
added. The resulting milky mixture was stirred at -45 °C for 45 min. a solution of LiBr (0.44 g, 
4.05 mmol) in THF (5 mL) was added via cannula at —45 °C. The suspension was allowed to 
warm to 0 °C and stirred for addition 1 h at which time the reaction was judged complete by TLC 
analysis. Cold water (20 cm3) and hexane (20 cm3) were added. The two layers were separated, 
and the aqueous layer was extracted with hexane (2x15 cm ). The combined organic layers were 
washed with satd. NaHCC>3 ( 1 x 1 5  cm3) and satd. NaCl ( 1 x 1 5  cm3) and dried over NaSC>4 . 
Evaporation of the solvent gave the bromide as a light yellow oil which was used without further 
purification.
To a suspension of NaH (0.10 g, 4.16 mmol) in anhydrous THF (15 cm3) was added ethyl 
acetoacetate (0.48 cm3, 3.78 mmol) dropwise at 0 °C. After 10 min, n-BuLi (2.5 M, 1.60 cm3, 
3.97 mmol) was added slowly over 3 min, during which time the colorless solution gradually 
turned yellow. It was stirred for additional 10 min at 0 °C, as a solution of above bromide 212 in 
THF (5 cm3) was added. The clear solution turned to a cloudy yellow suspension. After 30 min, 
TLC analysis showed the reaction was complete and HC1 (3 M, 2.0 cm3) was added, water (10 
cm ) and diethyl ether (10 cm ) were added, and the organic layer was separated. The aqueous 
layer was extracted with diethyl ether ( 2x10 cm3). The combined ethereal extracts were washed 
with water (2 x 1 0  cm3) and satd. NaCl (10 cm3), dried over MgSC>4 and then concentrated under 
reduced pressure. Purification of the crude product by flash column chromatography on silica gel 
with hexane and ethyl acetate (4 : 1) as eluent gave the title P-keto ester 216 as a pale yellow oil 
(0.13 g, 89% for two steps); Rf 0.21 (Hexane : EtOAc = 6  : 1); i)max (thin film)/crrf1 2981.9,
1743.5, 1716.2, 1644.2, 1443.4, 1408.2, 1368.4, 1314.1, 1236.9, 1178.5, 1096.9, 1034.8, 968.0 
and 855.9; 6 H (500 MHz, C2HC13) 1.30 (3 H, t, J7.0, CH2C//3), 1.63 (3 H, s, CCH3), 2.08 (2 H, m, 
C7/2CH2CO), 2.28 (4 H, m, CH2CH2CCH3), 2.58 (2 H, t, J  7.5, CH2C7/2CO), 3.44 (2 H, s, 
COCH2CO), 4.20 (2 H, q, J  7.0, C//2CH3), 4.83 (2 H, d, J H-f 47.5, CH2F), 4.98 (2 H, d, JH-f47.5, 
CH2F), 5.10 (1 H, td, J  7.0, J  1.0, CH3CC/7CH2) and 5.83 (1 H, m, CH2FCCtfCH2CH2); 6 C (125 
MHz, C2HC13) 14.08 (CH2CH3), 15.88 (CH3), 22.04, 25.91, 38.76 and 42.83 (2 x CH2CH2), 
49.33 (COCH2CO), 61.33 (CH2CH3), 76.88 (d, Jc-f 161.5, CH2F), 83.96 (d, Jc.F 163.5, CH2F), 
123.42 (CH3CCHCH2), 130.87 (t, JC-f 15.0, CCH2F), 135.15 (CH3C), 137.39 (t, JC-f 8.5, 
CH2FCCH), 167.18 and 202.38 (2 x C=0); 5F (250 MHz, proton decoupled, C2HC13) -211.9 (d, 
J¥.F 5.0) and -216.8 (t, JF-f 5.0); m/z (El-") 302.2 (20%, M+) and 189.1 (100).
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{\Z£E)~ 1 -(ethoxy carbonyl)-11 -fluoro-10-(fluoromethy I)-6 -methy lundeca-1,5,9-trien-2-y 1 
diethyl phosphate (217)
EtO'
To a stirred suspension of NaH (0.011 g, 0.48 mmol) in anhydrous diethyl ether (10 cm3) at 0 °C 
was added a solution of p-keto ester 216 (0.12 g, 0.40 mmol). The mixture was then stirred at 0 
°C for 30 min until the bubbling stopped. Diethyl chlorophosphate (0.09 cm3, 0.60 mmol) was 
added slowly to the resulting clear colorless solution. Stirring was continued at 0 °C for 
additional 15 min at which time, TLC showed that all the p-keto ester was consumed. The 
reaction was quenched by adding satd. NH4CI (5 cm3). Water (10 cm3) and diethyl ether (10 cm3) 
were added, and the organic layer was separated. The aqueous layer was extracted with diethyl 
ether (2x 10 cm ). The combined ethereal extracts were washed with satd. NaCl (1 * 10 cm ), 
dried over MgSC>4 and then concentrated under reduced pressure. Purification of the crude 
product by flash column chromatography on silica gel with hexane and ethyl acetate ( 1  : 1 ) as 
eluent gave the title compound as a pale yellow oil (0.14 mg, 8 8 %); Rf 0.29 (Hexane : EtO Ac = 
1 : 1 ) ;  HRMS (ES+, [M + H]*) found 439.2058. C20H34O6F2P requires 439.2056; umax (thin 
film)/cm_1 2982.6, 2358.2, 1726.0, 1663.3, 1445.9, 1370.8, 1280.1, 1204.9, 1147.6, 1097.9,
1034.5, 988.1 and 803.3; 6 H (500 MHz, C2HC13) 1.28 (3 H, t, J7.0, CH2CH3), 1.37 ( 6  H, t, J 7.0, 
2  x POCH2C//3), 1-63 (3 H, s, CC//3), 2.09 ( 2  H, t, J  7.5, C/f2CCH3), 2.26 (4 H, m, 2  x 
CHCH2CH2), 2.47 (2 H, t, J7.50, CH2CH2CO), 4.20 (2 H, q, J7.0, Gtf2CH3), 4.27 (4 H, quintet, 
J  7.0, 2 x POC//2CH3), 4.83 (2 H, d, J H-f 47.5, CH2F), 4.95 (2 H, d, JH-f 47.5, CH2F), 5.13 (1 H, 
td, J7.0, J  1.0, CH3CCi/CH2), 5.35 (1 H, s, C=CHC=0) and 5.84 (1 H, m, CH2FC=CtfCH2CH2);
167
8 c (125 MHz, C2HC13) 14.22, 15.97, 16.03 and 16.09 (4 * CH3), 24.85 and 25.95 (2 * 
C=CHC//2CH2), 35.09 (CH2C//2CO), 38.79 (C/ECCR), 59.89 (CH2CH3), 64.73 and 64.78 (2 * 
POCff2CH3), 76.86 (d, Jc.? 161.5, CH2F), 83.96 (d, JC.F 165.0, CH2F), 105.37 (d, Jc.? 7.5, 
C=CHCO), 123.04 (CH3C=CHCH2), 130.89 (t, Jc.f 15.0, CCH2F), 135.56 (CH3Q , 137.34 (t, JCF
8.5, CH2FC=CH), 161.12 (d, JC.P 7.5, CH2COP) and 163.73 (C02CH2CH3); 5P (500 MHz, 
tfHCh,) -8.78; 8 F (282 MHz, C2HC13) -211.98 (t, J H-F 47.0) and 216.73 (t, JH.F 47.0). m/z (Cl*)
456.3 (100%, [M + NR,]") and 439.2 (80, [M + H]+).
(£)-8-Fluoro-7-fluoromethyl-3-methylocta-2,6-dienal (221).
This compound was prepared from 211 in a manner identical to that for the aldehyde 181; 
purification by silica column chromatography using hexane and ethyl acetate (2 : 1 ) as eluent gave 
aldehyde 221 as a pale yellow oil (1.40 g, 90%); Rf 0.29 (Hexane : EtOAc = 2:1) ;  HRMS (C f, 
[M + NR,]*) found 206.1354. C,oH,8ONF2 requires 206.1351; 1W  (thin filmycnT1 2952.3,
2359.2, 1672.8, 1438.4, 1381.1, 1194.9, 1123.2, 967.7 and 865.9; 5H(500 MHz, C2HC13) 1.57 (3 
H, s, CH3), 1.67 (2 H, m, CH2C//2C), 1.83 (2 H, m, CR2CH2C), 4.62 (2 H, d, Jhf 47.5, CH2F), 
4.68 (2 H, d, Jhf 47.5, CR2F), 5.35 (1 H, b, CC//CH2CH2), 5.78 (1 H, d, J 7.5, C//CHO) and 9.92 
(1 H, d, J  7.5, CHC/ZO); 5C (125 MHz, C2HC13) 16.54 (CH3), 24.69 (CH2CH2C), 39.03 
(CH2CH2C), 76.29 (d, JCF 162.5, CH2F), 83.14 (d, J C f  166.5, CH2F), 127.53 (CHCHO), 131.96 (t, 
Jcr 15.0, CCH2F), 134.59 (t, JCF 7.5, CH2FCCH), 159.61 (CH2CCH3) and 189.50 (CHCHO); 5F 
(283 MHz, C2HC13) -212.04 (t, 47.5) and -216.79 (t, J H - f  47.5); m/z (Cl*) 206.2 (100%, [M +
NR,]*).
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(£)-9-Fluoro-8-fluoromethyl-4-methylnona-13,7-triene (220).
This compound was prepared from 221 in a manner identical to that for the triene 172; 
purification by silica column chromatography using hexane and ethyl acetate (9: 1) as eluent gave 
triene 220 as a light yellow oil (1.27 g, 92%); R f  0.34 (Hexane : EtOAc = 9:1) ;  HRMS (CI+, [M 
+ H]*) found 187.1290. C11H17F2 requires 187.1293; r w  ( th in  film)/cmM 2925.6, 2359.8, 1674.4,
1651.5, 1448.4, 1372.9, 1217.4, 986.8 and 901.0; 5H(500 MHz, C2HC13) 1.56 (3 H, s, CH3), 1.95 
(2 H, t, J  7.5, CH2CH2C), 1.83 (2 H, m, C=CHC//2CH2), 4.62 (2 H, d, Jw  47.5, CH2F), 4.75 (2 H, 
d, 7Hf47.5, CH2F), 4.80 (1 H, dd, J  10.0, J  1.5, CH CH =CH ^//cls), 4.90 (1 H, dd, J  17.0, J  1.5, 
C H C H C / Z ^ H c i s ) ,  5.64 (2 H, m, C=C//CH2CH2 and C//=CHCH2) and 6.35 (1 H ,  dt, J  17.0, J
10.0, CHC/7=CH2); 6 c (125 MHz, C2HC13) 16.56 (CH3), 25.91 (C=CHCH2CH2), 39.01 
(C=CCH2CH2), 76.86 (d, Jcf 161.0, CH2F), 83.92 (d, JC.T 165.0, CH2F), 115.44 (CHCH=CH2),
126.34 (CHCH=CH2), 131.07 ( t ,  J c - f  15.0,CCH2F), 133.04 (CHCH=CH2), 136.98 (dd, J c - f  10.0, 
J c - f  7.5, FCH2C=CH) and 137.62 (CH3C=CH); 8 F (300 MHz, C2HC13) -211.97 ( t ,  J H-f 47.5) and 
-216.70 ( t ,  J H-f 47.5); m/z (Cl*) 204.2 (100%, [M + NR,]*) and 187.1 (45, [M + H]+).
(22s,6£)-Ethy 112-fluoro-11 -flu oromethy 1-3,7-d imethy ldodeca-2,6,10-trienoate (219).
This compound was prepared from 220 in a manner identical to that for the ester 177; purification 
by silica column chromatography using hexane and ethyl acetate (9: 1) as eluent gave ester 219 as 
a light yellow oil (0.55 g, 29%); Rf 0.32 (Hexane : EtOAc = 9:1);  HRMS (ES+, [M + H]*) found
169
318.2239. C17H30O2NF2 requires 318.2239; umax(thin film)/cm_1 2932.0, 1713.8, 1648.7, 1446.7,
1370.8, 1350.3, 1274.9, 1222.6, 1145.3, 1096.0, 1040.0, 970.6, 865.3 and 735.4; 8H(500 MHz, 
C^HCb) 1.28 (3 H, t, J  7.0, CH2C//3), 1.62 and 2.17 ( 6  H, s, 2 x CH3), 2.07-2.30 ( 8  H, m, 2 x 
CHiCHi), 4.14 (2 H, q, J  7.0, Ctf2CH3), 4.83 (2 H, d, Jhf 47.5, CH2F), 4.96 (2 H, d, Jh f 47.5, 
CH2F), 5.12 and 5.85 (2 H, m, 2 * C=C//CH2CH2) and 5.67 (1 H, s, C=CHC02); 5c (125 MHz, 
C^HCU) 14.31 (CH2CH3), 15.91 and 18.74 (2 x CH3), 25.85 (CH2), 25.99 (CH2), 38.82 (t, Jcr 2.5, 
FCH2C=CHCH2), 40.75 (CH2), 59.48 (C//2CH3), 76.87 (d, JCf 161.5, CH2F), 83.95 (d, JCr 164.0, 
CH2F), 115.77 (C=CHC02), 124.11 (CH3C=CHCH2CH2), 130.84 (t, Jc-f 15.0, FCH2 C=CH), 
137.37 (dd, JCf 10.0, Jcf 7.5, FCH2C=CH), 134.65 and 159.41 (quaternary C) and 166.81 (C=0); 
5f (283 MHz, C2HC13) —211.76 (t, JHf 48.0) and -216.68 (t, J HF 48.0); m/z (Cl4) 318.3 (100%, [M 
+ NH 4 ]4), 301.3 (20, [M + H]4) and 281.2 (40, [M -  F]4).
(lE,6£)-12-Fluoro-ll-(fluoromethyl)-3,7-dimethyldodeca-2,6,10-trien-l-ol (222).
O H
This compound was prepared from 219 in a manner identical to that for the alcohol 175;
purification by silica column chromatography using hexane and ethyl acetate ( 1 : 2 ) as eluent gave
alcohol 222 as a light yellow oil (0.12 g, 6 8 %); Rf 0.26 (Hexane : EtOAc = 2 : 1 ) ;  HRMS (ES+,
[M + NEU]^ found 276.2132. C 15H 2 8 ONF2  requires 276.2133; Umax (thin film)/cm_1 3349.3,
2922.0, 2361.2, 1668.2, 1445.4, 1376.8, 1235.0, 987.5 and 569.1; 5H(500 MHz, C2HC13) 1.37 (1
H, s, OH), 1.53 and 1.61 ( 6  H, s, 2 x CH3), 1.95-2.22 ( 8  H, m, 2 x CH2CH2), 4.08 (2 H, d, y 7.0,
Cff2OH), 4.75 (2 H, d, JHr 47.5, CH2F), 4.88 (2 H, d, JHF 47.5, CH2F), 5.04 (1 H, dt, J  7.0, J  1.0,
CH3C=CHCH2CH2), 5.34 ( 1  H, dt, J  7.0, J  1.0, CHCH2OH) and 5.78 (1 H, m, FCH2C=CH); Sc
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(125 MHz, C2HC13) 15.91 and 16.25 (2 * CH3), 26.03 (CH2), 26.21 (CH2), 38.84 ( t ,  Jcr  2.5, 
FCH2C=CHCH2), 39.38 (CH2), 59.36 (C//2OH), 76.93 (d, Jcr  161.5, CH2F), 84.00 (d, Ja  165.0, 
CH2F), 123.52 (C=CHCH2OH), 125.00 (CH3C=CHCH2CH2), 130.74 ( t ,  J C f  15.0, FCH2C=CH), 
133.86 and 139.44 (2 x CH3O CH ) and 137.61 (dd, Jcr  10.0, Jcr 9.0, FCH2C=CH); SF (283 MHz, 
C^HCb) -211.62 (t, J H F 47.5) and -216.60 (t, J H - f  47.5); m/z  (Cl4), 276.2 (60%, [M + NR,]4),
258.2 (20, M4) and 241.1 (100, [M -  OH]4)
(2£',6£}-12-Fluoro-ll-fluoromethyl-3,7-dimethyldodeca-2,6,10-trien-l-yl diphosphate
tris-ammonium salt (154)
o- o- 
(NH4+)3
A stirred solution of 222 (0.12 g, 0.45 mmol) and triethylamine (0.13 cm3, 0.90 mmol) in 
anhydrous THF (5 cm3) was cooled to -45 °C and then methansulfonyl chloride (45 mm3, 0.59 
mmol) was added. The resulting milky mixture was stirred at —45 °C for 45 min and then a 
solution of lithium bromide (0.16 g, 1.80 mmol) in THF (5 cm3) was added via a cannula. The 
resulting suspension was allowed to warm to 0 °C and stirred for additional 1 h. Cold water (10 
cm3) and hexane (10 cm3) were added and the two layers were separated. The aqueous layer was 
extracted with hexane (2 x 1 0  cm3) and the combined organic layers were washed with saturated 
NaHCC>3 solution (10 cm3) and brine (10 cm3) then dried over Na2 SC>4 and filtered. The solvent 
was concentrated under reduced pressure to give bromide 223 as a light yellow oil, which was 
used directly without further purification. To a stirred solution of crude bromide 223 in anhydrous 
acotonitrile ( 1 0  cm3) under N2 was added freshly reciystallized tris(tetra-n-butyammonium)
hydrogenpyrophosphate (0.81 g, 0.90 mmol). The reaction mixture was stirred for 2 h, the solvent 
removed under reduced pressure and the resulting opaque residue dissolved in 2 cm3 of 1 : 49 
(v/v) isopropyl alcohol and 25 mM ammonium bicarbonate (ion-exchange buffer) . The pale 
yellow solution was slowly passed through a column containing 30 equiv. of DOWEX 50W-X8 
(1 0 0 - 2 0 0  mesh) cation-exchange resin that had been equilibrated with two column volumes of 
above mentioned ion-exchange buffer. The column was eluted with two column volumes of same 
buffer at a flow rate of one column volume per 15 min. The clear light yellow eluent was 
lyophilized to dryness to give a solid, which was purified by reverse phase HPLC (150 * 21.2 
mm Phenomenex Luna column, eluting with 10% B for 20 min, then a linear gradient to 60% B 
over 25 min and finally a linear gradient to 100% B over 5 min.; solvent A: 25 mM NH4HCO3 in 
water, solvent B: CH3CN, flow rate 5.0 cm3/min, detecting at 220 nm) to give the title compound 
154 as a white solid (21.2 mg, 10% over two steps); HPLC /r 36.58 min; Purity 94.90 % by 
analytical RP HPLC detecting at 220nm; HRMS (ES~, [M -  H]“) found 417.1044. C15H25O7F2P2 
requires 447.1049; tW K B r disc)/cirf' 2924.0, 2362.7, 1704.8, 1494.4, 1457.1, 1412.6, 1201.7,
1123.5, 1091.4, 1036.1, 911.4, 826.1 and 721.4; 8 H (500 MHz, 2H20  at pH 8.5 buffered with 
N2H4 0 2H) 188 1.48 (3 H, s, CH3), 1.57 (3 H, s, CH3), 1.93-2.20 ( 8  H, m, 2 * CH2CH2), 4.33 (2 H, t, 
J  6.5, CH20), 4.76 (2 H, d, Jar 47.5, CH2F), 4.91 (2 H, d, JHf47.5, CH2F), 5.07 (1 H, t, J  7.0, 
CH3C=C7/CH2CH2), 5.31 (1 H, t, J  7.0, C=CHCH20) and 5.87 ( 1  H, m, FCH2C=CH); 8C (125 
MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) 15.15 and 15.65 (2 x CH3), 25.58 (CH2), 25.63 
(CH2), 38.08 (CH2), 38.80 (CH2), 62.71 (d, JCP 5.0, CH20), 78.58 (d, J cf 154.0, CH2F), 85.67 (d, 
Jcf 156.5, CH2F), 119.72 (C=CHCH20), 125.11 (CH3C=CHCH2CH2), 129.97 (t, Jc.f 14.0, 
FCH2C=CH), 135.38 and!42.87 (2 x CH3C=CH) and 140.61 (t, Jcf 9.5, FCH2C=CH); 6 f (283
MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) -207.21 (d, J h f  47.5) and -216.83 (d, Jf.F 47.5); 
8 p (122 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) -6.61 (d, Jw 21.0) and -10.47 (d, JPP 
21.0); m/z (ES_) 417.1 (100%, [M -  H]").
(2Z,6£)-2-Fluoro-3,7,ll-trimethyldodeca-2,6,10-trien-l-oI (226) and
(22s,6£)-2-Fluoro-3,7,ll-trimethyldodeca-2,6,10-trien-l-ol (227)
OH
and OH
To a suspension of sodium hydride (60% dispersion in mineral oil, 0.10 g, 4.13 mol) in 
anhydrous THF (10 cm3) at 0 °C under and N2 atmosphere, triethyl 2-fluoro-2-phosphonoacetate 
(0.84 cm3, 4.13 mmol) and a solution of geranylacetone (1.02 cm3, 4.54 mmol) in anhydrous 
THF (5 cm3) were sequentially added, dropwise, with stirring. The complete reaction mixture 
was stirred for 14 h under N2 . Water (20 cm3) and diethyl ether (20 cm3) were added, and the 
organic layer was separated. The aqueous layer was extracted with diethyl ether ( 2 x 1 5  cm3). 
The combined ethereal extracts were washed with water (2 x 1 0  cm3) and satd. NaCl solution (10 
cm3), dried (MgSC>4), filtered and then concentrated under reduced pressure. The resulting ester 
was a 1:1 mixture of E and Z isomers and was reduced without further purification.
To a stirred solution of the crude ester in anhydrous THF (30 cm3) at -78 °C, was added, 
dropwise (over 3 min), diisobutylaluminum hydride (1.0 M solution in hexanes, 10.33 cm3, 10.33 
mmol). The reaction mixture was allowed to stir at -78 °C for 1 h, then 0 °C for 1 h and was then
o #
quenched with satd. sodium potassium tartrate solution (30 cm ). The resulting mixture was 
then extracted with diethyl ether (3 x 20 cm ). The combined organic extracts were dried over
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anhydrous MgSC>4 , filtered and then concentrated under reduced pressure. Purification of the 
residue by flash column chromatography on silica gel with hexane and ethyl acetate (4:1) as 
eluent gave the Z isomer (0.48 g, 48%) as a colorless oil followed by E isomer (0.46 g, 46%) as a 
colourless oil.
E isomer: TLC Rf 0.28 (4:1 hexane-ethyl acetate); HRMS (EI+, M+) found 240.1890. C15H25OF 
requires 240.1889; \w (th in  filmycm'1 3358.1, 2920.4, 1703.7, 1444.7, 1380.2, 1266.9, 1148.9,
1105.3 and 1012.5; 5H (500 MHz, C2HC13) 1.62 ( 6  H, s,2  * CH3), 1.70 (3 H, d ,J  1.0, CH3), 1.71 
(3 H, d, JH-f 3.48, C773C=CF), 1.79 (1 H, broad s, OH), 1.99-2.14 ( 8  H, m, 2  x CH2CH2), 4.19 (2
H, dd, J H-f 23.0, J  6.0, C//2OH) and 5.09 (2 H, m, 2  x CCH); 5c (125 MHz, C2HC13) 13.48 (d, 
Jc-f 9.0, CH3C=CF), 15.99 (CH3), 17.67 (CH3), 25.67 (CH3), 26.36 (d, JC.F 4.0, CH2CH2C=CF),
26.62 (CH2), 31.71 (d, JC F 5.0, CH2CH2C=CF), 39.67 (CH2), 57.67 (d, Jc-f 31.0, C=CFCH2OH), 
115.74 (d, Jc-f 14.0, CH3C=CFCH2), 123.00 and 124.14 (2 x C=CH), 131.52 and 136.52 
(quaternary C) and 152.57 (d, Jc.? 242.5, CH3C=CF); SF (283 MHz, C2HC13) -119.5 (t, J H-f 23.0); 
m/z (EI+) 240.2 (2%, M+), 81.1 (20) and 69.1 (100).
Z isomer: TLC Rf 0.20 (4:1 hexane-ethyl acetate); HRMS (FI' M ) found 240.1897. CisH^OF 
requires 240.1889; t>max(thin filmycm'1 3349.0, 2931.5, 2361.3, 1703.1, 1667.2, 1450.6, 1380.5,
1270.8, 1238.0, 1158.9, 1105.5, 1012.8 and 910.9; SH (500 MHz, C2HC13) 1.62 (6 H, s, 2 x CH3),
I.70 (3 H, d, J H - f  2.5, CH3CCF), 1.70 (3 H, s, CH3), 1.82 (1 H, b, OH), 1.98-2.15 ( 8  H, m, 2  x 
CH2CH2), 4.23 (2 H, dd, J H-f 22.5, J  5.5, CH2OH) and 5.11 (2 H, m, 2  x CCH); 5c (125 MHz, 
C^HCb) 15.37 (d, Jc-f 5.0, CH3CCF), 15.96 (CH3), 17.67 (CH3), 25.67 (CH3), 25.87 (d, JC-f 1.25, 
CH2CH2C=CF), 26.70 (CH2), 29.77 (d, JC-f 6.25, CH2 CH2C=CF), 39.69 (CH2), 57.94 (d, Jc.f
32.5, CH2OH), 116.02 (d, J C - f  16.25, CH3C=CFCH2), 123.53 and 124.32 (2 x C=CH), 131.36
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and 135.73 (quaternary C) and 151.79 (d, JC-r 240.0, CH3C=CF); SF (283 MHz, C2HC13) 121.13 
( t , y H-F 22.5); m/z (El*) 240.2 (4%, M+), 81.1 (35) and 69.1 (100).
(2Z,6£)-2-fluoro-3,7,ll-trimethyldodeca-2,6,10-trien-l-yl diphosphate tris ammonium salt 
(155)
(NH4)+3
This compound was prepared from alcohol 226 and purified in a manner identical to that for the 
diphosphate 154 to give diphosphate 155 as a white solid (0.15 g, 36%); HPLC /r 36.99 min; 
Purity 96.33% by analytical RP HPLC 220 nm; HRMS (Er, [M -  H]“) found 399.1135. 
C15H26O7FP2 requires 399.1143; \w (K B r discycm' 1 2963.4, 1701.8, 1494.4, 1455.4, 1411.8,
1204.0, 1164.6, 1122.1, 1091.9, 1034.7, 908.7, 825.9, 723.3, 595.4 and 552.7; SH (500 MHz, 
2H20) 1.47 (3 H, s, CH3), 1.48 (3 H, s, CH3), 1.54 (3 H, s, CH3), 1.59 (3 H, d, J H-f 2.5, 
CH3C=CF), 1.86-2.01 ( 8  H, m, 2 x CH2CH2), 4.42 (2 H, dd, JH-f24.0, JH-p 6.0, CCFC//2OP),
5.02 (1 H, t, J 7.0, C=CH) and 5.06 (1 H, m, C=CH); 6 C (125 MHz, 2H20) 4.82 (d, Jc.f 5.0, 
CH3C=CF), 15.33, 17.06 and 24.98 (3 x CH3), 25.33 and 26.04 (2 x CH2), 29.38 (d, Jc-f 6.0, 
CH2CH2C=CF), 39.04 (CH2), 60.54 (dd, Jc.f 31.25, JC-p 5.0, C=CFCH2OP), 119.33 (d, JC-f 14.0, 
CH3C=CFCH2), 123.92 and 124.44 (2 x C=CH), 132.82 and 136.62 (quaternary C) and 149.25 
(dd, Jc.F 237.5, Jc.p 9.0, CH3CCFCH2OP); 5F (283 MHz, 2H20) -120.23 (t, JH.F 24.0); 5P (122 
MHz, 2H20) -6.29 (d, yPP 21.0) and 10.50 (d, JP.P21.0); m/z (ESI 399.2 (15%, [M -  H]“) and 
74.9 (100).
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(Z)-2-Fluoro-3,7-dimethylocta-2,6-dien-l-ol (231) and
(Zs)-2-fluoro-3,7-dimethylocta-2,6-dien-l-ol (232)
F
O H
and O H
These two compounds were prepared from 6-methyl-5-hepten-2-one in a manner identical to that 
for the alcohol 226 and 227; purification by silica column chromatography using hexane and 
ethyl acetate (4: 1) as eluent gave the title compound (Z isomer) as a colourless oil (1.79 g, 46%) 
and the E isomer (1.72 g, 44%).
Z isomer: TLC Rf 0.14 (Hexane : EtOAc = 4 : 1 ) ;  HRMS (ES+, [M + m u T )  found 190.1602. 
CioH2,ONF requires 190.1602; Umax (thin film)/cm“' 3341.8, 2918.9, 1704.5, 1449.9, 1378.1,
1157.6 and 1011.2; SH (500 MHz, C2HC13) 1.63 (3 H, s, CH3), 1.69 (3 H, d, J H F 7.5, CR3CCF),
1.71 (3 H, d, J  0.5, CHi), 1.81 (1 H, b, OH), 2.10 (4 H, m, CH2CH2), 4.23 (2 H, d, J h - f  25.0, 
C//2OH) and 5.13 (I H, t, J  6.03, C//CH2CH2); 5c (125 MHz, C2HC13) 15.32 (d, J  c . f  6.25, 
CH3C=CF), 17.62 and 25.64 (2 x  CH3), 25.97 and 29.78 (d, J c.f  6.5, CH2CH2), 57.95 (d, J c - f
31.5, CH2OH), 116.00 (d, JC-r 15.0, CH3C=CF), 123.67 (CH), 132.08 (quaternary C) and 151.79 
(d, J c -f  240.0, CH3C=CF); 5 f  (250 MHz, proton decoupled, C2HC13) -121.33; m /z  (C l*) 190.1 
(100%, [M + NR,]*) and 172.2 (20, M*).
E isomer: TLC Rf 0.21 (Hexane : EtOAc = 4 : 1 ) ;  HRMS (ES+, [M + NR,]*) found 190.1600. 
CioH2,ONF requires 190.1602; Umax (thin film)/cm_l 3345.4, 2920.1, 2860.4, 2359.0, 1704.4,
1449.8, 1378.3, 1267.8, 1149.3, 1021.2, 908.3 and 830.2; SH (500 MHz, C2HC13) 1.61 (3 H, s, 
CHi), 1.70 and 1.71 (6 H, CR3CCF and terminal CH, overlap), 1.88 (1 H, b, OH), 2.04-2.12 (4 H, 
m, CH2CH2), 4.18 (2 H, d, Jh f 25.00, CR2OH) and 5.10 (1 H, tt, J  7.0, J  1.5, CHCH2CH2); 5C
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(125 MHz, C2HC13) 13.46 (d, J  C.F 9.0, CH3CCF), 17.62 and 25.61 (2 * CH3), 26.40 (d, Jc.f 2.5) 
and 29.78 (d, Jc-f 5.0, CH2CH2), 57.63 (d, JC-f 31.25, CH2OH), 115.62 (d, JC-f 15.0, CH3C=CF), 
123.26 (CH), 132.96 (quaternary C) and 152.66 (d, Jc-f 242-5, CH3C=CF); 5F (250 MHz, proton 
decoupled, C2HC13) -1 19.5; m/z (C f) 190.1 (100%, [M + NFUJ*) and 172.2(15, M+).
(Z)-Ethyl 6-fluoro-7,ll-dimethyl-3-oxododeca-6,10-dienoate (234)
F
A solution of the alcohol 231 (0.62 g, 3.62 mmol) and triethylamine (1.03 cm3, 7.40 mmol) in 
anhydrous THF (40 cm3) under N2 was stirred and cooled at —45 °C as MsCl (0.37 cm3, 4.80 
mmol) was added. The resulting milky mixture was stirred at —45 °C for 45 min, and a solution of 
LiBr (1.29 g, 14.8 mmol) in THF (10 cm3) was added via cannula at —45 °C. The suspension was 
allowed to warm to 0 °C and stirred for an additional 1 h, and then cold water (20 cm ) and 
hexane (20 cm3) were added. The two layers were separated, and the aqueous layer was extracted 
with hexane (2x15 cm3). The combined organic layers were washed with satd. NaHCC>3 solution 
(15 cm3) and then brine (15 cm3), dried over NaSC>4 and filtered. Concentration of the solvent 
gave the bromide 233 as a light yellow oil which was used without further purification.
To a stirred suspension of NaH (0.27 g, 11.3 mmol) in anhydrous THF (100 cm3) was added ethyl 
acetoacetate (1.30 cm3, 10.2 mmol) dropwise at 0 °C. After 10 min, n-BuLi (2.5 M, 4.29 cm3,
10.7 mmol) was added slowly over 3 min, during which time the colourless solution gradually 
turned yellow. Stirring was continued for an additional 10 min at 0 °C, and then a solution of the 
above bromide in THF (2 cm3) was added. The clear solution turned to a cloudy yellow
177
\
suspension. After stirring for 30 min at 0 °C, HC1 (3 M, 5.0 cm3) was added followed by water 
(20 cm ) and diethyl ether (20 cm ) then the organic layer was separated. The aqueous layer was 
extracted with diethyl ether (2x15 cm3). The combined ethereal extracts were washed with water 
(2x15 cm3) and brine (15 cm3), dried over MgSC>4 then filtrated and concentrated under reduced 
pressure. Purification of the crude product by flash column chromatography on silica gel with 
hexane and ethyl acetate (4 : 1) as eluent gave the title compound as a pale yellow oil (0.95g, 
98%). TLC Rf 0.40 (Hexane : EtOAc = 4 : 1 ) ;  HRMS (ES+, [M + Na]+) found 307.1672. 
CieH^OsFNa requires 307.1685; Umax (thin film)/cm_1 2968.6, 2921.1, 1746.8, 1719.6, 1650.0, 
1445.6, 1368.1, 1317.8, 1235.8, 1156.0, 1077.9, 1036.4 and 832.6; 5H (500 MHz, C2HC13) 1.21 (3 
H, t, J7.15, CH2Ctf3), 1-52 and 1.53 (6 H, CH3C=CF and a terminal CH3 overlap), 1.61 (3 H, s, 
Ctf3), 1.98 (4 H, br, CH2CH2), 2.45 (2 H, dt, JH-f 22.0, J  7.5, CFCtf2CH2), 2.67 (2 H, t, J  7.5, 
CFCH2CH2\  3.38 (2 H, s, C0CH2C02\  4.12 (2 H, q, J  7.0, CH2CH3) and 5.01 (1 H, b, 
CHCH2CH2); 6c (125 MHz, C2HC13) 14.06 (CH2CH3), 15.41 (d, Jc.f 6.5, CH3C=CF), 17.59 
(CH3), 22.57 (d, Jc-F 30.0, CFCH2CH2), 25.64 (CH3), 26.16 and 29.65 (d, JC.F 7.5, CH2CH2),
39.62 (CFCH2CH2), 49.36 (C0CH2C02), 61.38 (CH2CH3), 112.41 (d, JC-F 17.5, CH3C=CF),
123.55 (CH), 131.73 (quaternary C), 151.50 (d, JC.F 239.0, CH3C=CF) and 167.00 and 201.59 
(C=0); 6f (250 MHz, proton decoupled, C2HC13) -114.72; m/z (ES*) 307.2 (100%, [M + Na]*).
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(lZ,5Z)-l-(Ethoxycarbonyl)-5-fluoro-6,10-dimethylundeca-l,5,9-trien-2-yl diethyl
phosphate (235)
EtO'
To a stirred suspension of NaH (0.07 g, 2.79 mmol) in anhydrous diethyl ether (50 cm3) at 0 °C
was added slowly a solution of p-keto ester 234 in diethyl ether. The mixture was then stirred at 0
°C for 30 min until bubbling stopped. Diethyl chlorophosphate (0.51 cm3, 3.49 mmol) was added
slowly to the resulting clear colourless solution. Stirring was continued at 0 °C for additional 15
min and the reaction quenched by adding satd. NH4CI (20 cm3). The mixture was diluted with
water (20 cm3), and the organic layer was separated. The aqueous layer was extracted with
diethyl ether ( 2x15 cm3). The combined ethereal extracts were washed with water ( 2x15 cm3)
and brine (15 cm3), dried over MgSC>4 then filtered and concentrated under reduced pressure.
Purification of the crude product by flash column chromatography on silica gel with hexane and
ethyl acetate (2 : 1) as eluent gave the title compound as a pale yellow oil (0.94g, 97%). TLC Rf
0.14 (Hexane : EtOAc = 2 : 1 ) ;  HRMS (ES+, [M + Na]*) found 421.2144. C20H35O6FP requires
421.2155; iw (th in  film)/cm_1 2979.7, 2925.4, 2353.0, 1727.5, 1663.9, 1443.4, 1368.1, 1280.1,
1207.5, 1147.1, 1035.2, 991.5 and 800.6; 6 H (500 MHz, C2HC13) 6  1.19 ( 3 H , U =  7.15,
CO2CH2C//3), 1.30 (6 H, dt, J  7.0, J 1.0, 2 x POCH2C//3), 1.51 (3 H, d, J  2.5, C//3C=CF), 1.53 (3
H, s, C//3C=CH), 1.61 (3 H, s, C//3CCH), 1.96-2.00 (4 H, m, (CH3)2C=CHC//2C//2), 2.44-2.54
(4 H, m, CFC//2C//2), 4.07 (2 H, q, J  7.0, C02C/f2CH3), 4.20 (4 H, quintet, J  7.0, 2 x
POC//2CH3), 5.02 (1 H, b, (CH3)2C=Ci/CH2) and 5.30 (1 H, s, C=CHC02); 6C (125 MHz,
C^HCb) 14.19 (C02CH2CH3), 15.43 (d, JC-f 6.5, CH3C=CF), 16.01 (POCH2CH3), 16.07
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(POCH2CH3), 17.58 (CH3C=CH), 25.62 (CH3C=CH), 25.94 (d, Jc-f 30.0, CFCH2CH2), 26.22 (d, 
Jc-f 1.5, (CH3)2C=CHCH2CH2), 29.70 (d, Jc.f 7.5, (CH3)2C=CHCH2CH2), 32.47 (CFCH2CH2), 
59.88 (C02 CH2CH3), 64.77 and 64.83 (2 x POC//2CH3), 106.07 (d, Jc-p 7.5, C0CHC02), 113.16 
(CH3C=CFCH2), 123.92 ((CH3)2C=CHCH2), 131.71 (quaternary C), 151.05 (d, Jc-r 241.5, 
CH3C=CF), 160.04 (d, J  7.5, quaternary C) and 163.54 (quaternary C) ; 5f (250 MHz, proton 
decoupled, C2 HC13) -114.32; 8 P (500 MHz, C2HC13,) - 8 .6 6 ; m/z (ES*) 421.2 (100 %, [M + 
Hf).
(2Zs,6Z)-Ethyl 6-fluoro-3,7,ll-trimethyldodeca-2,6,10-trienoate (236)
F
To a stirred suspension of Cul (0.84 g, 4.43 mmol) in diethyl ether (50 cm3) at 0 °C was added 
MeLi (1.6 M in diethyl ether, 5.54 cm3, 8 . 8 6  mmol). A yellow precipitate formed immediately, 
and the mixture was stirred for 30 min at 0 °C, at which time all the yellow precipitate 
disappeared, and a nearly colorless solution remained. The colorless solution was then cooled to 
-78 °C, and enol phosphate 235 (0.93 g, 2.21 mmol) in diethyl ether (5 cm3) was added slowly 
over 5 min. The resulting yellow solution was stirred for 3 h at -78 °C. Mel (1.38 cm3, 22.1 
mmol) was added, and the mixture was stirred for an additional 15 min at -78 °C before the 
yellow orange mixture was poured into an ice-cooled mixture of satd. N H 4 C I  and conc. N H 4 O H  
(1 : 1, 10 cm3). The organic layer was separated, and the aqueous layer was extracted with diethyl 
ether (2 x 20 cm3). The combined ethereal extracts were washed with water ( 2 x 1 5  cm3) and 
brine (15 cm3), dried over MgSC>4 then filtered and concentrated under reduced pressure.
Purification of the crude product by flash column chromatography on silica gel with hexane and 
ethyl acetate (9 : 1) as eluent gave the title compound 236 as a pale yellow oil (0.56 g, 95%); 
TLC Rf 0.45 (Hexane : EtOAc = 9 : 1 ) ;  HRMS (EI+, M+) found 282.1988. C17H27O2F requires 
282.1995; iw (th in  film)/cm_1 2965.6, 2925.3, 2855.1, 1717.5, 1649.0, 1447.3, 1381.8, 1272.6,
1223.3, 1149.5, 1049.6 and 855.9; 5H (500 MHz, C2HC13) 1.28 (3 H, t, J7.0, C02CH2C//3), 1.57 
(3 H, d, J2.5, CH3C=CF), 1.61 (3 H, s, Ctf3C=CHCH2CH2), 1.69 (3 H, s, CH3C=CH CH2CH2), 
2.05-2.08 (4 H, m, (CH3)2C=CHCH2CH2)t 2.19 (3 H, d, J  1.0, CH3C=CHC02), 2.32 (2 H, t, J7.5, 
CFCH2C//2), 2.37-2.44 ( 2  H, m, CFC7/2CH2), 4.15 ( 2  H, q, J 7.0, C02C/72CH3), 5.11 ( 1  H, b, 
(CH3)2C=C//CH2) and 5.69 ( 1  H, s, C=CHC02); 6 c (125 MHz, C2HC13) 14.29 (C02CH2CH3),
15.47 (d, J c-f 6.5, CH3C=CF), 17.58 (CH3C=CHCH2), 18.66 (CH3C=CHC02), 25.64 
(CH3C=CHCH2), 26.23 (d, Jc-f 2.5, (CH3)2C=CHCH2CH2), 26.87 (d, JC-f 30.0, CFCH2CH2),
29.67 (d, J c-f 7.5, (CH3)2C=CHCH2CH2), 37.74 (CFCH2CH2), 59.48 (C0 2CH2CH3), 1 1 2 . 2 1  (d, 
J c-f 16.5, CH3C=CFCH2), 116.24 (COCtfC02), 123.99 ((CH3)2C=CHCH2), 131.68 (quaternary 
C), 152.06 (d, J c-f 240.0, CH3C=CF), 158.32 and 166.65 (quaternary C); 6 f (250 MHz, proton 
decoupled, C2HC13) -113.40; m/z ( E f )  282.2 (2%, M+) and 69.1 (100).
(2E,6Z)-6-Fluoro-3,7,ll-trimethyldodeca-2,6,10-trien-l-ol (237)
O H  
F
This compound was prepared from 236 in a manner identical to that for the alcohol 175; 
purification by silica column chromatography using hexane and ethyl acetate (1 : 2 ) as eluent gave 
alcohol 237 as a colourless oil (0.30 g, 91%); TLC Rf 0.32 (Hexane : EtOAc = 2:1) ;  HRMS (El*,
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M*) found 240.1897. C15H25OFrequires 240.1889; omax(thin film)/cm 1 3327.8, 2919.0, 1706.3,
1670.5, 1449.1, 1381.5, 1288.4, 1189.6, 1142.0, 1110.8, 1075.8, 1006.2, 924.5 and 829.9; 5H (500 
MHz, C2HC13) 1.46 (1 H, s, OH), 1.49 (3 H, d, J2.5, C//3CCF), 1.53 (3 H, s, CH3C=CHCH2OH), 
1.61 (3 H, s, C//3C=CHCH2CH2), 1.62 (3 H, s, Ctf3C=CHCH2CH2), 1.97 (4 H, m, 
(CH3>2C=CHC//2C//2), 2.12 (2 H, t, J7.5, CFCH2C//2), 2.22 (2 H, m, CFCtf2CH2), 4.06 (2 H, d, 
J7.0, C//2OH), 5.03 (1 H, b, (CH3>2C=Ci7 CH2) and 5.36 (1 H, dt, J7.0, J1.0, CC//CH2OH); 5c 
(125 MHz, C2HC13) 15.47 (d, Jc.f 6.5, CH3C=CF), 16.18 (CH3C=CHCH2CH2), 17.61 
(CH3C=CHCH2OH), 25.65 (CH3C=CHCH2CH2), 26.28 (CH3)2C=CHCH2CH2), 27.28 (d, Jc-f
29.0, CFCH2CH2), 29.65 (d, J C-f 7.5, (CH3)2C=CHCH2CH2), 36.44 (CFCH2CH2), 59.29 
(CH2OH), 111.48 (d, J c-f 17.5, CH3C=CFCH2), 124.06 (CtfCH2OH), 124.08 [(CH3)2C=CHCH2],
131.67 and 138.64 (quaternary C) and 152.96 (d, Jc.F 241.5, CH3C=CF); 5F (250 MHz, proton 
decoupled, C2HC13) -112.73; m/z (El*) 240.2 (6 %, M^ and 202.2 (100).
(22s,6Z)-6-Fluoro-3,7,ll-trimethyldodeca-2,6,10-trien-l-yl diphosphate (156)
o o
I I
0/ f \^ 0 /F \^ 0 '
O" O"
(NH4+)3
This compound was prepared in a manner identical to that for the diphosphate 154, using the 
alcohol 237 (0.21 g, 0.86 mmol) to give the title compound 156 as a white fluffy solid (188 mg, 
48% for two steps); HPLC /r = 36.45 min; Purity 96.57 % by analytical RP HPLC under 220 nm; 
HRMS (ES~, [M -  H]~) found 399.1145. CisH26 0 7 FP2 requires 399.1143; umax (KBr disc)/cm_1
2929.9, 1707.6, 1494.4, 1456.3, 1200.2, 1124.7, 1088.8, 1041.5, 914.1, 809.9, 720.8 and 595.0; 
8 h (500 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) 1.45 (3 H, d, J2.0, Ctf3C=CFCH2), 1.49
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(3 H, s, CH3CCHCH 2CH2), 1.56 (3 H, s, C//3C=CHCH20), 1.61 (3 H, s, C//3C=CHCH2CH2), 
1.96 (4 H, m, (CH3)2C=CHC//2C//2), 2.10 (2 H, t, 77.5, CFCH2C//2), 2.26 (2 H, td, 725.0,77.5, 
CFC772CH2), 4.34 (2 H, t, 76.5, CHC//20), 5.06 (1 H, br, (CH3)2C=07CH2) and 5.35 (1 H, t, 7  
7.5, C=C//CH20); Sc (125 MHz, 2H20  at pH 8.5 buffered with N2H40 2H) 14.57 (d, 7C.F 6.5, 
CH3C=CF), 15.60 (CH3C=CHCH2CH2), 16.95 (CH3C=CHCH2CH2), 24.90 (CH3C=CHCH20), 
25.45 (CH3)2C=CHCH2CH2), 26.63 (d, 7C-f 25.0, CFCH2CH2), 28.86 (d, 7C.F 7.5, 
(CH3)2C=CHCH2CH2), 35.94 (CFCH2CH2), 62.47 (d, 7C.P 5.0, CHCH2O), 112.22 (d, 7C.F 16.5, 
CH3C=CFCH2), 120.56 (d, 7c.p 9.0, CHCH20 ), 124.14 ((CH3)2C=CHCH2), 133.75 and 141.06 
(quaternary C) and 153.48 (d, 7C.F 236.5, CH3C=CF); SF (283 MHz, 2H20  at pH 8.5 buffered with 
N2H ,0 2H) -113.69 (t, 7h.f 24.5); 8P (202 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) -6.95 (d, 
7P.P21.0) and -10.38 (d, 7P.P21.0); m/z (ES") 399.1 (100%, [M -  H]“).
Ethyl 2-fluoro-3-methylbut-2-enoate (240)
F
To a stirred solution of triethyl-2-fluoro-2-phosphonoacetate (4.20 cm , 20.6 mmol) in anhydrous 
THF (40 cm3) was added a suspension of NaH (0.55 g, 22.7 mmol) in THF (5 cm3) was added at 
0 °C under an argon atmosphere. After stirring of 30 min at RT, a mixture of acetone (1.82 cm3,
24.7 mmol) was added, and then the whole reaction mixture was stirred overnight. After 
quenching with cold saturated N H 4 C I  solution (30 cm ), the result mixture was extracted with 
diethyl ether (3 x 30 cm3), and the organic phases were combined, washed with brine (30 cm3) 
and dried (MgSO^, filtered and then concentrated under reduced pressure to give the title
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compound as a pale yellow oil, Purification of the crude product by flash column 
chromatography on silica gel with hexane and ethyl acetate (30 : 1) as eluent gave the title 
compound 240 as a colorless oil (1.34 g, 47%); TLC Rf 0.49 (Hexane : EtOAc = 9:1) ;  Umax (thin 
film)/cm“‘ 2986.0, 2926.6, 1724.5, 1617.3, 1448.8, 1373.1, 1299.5, 1236.6, 1152.7, 1089.3,
1022.4, 934.0 and 864.6; 8 H (500 MHz, C2HC13) 1.35 (3 H, t, J  7.0, CH2C//3), 1.87 (3 H, d, J h-f
4.0, CH3), 1.61 (3 H, d, J h-f 3.0, CH3) and 4.27 (2 H, q, J7.0, CH2CU3); 5c  (125 MHz, C2HC13) 
14.17 (CH2CH3), 18.48 and 18.56 (2 x CH3), 60.87 (CH2CH3), 129.49 (d, J  14.0, (CH3)2C=CF),
142.71 (d, J  244.0, (CH3)2C=CF) and 161.21 (d, J  34.0, C02CH2CH3); 5F (283 MHz, C2HC13) 
-128.06; m/z (Cl*) 164.1 (100%, [M+NH4]+).
l-{[(Zs)-3,7-Dimethylocta-2,6-dienyloxy] methyl} benzene (245).
This compound was prepared from geraniol in a manner identical to that for the benzyl ether 207; 
purification by silica column chromatography using hexane and ethyl acetate (9: 1) as eluent gave 
the title compound 245 as a colourless oil (5.75 g, 94%); TLC Rf 0.49 (Hexane : EtOAc = 9 : 1); 
HRMS (EI+, M*) found 244.1839. C17H24O requires 244.1827; Umax (thin film)/cm_1 2966.7,
2918.6, 2854.2, 1667.6, 1495.6, 1451.5, 1379.4, 1246.4, 1202.5, 1067.9, 1026.5, 1009.0 and 
942.3; 5H (500 MHz, C2HC13) 1.64 (3 H, s, CH3), 1.68 (3 H, s, CH3), 1.72 (3 H, s, CH3), 2.08 (2 
H, t, J  7.5, CHCH2C/72C), 2.14 (2 H, q, J  7.5, CHC//2CH2C), 4.06 (2 H, d, J  7.0, CHCiftO), 4.54 
(2 H, s, OCtf2Ph), 5.14 (1 H, m, (CH3)2CC//CH2), 5.44 (1 H, td, J  7.0, J  1.0, CCHCH20) and 
7.29 (5 H, m, Ar-H); 5c (125 MHz, C2HC13) 16.50 (CH3), 17.70 (CH3), 25.71 (CH3), 26.40 and
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39.63 (CHCH2CH2C), 66.61 (CHCH20), 71.97 (OCH2Ph), 120.86 (CHCH20), 124.04 
(CHCH2CH2), 127.52, 127.84 and 128.35 (Ar-CH) and 131.66, 138.64 and 140.41 (quaternary C); 
m/z (E f) 244.2 (2%, M+) and 91.0 (100).
(2£,6£)-8-(Benzyloxy)-2,6-dimethylocta-2,6-dien-l-ol (246)
To a stirred solution of benzyl ether 245 (5.70 g, 23.4 mmol) in DCM (40 cm ) was added 
selenium dioxide (0.26 g, 2.30 mmol), tert-butyl hydroperoxide (70% in H20 , 55.6 cm3, 84.2 
mmol) and acetic acid (0.13 cm3, 2.30 mmol) under an argon atmosphere. The whole reaction 
mixture was then stirred overnight at RT. Water (30 cm3) was added and the resulting mixture 
was extracted with diethyl ether (3 x 30 cm3), and the organic phases were combined, washed 
with 1 0 % aqueous potassium hydroxide (30 cm3), brine (30 cm3) and dried (MgSCU), filtered and 
then concentrated under reduced pressure to give the title compound as a pale yellow oil. 
Purification of the crude product by flash column chromatography on silica gel with hexane and 
ethyl acetate (2 : 1) as eluent gave the title compound as a colorless oil (1.95 g, 32%); TLC Rf 
0.26 (Hexane : EtOAc = 2 : 1 ) ;  Umax (thin film)/cm_1 3391.9, 2919.0, 2856.3, 1667.6, 1451.8,
1364.0, 1202.5, 1065.5, 1010.6, 736.0 and 697.8; 5H (500 MHz, C2HC13) 1.67 (3 H, s, CH3), 1.69 
(3 H, s, CH3), 2.11 (2 H, t, J  1.5, CHCH2C//2C), 2.19 (2 H, q, J7.5, CHC772CH2C), 4.00 (2 H, s, 
CGfifcOH), 4.04 (2 H, d, J  7.0, CHC/720), 4.53 (2 H, s, OCtf2Ph), 5.40 (2 H, m, 2 x C=CHCH2) 
and 7.29 (5 H, m, Ar-H); 6 C (125 MHz, C2HC13) 13.71 (CH3), 16.46 (CH3), 25.81 and 39.15 
(CHCH2CH2C), 66.57 (CHCH20), 68.95 (CCH2OH), 72.11 (OCH2Ph), 121.17 and 125.63 (2 x
C=C//CH2), 127.57, 127.84 and 128.37 (Ar-CH) and 135.15, 138.52 and 139.94 (quaternary C); 
m/z (CO 278.3 (75%, [M + N H ^  and 135.0 (100).
l-[(2£',6£}-8-(Benzyloxy)-2,6-dimethylocta-2,6-dienylsulfonyl] benzene (242)
A stirred solution of alcohol 246 (1.60 g, 6.15 mmol) and triethylamine (1.71 cm3, 12.3 mmol) in 
anhydrous THF (40 cm3) was cooled to —45 °C and then MsCl (0.62 cm3, 8.01 mmol) was added. 
The resulting milky mixture was stirred at -45 °C for 45 min and then a solution of LiBr (2.14 g,
24.6 mmol) in THF (5 mL) was added via a cannula at —45 °C. The suspension was allowed to 
warm to 0 °C and stirred for addition 1 h. Cold water (40 cm3) and hexane (40 cm3) were added. 
The two layers were separated, and the aqueous layer was extracted with hexane (2 x 30 cm3). 
The pooled organic layers were washed with saturated NaHCC>3 solution (30 cm3) and saturated 
NaCl solution (30 cm3) and then dried over anhydrous NaSC>4 . Concentration of the solvent under 
reduced pressure gave the required bromide 247 as a light yellow oil which was used without 
further purification. The crude bromide 247 and benzensulfmic acid sodium salt (1.22 g, 7.38 
mmol) were dissolved in anhydrous DMF (30 cm3). The mixture was stirred for 20 h, and then 
hydrolyzed with water (30 cm3). The aqueous layer was extracted with diethyl ether (3 x 30 cm3), 
and the organic phases were combined, washed with water (30 cm3) and brine (30 cm3), dried 
(MgSC>4), filtered and then concentrated under reduced pressure to give the title compound as a 
pale yellow oil. Purification of the crude product by flash column chromatography on silica gel 
with hexane and ethyl acetate ( 2  : 1 ) as eluent gave the title compound as a colorless oil (1.91 g,
82%); TLC Rf 0.31 (Hexane : EtOAc = 2 : 1 ) ;  HRMS (ES+, [M + NH tf) found 402.2097. 
C23H32O3NS requires 402.2097; t w  (thin film)/cm“‘ 3061.7, 2918.5, 2855.5, 1666.7, 1585.9,
1448.9, 1386.4, 1310.5, 1255.3, 1134.0, 1086.9, 1026.2, 876.5, 740.8, 691.4 and 616.2; 6 H (500 
MHz, C’HCb) 1.61 (3 H, s, CH3), 1.78 (3 H, s, CH3), 1.89 (2 H, t, 77.5, CHCH2C//2C), 2.08 (2 
H, q, 7  7.5, CHC772CH2C), 3.73 (2 H, s, CC//2S02), 4.01 (2 H, d, 7  6.5, CHCftO), 4.52 (2 H, s, 
OCftPh), 5.06 (1 H, t, 7  7.0, C=C//CH2CH2), 5.32 (1 H, td, 7  6.5, 7  1.0, C=C//CH20) and
7.29-7.86 (10 H, m, 2  x Ar-H); Sc (125 MHz, C2HC13) 16.42 (CH3), 16.71 (CH3), 26.57 and
38.48 (CHCH2 CH2C), 66.22 (CCH2S02), 66.54 (CHCH20), 72.20 (OCH2Ph), 121.31 (CHCH20), 
127.60, 127.81,128.38, 128.52,128.90 and 133.51 (Ar-CH), 135.64 (C=CHCH2CH2) and 123.61, 
138.47, 138.49 and 139.35 (quaternary C); m/z (Cl*) 402.3 (40%, [M + N R tf) and 135.1 (100).
l-[(6£',10£)-12-(beiizyIoxy)-3-fluoro-2,6,10-trimethyldodeca-2,6,10-trien-5-ylsulfonyl]benze 
ne (248)
F 0 = S = 0
To the mixture of sulfone 242 (1.57 g, 4.11 mmol) and bromide 241 (0.601 g, 3.60 mmol) in 
anhydrous THF (25 cm3) at -78 °C was added «-BuLi (2.2 M, 1.87 cm3, 4.11 mmol) dropwise 
over 15 min, and the mixture stirred for 2 h at -78 °C. The cooling bath was then removed and 
the reaction mixture was allowed to warm slowly to 0 °C. Water (20 cm ) was added and the 
aqueous layer was extracted with diethyl ether (3 x 20 cm3), and the organic phases were 
combined, washed with water ( 2 0  cm ), brine ( 2 0  cm ) and dried (MgSCU), filtered and then
concentrated under reduced pressure to give the title compound as a pale yellow oil. Purification 
of the crude product by flash column chromatography on silica gel with hexane and ethyl acetate 
(4 : 1) as eluent gave the title compound as a light yellow oil (1.29 g, 76%); TLC Rf 0.29 
(Hexane : EtOAc = 4 : 1 ) ;  HRMS (ES+, [M + NH4T) found 488.2628. C28H39O3NFS requires 
488.2629; iw (th in  film)/cm_1 2922.3, 2860.0, 1714.5, 1666.9, 1449.5, 1365.9, 1305.8, 1198.9,
1145.1, 1086.5, 737.7, 692.0 and 606.7; 5H (500 MHz, C^HCL) 1.59 (9 H, m, 3 x CH3), 1.69 (3 H, 
s, CH3), 1.81 (2 H, t, J  7.5, CHCH2C//2C), 1.99 (2 H, m, CHCH2CH2C), 2.91 (2 H, m, 
CFC//2CH), 3.79 (1 H, dd, J 11.0, J 4.0, CFCH2GH), 4.00 (2 H, d, J  6.5, CHC//2O), 4.52 (2 H, s, 
OCtf2Ph), 5.15 (1 H, t, J  7.5, C=CHCH2CH2), 5.31 (1 H, td, J  6.5, J  1.0, C=CHCR20 ) and
7.29-7.83 (10 H, m, 2  x Ar-H); 5c (125 MHz, C2HC13) 13.79 (CH3), 15.62 (d, J9.0, CH3), 16.40 
(CH3), 16.71 (d, J  12.5, CH3), 25.38 (d, JC-f 29.0, CFCH2CH), 26.49 and 38.36 (CHCH2CH2C),
66.55 (CHCH2O), 70.98 (CFCH2CH), 72.23 (OCH2Ph), 110.60 (d, J C - f  17.5, C=CFCH2CH), 
121.21 (CHCH2O), 127.58, 127.82, 128.38, 128.80, 128.81 and 133.51 (Ar-CH), 135.58 
(C=CHCH2CH2), 126.36, 137.94, 138.50 and 139.46 (quaternary C) and 148.42 (d, J C - f  240.0, 
CFCH2CH); 5f (283 MHz, C2HC13) -114.54 (dd, JH-f 28.0); m/z (CI+) 488.3 (2%, [M + N IL f) 
and 94.1 (100).
(2£',6£)-10-Fluoro-3,7,ll-trimethyldodeca-2,6,10-trien-l-ol (249)
O H  
F
Tert-butyl alcohol (2.0 cm3) and benzyl ether 248 (0.37 g, 0.79 mmol) dissolved in anhydrous 
THF (10 cm3) were added via a cannula to a lithium bits (0.06 g. 8.57 mmol) with stirring. The
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reaction mixture was stirred under nitrogen atmosphere for 5 h, after which another pertion of Li 
(0.06 g, 8.57 mmol) was added to the reaction mixture together with tert-butyl alcohol (2.0 cm3) 
at 0 °C. The reaction mixture was then left to stir overnight. Cold water (10 cm3) was added and 
the result mixture was extracted with diethyl ether (3 x 10 cm3), and the organic phases were 
combined, washed with brine ( 1 0  cm ) and dried (MgS0 4 ), filtered and then concentrated under 
reduced pressure to give the title compound as a pale yellow oil. Purification of the crude product 
by flash column chromatography on AgNC>3-impregnated silica gel (5% AgN03 on silica gel) 
with hexane and ethyl acetate (3 : 1) as eluent gave the title compound as a colorless oil (0.053 g, 
28%); TLC Rf 0.29 (Hexane : EtOAc = 4 : 1 ) ;  HRMS (Ef, [M -  U2OT) found 222.1778. 
C15H23F requires 222.1784; n o t h in  filmycm' 1 3333.7, 2932.4, 2862.2, 1714.5, 1667.9, 1445.9,
1383.6, 1301.9, 1258.2, 1152.4, 1102.7, 1005.5, 898.1, 798.4 and 737.6; 6 H (500 MHz, C2HC13)
1.44 (1 H, s, OH), 1.49 (3 H, d, JH-f 2.5, CH3), 1.55 ( 6  H, s, 2  x CH3), 1.61 (3 H, s, C//3), 1.96 (2 
H, t, J7.5, CHCH2C//2C), 2 . 0 2  (4 H, m, CHC/72CH2C and CFCH2C/72), 2.18 ( 2  H, dt, JH-f 23.0, 
J  7.5, CFC//2CH2), 4.08 (2 H, d, J  7.0, CHCtf2OH), 5.06 (1 H, td, J  7.0, J  1.0, C=C//CH2CH2) 
and 5.34 (1 H, tq, J  7.0, J  1.0, C=CHCH2OH); 6 c (125 MHz, C2HC13) 15.45 (d, JC-f 10.0, 
CH3CCFCH 2), 15.91 (CH3), 16.26 (CH3), 17.57 (d, Jc.f 6.5, CH3C=CFCH2), 26.32 
(CHCH2CH2C), 27.51 (d, JC-f 30.0, CFCH2CH2), 36.58 (CFCH2CH2), 39.44 (CHCH2CH2C),
59.38 (CHCH2OH), 107.14 (d, JC-f 17.5, C=CFCH2CH2), 123.40 (CHCH2OH), 124.53 
(C=CHCH2CH2), 134.41 and 139.67 (quaternary C) and 153.00 (d, JC-f 240.0, CFCH2CH2); 5F 
(283 MHz, C2HC13) -112.75 (t, JH-f 22.5); m/z (EI+) 222.2 (5%, [M -  HzOft and 69.1 (100).
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(2£',6£)-10-Fluoro-3,7,ll-trimethyldodeca-2,6,10-trien-l-yl diphosphate tris ammonium salt 
(157)
F (NH4)+3
This compound was prepared in a manner identical to that for the diphosphate 154, using the 
alcohol 249 (0.041 g, 0.171 mmol) to give the title compound as a white puffy solid (43 mg, 56% 
for two steps); HPLC /r = 36.41 min; Purity 96.88 % by analytical RP HPLC under 220 nm; 
HRMS (ES“, [M -  H]") found 399.1124. C15H26O7FP2 requires 399.1138; umax (KBr disc)/cm_1
2818.0, 1716.4, 1670.0, 1456.4, 1201.1, 1120.7, 1090.0, 1025.5, 907.2, 804.7, 722.0, 596.3, 
552.5 and 512.9; 5H (500 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) 1.41 (3 H, d, JH.F 2.5, 
C//3C=CFCH2), 1.43 (3 H, d, JH.F 3.0, C//3C=CFCH2), 1.48 (3 H, s, CH3), 1.56 (3 H, s, CH3), 
1.92 ( 2 H , t , 7 7.5, CHCH2C//2C), 1.98 (4 H, m, CHCtf2CH2C and CFCH2C//2), 2.20 (2 H, dt, 
Jh-f 25.0, J  7.0, CFC//2CH2), 4.31 (2 H, t, J  6.5, CHC//2O), 5.07 ( 1  H, t, J  6.5, C=C//CH2CH2) 
and 5.31 (1 H, t, J  7.0, C=C/fCH20); 6 C (125 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) 
14.63 (d, J c-f 10.0, CH3C=CFCH2), 15.10 (CH3), 15.64 (CH3), 16.80 (d, Jc.f  6.5, 
CH3C=CFCH2), 25.74 (CHCH2CH2C), 26.52 (d, Jc.f 29.0, CFCH2CH2), 35.75 (CFCH2CH2), 
38.79 (CHCH2CH2C), 62.51 (d,Jc.P5.0, CHCH20), 108.63 (d, J C-f 16.5, C=CFCH2CH2), 119.81 
(d, Jc-p 9.0, CHCH2O), 125.04 (C=CHCH2CH2), 135.49 and 142.79 (quaternary C) and 152.94 (d, 
J c-f 236.5, CFCH2CH2); 5f  (283 MHz, 2H20  at pH 8.5 buffered with N 2H 4 0 2H ) -113.98 (t, J H-f 
25.5); SP (122 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) -7.05 (d, JP.P21.0) and -10.35 (d, 
Jp.P21.0); m /z  (ES-) 399.1 (100%, [M -  H]").
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Ethyl 4-(benzyloxy)-3-oxobutanoate (252)
Benzyl alcohol (8.28 cm3, 80.0 mmol) was added dropwise to a suspension of sodium hydride 
(3.21 g, 80.0 mmol) in toluene (200 cm3), slight cooling was required with ice bath to maintain 
the temperature at RT. After hydrogen evolution had ceased while the thick slurry was allowed to 
stir for 2 h. Ethyl 4-chloroacetoacetate (5.44 cm3, 40.0 mmol) was added dropwise over 20 min 
and the reaction mixture left to stir overnight. Water (100 cm3) was then added. The result 
mixture was extracted with diethyl ether (3 x 50 cm3), and the organic phases were combined, 
washed with brine (50 cm3) and dried (MgSCU), filtered and then concentrated under reduced 
pressure to give the title compound as a pale yellow oil, Purification of the crude product by flash 
column chromatography on silica gel with hexane and ethyl acetate (4 : 1) as eluent gave the title 
compound as a pale yellow oil (7.69 g, 82% yield); TLC Rf 0.31 (Hexane : EtOAc = 4 : 1); Umax 
(thin film)/cnf1 2982.3, 1747.6, 1722.4, 1657.6, 1496.4, 1453.7, 1399.9, 1367.4, 1319.0, 1229.5,
1140.9, 1100.1, 1032.9, 743.3 and 700.3; 5H (500 MHz, C2HC13) 1.27 (3 H, t, J7 .0 , CH2C//3),
3.56 (2 H, s, C=OCH2C=0), 4.17 (2 H, s, CH20Ctf2C=0), 4.19 (2 H, q, J7.0, CH2CH3), 4.61 (2 
H, s, PhCtf20) and 7.34 (5 H, m, Ar-H); 6 c (125 MHz, C2HC13) 14.07 (CH2CH3), 46.08 
(C=OCH2C=0), 61.41 (CH2CH3), 73.51 (PhCH20), 74.82 (CH20CH2C=0), 127.94, 128.12 and
128.56 (Ar-CH), 136.94 (quaternary C), 167.00 (C02CH2CH3) and 201.72 (C=OCH20); m/z (CI+)
254.2 (100%, [M + NH4]+).
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Ethyl 4-hydroxy-3-oxobutanoate (253)
Ethyl 4-benzyloxyacetoacetate 252 (7.70 g, 32.6 mmol) was dissolved in anhydrous ethanol (80 
cm3). Pd-C (3.08 g, 10% w/w) was added, and the solution stirred strongly under a hydrogen 
atomosphere for 16 h. The solution was filtered through Celite® to remove the catalyst, and the 
filtrate was concentrated under reduced pressure to give the crude product as a pale yellow oil. 
Purification by flash column chromatography on silica gel with hexane and ethyl acetate (1 : 2) as 
eluent gave the title compound as a pale yellow oil (4.52 g, 95 % yield); TLC Rf 0.37 (Hexane : 
EtOAc = 1 : 2 ) ;  (thin film)/cm_1 3455.5, 2984.9, 1720.7, 1623.8, 1408.9, 1370.3, 1321.2,
1269.3, 1152.7, 1026.9, 943.9, 858.7 and 810.5; SH (500 MHz, C2HC13) 1.29 (3 H, t, J  7.0, 
CH2C//3), 3.02 (1 H, br, OH), 3.51 (2 H, s, C=0CH2C=0), 4.20 (2 H, q, J7.0, CH2CH}) and 4.39 
(2 H, s, CH2OH); Sc (125 MHz, C2HC13) 14.03 (CH2CH3), 45.36 (C=OCH2C=0), 61.84 
(CH2CH3), 68.54 (CH2OH); 166.46 (C02CH2CH3) and 202.49 (C=OCH2OH); m/z (C f) 164.1 
(100%, [M + NH*]+).
Ethyl 5-methyl-2-(2-(tetrahydro-2H-pyran-2-yloxy)acetyl)hex-4-enoate (257)
The alcohol 253 (6.30 g, 43.2 mmol) was dissolved in anhydrous DCM (80 cm3) under a nitrogen
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atmosphere. 3,4-dihy dro-2//-pyran (7.87 cm3, 86.3 mmol) and p-toluenesulfonic acid (0.4 lg, 2.16 
mmol) were added, and the solution was stirred overnight. The solvent was removed under 
reduced pressure, and the resulting oil was diluted with ethyl acetate (50 cm ) and water (50 cm ).
X  XThe organic layer was washed with water (50 cm ) and brine (50 cm ), dried and concentrated to 
afford the crude THP ether as a amber oil, which was purified by flash column chromatography 
on silica gel with hexane and ethyl acetate (4 : 1) as eluent to give the partially purified THP ether 
254 as a yellow oil (7.25, 73%). This product was used in next step without further purification. 
To a suspension of NaH (0.37 g, 15.2 mmol) in anhydrous THF (50 cm3) at 0 ° C  was added the 
THP ether 254 (3.50 g, 15.2 mmol) from last step in THF (5 cm3). The solution was warmed to 
RT and stirred for 1 h, and then l-Bromo-3-methylbut-2-ene (2.30 g, 15.2 mmol) was added. The 
reaction mixture was stirred overnight. Water (50 cm ) was then added. The result mixture was 
extracted with ethyl acetate (3 * 30 cm3), and the organic phases were combined, washed with 
brine (30 cm3) and dried (MgSC^), filtered and then concentrated under reduced pressure to give 
the title compound as a pale yellow oil, Purification of the crude product by flash column 
chromatography on silica gel with hexane and ethyl acetate (5 : 1) as eluent gave the title 
compound as a light yellow oil (2.34 g, 53%); TLC Rf 0.33 (Hexane : EtOAc = 5 : 1); HRMS 
(ES+, [M + NH4f )  found 316.2122. C16H30O5N requires 316.2118; umax (thin film)/cm~' 2940.1,
1721.2, 1443.2, 1374.3, 1323.6, 1267.3, 1203.0, 1130.1, 1077.2, 1038.6, 968.8, 906.1, 871.5 and 
816.6; SH (500 MHz, C2HC13) 1.20 (3 H, td, J  7.0, J  2.0, CH2CH3), 1.56 (3 H, s, CH3), 1.60 (3 H, 
s, CH3), 1.47-1.77 ( 6  H, m, J C t f 23C / / 24C 7/ 2) ,  2 A 6 ~ 2 -5 3  ( 2  H> m > C=CHC7/2CH), 3.44 and 3.72 ( 2  
H, m, CH2CH2CH25C7720), 3.54 (1 H, dt, J  27.0, J  7.5, C=OC//C=0), 4.07-4.28 (4 H, m, 
C=OCH20  and Cf/2CH3), 4.55 (1 H, dt, J  13.0, J  3.5, 1CHCH2CH2CH2) and 5.06 (1 H, m,
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CH3C=CtfCH2); 8 c (125 MHz, C2HC13) 14.07 (d, 7  1.5, CH2CH3), 17.72 (CH3), 18.81 (d, 7  29.0, 
2CH23CH24CH2), 25.23 (2CH23CH24CH2), 25.72 (CH3), 26.46 (d,76.5, C=CHCH2CH), 30.08 (d, 
7 10.0,2CH23CH24CH2), 55.14 (d, 7 18.0, COCHCO), 61.19 (d,76.5, CH2CH3), 61.92 (d, 741.5, 
CH2CH2CH25CH20), 71.63 (d,729.0, C=0CH20), 98.46 (d,759.0, 'CHCH2CH2CH2), 119.87 (d,
75.0, CH3C=C7/CH2), 134.60 (d, 7  10.0, CH3C=CHCH2), 169.19 (d, 7  12.5, C02CH2CH3) and 
203.40 (d, 7  30.0, C=0CH20); mJz (Cl*) 316.3 (15%, [M + NR,]*) and 102.1 (100).
6-Methyl-l-(tetrahydro-2H-pyran-2-yloxy)hept-5-en-2-one (258)
Ester 257 (2.5 g, 8.4 mmol) was dissolved in the mixture of ethanol (80 cm3) and water (30 cm3). 
KOH (3.53 g, 63 mmol) was added, and the solution was stirred for 24 h. The solvent was 
removed under reduced pressure. The residue was diluted with EtOAc, and washed with water
“X  "X(50 cm ) and brine (50 cm ) and dried (MgS0 4 ), filtered and then concentrated under reduced
pressure to give the title compound as a pale yellow oil, Purification of the crude product by flash
column chromatography on silica gel with hexane and ethyl acetate (5 : 1) as eluent gave the title
compound as a light yellow oil product (0.95g, 52%); TLC Rf 0.36 (Hexane : EtOAc = 5:1) ;
HRMS (ES+, [M + NH4f )  found 244.1906. C13H26O3N requires 244.1907; Umax (thin film)/cm_1
2941.5, 1720.2, 1442.3, 1380.2, 1263.6, 1203.2, 1127.8, 1074.4, 1037.8, 969.1, 905.9, 871.4 and
815.6; SH (400 MHz, C2HC13) 1.54-1.89 ( 6  H, m, 2Ctf23Ctf24C772), 1.62 (3 H, s, CH3), 1.68 (3 H,
s, CH3), 2.28 (2 H, q, 77.5, C=CHCtf2CH2), 2.49 (2 H, m, C=CHCH2C//2), 3.51 and 3.81 (2 H,
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m, CH2CH2CH25C//20), 4.10 (1 H, d, J  17.0, C=0CBH20), 4.24 (1 H, d, J  17.0, C=0CA7720), 
4.65 ( l H , t , 7 3.5, 'C//CH2CH2CH2) and 5.08 (1 H, m, CH3C=CflCH2); 8c (100 MHz, C2HC13)
17.67 (CH3), 19.14 (2CH23CH24CH2), 22.07 and 39.16 (C=CHCH2CH2C=0), 25.29
(2CH23CH24CH2), 25.70 (CH3), 30.26 (2CH23CH24CH2), 62.28 (CH2CH2CH25CH20), 72.06 
(C=0CH20), 98.69 ('CHCH2CH2CH2), 122.61 (CH3C=CHCH2), 132.91 (CH3C=CHCH2) and
208.60 (C=OCH20); mJz (Cl4) 244.2 (10%, [M + NH4f )  and 102.1 (100).
l-Hydroxy-6-methylhept-5-en-2-one (259)
H C L
Ketone 258 (0.95 g, 4.2 mmol) was dissolved in ethanol (40 cm3) under N2 . PPTS (0.11 g, 0.42
mmol) was added, and the solution stirred overnight. The resulting solution was then heated to 50
°C for 1 h, and then the solvent was removed under reduced pressure. The residue was diluted
with ethyl acetate (40 cm3), and washed with water (40 cm3) and brine (40 cm3) and dried
(MgSC>4), filtered and then concentrated under reduced pressure to give the title compound as a
pale yellow oil. Purification of the crude product by flash column chromatography on silica gel
with hexane and ethyl acetate (4 : 1) as eluent gave the title compound as a light yellow oil
product (0.57g, 95%); TLC Rf 0.24 (Hexane : EtOAc = 4 : 1); HRMS (ES+, [M + NR*]*) found
160.1330. C8H18O2N requires 160.1332; Umax (thin film)/cm_1 3440.6, 2969.2, 2917.1, 1720.4,
1441.8, 1405.8, 1378.2, 1276.3, 1068.1, 996.0 and 829.2; SH (500 MHz, C2HC13) 1.62 (3 H, s,
CH3), 1.68 (3 H, s, CH3), 2.32 (2 H, q, J7.0, C=CHC/72CH2), 2.44 (2 H, t, J5.0, C=CHCH2C//2),
3.17 (1 H, t, J  7.0, OH), 4.23 (2 H, d, J  5.0, Ci/2OH) and 5.05 (1 H, m, CH3C=C77CH2); 6C (125
MHz, C2HC13) 17.63 (CH3), 22.39 (CHCH2CH2), 25.62 (CH3), 38.48 (CHCH2CH2), 68.26
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(CH2OH), 121.94 (CH3C=CHCH2), 133.57 (CH3C=CHCH2) and 209.55 (C=OCH2OH); m/z (CI+)
160.2 (45%, [M + NHaT) and 127.1 (100).
2-((21s,6Z)-7-(Fluoroniethyl)-3,ll-dimethyldodeca-2,6,10-trienyloxy)-tetrahydro-2H-pyran 
(261)
Hydroxyketone 259 (0.57 g, 4.01 mmol) was dissolved in anhydrous DCM (30 cm3) under N2. 
2,6-Lutidine (1.11 cm3, 9.56 mmol) was added, and the solution was cooled to 0 °C. Triflic 
anhydride (0.81 cm3, 4.81 mmol) was added dropwise, and the solution was stirred at 0 °C for 45 
min. The solvent was removed under reduced pressure and the residue diluted with ethyl acetate 
(20 cm3), washed with 10% CuSC>4 (20 cm3), KHC03 (20 cm3) and brine (20 cm3), dried 
(MgSC>4), filtered and then concentrated under reduced pressure to a red oil. The oil was 
immediately dissolved in anhydrous THF (30 cm3) under nitrogen. TBAF (1 M solution in THF,
8.02 cm3, 8.02 mmol) was added dropwise, and the solution was stirred for 1.5 h. The solution 
was concentrated under reduced pressure and the residue purified by flash column 
chromatography on silica gel with hexane and ethyl acetate (19 : 1) as the eluent. Due to the 
volatility of the fluoro ketone 260, the solvent was not removed under pressure totally and the 
product used in next step directly.
A mixture of compound 213 (6.05 g, 21.8 mmol) and triphenylphosphine (8.59 g, 32.8 mmol) in 
anhydrous acetonitrile (100 cm3), under a nitrogen atmosphere, was heated under reflux for 14 h. 
After cooling, the solvent was concentrated under reduced pressure to afford an oily mixture.
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Excess triphenyl phosphine was removed by triturating the mixture with anhydrous diethyl ether, 
and the sticky residue was dried in vacuo for 5 h. to afford the intermediate phosphonium salt 214 
as a viscous oil. To a stirred solution of crude 214 (1.51 g, 2.80 mmol) in anhydrous THF (40 
cm3) under N2 at -78 °C, was added lithium hexamethyldisilazide (1 M solution in THF, 2.80 cm3, 
2.80 mmol). The mixture was stirred for 30 min at -78 °C, and then the fluoro ketone 260 above 
was added dropwise. The whole reaction mixture was allowed to warm to -20 °C over 1 h, and 
then maintained at -20 °C for 2 h. The reaction was then quenched by addition of diethyl ether 
(20 cm ) and water (20 cm ). The aqueous layer was extracted with diethyl ether (3 x 2 0  cm ) and 
the combined ethereal extracts were washed brine (20 c m ), dried over MgSC>4, filtered and then 
concentrated under reduced pressure. Purification by flash column chromatography on silica gel 
with hexane and ethyl acetate (30 : 1) as eluent gave THP ether 261 as a light yellow oil (0.39 g, 
30% over 2 steps); TLC Rf 0.33 (Hexane : EtOAc = 30 : 1); HRMS (ES+, [M + N af) found 
347.2360. C2oH330 2FNa requires 347.2357; tw (th in  film)/cm_l 2937.9, 1739.2, 1667.5, 1443.3,
1380.6, 1261.1, 1200.2, 1134.2, 1117.5, 1075.9, 1024.1, 974.6, 904.5, 869.4 and 813.4; 8 H (500 
MHz, C2 HC13) 1.43-1.78 ( 6  H, m, 2CH2}CH2 CH2), 1.53 (3 H, s, CH}), 1.61 ( 6  H, d, 7 3.0, 2 x 
CH{), 1.98-2.17 ( 8  H, m, 2 * C=CHC//2C//2CCH), 3.42 and 3.80 (2 H, m, CH2CH2CH25C7720), 
3.93(1 H, dd, 7  12.0, 7  7.0, C=CHCB//20), 4.15(1 H, dd, J  12.0, J  6.5, C=CHCAH20), 4.55 (1 H, 
t, 73.5, lC//CH2CH2CH2), 4.77 (2 H, d, 748.0, CH2F), 5.03 (1 H, m, (CH3)2C=C//), 5.30 (1 H, m, 
CCffCH 20) and 5.35 (1 H, td, 7  7.5, 7  3.0, FCH2C=C//); 5C (125 MHz, C2HC13) 16.39 (CH3), 
17.69 (CH3), 19.61, 25.51 and 30.72 (2CH23CH24CH2), 25.67 (CH3), 25.94 (d, 7  1.25), 26.88,
34.81 and 39.58 (d, 72.5) (2 « C=CHCH2CH2), 61.28 (CH2CH2CH25CH20), 63.58 (OCHCH20), 
79.71 (d, 7  158.75, CH2F), 97.87 ('CHCH2CH2CH2), 121.29 (C=CHCH20), 123.85
(CH3)2C=Cfl), 130.72 (d, J  10.0, FCH2C=CH), 131.78 and 139.27 (quaternary C) and 134.65 (d, 
J  14.0, FCH2C=CH); 5f (283 MHz, C2HC13) -214.38 (t, JH-f 48.5); m/z (Cl*) 342.4 (20%, [M + 
N H tftand 102.1 (100).
(2E,6Z)-7-(Fluoromethyl)-3,ll-diinethyldodeca-2,6,10-trien-l-ol (262)
OH
This compound was prepared from 261 in a manner identical to that for the alcohol 211; 
purification by silica column chromatography using hexane and ethyl acetate (4: 1) as eluent gave 
alcohol 262 as a colourless oil (0.11 g, 91%); TLC Rf 0.21 (Hexane : EtOAc = 4 : 1); HRMS (EI+, 
M*) found 240.1889. C15H25OF requires 240.1889; Umax (thin film)/cm_1 3337.4, 2966.8, 2920.9,
1667.4, 1445.1, 1380.2, 1241.6, 1103.5, 978.2, 825.5 and 741.7; SH (500 MHz, C2HC13) 1.37 (1 H, 
b, OH), 1.62 (3 H, s, CH3), 1.69 (3 H, CH3), 1.70 (3 H, CH3), 2.07-2.24 ( 8  H, m, 2 x 
C=CHC//2C//2CCH), 4.16 (2 H, d, J 7.0, CHC//2OH), 4.86 (2 H, d, J48.0, C//2F), 5.11 (1 H, m, 
(CH3)2C=Ctf) and 5.42 (2 H, m, 2 * C=CHCU2); 5c (125 MHz, C2HC13) 16.25 (CH3), 17.64 
(CH3), 25.67 (CH3), 25.96 (d, J  2.5), 26.86, 34.82 (d, J  1.5) and 39.43 (d, J  2.5) (2 x 
C C H C //2C//2), 59.30 (CHCH2OH), 79.72 (d, J  160.0, CH2F), 123.81 (CH3)2C=Ctf), 124.06 
(CHCH2OH), 130.68 (d, J  9.0, FCH2C=CH), 131.85 and 138.78 (quaternary C) and 134.73 (d, J
15.0, FCH2C=CH); 5f (283 MHz, C2HC13) -214.03 (t, JH-f48.5); m/z (EI+) 240.2 (1%, M^ and
69.1 (100).
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(2£,&Z)-7-(Fluoromethyl)-3,ll-dimethyldodeca-2,6,10-trien-l-yl diphosphate (158)
(NH4)+3
This compound was prepared in a manner identical to that for the diphosphate 154, using the 
alcohol 262 (0.10 g, 0.42 mmol) to give the title compound as a white fluffy solid (85.2 mg, 45% 
for two steps); HPLC Jr = 36.17 min; Purity 98.20 % by analytical RP HPLC; HRMS (ES“, [M -  
HD found 399.1124. C15H26O7FP2 requires 399.1138; i w  (KBr disc)/cm_1 2898.3, 1729.0,
1669.0, 1494.4, 1457.6, 1412.6, 1199.9, 1123.0, 1079.8, 1022.1, 909.2, 804.5, 721.0 and 597.1; 
5h (500 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) 1.47 (3 H, s, CH3), 1.55 (3 H, s, CH3),
1.57 (3 H, s, CH3), 1.96-2.13 ( 8  H, m, 2 x CHCH2CH2), 4.32 (2 H, t, J6.5, CHCtf20), 4.83 (2 H, 
d , J H-f 47.0, CH2F), 5.05 (1 H, b, (CH3)2C=C//CH2CH2), 5.32 (1 H, t, J  6.5, C/fCH20) and 5.44 
(1 H, m, FCH2C=CtfCH2CH2); 5C (125 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) 15.63 
(CH3), 17.98 (CH3), 24.85 (CH3), 25.47 (d, Jc.f 2.5), 26.13, 34.10 and 38.85 (d, Jc.f 4.0) (2 x 
CHCH2CH2), 62.48 (d, Jc-p 6.5, CHCH20), 81.01 (d, JC.F 151.5, CH2F), 120.27 (d, JC-p 9.0, 
CHCH2O), 124.03 [(CH3)2C=CHCH2CH2], 132.60 (FCH2C=CHCH2CH2), 133.77 and 142.03 
(quaternary C) and 134.09 (d, J  12.5, CCH2F); 8 F (283 MHz, 2H20  at pH 8.5 buffered with 
N2H4 0 2H) -210.48 (t, J H-f 48.0); 5P (122 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) -7.54 (d, 
Jp.p2 1 .0 ) and-10.38 (d, JP.P2 1 .0 ); m/z (ESI 399.1 (1 0 0 %, [M-HD-
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(JE)-Ethyl 5,9-dimethyl-2-(2-(tetrahydro-2H-pyran-2-yloxy)acetyl)deca-4,8-dienoate (265)
This compound was prepared and purified in a manner similar to that described for the compound 
257, using the THP ether 254 (7.16 g, 31.1 mmol) to give the title compound 265 as a colourless 
oil (5.23 g, 46%); TLC Rf 0.33 (Hexane ; EtOAc = 4 :1 ) ;  t w  (thin film)/cm'' 2935.9, 1720.6,
1442.6, 1373.6, 1320.8, 1264.7, 1201.9, 1076.1, 1037.9, 969.1, 905.6, 870.9 and 815.9; 5H (500 
MHz, C2HC13) 1.28 (3 H, td, J  7.0, J  1.5, CH2GH3), 1.61 (3 H, s, CH3), 1.64 (3 H, s, CH3), 1.69 
(3 H, s, CH3), 1.56-1.86 ( 6  H, m, 2CH2 CH2 CH2), 1.97-2.07 (4 H, m, C=CHCH2CH2), 2.56-2.63 
(2 H, m, C=CHCtf2CH), 3.52 and 3.81 (2 H, m, CH2CH2CH25C//20), 3.64 (1 H, dt, J  25.5, J  7.5, 
C=0CHC=0), 4.16-4.38 (4 H, m, C=OCH20  and C//2CH3), 4.64 ( 1  H, dt, J  13.0, J  3.0, 
’CHCH2CH2CH2) and 5.06 (2 H, m, 2  * CH3C=C//CH2); 5c (125 MHz, C2HC13) 14.12 
(CH2CH3), 16.11 (CH3), 17.72 (CH3), 18.81, 19.04 and 25.25 (2CH23CH24 CH2), 25.71 (CH3),
26.39 (d, J  7.5, C=CHCH2CH) 26.54 and 39.70 (C=CHCH2CH2), 55.20 (d, J  14.0, C=OCHC=0), 
61.28 (d, J 14.0,5, CH2CH3), 61.93 (d, J  41.0, CH2CH2CH25CH20), 71.66 (d, J  29.0, C=OCH20),
98.44 (d, J  59.0, ‘CHCH2CH2CH2), 119.69 (d, J  4.0, CH3CCHCH2), 124.02 (d, J  2.5, 
CH3CCHCH2), 131.56 (d, J  2.0, CH3CCHCH2CH2), 138.31 (d, J  9.0, CH3CCHCH2CH), 169.24 
(d, J  12.0, C02CH2CH3) and 203.48 (d, 728.0, C=OCH2 0); m/z (CI+) 384.4 (100%, [M + NR,]*).
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(E)-6,10-Dimethyl-l-(tetrahydro-2H-pyran-2-yloxy)undeca-5,9-dien-2-one (266)
3
2
This compound was prepared and purified in a manner similar to that described for the compound 
258, using the compound 265 (4.93 g, 13.5 mmol) to give the title compound 266 as a colourless 
oil (2.96 g, 75%); TLC Rf 0.18 (Hexane : EtOAc = 9 : 1); umax(thin film)/cm_1 2924.0, 1720.1,
1442.0, 1380.7, 1353.4, 1263.2, 1203.1, 1127.3, 1073.1, 1037.8, 968.8, 905.6, 871.5 and 816.5; 
8 h  (500 MHz, C2HC13) 1.61 (3 H, s, CH3), 1.63 (3 H, s, CH3), 1.69 (3 H, s, CH3), 1.56-1.87 ( 6  H, 
m, 2CH23CH2 CH2), 1.98 (2 H, t, J  7.5, C=CHCH2C/72CCH), 2.06 (2 H, q, J  7.5, 
C=CHCH2CH2CCH), 2.30 (2 H, q, J  7.5, C=CHC//2CH2CO), 2.50 (2 H, td, J  7.5, J  3.0, 
C=CHCH2C//2CO), 3.52 and 3.83 (2 H, m, CH2CH2CH25CH20), 4.12 (1 H, d, J  17.5, COCBH20), 
4.24 (1 H, d, J  17.5, C=OCAH20), 4.66 (1 H, t, J3 .5 , 'CHCH2CH2CH2) and 5.07 (2 H, m, 2 x 
CH3C=CHCH2); Sc (125 MHz, C2HC13) 15.98 (CH3), 17.67 (CH3), 19.17, 25.30 and 30.28 
(2CH23CH24 CH2), 22.01 (C=CHCH2CH2C=0), 25.67 (CH3), 26.62 (C=CHCH2CH2C=CH), 38.52 
(C=CHCH2CH2C=0), 39.64 (C=CHCH2CH2C=CH), 61.93 (CH2CH2CH25CH20), 72.09 
(C=OCH20), 98.74 ('CHCH2CH2CH2), 122.49 and 124.19 (2 x CH3C=CHCH2), 131.41 and 
136.50 (quaternary C) and 208.52 (COCH20); m/z (Cl4) 312.4 (100%, [M + NR,]*).
(2s)-l-Hydroxy-6,10-dimethylundeca-5,9-dien-2-one (267)
H C L
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This compound was prepared and purified in a manner identical to that described for the 
compound 259, using the THP ether 266 (2.78 g, 9.46 mmol) to give the title compound 267 as a 
colourless oil (1.53 g, 81%); TLC Rf 0.21 (Hexane : EtOAc = 4 : 1); Umax (thin film)/cm_1 3434.8,
2965.6, 2916.8, 1720.4, 1441.4, 1379.3, 1273.1, 1065.7, 990.4 and 830.7; 5H (500 MHz, C2HC13) 
1.62 (3 H, s, CH3), 1.63 (3 H, s, CH3), 1.70 (3 H, s, CH3), 1.99 (2 H, t, J  7.5, 
C=CHCH2C//2C=CH), 2.07 (2 H, q, J  7.5, C=CHCi/2CH2C=CH), 2.35 (2 H, q, J  7.5, 
C=CHC/72CH2C=0), 2.47 (2 H, t, J  7.5, C=CHCH2C/72C=0), 4.25 (2 H, s, C/f2OH) and 5.08 (2 
H, m, 2 x CH3C=C7/CH2); 6 c (125 MHz, C2HC13) 15.99 (CH3), 17.68 (CH3), 22.36 
(C=CHCH2CH2C=0), 25.67 (CH3), 26.55 (C=CHCH2CH2C=CH), 38.52 (C=CHCH2CH2C=0),
39.60 (C=CHCH2CH2C=CH), 68.30 (CH2OH), 121.79 and 124.04 (2 x CH3C=CHCH2), 131.56 
and 137.24 (quaternary C) and 209.53 (COCH2OH); m/z (CI+) 228.3 (100%, [M + N H ^ .
(ZT)-l-Fluoro-6,10-dimethylundeca-5,9-dien-2-one (268)
Hydroxyketone 267 (1.27 g, 6.05 mmol) was dissolved in anhydrous DCM (50 cm3) under
nitrogen. 2,6-Lutidine (1.69 cm3, 14.5 mmol) was added and the solution was cooled to 0 °C.
Triflic anhydride (1.22 cm3, 7.26 mmol) was added dropwise, and the solution was stirred at 0 °C
for 45 min. The solvent was removed under reduced pressure and the residue diluted with ethyl
acetate (30 cm3), washed with 10% CuSC>4 (30 cm3), KHC03 (30 cm3) and brine (30 cm3), dried
(MgSC>4), filtered and then concentrated under reduced pressure to give a red oil. The oil was
immediately dissolved in anhydrous THF (50 cm3) under nitrogen. TBAF (1 M solution in THF,
12.1 cm3, 12.1 mmol) was added dropwise, and the solution was stirred for 1.5 h. The solution
202
was concentrated under reduced pressure and the residure purified by flash column 
chromatography on silica gel with hexane and ethyl acetate (9 : 1) as eluent to give the title 
compound as a yellow oil (0.88 g, 69%); TLC Rf 0.43 (Hexane : EtOAc = 4 : 1); 'umax (thin 
film)/cm_1 2966.7, 2920.9, 2856.1, 1727.0, 1436.0, 1380.1, 1148.3, 1052.0, 983.9 and 829.7; 5H 
(500 MHz, C2HC13) 1.53 (3 H, s, CH3), 1.55 (3 H, s, CH3), 1.61 (3 H, s, CH3), 1.90 (2 H, t, J  7.5, 
C=CHCH2Ctf2C=CH), 1.98 (2 H, q, J  7.5, C=CHCtf2CH2C=CH), 2.24 (2 H, q, J  7.5, 
C=CHC/72CH2C=0), 2.50 (2 H, td, J  7.5, J  2.5, C=CHCH2C//2C=0), 4.68 (2 H, d, J H-f 47.5, 
C//2F) and 5.00 (2 H, m, 2 * CH3C=C//CH2); 5c (125 MHz, C2HC13) 15.99 (CH3), 17.71 (CH3),
21.45 (C=CHCH2CH2C=0), 25.72 (CH3), 26.56 (C=CHCH2CH2C=CH), 38.44
(C=CHCH2CH2C=0), 39.63 (C=CHCH2CH2C=CH), 84.32 (d, Jc.f 184.0, CH2F), 121.96 and 
124.09 (2 x CH3CCHCH2), 131.56 and 136.99 (quaternary C) and 206.82 (d, Jc.F 20.0, 
C=OCH2F); 5f (283 MHz, C2HC13) -227.30 (t, JH.f 48.0); m/z (C t)  230.3 (100%, [M + NRj]*).
(2Z,6£)-Ethyl 3-(fluoromethyl)-7,ll-dimethyldodeca-2,6,10-trienoate (269)
NaH (0.12 g, 4.92 mmol) was suspended in anhydrous THF (50 cm3) under nitrogen. Triethyl
phosphonoacetate (0.98 cm3, 4.92 mmol) was added dropwise, and the solution stirred for 1 h. A
solution of ketone 268 in anhydrous THF (10 cm3) was added, and the solution stirred overnight.
Water (30 cm3) and diethyl ether (30 cm3) were added, and the organic layer was separated. The
aqueous layer was extracted with diethyl ether (2 x 25 cm3). The combined ethereal extracts were
washed with water (2 x 20 cm3) and satd. NaCl (20 cm3), dried over MgSC>4 , filtered and then
concentrated under reduced pressure. Purification of the crude product by MPLC with hexane and
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ethyl acetate (80 : 1) as eluent gave the title compound as a light yellow oil (0.65 g, 64%); TLC 
Rf 0.19 (Hexane : EtOAc = 60 : 1); tw (th in  film)/crrf' 2975.1, 2922.6, 2857.0, 1717.9, 1660.4,
1446.2, 1380.9, 1320.1, 1238.9, 1163.2, 1125.2, 1043.7 and 867.0; SH (500 MHz, C2HC13) 1.21 (3 
H, t, J  7.0, CH2C//3), 1 .53 (3 H, s, CH3), 1.54 (3 H, s, CH3), 1.61 (3 H, s, CH3), 1.91 (2 H, t, J  7.5, 
C=CHCH2C7/2C=CHCH2), 1.97 (2 H, q, J  7.5, C=CHCtf2CH2C=CHCH2), 2.14 (2 H, q, J  7.5, 
C=CHCH2CH2CCH2F), 2.29 (2 H, t, J7.5, C=CHCH2C//2CCH2F), 4.06 (2 H, q, J  7.5, CH2CH3),
5.00 (2 H, m, 2 x CH3C=CHCH2), 5.43 (2 H, dd, JH-f 48.0, J  2.0, CH2¥) and 5.63 (1 H, d, J  1.5, 
C//C02CH2CH3); 5c (125 MHz, C2HC13) 14.23 (CH2CH3), 16.00 (CH3), 17.67 (CH3), 25.66 
(CH3), 26.34 (C=CHCH2CH2CCH2F), 26.67 (C=CHCH2CH2C=CHCH2), 33.61 (d, J  7.5, 
C=CHCH2 CH2CCH2F), 39.66 (C=CHCH2CH2C=CHCH2), 60.10 (C//2CH3), 81.43 (d, JC-f 162.5, 
CH2F), 116.02 (d, J  5, CHC02CH2CH3), 122.67 and 124.19 (2 x CH3C=CHCH2), 131.43 and 
136.49 (quaternary C), 158.60 (d, J 19.0, C=CH2F) and 165.85 (CHC02CH2CH3); SF (283 MHz, 
C2HC13) -214.06 (t, J H-f 47.5); m/z (Cl*) 300.3 (60%, [M + NR,]*), 263.3 (100, [M -  F]*).
(2Z,6£)-3-(fluoromethyl)-7,ll-dimethyldodeca-2,6,10-trien-l-ol (270)
O H
This compound was prepared from 269 (0.61 g, 2.26 mmol) in a manner similar to that for the 
alcohol 175; purification by silica column chromatography using hexane and ethyl acetate (5: 1) 
as eluent gave alcohol 270 as a colourless oil (0.42 g, 80%); TLC Rf 0.28 (Hexane : EtOAc = 5 : 
1); Umax (thin film)/crrf1 3350.5, 2964.9, 2921.9, 2855.1, 1666.6, 1448.6, 1380.7, 1242.6, 1083.4,
999.8, 830.4 and 738.5; 5H (500 MHz, C2HC13) 1.53 ( 6  H, s, 2  x CH3), 1.61 (3 H, s, CH3), 1.91 (2 
H, t, J7.5, C=CHCH2Cff2CCHCH2), 1.99 (2 H, q, J  7.5, C=CHCi?2CH2C=CHCH2), 2.10 (4 H, m,
C=CHC//2C772CCH2F), 4.13 (2 H, dd, J7.0, J3.5, C//2OH), 4.82 (2 H, d, Jn.f 47.5, CH2F), 5.02 
(2 H, m, 2 x CH3C=C//CH2) and 5.63 (1 H, d, J  1.5, CtfCH2OH); Sc (125 MHz, C2HC13) 16.03 
(CH3), 17.68 (CH3), 25.68 (CH3), 26.46 (C=CHCH2CH2CCH2F), 34.57 (d, J  1.5, 
C=CHCH2CH2CCH2F), 26.69 (C=CHCH2CH2C=CHCH2), 39.68 (C=CHCH2CH2C=CHCH2),
58.60 (CH2OH), 79.70 (d, J C - f  161.5, CH2F), 123.28 and 124.26 (2 x  CH3C=CHCH2), 129.13 (d, 
J  7.5, CHCH2OH), 131.41 and 135.90 (quaternary C) and 137.92 (d, J  14.0, C=CH2F); 6 F (283 
MHz, C2HC13) -214.06 (t, JH-f 47.0); m/z (Cf) 258.3 (100%, [M + NH4]+).
(2Z,6£)-3-(FIuoromethyl)-7,ll-dimethyldodeca-2,6,10-trien-l-yl diphosphate (159)
(NH4)+3
This compound was prepared in a manner identical to that for the diphosphate 154, using the 
alcohol 270 (0.23 g, 0.98 mmol) to give the title compound as a white puffy solid (188 mg, 43% 
for two steps); HPLC /r = 36.99 min; Purity 97.61 % by analytical RP HPLC; HRMS (ES~, [M -  
HD found 399.1140. Ci5H260 7FP2 requires 399.1143; i w  (KBr disc)/cm-1 2924.3, 1721.1,
1674.2, 1457.5, 1405.9, 1200.3, 1123.8, 1092.4, 1030.5, 995.0, 913.7, 802.7 and 720.5; 6 H (500 
MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) 1.46 ( 6  H, d, J  4.0, 2 x CH3), 1.53 (3 H, s, CH3), 
1.86-2.05 ( 8  H , m, 2  x CHCH2CH2\  4.36 (2 H, m, CHC//20), 4.87 (2 H, d, Jh-f 47.0, C/f2F),
5.02 (1 H, b, CH3C=C/fCH2), 5.07 (1 H, b, CH3C=C/7CH2) and 5.60 (1 H, m, C//CH20); 6 C (125 
MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) 15.14 (CH3), 16.86 (CH3), 24.75 (CH3), 25.65, 
25.76, 33.73 and 38.69 (2 x CHCH2CH2), 61.31 (d, J 5.0, CHCH20), 80.30 (d, Jc.f 155.0, CH2F), 
123.78 and 124.35 (2 x CH3C=CHCH2), 126.56 (t, J  9.0, CHCH20), 133.44 and 136.87
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(quaternary C) and 1 3 8 .6 4  (d, J  14 .0 , CCH2F); 6F (2 8 3  MHz, 2H20  at pH 8.5 buffered with 
N2H4 0 2H) -2 1 2 .9 0  (t, J H-f 4 7 .5 );  5 P (1 2 2  MHz, 2H20  at pH 8 .5  buffered with N2Hi02H) - 6 .4 6  (d, 
y P.P2 1 .0 )  and - 1 0 .4 5  (d, J P.P2 1 .0 );  m/z (ESI 399 .1  (100% , [M -  H]~).
(£)-ethyl 3-phenylbut-2-enoate (273)
To a stirred solution of sodium hydride (4.40 g, 110 mmol) in anhydrous 1,2-dimethoxyethane 
( 2 0 0  cm ) at room temperature, triethyl phosphonoacetate (2 1 . 8  cm , 1 1 0  mmol) and a solution 
of acetophenone (11.7 cm3, 100 mmol) in anhydrous dimethoxyethane were sequentially added, 
dropwise. After 3 h, water (50 cm3) was added and the organic layer was separated. The aqueous 
layer was extracted with diethyl ether (3 x 50 cm ). The combined organic phases were washed 
with brine (50 cm3), dried (MgSCU), filtered and then concentrated under reduced pressure to give 
the intermediate ester as a pale yellow oil (11.6 g, 61%); TLC Rf 0.39 (Hexane : EtOAc = 9 : 1); 
HRMS (ES+, [M + H]*) found 191.1067. C12H15O2 requires 191.1067; \)max(thin filmycm' 1 2980.1,
1713.0, 1628.4, 1576.4, 1494.0, 1446.0, 1365.9, 1343.8, 1272.6, 1171.3, 1044.1,872.4, 766.9 and 
694.9; 6 h (500 MHz, C2HC13) 1.23 (3 H, t, J7.5, CH3CH20 ), 2.50 (3 H, d, J  1.5, C//3CPh), 4.13 
(2 H, q, J  7.5, CH3CH2O), 6.05 (1 H, q, J  1.5, PhC=Ctf) and 7.27-7.40 (5 H, m, Ar-H); Sc (125 
MHz, C2HC13) 14.36 (CH3CH20), 17.95 (CH3C=CH), 59.83 (CH3CH20), 117.22 (PhC=CH), 
126.31, 128.49 and 128.97 (Ar-CH), 142.27 and 155.49 (quaternary C) and 166.87 (C=0); m/z 
(ES+) 191.1 (100%, [M + Hf).
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(£)-3-Phenylbut-2-en-l-ol (274)
O H
Alcohol 274 was prepared from ester 273 in a manner identical to that for the alcohol 175; the 
crude alcohol was purified by silica column chromatography using hexane and ethyl acetate (2 : 1) 
as eluent to give the title compound as a light yellow oil (6.7 g, 96%); Rf 0.27 (Hexane : EtOAc = 
2 : 1); HRMS: (EI+, NT) found 148.0890. CioH,20  requires 148.0888; iw (thin film)/cm'' 3347.2,
2922.2, 2597.9, 1493.8, 1444.5, 1379.9, 1003.0, 758.1 and 696.1; 5H(500 MHz, C2HC13) 2.11 (3 
H, t, J  0.5, CH}CPh), 4.40 (2 H, dd, J  0.5, J  6.5, CftOH), 6.01 (1 H, tq, J  1.5, J  6.5, PhOCtf) 
and 7.28-7.45 (5 H, m, Ar-H); 5c (125 MHz, C2HC13) 16.06 (CH3CPh), 59.96 (CH2OH), 126.52 
(CHCH2OH), 125.81, 127.32 and 128.32 (Ar-CH) and 137.84 and 142.87 (quaternary C); m/z 
(Ef) 148.1 (13%, M"), 115.1 (100).
(£)-3-Phenylbut-2-enal (276)
This compound was prepared from 274 (6.7 g, 45 mmol) in a manner identical to that for the 
aldehyde 176; purification by silica column chromatography using hexane and ethyl acetate (1: 2) 
as eluent gave aldehyde 276 as a yellow oil (3.7 g, 57%); Rf 0.37 (Hexane : EtOAc = 4 :1 ) ;  
HRMS: (EI+, M*) found: 146.0730. C10H10O requires 146.0732; Umax(thin filmycm' 1 1722.2,
1659.7, 1446.2, 1377.3, 1248.1, 1144.5, 865.5 and 758.6; 5H(500 MHz, C2HC13) 1.94 (3 H, d, J
1.0, CH3CPh), 6.41 (1 H, dq, J  7.5, J  1.0, PhC=Ctf), 7.10-7.18 (5 H, m, Ar-H) and 10.05 (1 H, d,
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J  7.5, CHO); 5 c  (125 MHz, C2HC13) 15.45 (CHjCPh), 127.37 (PhC=CH), 126.16, 128.49 and 
129.52 (Ar-CH), 140.77 and 155.78 (quaternary C) and 189.77(CHO). m/z (El*) 146.1 (46%, M+),
145.1 (100).
(E) 4-Phenyl-buta-l,3-diene (275)
This compound was prepared from 276 in a manner identical to that for 172; purification by silica 
column chromatography using hexane and ethyl acetate (2: 1) as eluent gave 275 as a light yellow 
oil (1.70 g, 78%); Rf 0.57 (Hexane : EtOAc = 19 : 1); HRMS: (Ef, M+) found 144.0938. CuUn 
requires 144.0939; n o th in  film)/cm'‘ 3029.5, 2923.2, 1803.9, 1627.6, 1594.2, 1493.3, 1445.8,
1380.1, 1175.1, 1027.4, 985.3, 903.6, 759.8 and 694.8; SH (400 MHz, C2HC13) 2.09 (3 H, s, 
CH3CPh), 5.10 (1 H, d, J  10.0, C H C H C H ^//c,s), 5.22 (1 H, d, J  17.0, CHCHC//lra«Hcls), 6.37 
(1 H, d, J  11.0, C/ZCHCHi), 6.68 (1 H, dt, J  17.0, J  10.5, CHC«CH2) and 7.14-7.26 (5 H, m, 
Ar-H); 5c  (100 MHz, C2HC13) 16.07 (CH3CPh), 117.65 (CHCHCH2), 127.76 (CHCHCH2), 
125.74, 127.22 and 128.33 (Ar-CH), 133.60 (CHCHCH2) and 136.77 and 143.03 (quaternary C); 
m/z (E f) 144.1 (35%, M*) and 129.1 (100, [M -  CH3]+).
(2E,6E)-Ethyl 3-methyl-7-phenylocta-2,6-dienoate (277).
This compound was prepared from 275 in a manner identical to that for the ester 177; purification
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by silica column chromatography using hexane and ethyl acetate (2: 1) as eluent gave 277 as a 
light yellow oil (1.51 g, 59%); Rf 0.27 (Hexane : EtOAc = 19 : 1); HRMS: (ES+, [M + NH4]+) 
found 276.1959. C17H26O2N requires 276.1958; umax(thin filmycm' 1 2978.8, 2930.2, 1714.9,
1647.6, 1493.8, 1444.3, 1381.4, 1327.6, 1272.3, 1222.8, 1146.1, 1098.9, 1049.6, 864.4, 757.9 and 
696.4; 5h (500 MHz, C2HC13) 1.20 (3 H, t, J  7.0, C//3CH20), 1.96 (3 H, d, J  1.0, 
Ctf3C=CHC02Et), 2.13 (3 H, d, J 1.0, CH3CPh), 2.19-2.32 (4 H, m, CH2CH2), 4.07 (2 H, q, J  7.0, 
CH3C//20), 5.64 (2 H, m, 2 x C=CH) and 7.13-7.30 (5 H, m, Ar-H); Sc (125 MHz, C2HCI3)
14.37 (CH3CH20), 15.92 (CH3CCHCO), 18.87 (CH3CPh), 26.76 and 40.62 (CH2CH2), 59.57 
(CH3CH20), 115.93 (CHCO), 126.66 (PhC=CH), 125.68, 126.73 and 128.22 (Ar-CH), 135.78,
144.67 and 159.32 (quaternary C) and 166.86 (C=0); m/z (Cl*) 276.2 (100%, [M + NH4]*).
(2Zs,62i)-3-Methyl-7-phenylocta-2,6-dien-l-ol (280).
OH
This compound was prepared from 277 in a manner identical to that for the alcohol 175; 
purification by silica column chromatography using hexane and ethyl acetate (2 : 1 ) as eluent gave 
280 as a light yellow oil (1.2 g, 96%); Rf 0.27 (Hexane : EtOAc = 2 :1) ;  HRMS: (ES+, [M + 
m u T )  found 234.1851. C15H24ON requires 234.1852; omax(thin filmycm' 1 3363.0, 2923.4,
1493.3, 1444.0, 999.4, 756.3 and 695.8; 6H(500 MHz, C2HC13) 1.65 (3 H, s, Ctf3C=CHCH2OH), 
1.96 (3 H, d, J  0.9, CH3CPh), 2.09-2.29 (4 H, m, CH2CH2), 4.09 (2 H, d, J  10.0, CH2OH), 5.40 
(1 H, tq, J  10.0, J  1.5, C//CH2OH), 5.68 (1 H, tq, J7.0, J  1.5, CtfCH2CH2) and 7.13-7.31 (5 H, 
m, Ar-H); 6 C (125 MHz, C2HC13) 15.87 (CH3CCH2OH), 16.36 (CH3CPh), 27.07 and 39.22
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(CH2CH2), 59.44 (CH2OH), 123.70 (CHCH2OH), 127.68 (PhCCH), 125.62, 126.59 and 128.20 
(Ar-CH), 135.03, 139.44 and 143.85 (quaternary C); m/z (Cl4) 234.2 (100%, [M + NH4]+).
(2£’,6£)-3-methyl-7-phenylocta-2,6-dienal (281).
This compound was prepared from 280 in a manner identical to that for the compound 181; 
purification by silica column chromatography using hexane and ethyl acetate (2: 1) as eluent gave 
281 as a light yellow oil (0.86 g, 89%); Rf 0.33 (Hexane : EtOAc = 4 : 1 ) ;  HRMS: (E f, M4) 
found 214.1350. C15H18O requires 214.1352; Umax(thin filmycm'1 1672.0, 1493.5, 1443.9, 1193.1,
1124.0, 757.7 and 696.2; 8H(500 MHz; C62H6) 1.62 (3 H, d, J  1.1, C7/3C=CHCHO), 1.92 (3 H, d, 
J  1.0, CH3CPh), 1.86-2.10 (4 H, m, CH2CH2), 5.64 (1 H, tq, J7.0, J  1.0, C=C7/CH2CH2), 5.95 (1 
H, dq, J  7.5, J  1.0, C//CHO), 7.21-7.44 (5 H, m, Ar-H) and 9.98 (1 H, d, J  7.5, CHO); Sc (125 
MHz; d6-benzene) 15.69 (CH3CPh), 16.72 (CH3C=CHCHO), 26.33 and 39.75 (CH2CH2), 126.32 
(PhC=CH), 127.50 (CHCHO), 125.81, 126.96 and 128.37 (Ar-CH), 136.00, 143.75 and 160.88 
(quaternary C) and 189.61 (CHO); m/z (Cl4) 232.2 (100%, [M + NH4]4 ).
(22s,72s)-8-Phenyl-4-methyI-nona-l,3,7-triene (278).
This compound was prepared from 281 in a manner identical to that for the 172; purification by 
silica column chromatography using hexane and ethyl acetate (2 : 1) as eluent gave 278 as a light
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yellow oil (0.68 g, 81%); Rf 0.68 (Hexane : EtOAc = 9 :1 ) ;  HRMS: (El*, M*) found 212.1559. 
Ci6H20 requires 212.1560; xw(thin film)/cm‘' 2919.4, 1649.7, 1597.7, 1493.5, 1443.8, 1379.7,
987.8, 896.6, 756.3 and 695.3; 8H(500 MHz, C2HC13) 1.73 (3 H, s, C//3C=CHCH=CH2), 1.92 (3 
H, s, CH3CPh), 2.11-2.29 (4 H, m, CH2CH2), 4.92 (1 H, d, J  10.0, CH=CHCH^//cls), 5.02 (1 H, 
dd, J  17.0, J  1.5, C H = C //^H c,s), 5.68 (1 H, t, J  7.0, C=C//CH2CH2), 5.82(1 H, d, J  11.0, 
CHCH=CH2), 6.52 (1 H, dt, J  17.0, J  10.5, C//=CH2) and 7.12-7.30 (5 H, m, Ar-H); 8c (125 
MHz, C2HC13) 15.88 (CH3CPh), 16.76 (CH3C=CHCH2CH2), 27.26 and 39.55 (CH2CH2), 114.91 
(CH=CH2), 125.79 (CHCH=CH2), 127.76 (PhC=CH), 125.66, 126.57 and 128.19 (Ar-CH),
133.37 (CH=CH2) and 135.03, 139.13 and 143.92 (quaternary C); m/z (Cl*) 213.1 (100%, [M + 
H f ).
(2E,6E, 10£)-Ethy 13,7-dimethyl-ll-phenyIdodeca-2,6,10-trienoate (279)
This compound was prepared from 278 in a manner identical to that for the ester 177; purification 
by silica column chromatography using hexane and ethyl acetate (2 : 1) as eluent to gave 279 as a 
light yellow oil (0.56 g, 54%); Rf 0.32 (Hexane : EtOAc = 25 : 1); HRMS (ES+, [M + H]+) found 
327.2320. C22H3i0 2 requires 327.2319; tw (thin  film)/cm'‘ 2928.8, 1714.9, 1647.2, 1444.1,
1381.4, 1221.1, 1143.0, 757.1 and 695.9; 8H(500 MHz, C2HC13) 1.21 (3 H, t, J 6.5, C//3CH20), 
1.50, 1.58 and 1.96 (9 H, s, 3 x CH3C), 2.02-2.24 (8 H, m, 2 x CH2CH2), 4.07 (2 H, q, J  6.5, 
CH3Cff20), 5.08 and 5.67 (2 H, m, 2 x C=CHCH2CH2), 5.60 (1 H, d, J  1.0, CHC02Et) and 
7.13-7.30 (5 H, m, Ar-H); Sc (125 MHz, C2HC13) 14.37 (CH3CH20), 15.83,16.09 and 18.87 (3 x
CH3), 25.99, 27.40, 39.35 and 40.95 (2 x CH2CH2), 59.51 (CH3CH20), 115.62 (CHC02Et), 
123.33 and 128.08 (C=CH), 125.59, 126.96 and 128.17 (Ar-CH), 131.56, 135.84, 143.95 and
159.81 (quaternary C) and 166.94 (C=0); m/z (Cl*) 344.3 (100%, [M + NH4]+) and 327.3 (65, 
[M + H]+ ).
(2E,6£,10£)-3,7-Dimethyl-ll-phenyldodeca-2,6,10-trien-l-ol (282)
OH
This compound was prepared from 279 in a manner identical to that for the alcohol 175; 
purification by silica column chromatography using hexane and ethyl acetate (2 : 1) as eluent 
gave 282 as a light yellow oil (0.41 g, 86%); Rf 0.31 (Hexane : EtOAc = 2 : 1); HRMS (EI+, M*) 
found 284.2141. C2oH2sO requires 284.2140; Umax(thin filmycm1 3321.5, 2921.0, 1666.9, 1597.7,
1493.7, 1444.1, 1381.1, 1000.4, 846.3, 756.6 and 696.1; 5H(500 MHz, C2HC13) 1.57 (3 H, s, 
C//3CCH), 1.60 (3 H, s, C//3C=CHCH2OH), 1.96 (3 H, d, J  1.0, PhCC//3), 1.97-2.25 (8 H, m, 2 x 
CH2CH2), 4.04 (2 H, d, J  7.0, C7/2OH), 5.08 (1 H, dt, J  1.0, J  7.0, CH3C=Ctf), 5.33 (1 H, m, 
C=C//CH2OH), 5.68 (1 H, dt, J  1.5, J 7.0, PhC=Ctf) and 7.12-7.30 (5 H, m, Ar-H); 5c(125 MHz, 
C2HC13) 15.84, 16.06 and 16.32 (3 x CH3), 26.29, 27.37, 39.36 and 39.53 (2 x CH2CH2), 59.41 
(CH2OH), 123.39 (CHCH2OH), 124.25 (CH3C=CH) and 128.16 (PhC=CH), 125.61, 126.49 and 
128.18 (Ar-CH), 134.63, 135.01, 139.71 and 144.01 (quaternary C); m/z (EI+) 284.2 (1%, M*),
266.2 (2, [M -  H20]*) and 131.1 (100).
(2£’,6£,,10£)-3,7-Dimethyl-ll-phenyldodeca-2,6,10-trien-l-yl diphosphate tris-ammonium 
salt (160)
o o
I I
o - M - o -o- o-
(NH4+)3
This compound was prepared from alcohol 282 and purified in a manner identical to that for the 
diphosphate 154 to give the title compound 160 as a white solid (0.12 g, 31%); HPLC /r 39.28 
min, Purity 94.6% by analytical RP HPLC under 220 nm; HRMS (ES~, [M -  H]“) found 
443.1410. C20H29O7P2 requires 443.1389; Umax(KBr disc)/cm'] 2922.8, 2190.6, 1668.4, 1493.0,
1444.1, 1381.1, 1201.3, 1092.4, 1024.6, 906.9, 798.2, 757.3, 722.5 and 696.3; 6H(500 MHz; 
2H20  at pH 8.5 buffered with N2H4 0 2H) 1.46 (3 H, s, C//3CCH), 1.59 (3 H, s, C//3C=CHCH20), 
1.76 (3 H, s, PhCCH3), 1.89-2.10 (8 H, m, 2 x CH2CH2\  4.37 (2 H, t, J5.5, CHC//20), 5.03 (1 H, 
U J 6.5, CH3CC//), 5.33 (1 H, t, J 7.0, C=C//CH20), 5.68 (1 H, t, J6.5, PhC=C//) and 6.98-7.16 
(5 H, m, Ar-H); 5C(125 MHz; 2H20  at pH 8.5 buffered with N2H4 0 2H) 15.11 (PhCCH3), 15.41 
(CH3CCH), 15.78 (CH3C=CHCH20), 26.02, 26.90, 38.85 and 39.12 (2 * CH2CH2), 62.37 (d, J
5.0, CH20), 119.68 (d, J  7.5, CHCH20), 124.36 (CH3CCH), 127.96 (PhCCH), 125.31, 126.55 
and 128.16 (Ar-CH), and 134.58, 135.49, 142.43 and 143.34 (quaternary C); SP(122 MHz; 2H20  
at pH 8.5 buffered with N2H4 0 2H) -6.58 (1 P, d, JPP 22.0) and -10.34 (1 P, d, JP? 22.0); m/z (ES“)
443.1 (100%, [M -H]-).
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(Z)-Ethyl 3-phenylbut-2-enoate (285)
To a stirred solution of the iodide 179 (7.20 g, 30.0 mmol) in anhydrous toluene (100 cm3) under 
nitrogen atmosphere was added palladium (II) acetate (0.34 g, 1.50 mmol), triphenylarsine (0.79 
g, 3.0 mmol), tripotassium orthophosphate (19.1 g, 90.0 mmol) and phenylboronic acid (5.49 g,
45.0 mmol). The complete reaction mixture was then stirred at 90 °C for 6  h. Water (50 cm3) and 
diethyl ether (50 cm3) were added, and the organic layer was separated. The aqueous layer was 
extracted with diethyl ether (2 x 30 cm3). The combined ethereal extracts were washed with water 
(2 x 30 cm3) and brine (30 cm3), dried over MgS(>4, filtered and then concentrated under reduced 
pressure. Purification by flash column chromatography on silica gel with hexane and ethyl acetate 
(9 : 1) as eluent gave 285 as a light yellow oil (2.49 g, 85%); Rf 0.30 (Hexane : EtOAc = 9 : 1); 
HRMS (ES+, [M + H]+) found 191.1067. C12H15O2 requires 191.1067; umax (thin film)/cm_1
2979.6, 1725.4, 1639.5, 1492.5, 1442.6, 1374.8, 1277.2, 1230.2, 1162.1, 1095.6, 1076.6, 1047.3,
867.6, 768.4 and 698.1; 6H(500 MHz, C2HC13) 1.14 (3 H, t, J7.5, CH2C//3), 2.23 (3 H, d, J  1.5, 
C//3CPh), 4.05 (2 H, q, J  7.5, C//2CH3), 6.05 (1 H, q, J  1.5, PhC=Ctf) and 7.26-7.42 (5 H, m, 
Ar-H); 5C (125 MHz, C2HC13) 14.02 (CH2CH3), 27.19 (CH3CPh), 59.77 (CH2CH3), 117.84 
(PhC=CH), 126.88, 127.77 and 127.94 (Ar-CH), 140.91 and 155.41 (quaternary C) and 165.92 
(C=0); m/z (C r) 208.1 (100%, [M + NFL*]*) and 191.0 (35, [M + H]*).
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(Z)-3-Phenylbut-2-enol (286)
OH
This compound was prepared from 285 in a manner identical to that for the alcohol 175; 
purification by silica column chromatography using hexane and ethyl acetate (2 : 1) as eluent 
gave 286 as a light yellow oil (4.12 g, 99%); Rf 0.26 (Hexane : EtOAc = 2:1);  HRMS (CI+, [M + 
NH(]+) found 166.1229. C10H16ON requires 166.1226; Umax (thin film)/cm-1 3331.7, 3055.2,
2969.9, 1656.1, 1600.0, 1493.6, 1434.8, 1376.0, 1246.4, 1065.2, 1002.0,764.1 and 700.8; 5H (500 
MHz, C2HC13) 1.46 (1 H, b, OH), 2.02 (3 H, d, J  1.0, C/73CPh), 3.99 (2 H, dd, J  7.0, J  1.0, 
CftOH), 5.64 (1 H, tq, J  7.0, J  1.5, PhC=C//) and 7.09-7.28 (5 H, m, Ar-H); 5c (125 MHz, 
C2HC13) 25.37 (CH3CPh), 60.31 (CH2OH), 126.09 (PhC=CH), 127.20, 127.78 and 128.17 
(Ar-CH) and 140.26 and 140.78 (quaternary C); m/z (Cf) 166.1 (20%, [M + NH4]+), 148.1 (50, 
M*) and 131.0 (100, [M -  OH]*),.
(Z)-3-Phenylbut-2-enal (287)
To a stirred solution of oxalyl chloride (2.69 cm3, 31.3 mmol) in anhydrous CH2CI2 (80 cm3) at 
-78 °C under nitrogen atmosphere, was added anhydrous dimethylsulfoxide (4.44 cm , 62.6 
mmol). The reaction mixture was stirred for 5 min then a solution of alcohol 286 (3.85 g, 26.1 
mmol) in CH2CI2 (5.0 cm3) was added over 5 min and stirring continued for an additional 15 min.
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Triethylamine (18.2 cm , 130 mmol) was added and the reaction mixture was stirred for 5 mm
and then allowed to warm to room temperature. Water (50 cm3) was then added, and the organic 
layer separated. The aqueous layer was extracted with CH2CI2 (2 x 30 cm3). The combined 
organic extracts were washed with water (2 x 30 cm ) and brine (1 x 30 cm ), dried over MgS0 4 , 
filtered and then concentrated under reduced pressure. Purification by flash column 
chromatography on silica gel with hexane and ethyl acetate (2 : 1) as eluent gave 287 as a light 
yellow oil (3.36 g, 88%); Rf 0.48 (Hexane : EtOAc = 2 : 1 ) ;  HRMS (ES+, [M -  H f) found 
145.0645. C10H9O requires 145.0648; Umax (thin film)/cm_l 2357.8, 1668.3, 1614.1, 1433.3,
1388.2, 1136.6, 767.0 and 701.5; 8H(500 MHz, C2HC13) 1.81 (3 H, s, CH3CPh), 6.09 (1 H, d, J
8.0, PhC=CH), 6.95-7.13 (5 H, m, Ar-H) and 9.71 (1 H, dd, J  8.0, J  3.5, CHO); Sc(125 MHz, 
C^HCls) 25.62 (CH3CPh), 128.27, 128.35 and 128.69 (Ar-CH), 129.40 (PhCCH), 138.53 and 
160.14 (quaternary C) and 191.63 (CHO); m/z (Cl*), 164.1 (95%, [M + NH4]+), 161.1 (100%) 
and 146.1 (30, M*).
(Z)-4-Phenyl-penta-l,3-diene (284)
This compound was prepared from aldehyde 287 in a manner identical to that for the triene 172;
purification by flash chromatography using hexane and ethyl acetate (2 : 1) as eluent gave 284 as
a light yellow oil (1.80 g, 76%); Rf 0.63 (Hexane : EtOAc = 9 : 1); HRMS (EI+, M+) found
144.0938. C11H12 requires 144.0939; n o th in  film)/cm_l 3080.3, 2960.4, 2856.8, 1805.6, 1636.2,
1601.6, 1492.1, 1433.6, 1414.1, 1375.3, 1024.7, 995.6, 898.4, 766.1 and 700.2; 8H(400 MHz,
2 1 6
!
\
C2HC13) 2.04 (3 H, s, CH3CPh), 4.86 (1 H, d, J  10.0, CHCH=CHlram//cls), 5.08 (1 H, d, J  17.0, 
CHCP^CHonraHcis), 6.06 (1 H, d, J 11.0, C//CH=CH2), 6.32 (1 H, dt, J  17.0, J  10.5, CHC/7=CH2) 
and 7.14-7.28 (5 H, m, Ar-H); 5c(100 MHz, C2HC13) 25.48 (CH3CPh), 116.05 (CHCH=CH2)> 
127.94 (CHCH=CH2), 127.05, 128.13 and 128.29 (Ar-CH), 134.57 (CHCHCH2) and 139.45 and 
141.47 (quaternary C); m/z (El4) 144.1 (35%, M4) and 129.1 (100, [M -  CH3]4).
(2£',6Z)-Ethyl 3-methyl-7-phenylocta-2,6-dienoate (288)
This compound was prepared from diene 284 in a manner identical to that for the ester 177; the 
crude product was purified by flash chromatography using hexane and ethyl acetate ( 2  : 1) as 
eluent to give 288 as a light yellow oil (1.33 g, 41%); Rf 0.35 (Hexane : EtOAc = 9 :1) ;  HRMS 
(ES+, [M + H]*) found 259.1691. C17H23O2 requires 259.1693; umax (thin film)/cm_1 2975.8,
2359.6, 1715.0, 1647.3, 1493.4, 1442.0, 1367.2, 1221.8, 1146.1, 1099.6, 1052.2, 865.4, 763.2 and 
701.0; 5h (500 MHz, C2HC13) 1.18 (3 H, t, J  7.0, CH2C//3), 1.95 (3 H, s, Cff3C=CHC02Et), 1.98 
(3 H, d, J  1.0, CH3CPh), 2.07 (4 H, m, CH2CH2), 4.07 (2 H, q, J  7.0, Ctf2CH3), 5.32 ( 1  H, m, 
CHCH2CH2), 5.52 (1 H, d, J  0.5, CHC02) and 7.07-7.30 (5 H, m, Ar-H); 5C (125 MHz, C2HC13) 
14.36 (CH2CH3), 18.74 (CH3CPh), 25.65 (CH3CCHCO), 26.93 and 41.15 (CH2CH2), 59.50 
(CH2CH3), 115.72 (C=CHC02Et), 125.84 (PhC=CH), 126.64, 127.85 and 128.16 (Ar-CH), 
137.46, 141.83 and 159.38 (quaternary C) and 166.85 (C=0); m/z (Cl4) 276.2 (100%, [M + 
NH4]4) and 259.2 (95, [M + H]4).
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(2£’,6Z}-3-Methyl-7-phenylocta-2,6-dien-l-ol (289)
O H
This compound was prepared from ester 288 in a manner identical to that for the alcohol 175; 
purification by flash chromatography on silica gel using hexane and ethyl acetate ( 2  : 1 ) as eluent 
gave 289 light yellow oil (0.816 g, 91%); Rf 0.31 (Hexane : EtOAc = 2:1);  HRMS (ES+, [M + 
NR,]*) found 234.1850. C15H24ON requires 234.1852; t w  (thin film)/cm“‘ 3335.5, 2965.2,
2914.6, 1667.9, 1492.8, 1436.1, 1376.6, 999.9, 763.1 and 700.1; 5H(500 MHz, C2HC13) 1.22 ( 1  H, 
b, OH), 1.50 (3 H, s, C//3C=CHCH2OH), 1.95 (3 H, d, J=  1.14, CH3CPh), 1.97-2.04 (4 H, m, 
CH2CH2), 4.04 (2 H, d, J  7.0, C//2OH), 5.28 (1 H, dt, J  7.0, J 1.0, C=C#CH2OH), 5.36 (1 H, dt, J
7.0, J  1.5, C=Ci/CH2CH2) and 7.10-7.28 (5 H, m, Ar-H); 6c (125 MHz, C2HC13) 16.24 
(CH3C=CHCH2OH), 25.60 (CH3CPh), 27.32 and 39.79 (CH2CH2), 59.40 (CH2OH), 123.45 
(CHCH2OH), 126.82 (PhC=CH), 126.51, 127.91 and 128.08 (Ar-CH) and 136.60, 139.45 and
142.05 (quaternary C); m/z (Cl*) 234.2 (100%, [M + NR]*), 216.2 (80, M*) and 199.1 (40, [M -  
OH]*).
(2/i,6Z)-3-Methyl-7-phenylocta-2,6-dienaI (290)
This compound was prepared from alcohol 289 in a manner identical to that for the compound 
181; purification by flash chromatography using hexane and ethyl acetate ( 2  : 1 ) as eluent to gave
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290 as a light yellow oil (0.86 g, 87%); Rf 0.45 (Hexane : EtOAc = 2 : 1); HRMS (El*, M*) found 
214.1352. CisHigO requires 214.1358; umax (thin film)/cm_1 2912.7, 2851.7, 2360.2, 1672.8,
1630.3, 1492.6, 1439.9, 1379.2, 1193.2, 1124.0, 1025.8, 831.0, 764.1, 702.0 and 668.1; 5H(500 
MHz, C2HC13) 1.49 (3 H, d, J  1.0, CH3C=CHCHO), 1.85-2.08 (4 H, m, CH2CH2), 2.03 (3 H, d, J
1.0, CH3CPh), 5.30 (1 H, td, J  7.0, J  1.0, CHCH2CH2), 5.85 (1 H, dd, J  8.0, J  1.0, CHCHO), 
7.17-7.29 (5 H, m, Ar-H) and 9.91 (1 H, d, J  8.0, CHO); 5C (125 MHz, C2HC13) 16.42 
(CHjCCHCHO), 25.50 (CH3CPh), 26.66 and 40.42 (CH2CH2), 125.95 (PhC=CH), 127.57 
(CHCHO), 126.88, 127.92 and 128.31 (Ar-CH), 137.62, 141.80 and 160.81 (quaternary C) and 
189.58 (CHO); m/z (El*) 214.1 (2%, M*) and 131.1 (100).
(3£’,7Z)-4-Methy 1-8-pheny 1-nona-1,3,7-triene (291)
This compound was prepared from aldrhyde 290 in a manner identical to that for the triene 172;
purification by flash chromatography using hexane and ethyl acetate (2 : 1) as eluent gave 291 as
a light yellow oil (0.48 g, 8 6 %); Rf 0.62 (Hexane : EtOAc = 9:1);  HRMS (ES\ [M + H f) found
212.1569. Ci6H20 requires 212.1565; t w  (thin film)/cm~' 2964.8, 2358.3, 1649.8, 1598.9, 1493.0,
1436.5, 1378.1, 985.7, 896.9, 761.8 and 700.0; SH (500 MHz, C2HC13) 1.70 (3 H, s,
C/73C=CHCH), 2.07 (3 H, s, CffiCPh), 2.08-2.17 (4 H, m, CH2CH2), 5.00 (1 H, dd, J  10.0, J 1.5,
CH=CffcisHtraiis), 5.10 (1 H, dd, J  17.0, J  2.0, C H ^fW /tn^), 5.46 (1 H, dt, J  7.0, J  1.5,
C=C77CH2CH2), 5.83 (1 H, dd, J  11.0, J  0.5, C7 /CH=CH2), 6.59 (1 H, dt, J  17.0, J  10.5,
CHC/7=CH2) and 7.21-7.39 (5 H, m, Ar-H); 5c (125 MHz, C2HC13) 16.64 (CH3C=CHCH2),
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25.63 (CH3CPh), 27.40 and 40.11 (CH2CH2), 114.70 (C=CHCH2), 125.57 (CHCH=CH2), 126.91 
(PhC=CH), 126.50, 127.96 and 128.19 (Ar-CH), 133.38 (CH=CH2) and 136.59, 139.14 and 
142.09 (quatemaiy C); m/z (Er> 212.2 (5%, M+), 131.1 (100) and 91.1 (40).
(2is,6 Zs, 10Z)-Ethy 13,7-dimethyl-ll-phenyldodeca-2,6,10-trienoate (292)
This compound was prepared from 291 in a manner identical to that for the ester 177; purification 
by flash chromatography using hexane and ethyl acetate ( 2 : 1 )  gave 292 as a light yellow oil 
(0.29 g, 40%); Rf 0.33 (Hexane : EtOAc = 19 : 1); HRMS (ES+, [M + H]+) found 327.2318. 
C22H3 i0 2 requires 327.2319; \w (th in  film)/cm_1 2926.3, 1715.4, 1647.5, 1442.7, 1366.5, 1221.5,
1144.3, 1053.9, 865.3, 762.0 and 700.5; 8H(500 MHz, C2HC13) 1.20 (3 H, t, J7 .0 , OCH2C//3), 
1.43 (3 H, s, CH3C=CH), 1.95 (3 H, d, J  1.0, CH3C=CH), 2.08 (3 H, d, J  1.0, Ctf3C=CHC02Et), 
1.91-2.11 ( 8  H, m, 2  x CH2CH2), 4.06 (2 H, q, J7.0, OCtf2CH3), 4.97 (1 H, b, C=C//CH2CH2), 
5.35 (1 H, dt, J 7.0, J 1.0, C=C//CH2CH2), 5.58 (1 H, s, CHC02Et) and 7.09-7.30 (5 H, m, Ar-H); 
5c (125 MHz, C2HC13) 14.37 (OCH2CH3), 15.95 (CH3C=CH), 18.85 (CH3C=CHC02Et), 25.57 
(CH3C=CH), 25.96, 27.52, 39.92 and 40.95 (2 x CH2CH2), 59.50 (OCH2CH3), 115.59 
(CHC02Et), 123.12 and 127.20 (2 x C=CHCH2CH2), 126.43, 127.59 and 128.03 (Ar-CH), 
135.74, 136.20, 142.14 and 159.87 (quatemaiy C) and 166.93 (C=0); m/z (Cf) 344.3 (100%, [M 
+ m u T )  and 327.3 (50, [M + H]*).
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(2£',6£',10Z)-3,7-dimethyl-ll-phenyldodeca-2,6,10-trien-l-ol (293)
O H
This compound was prepared from 292 in a manner identical to that for the alcohol 175; 
purification by silica column chromatography using hexane and ethyl acetate (2 : 1 ) as eluent gave 
alcohol 293 as a light yellow oil (0.12 g, 77%); Rf 0.26 (Hexane : EtOAc = 2:1) ;  HRMS (ES+, 
[M + NH4f )  found 302.2477. C20H32ON requires 302.2478; r w  (thin filmVcm'1 3344.4, 2919.3,
1666.0, 1597.4, 1493.4, 1443.8, 1381.2, 998.9, 756.6 and 696.0; 5H(500 MHz, C2HC13) 1.23 (1 H, 
b, OH), 1.43 (3 H, s, CH3), 1.60 (3 H, s, CH3), 1.95 (3 H, d, J  1.0, CH3), 1.91-2.06 ( 8  H, m, 2 * 
CH2CH2), 4.07 (2 H, d, J  7.0, CH2OU), 4.99 (1 H, td, J  7.0, J  1.0, C=CH), 5.33 (2 H, m, 2 x 
C=CH) and 7.10-7.30 (5 H, m, Ar-H); 5C(125 MHz, C2HC13) 15.97, 16.31 and 25.58 (3 * CH3), 
26.26, 27.64, 39.54 and 39.97 (2 * CH2CH2), 59.42 (CH2OH), 123.32, 123.98 and 127.33 (3 * 
C=CH), 126.42, 127.96 and 128.02 (Ar-CH) and 135.01, 136.11, 139.83 and 142.17 (quaternary 
C); m/z (Cl") 302.3 (100%, [M + NR,]") and 284.3 (55, MT).
(2Is,6Is,10Z)-3,7-Dimethyl-ll-phenyIdodeca-2,6,10-trien-l-yl diphosphate tris- ammonium 
salt (161)
o -
( N H 4 + ) 3
This compound was prepared from alcohol 293 and purified in a manner identical to that for the
diphosphate 154 to give 161 as a white solid (63.8 mg, 36%); HPLC /r = 38.82 min; Purity
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97.53% by analytical RP HPLC under 220 nm; HRMS (ES", [M -  H]“) found 443.1374, 
C20H29O7P2 requires 443.1389; i w  (KBr disc)/cm~‘ 3292.3, 1494.2, 1457.3, 1409.4, 1202.2,
1122.0, 1089.8, 1024.0, 910.5, 757.0, 723.3 and 697.3; 5H (500 MHz, 2H20  at pH 8.5 buffered 
with N2H ,0 2H) 1.34 (3 H, s, CH3), 1.59 (3 H, s, CH3), 1.85 (3 H, s, CH3), 1.88-2.03 (8 H, m, 2 x 
CH2CH2), 4.39 (2 H, b, CHC//2OH), 4.98 (1 H, b, C=CH), 5.33 (2 H, bd, 2 x C=CH) and 
7.06-7.18 (5 H, m, Ar-CH); 8c(125 MHz; 2H20  at pH 8.5 buffered with N2H4 0 2H) 15.28, 15.69 
and 24.86 (3 x CH3), 25.87, 227.12, 39.04 and 39.33 (2 x CH2CH2), 62.60 (CCH2OH), 119.55, 
124.21 and 127.26 (3 x C=CH), 126.54, 127.75 and 128.03 (Ar-CH) and 135.39, 136.27, 141.76 
and 142.57 (quaternary C); 5P (122 MHz; 2H20  at pH 8.5 buffered with N2H4 0 2H) -6.51 (1 P, d, 
Jpp 21.0) and -10.33 (1 P, d, Jp-p 21.0); m/z (ES") 443.1 (100%, [M -  H] ").
(£)-Ethyl 7,ll-dimethyl-3-oxododeca-6,10-dienoate (303)
•5 1
A stirred solution of geraniol (2.60 cm g, 15.0 mmol) and triethylamine (4.20 cm , 30.0 mmol)
in anhydrous THF (100 cm3) was cooled to -  45 °C then methanesulfonyl chloride (1.50 cm3,
19.5 mmol) was added. The resulting milky mixture was stirred at -  45 °C for 45 min. A solution
of lithium bromide (5.20 g, 60.0 mmol) in THF (10 cm3) was then added via a cannula at -  45 °C.
The suspension was allowed to warm to 0 °C and stirred for an additional 1 h. Cold water (30
cm3) and hexane (30 cm3) were added to quench the reaction. The two layers were separated, and
the aqueous layer was extracted with hexane (2 x 20 cm3). The combined organic layers were
washed with saturated NaHCC>3 solution (20 cm3) and then brine (20 cm3), dried over NaSC>4 and
filtered. Concentration under reduced pressure gave the intermediate bromide 264 as a light
2 2 2
yellow oil which was used without further purification.
To a stirred suspension of NaH (60% dispersion in mineral oil, 1.20 g, 49.5 mmol) in anhydrous 
THF (100 cm3) was added ethyl acetoacetate (5.73 cm3, 45.0 mmol) dropwise at 0 °C. After 10 
min, n-BuLi (2.2 M, 21.5 cm3, 47.3 mmol) was added slowly over 3 min, during which time the 
colourless solution gradually turned yellow. This was stirred for additional 10 min at 0 °C, as a 
solution of the bromide 264 in THF (5 cm3) was added. The clear solution turned to a cloudy 
yellow suspension. After stirring for 30 min at 0 °C, hydrochloric acid (3 M, 10.0 cm3) was added 
followed by water (30 cm3) and diethyl ether (30 cm3) and then the organic layer was separated. 
The aqueous layer was extracted with diethyl ether (2 x 20 cm3). The combined ethereal extracts 
were washed with water (2 x 20 cm3) and brine (20 cm3), dried over MgSC>4 then filtered and 
concentrated under reduced pressure. Purification by flash column chromatography on silica gel 
with hexane and ethyl acetate (4 : 1) as eluent gave p-keto ester 303 as a pale yellow oil (3.61g, 
92%); Rf 0.45 (Hexane : EtOAc = 2 : 1 ) ;  HRMS (ES+, [M + H]+) found 267.1954. C16H27O3 
requires 267.1954; n o t h in  film)/cm_1 2968.0, 2918.6, 1746.5, 1717.2, 1648.9, 1445.8, 1409.9,
1367.4, 1313.3, 1235.8, 1177.2, 1035.9 and 839.8; 5H (500 MHz, C2HC13) 1.30 (3 H, t, J  7.0, 
CH2C#3), 1.61 (3 H, s, CH3), 1.63 (3 H, s, CH3), 1.69 (3 H, s, CH3), 1.98 (4 H, m, 
(CH3)2C=CHC//2C/72), 2.30 ( 2  H, q, J7.5, C//2CH2C=0 ), 2.59 ( 2  H, t, J7.5, CH2Ctf2C=0 ), 3.45 
(2 H, s, COCH2CO), 4.20 (2 H, q, J7.0, C7/2CH3) and 5.09 (2 H, dt, J  1.0, J7.0, 2 x C=CH); 5C 
(125 MHz, C2HC13) 14.13 (CH2CH3), 16.01 (CH3), 17.71 (CH3), 22.15 (CH2CH2C=0), 25.72 
(CH3), 26.60 and 39.35 [(CH3)2C=CHCH2CH2], 43.08 (CH2CH2CO), 49.42 (COCH2CO), 61.38 
(CH2CH3), 122.06 and 122.38 (2 x C=CH), 131.51 and 136.77 (quaternary C), 167.26 (ester C=0) 
and 202.72 (ketone C=0); m/z (C f) 284.2 (100%, [M + NB4T) and 267.2 (8 6 , [M + H]*).
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(lZ,5£)-l-(Ethoxycarbonyl)-6,10-dimethylundeca-l,5,9-trien-2-yl
trifluoromethanesulfonate (304)
A stirred solution of 303 (546 mg, 2.05 mmol) in anhydrous THF (15 cm3) under N2 was cooled 
to -78 °C and then potassium bis(trimethylsilyl)amide (0.5 M in THF, 4.93 cm3, 2.46 mmol) was 
added. The resulting mixture was stirred at -78 °C for 30 min. Trifluoromethanesulfonic 
anhydride (414 mm3, 2.46 mmol) was added at -78 °C and the solution was stirred for 16 h
•y
whilst slowly warming to room temperature. Diethyl ether (20 cm ) was added and the solution 
washed with 10% citric acid solution (2 x 15 cm3) and water (15 cm3). The separated organic 
layer was dried over MgSC>4 and filtered. Concentration of the solvent under reduced pressure 
gave a yellow oil which was purified by flash chromatography on silica gel with hexane and ethyl 
acetate (4 : 1) as eluent to give 304 as light yellow oil (0.42 g, 51%); Rf 0.41 (Hexane : EtOAc = 
4 : 1); umax (thin film)/cm_1 2975.6, 2905.3, 2855.1, 2353.0, 1731.9, 1676.1, 1427.9, 1209.1,
1141.0, 1037.6, 923.1 and 840.1; 5H (500 MHz, C2HC13) 1.24 (3 H, t, J7.0, OCH2C/73), 1.53 (3 H, 
s, CH3), 1.54 (3 H, s, CH3), 1.61 (3 H, s, CH3), 1.91 (4 H, m, (CH3)2C=CHC//2C//2), 2.20 (2 H, q, 
J  7.5, CH2CH2CO), 2.34 (2 H, t, J7.5, CH2C//2CO), 4.17 (2 H, q, J7.0, OC//2CH3), 4.99 (2 H, t, 
J7.0, 2 x C=C//CH2CH2) and 5.67 (1 H, s, 0-C=CH); Sc (125 MHz, C2HC13) 14.05 (OCH2CH3),
16.05 (CH3), 17.70 (CH3), 24.37 (CH2CH2CO), 25.68 (CH3), 26.52 and 39.60
(CH3)2C=CHCH2CH2), 34.60 (CH2CH2C=0), 61.27 (OCH2CH3), 112.04 (0-C=CH), 120.61 and 
123.93 (2 x C=CH), 131.68 and 138.18 (2 x C=CH), 158.52 (CH=C0S02CF3) and 162.52 (C=0); 
SF (283 MHz, C2HC13) -74.6 (s); m/z (C f) 398.1 (2%, M+), 358.0 (80) and 114.0 (100).
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(2Z,62s)-Ethyl 7,ll-dimethyl-3-phenyldodeca-2,6,10-trienoate (302)
To a stirred solution of 304 (0.36 g, 0.91 mmol) in anhydrous THF (10 cm3) under N2, was added 
palladium (II) acetate (0.02 g, 0.09 mmol), triphenylarsine (0.11 g, 0.36 mmol), silver oxide (0.42 
g, 1.81 mmol) and phenylboronic acid (0.17 g, 1.36 mmol) in quick succession, and the complete
“X 7mixture heated under reflux for 15 h. Water (20 cm ) and diethyl ether (20 cm ) were added, and 
the organic layer was separated. The aqueous layer was extracted with diethyl ether (2x15 cm3). 
The combined ethereal extracts were washed with water (2 x 10 cm3) and brine (10 cm3), dried 
over MgSC>4 filtered and concentrated under reduced pressure. Purification by flash column 
chromatography on silica gel with hexane and ethyl acetate (9 : 1) as eluent gave 302 as a light 
yellow oil (0.19 g, 6 6 %); Rf 0.35 (Hexane : EtOAc = 9 : 1 ) ;  HRMS (ES+, [M + H]4) found 
327.2324. C22H31O2 requires 327.2319; omax (thin filmycm" 1 2975.7, 2926.3, 2361.9, 1727.2,
1638.2, 1442.5, 1377.2, 1276.4, 1223.8, 1159.0, 1042.6, 865.8 and 698.6; 5H (500 MHz, C2HC13) 
0.99 (3 H, t, J  7.0, CH2C//3), 1.45 (3 H, s, CH3), 1.53 (3 H, s, CH3), 1.60 (3 H, s, CH3), 1.88 ( 6  H, 
m, (CH3)2C=CHC//2C/ / 2  and C//2CH2CPh), 2.40 (2 H, dt, J 1.0, J  8.0, CH2C//2CPh), 4.90 (2 H, q, 
J7.0, CH2CH3), 5.01 (2 H, dt, J1.0, J7.0, 2 x C=CH), 5.81 (1 H, s, C=C//C02Et) and 7.07 (5 H, 
m, Ar-H); 5C (125 MHz, C2HC13) 13.95 (CH2CH3), 16.06 (CH3), 17.69 (CH3), 25.68 (CH3), 25.86, 
26.65, 39.65 and 40.46 ( 2  x CH2CH2), 59.74 (CH2CH3), 117.42 (CHCO), 122.73 and 124.24 ( 2  x 
CHCH2CH2), 127.16, 127.54 and 127.80 (Ar-CH) and 131.41, 136.25, 140.16, 159.30 and 166.07 
(quaternary C); m/z (Cl4) 344.4 (53%, [M + NHJ4) and 327.4 (100, [M + H]+).
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(2Z,6£)-7,ll-Dimethyl-3-phenyldodeca-2,6,10-trien-l-ol (305)
O H
This compound was prepared from 302 in a manner identical to that for the alcohol 175; 
purification by flash chromatography on silica gel using hexane and ethyl acetate (2: 1) as eluent 
gave alcohol 305 as a light yellow oil (0.1 lg, 85%); Rf 0.38 (Hexane : EtOAc = 2 :1) ;  HRMS 
(EI+, M*) found 284.2147. C20H28O requires 284.2140; omax (thin film)/cm-1 3355.5, 2965.4,
2922.2, 2855.4, 1650.6, 1491.7, 1442.2, 1379.7, 1080.3, 1005.6, 830.9 and 769.8; 8H (500 MHz, 
C2HC13) 1.42 (1 H, b, CH20//), 1.54 (3 H, s, CH3), 1.59 (3 H, s, CH3), 1.71 (3 H, s, CH3), 1.97 (6 
H, m, (CH3)2C=CHC/f2C//2 and C//2CH2CPh), 2.44 (2 H, t, J7.5, CH2Ctf2CPh), 4.07 (2 H, d, J
7.0, Ci/2OH), 5.11 (2 H, m, 2 x C=CH), 5.72 (1 H, t, J7.0, C=C//CH2OH) and 7.15 (5 H, m, 
Ar-H); 8C (125 MHz, C2HC13) 16.03 (CH3), 17.69 (CH3), 25.69 (CH3), 26.49, 26.71, 39.00 and 
39.68 (2 x CH2CH2), 60.28 (CH2OH), 123.54 and 124.38 (2 x C=CH), 125.68 (C=CHCH2OH), 
127.07, 128.09 and 128.20 (Ar-CH) and 131.34, 135.54, 140.00 and 144.59 (quaternary C); m/z 
(El*) 284.2 (10%, M*) and 266.2 (100, [M -  H20]*),.
(2Z,6£)-7,ll-Dimethyl-3-phenyldodeca-2,6,10-trien-l-yl diphosphate tris-ammonium salt 
(162)
This compound was prepared from alcohol 305 and purified in a manner identical to that for the
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diphosphate 154 to give diphosphate 162 as a white solid (53.9 mg, 31%); HPLC /r 39.02 min; 
Purity 96.92% by analytical RP HPLC under 220 nm; HRMS (ES_, [M -  H]~) found 443.1375. 
C20H29O7P2 requires 443.1389; umax (KBr disc)/cm_1 2924.0, 1442.5, 1200.4, 1128.9, 1 1 0 1 .1 ,
1023.2, 971.5, 927.5, 812.5 and 706.3; SH (500 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) 
1.16 (3 H, s, CH3), 1.23 (3 H, s, CH3), 1.31 (3 H, s, CH3), 1.61 ( 6  H, m, (CH3)2C=CHC//2Ctf2 
and C/72CH2CPh), 2.24 (2 H, t, J7.5, CH2Ctf2CPh), 4.32 (2 H, t, J6.5, CH20), 4.77 (1 H, t, J6.5, 
C=Cfl), 4.84 (1 H, t, J  6.5, C=C//), 5.67 (1 H, t, J7.0, C=Ci/CH20) and 7.05 (5 H, m, Ar-H); 5C 
(125 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) 15.49 (CH3), 17.13 (CH3), 25.10 (CH3), 
26.29, 26.53, 38.71 and 39.25 (2 x CH2CH2), 63.90 (CH20), 122.42 (C=CHCH20), 123.66 and 
124.34 (2 x C=CH), 127.54, 128.33 and 128.39 (Ar-CH) and 131.17, 135.48, 139.41 and 145.93 
(quaternary C); 5p (122 MHz, 2H20  at pH 8.5 buffered with N2H4 0 2H) -10.18 (d, Jpp21.0) and 
-10.82 (d, JPP21.0); m/z (ES") 443.1 (100%, [M -  H]“).
4.3 Incubation of FPP analogues with AS and characterisation of products 
with GC-MS
Purified AS (50 pM) was incubated with each FPP analogue (200 mM) in 10 mM Tris, 5 mM 
MgCl2, 5 mM 2-mercaptoethanol and 15% glycerol (pH 7.5) in a final volume of 500 mm3 
overlayed with pentane (200 mm3) at 30 °C for 1-7 days. Reactions were terminated by addition 
of EDTA (100 mM, 100 mm3) and the products were extracted by vortexing against pentane (3 x 
3 cm3). The pooled extracts were vortexed with 1.5 g of silica then decanted and concentrated 
under reduced pressure on ice.
The hexane extractable products were analysed by GCMS. This was performed on a system
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comprising of a Hewlett Packard 6890 GC fitted with a J&W scientific DB-5MS column (30 m x 
0.25 mm internal diameter) and a Micromass GCT Premiere detecting in the range m/z 50-800 in 
EI+mode with scanning once a second with a scan time of 0.9 s. Injections were performed in 
split mode (split ratio 5:1) at 50 °C unless otherwise stated and used helium as the carrier gas. 
Chromatograms were begun with an oven temperature of 50 °C rising at 4 °C min' 1 for 25 min 
(up to 150 °C) and then at 20 °C min' 1 for 5 min (250 °C final temperature).
4.4 Preparative scale incubation of 2-fluoro farnesyl pyrophosphate (155) with 
AS and characterisation of products
Aristolochene synthase solution (3.60 cm3, 638 pM) was diluted to 33.5 cm3 with buffer 
consisting of 20 mM Tris-HCl, 5 mM 2-mercaptoethanol, 5 mM MgCb, and 15 % (v/v) glycerol, 
pH 7.5. The assay solution was gently mixed as 155 (30.0 mg, 0.067 mmol) was added followed 
by pentane (2 cm ). After incubation for 48 h at 25 °C, the olefin products were extracted with 
pentane (3 * 80 cm ). The pooled pentane extracts were concentrated under a nitrogen stream 
until about 5 cm of solvent remained. This solution was passed through a short pad of silica gel 
overlayed with anhydrous MgSCU. The pentane was concentrated under reduced pressure to yield 
a single product as judged by GCMS analysis in a manner identical to that for the small scale 
incubation (vide supra) (4.0 mg, 27%); GCMS Tr = 26.24 min; HRMS (Ef) found 222.1785, 
C15H23F requires 222.1784. Compound displayed conformational isomerism complicating the 
interpretation of its NMR spectra. Consequently variable temperature NMR experiments were 
performed (vide supra). The lU NMR data are reported in Table 4.1. The 13C NMR spectrum 
could not be observed directly due to the small quantity of material isolated and reduction of line
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intensity due to the conformational isomerism but could be indirectly observed and interpreted 
through the cross peaks observed in the various 2D spectra. 5c (125 MHz, d8-toluene, 25 °C) 14.7 
(C-14), 19.5 (C-13 and C-15), 25.1 (C-5), 27.5 (C-4), 33.3 (C-9), 33.8 (C-8) 34.1 (C-l) 45.4 
(C-10), 108.9 (C-l2), 112.0 (C-3), 128.2 (C-7), 137.1 (C-6), 149.6, (C-ll), 154.5 and 156.7 (d, 
C-2); 5f (283 MHz, d8-toluene, -60 °C) -89.2 (major conformer) and -91.8 (minor); 5f (283 MHz, 
d8-toluene, 25 °C) -88.8 (major conformer) and -91.3 (minor); m/z (EI+) 222.2 (12%, M^), 207.2 
(19%, [M-CH3]+), 202.2 (10%, [M-HF]*), 68.1 (100%).
-60 °C major -60 °C minor 25 °C 90 °C
CH2 -1 1.90-2.07 (m) and 1.90-2.07 (m) and 1.99-2.14 (m)and 1.88-2.02 (m) and
2.33-2.44 (m) 2.33-2.44 (m) 2.35-2.45 (m) 2.42 CH2-I (ddd, „
3.5, 14.5, 32.5 Hz)
CH2 - 4 1.51-1.58 (m) 1.51-1.58 (m) 1.53-1.58 (m) and 1.52-1.60 (m) and
2.95 (ddt, J  2, 6, 3.03 (br q, J  10 2.83-3.02 (br m) 2.83-2.90 (dq,J 1.5
12.5 Hz) Hz) 9.5 Hz)
3.00-3.06 (m)
CH2 - 5 2.02-2.14 (m) and 2.02-2.14 (m) and 2.11-2.14 (m) and 2.12-2.17 (m) and
2.25 (ddt, J  1.5, 2.25 (ddt, J  1.5, 2.22-2.30 (br, m) 2.24-2.26 (m)
5.5, 12 Hz) 5.5, 12 Hz)
CH-6 5.36 (br, d, J  12.5 5.05 (t, .78 Hz) 5.02-5.10 (br, s) 5.18 (m)
Hz) and
5.25-5.32 (br, m)
CH2 - 8 2.02-2.14 (m) 2.02-2.14 (m) 2.11-2.14 (m) 2.12-2.17 (m)
CH2 - 9 1.51-1.58 (m) and 1.51-1.58 (m) and 1.53-1.58 (m) and 1.52-1.60 (m) and
1.90-2.07 (m) 1.90-2.07 (m) 1.99-2.14 (m) 1, 8 8 -2 . 0 2  (m)
CH-10 2.02-2.14 (m) 2.02-2.14 (m) 2.11-2.14 (m) 2.12-2.17 (m)
CH2-I2 pseudo AB system pseudo AB system 4.68 (br, s) and 4.64 (s) and 4.70 (s)
4.70, 4.73, 4.76 4.70, 4.73, 4.76 4.73 (s)
and 4.78 and 4.78
CH3-B 1.67 (s) 1.79 (s) 1.62 (s) 1.62 (s)
CHs-14 1.60 (s) 1.62 (s) 1.67 (br) 1 . 6 6  (s)
CH3-I5 1.26 (d, Jhf 3 Hz) 1.28 (d, Jm  3 Hz) 1.32 (d, Jhf 3 Hz) 1.36 (d, Jhf 2.5 Hz)
Table 4.1. !HNMR spectra o/314 at -60, 25 and 90 °C.
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4.5 Preparation of wild-type aristolochene synthase
The expression of cDNA for AS and the purification of AS were performed according to 
published procedure.64
4.5.1 Transformation of E. coli BL21 (DE3) with cDNA for wild-type AS
A 100 mm3 aliquot of E. coli BL21 (DE3) competent cells (from Mr L. H. Tey) was thawed 
slowly on ice, then 1-2 jig of vector containing a cDNA for AS64 were added and the mixture was 
kept on ice for 20 min. The cells were then heat shocked at 42 °C for 2 min in a water-bath and 
then returned to ice for 2 min. 1 cm3 of LB medium was added and the solution incubated at 37 
°C for 1 h. After this time, the transformed cells were harvested in a centrifuge at 14,000 rpm for 
1 min and the supernatant discarded to a volume of 100 mm3. The cells were re-suspended and 
the 100 mm3 cell suspension was aseptically spread on an agar - ampicillin plate. The plate was 
then incubated at 37 °C overnight.
4.5.2 Overexpression of recombinant AS
A single E. coli BL21 (DE3) colony, transformed with the vector containing Aril, was grown in 
60 cm3 LB media in the presence of ampicillin at 37 °C overnight. Overnight cultures (6x10 cm3) 
were used to inoculate in 6  x 500 cm of sterile LB medium in 6  x 2 litres conical flasks, to each 
of which 50 mg of ampicillin was added followed by incubation at 37 °C for 3 h with shaking 
(180 rpm). At various intervals, 1 ml of the growing culture was transferred to a 1 ml cuvette and 
the OD at 600 nm was measured to monitor the growth of bacteria. When the OD at 600 nm was 
higher than 0 . 6  the remaining culture was induced by the addition of
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Isopropyl-1-thio-P-D-galactopyranoside (IPTG) up to a final concentration of 0.6 - 1 mM. The 
induced cultures were incubated with shaking (180 rpm) at 37 °C for a further 3 h as it was
1 so i ondescribed for epi-aristolochene synthase. ’ Cells were harvested by centrifugation at 5,100 
rpm at 4 °C for 20 min. The supernatant solution was discarded and the pellets were stored at -20 
°C until required.
4.5.3 Base extraction and refolding of wild-type aristolochene synthase
The pellet (from above, section 4.5.2) was redissolved in 50 cm3 cell lysis buffer (5 mM EDTA, 5 
mM p-mercaptoethanol, 20 mM Tris, at pH 7.5). The suspension was sonicated for a total of 15 
min (30 s on 30 s off) on ice using a Lab Plant (ultrason 250) fitted with the medium probe. The 
sonicated sample was centrifuged at 5 000 rpm for 10 min and the supernatant solution discarded. 
The pellets were resuspended in 150 ml of fresh lysis buffer and titrated on ice to pH 11.75 with 
sodium hydroxide (0.1 M). The solution was stirred on ice for 30 min. The pH was then lowered 
to pH 8.0 with hydrochloric acid (0.1 M) and P-mercaptoethanol added to a final concentration of 
5 mM. The resulting solution was stirred for 30 min on ice and centrifuged at 15000 rpm at 4 °C 
for 30 min, after which solubilised protein was found in the supernatant solution and stored at 4 
°C.49
4.5.4 Purification of wild-type AS by ion-exchange chromatography
Anion exchange columns are generally used to purify aristolochene synthase75, 191. A
t*w  nrw
Q-Sepharose (Amersham Pharmacia Biotech ) High Performance (2.5 x 20 cm) column at 4 
°C, was used to purify the protein from the supernatant solution described above (section 4.5.3).
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The column was washed with 150 cm3 of column buffer (20 mM tris, 5 mM EDTA, 5 mM 
p-mercaptoethanol, pH 7.5). Approximately 50 cm3 of cell free extract was loaded onto the 
column followed by another 150 cm3 of buffer to elute any unbound protein. A 0.1 - 0.6 M NaCl 
(500 cm3) gradient was applied to the column and the fractions were collected every 48 s (typical 
fraction size = 5 cm ). The column was then washed with 200 cm of 1 M NaCl solution to elute 
any other product still bound to the resin. The absorbance of the fractions were measured at 280
1 Q'y m
nm to identify fractions containing protein , followed by SDS-PAGE electrophoresis to estimate 
the purity of the 39 kDa protein.
4.5.5 Dialysis and concentration of AS
To remove the high salt concentration of the protein solution that eluted from the column, the
-rw
protein solution was dialysed using Spectrum Spectra/Por molecular porous dialysis membrane 
(MW = 3500 cut off), at 4 °C for 3 days in 3 litres of dialysis buffer (10 mM tris, 5 mM 
P-mercaptoethanol, pH 7.5). The buffer was replaced twice daily.
Following dialysis, the protein was transferred to an Amicon™ ultrafiltration apparatus 
containing a millipore 44.5 mm ultrafiltration membrane, and concentrated at a pressure of 3 bar 
at 4 °C, to give a final volume of approximately 3-5 cm . Once concentrated, the protein sample 
was aliquoted (0.5 cm3), fast frozen in liquid N2 and stored at -20 °C.
4.5.6 Protein concentration determination
For the determination of wild-type of aristolochene synthase concentrations, the microtannin
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assay, was carried out Tannin solutions A (196 cm3 HC1 1 M, 4 cm3 phenol, 20 g tannic acid) and 
B (0.4 g gum Arabic, 200 cm3 H2O) were prewarmed in a water bath at 30 °C. Bovine Serum 
Albumin (BSA) was used as the standard and the reactions for the calibration curved were 
prepared as described in Table 4.2.
To 1 cm solutions of BSA standards and samples, 1 cm of prewarmed solution A was added. 
Immediately after addition of solution A, standards and samples were incubated at 30 °C for 10 
minutes. Then, 1 cm3 of prewarmed solution B was added to each tube of standard and sample 
and the solutions were kept at room temperature for 10 minutes. The absorbance of the reactions 
was read at 500 nm.
[BSA] (pg 
m l1)
Water
0*1)
0 1000
10 990
20 980
30 970
40 960
50 950
60 940
70 930
Table 4.2 Calibration curve reaction for the microtannin assay.
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12,13-Difluorofamesyl diphosphate, prepared using Suzuki- 
Miyaura chemistry, is a potent inhibitor of aristolochene 
synthase (AS), indicating that the initial cyclisation during AS 
catalysis generates germacryl cation in a concerted reaction.
The terpenoid family of natural products consists of many 
thousand compounds of enormous structural and stereochemical 
diversity that derive from only a small number of linear isoprenoid 
precursors. Sesquiterpene synthases, for instance, catalyse the 
cyclisation of the universal acyclic precursor famesyl diphosphate 
(la, FPP) to produce more than 300 different hydrocarbon 
skeletons, often with high regio- and stereospedficity. 1 ' 4
The solution of the X-ray crystal structures of 5 sesquiterpene 
synthases, namely 5-epi-aristolochene synthase from Nicotiana 
tabacum,5 pentalenene synthase from Streptomyces UC5319,6 
trichodiene synthase from Fusarium sporotrichoides1 and aristo­
lochene synthase (AS) from both Penicillium roqueforti and 
Aspergillus terreus9 revealed that, in spite of the absence of 
significant sequence similarities, they all adopt the mainly a-helical 
class I terpene fold. Sesquiterpene synthases therefore serve as high 
fidelity templates that subtly channel conformation and stereo­
chemistry during the cyclisation reactions.
The mechanisms of the enzyme-catalysed cyclisations of 
sesquiterpenoids are inherently difficult to study spectrometrically 
and their elucidation has been largely dependent on the use of 
substrate mimics and site directed enzyme mutants. Mechanistic 
studies with substrate analogues suggested that AS converts la 
into the bicyclic sesquiterpene aristolochene (5a) through an initial 
cyclisation to generate the intermediate (S)-germacrene A (4a) 
followed by protonation, 1 , 2  hydride and methyl shifts and 
stereospecific deprotonation from C8  (Scheme 1). Surprisingly 
little is known about the reaction mechanism of the formation of 
the decalin ring system that could be formed by several 
mechanistically distinct pathways. The results obtained with site- 
specific mutants of AS suggested that diphosphate ionisation led to 
the formation of famesyl cation (2 a) which was attacked by the 
C10-C11 ir-bond to generate germacryl cation (3a) (path a, 
Scheme l ) . 1 0 ,1 1  Alternatively, the formation of 3a could take place 
in a concerted reaction in which famesyl diphosphate ionisation is 
accompanied by electrophilic attack of Cl of FPP by the CIO, Cl 1 
7t-system (path b) . 9  This mechanism is in agreement with the 
observation that the reaction of stereospecifically deuterated FPP
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Scheme 1 Possible mechanisms for the initial cyclisation during catalysis 
by aristolochene synthase.
occurred with inversion of configuration at C l . 1 2  In path c, 
cyclisation is initiated by deprotonation from C121 3  and 
concurrent bond formation between CIO and Cl. Since it has 
become increasingly apparent that only a few amino add 
substitutions can be sufficient to remodel the active site template 
provided by terpene synthases, thereby often dramatically altering 
the reaction products, a detailed mechanistic understanding of the 
reaction catalysed by these enzymes is central to their further 
evolution in vitro or in vivo for the generation of novel products. 1 4
Fluoro analogues of prenyl diphosphates have recently been 
used as powerful reagents to explore the mechanism of the 
enzyme-catalysed cyclisations to terpenoid products. 1 5  Fluoro 
substituents do not greatly affect the binding affinities as a 
consequence of size and shape but at the same time exert a strong 
influence on the electronic environment at the site of replacement 
in that they stabilize cations on the a-carbon by ir-donation but 
exert a destabilizing inductive effect on cations located on the 
P-carbon. Here we report the synthesis of 12,13-difluorofamesyl 
diphosphate (lb) and its effects on AS-catalysis.
Due to the electronic effects of fluoro substituents on 
carbocations described above, incubation of 12,13-difluorofamesyl
This journal is © The Royal Society of Chemistry 2007 Chem. Commun., 2007, 4155-4157 | 4155
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Scheme 2 Synthesis of 12,13-difluorofamesyl diphosphate lb. Reagents and conditions', (i) triethyl phosphonoacetate, NaH, THF, 0 °C, 68%; (ii) DIBAL- 
H, THF, -78 °C, 98%; (iii) 3,4-DHP, CH2Q 2, p-TsOH, 98%; (iv) PPh3, CH3CN, A; (v) LiHMDS, THF, -78 °C, 87%; (vi) PPTS, EtOH, 55 °C, 97%; (vii) 
TPAP, NMO, CH3CN, 82%; (viii) CH3PPh3Br, n-BuLi, THF, 78%; (ix) 9-BBN, THF then 14, PdCljdppf, NaOH, AsPh3, THF, 50 °C, 28%; (x) DIBAL- 
H, THF, -78 °C, 68%; (xi) NEt3, MsCl, -45 °C then LiBr; (xii) (Bu4N)3HP207, CH3CN then DOWEX ion exchange Bu4N+/NH4+,10%.
diphosphate with AS would be expected to generate different 
outcomes for the three cyclisation pathways of Scheme 1. For path 
a, the destabilizing effect of the two fluoro substituents on the 
putative carbocation on C ll should lead to the accumulation of 
the 12,13-difluorofamesyl cation (2 b) and the formation of 12,13- 
difluoro-ff^FHx-famesene (6 b) and 12,13-difluoro-(£)-P-famesene 
(7b) through deprotonation from C4 or C15. For a reaction where 
phosphate departure occurs simultaneously with electron flow 
from the CIO, C ll double bond, 12,13-difluorofamesyl dipho­
sphate would be expected to act as a competitive inhibitor. In 
pathway c, the acidifying effect of the fluoro substituents on the 
protons on C12 and C l3 should allow the reaction to prooeed, 
ultimately generating 12,13-difluoroaristolochene (5b).
12,13-Difluorofamesyl diphosphate (lb) was synthesised from 
bromoketone 8  (Scheme 2) . 1 6  Compound 8  was initially subjected 
to a Homer-Emmons reaction with triethyl phosphonoacetate to 
generate bromoester 9 with good stereoselectivity (E : Z  = 11: l ) . 1 7  
Reduction of the ester with DIBAL-H in THF at -78 °C followed 
by protection of the resulting alcohol with a THP group gave 10b 
in near quantitative yield. This compound was converted to the 
phosphonium bromide salt 11 and then treated with 1,3- 
difluoroacetone in a Wittig reaction to give 12a in 87% yield. 
The THP ether was removed and the alcohol 12b converted to 
the 1,3-diene 13b by successive TPAP oxidation and Wittig 
reaction. A Suzuki-Miyaura coupling with the crotonyl iodide 1418 
resulted in the production of ester 15, which was converted to 
the diphosphate lb by reduction to the alcohol and 
diphosphorylation. 1 9  It is worthy of note here that attempts to 
prepare the ester 15 by the more conventional chain extension 
chemistry of Weiler and Sum2 0  failed since the use of lithium
dimethylcuprate resulted in loss of fluorine atoms, most likely by 
elimination of hydrogen fluoride.
Incubation of lb with purified recombinant AS under the 
standard reaction conditions previously used for the conversion of 
la to aristolochene11 did not lead to any hexane extractable 
products as judged by GC-MS analysis, even after prolonged 
incubation. Since 12,13-difluorofamesyl diphosphate clearly did 
not act as a substrate for AS, the steady-state kinetic parameters of 
purified recombinant AS were measured in the presence of varying 
amounts of lb by incubation with [1-3 H]-FPP and monitoring the 
formation of tritiated, hexane extractable products. 2 1  A double 
reciprocal plot indicated that lb was a reversible competitive 
inhibitor of AS (Fig. 1). The measured K\ of 0.8 ± 0.2 pM was 
comparable to the Michaelis constant for AS catalysis (KM = 
2.3 pM) reported previously, indicating that the fluoro substituents 
do not have a negative effect on the affinity of the enzyme for this 
compound. For comparison, famesyl thiodiphosphate,2 2 ,:j: a 
compound known to act as a potent inhibitor of undecaprenyl 
diphosphate synthase from E. coli and S. aureus, 2 2 - 2 4  was also 
tested and found to also act in a competitive fashion, albeit with 
much reduced affinity (K\ = 10 pM).
The observation that lb acts as an inhibitor of AS suggests that 
the cyclisation of FPP occurs along path b in which famesyl 
diphosphate ionisation is accompanied by electrophilic attack of 
Cl by the CIO, C ll it-bond with inversion of configuration at Cl 
resulting in the formation of germacryl cation. This conclusion is 
different from that reached previously from experiments with site- 
specific mutant AS-F112A, in which Phe 112 was replaced with 
alanine, leading to the production of 36% (E)-P-famesene (7a) and 
53.5% (E^Ej-a-famesene (6 a) in addition to a small amount of
4156 | Chem. Commun., 2007, 4155-4157 This journal is © The Royal Society of Chemistry 2007
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Fig. 1 Double reciprocal plot for inhibition of AS catalysed turnover of 
la by lb at 0 (•), 0.4 pM (A), 0.6 pM (A) and 1 pM (O) of lb.
germacrene A (4a) . 11 The presence of these linear sesquiterpenoids 
suggested that famesyl cation 2 a accumulated during catalysis in 
the mutant enzyme due to the absence of stabilization through 
interaction with the aromatic ring of Phe 112 of germacryl cation 
and the transition state preceding it. The results presented here 
suggest that in addition to stabilizing carbocation 3a through its 
aromatic ring, the presence of Phe 112 (together with other active 
site residues) may also exert a stereoelectronic effect on the 
reaction through its steric bulk by aligning the 7i-orbital of the CIO, 
C ll double bond with the breaking Cl-O  bond of the 
diphosphate group. When the size of this side chain is reduced 
by replacing the benzyl group with the smaller methyl group, this 
alignment may no longer be optimal, thereby preventing the 
immediate quenching of the developing positive charge on Cl and 
leading to the accumulation of famesyl cation (2 a) and the 
production of the linear famesenes 6 a and 7a.
According to this argument, lb should act as a substrate of the 
mutant enzyme AS-F112A since the less hindered rotation around 
the Cl-O bond of lb in the mutant should lead to the formation of
12,13-difluorofamesyl cation (2b) and hence of the difluorinated 
famesenes, 6 b and 7b. One major and two side products with the 
molecular ion peaks of mlz of 240 expected for difluorinated 
sesquiterpenoids were detected in the gas chromatogram of the 
hexane extractable products of incubations of the AS-F112A with 
lb (ESI). While the low activity of AS-F112A even with the 
unfluorinated substrate (la ) 11 allowed for the production of only a 
small amount of fluorinated products and prevented the detailed 
molecular characterization of the products, this experiment 
nevertheless confirmed that AS-F112A could indeed turnover lb. 
This result strongly supported the proposal that AS catalyses the 
breaking of the ester bond in la  and the formation of the cyclic 
germacryl cation (3a), at least in part, by facilitating optimal 
orbital overlap between the C10-C11 and Cl-O bonds in la 
through the templating effect of bulky active site residues such as 
Phe 112.
It appears therefore that the interpretation of results from site- 
specific mutants of terpene cyclases requires some caution, since 
the change of only a single amino acid in their active site can alter 
their templating potential. Such local geometrical changes may be 
inherently difficult to detect since they may not affect the global 
fold of the proteins but nevertheless lead to the synthesis of novel 
products through subtle alterations of the reaction pathway. The 
strong influence on the reactivity exerted by fluoro substituents 
without significantly affecting size and shape may make these 
reagents more suitable than mutagenesis experiments to explore 
the chemistry of terpene synthases. However, only through a 
combination of experimental approaches will the intricate details 
of this masterpiece in combinatorial chemistry be deciphered.
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Aristolochene Synthase-Catalyzed Cyclization of 
2-Fluorofarnesyl-Diphosphate to 2- 
Fluorogermacrene A
David J. Miller, Fanglei Yu, and Rudolf K. Allemann*[a]
The mechanism o f the conversion o f (E,E)-farnesyi diphosphate 
(FPP, la )  to aristolochene (6) catalyzed by aristolochene synthase 
from Penicillium roqueforti has been proposed to proceed 
through toe neutral intermediate germacrene A (4a). However, 
much o f the experimental evidence is also in agreement with a 
mechanism in which germacrene A is not an intermediate in the 
predominant mechanism that leads to the formation o f aristolo­
chene, but rather an off-pathway product that is formed in a 
side reaction. Hence, to  elucidate the mechanism o f FPP cyclisa­
tion the substrate analogue 2-fluoroFPP (1b) was synthesized, 
and upon incubation with aristolochene synthase m is converted 
to a single pentane extractable product according to GC-MS
analysis. On the basis o f NMR analyses this product was identi­
fied as 2-fluorogermacrene A (4 b). Variable temperature 'H NMR 
spectroscopy indicated the existence o f two conformers o f 4 b 
that were in slow exchange a t -6 0 °C  while a t 90°C the two iso­
mers gave rise to averaged NMR signals. In the major isomer 
(-75%) the methyl groups on C3 and C7 were m ost likely in the 
down-down orientation as had been observed for other (E,E)-ger- 
macranes. This work suggests that after an initial concerted cycli­
sation o f FPP to germacryl cation deprotonation leads to the for­
mation o f germacrene A  and provides compelling evidence that 
germacrene A is indeed an on-pathway product o f catalysis by 
aristolochene synthase.
is fOPP 13
FPP 1a X * H
1b X = F
6, (+)-Aristoiochene 4a (-)-Germacrene A 
4bX = F
7a-b
Scheme 1. Reaction schemes for the AS catalysed conversion of FPP (1 a) to aristolochene (6) and of 2F-FPP 
(1 b) to 2-fluorogermacrene A (4 b).
Introduction
Terpene synthases are a fascinat­
ing class of enzymes due to their 
almost unique ability to direct the 
formation and rearrangement of 
carbocationic species.111 Sesquiter­
pene synthases, many of which 
share a common mainly a-helical 
fold, transform the shared sub­
strate, farnesyl diphosphate (FPP,
1 a) with often exquisite regio- 
and stereochemical control into 
more than three hundred different 
hydrocarbon scaffolds that form 
the structural basis of the large 
family of sesquiterpenoids with 
many tens of thousands of complex natural products.121
Aristolochene synthase (AS) from Penicillium roqueforti cata­
lyses the Mg2+-dependent conversion of 1 a to (-h)-aristolo- 
chene (6)—the biochemical precursor of several fungal toxins, 
which include the potentially lethal PR toxin (Scheme I).131 
Based on mechanistic studies with labelled substrates and 
through the analysis of the reaction products obtained with 
enzyme mutants a reaction mechanism was proposed in which 
the initial cleavage of the alkyl diphosphate bond leads to far­
nesyl cation (2 a) prior to cyclisation. Attack by the C10=C11 
double bond to produce germacryl cation (3 a) followed by 
proton loss from C12 has been proposed to lead to germa­
crene A (4a). This uncharged intermediate was then postulated 
to undergo protonation of the C6=C7 double bond and a fur­
ther cyclisation to form the bicydic eudesmane cation (5). Suc­
cessive 1,2-hydride shift and methyl migration followed by loss 
of Hji on C8 results in the generation of (-t-)-aristolochene (6).W1
The intermediacy of germacrene A is tentatively supported 
by the observation that 4a is a minor by product of AS cataly­
sis.151 In addition, results obtained with some AS mutants can 
be interpreted to support a mechanism that involves germa-
[a] Dr. D. J. Miller, F. Yu, Prof. Dr. R. K. Allemann
School o f Chemistry, Main Building, Cardiff University 
Park Place, Cardiff, CF10 3AT (UK)
Fax: (+  41) 29-2087-4030 
E-mail: allemannrk@cf.ac.uk
Supporting information for this article is available on the WWW under 
http-J/www.chembiochem.org or from the author.
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Scheme 2.
crene A as an intermediate. Replacement of Trp334 with ala­
nine, which based on the 2.5 A X-ray crystal structure of apo- 
AS[61 has been postulated to be involved in the stabilization of 
the positive charge in eudesmane cation, led to the exclusive 
production of germacrene A,m while replacement of Tyr92 with 
phenylalanine led to increased production of 4a. While these 
observations are largely in agreement with the above reaction 
mechanism, other experiments suggest that germacrene A 
might not be an intermediate in the predominant mechanism 
that leads to the formation of aristolochene, but is rather an 
off-pathway product that is formed in a side reac­
tion. In particular, 4a  does not appear to act as a 
substrate of AS, as would be expected if germacre­
ne A was an intermediate in the predominant mech­
anism that leads to the formation of aristolochene.®
In addition, the active site acid that protonates ger­
macrene A has so far been difficult to identify, even 
though several candidates have been proposed, 
which include a proton shuttle from the solvent to 
Tyr92 in the active site by way of Arg200, Asp203 
and Lys206, an unprecedented active site oxonium 
ion,181 or the pyrophosphate group.®
Rather than analyzing the effects of structural 
changes of the enzyme on product distribution, sub­
strate analogues can be used to study the reaction 
mechanism. The turnover of the 6,7-dihydro ana­
logue of FPP by AS generates dihydro germacrene A.[101 How­
ever, X-ray crystallographic studies with sesquiterpene cyclases 
have suggested that the conformation of FPP in the active site 
is central to the selectivity of the cyclisation reaction. Hence, 
the reduction of the C6=C7 double bond of FPP might change 
the reaction mechanism by altering the conformation of both 
substrate and intermediate. The aim of this work was to ad­
dress the intermediacy of germacrene A by intercepting the 
AS-catalysed ring closure to eudesmane cation through the 
use of a suitable substrate analogue, and to identify the struc­
ture of the putative germacrene A analogue. Fluorinated sub­
strates have proved useful in the elucidation of mechanistic 
details of terpenoid biosynthesis due to the special properties 
of fluorine substituents which do not greatly affect binding af­
finities by altering size and shape. At the same time fluorine 
substituents exert a strong influence on the electronic environ­
ment at the site of replacement in that they stabilize cations 
on the a  carbon by ji donation, but exert a destabilizing induc­
tive effect on cations located on the (3 carbon.
We report here the synthesis of 2-fluorofarnesyl diphosphate 
(1 b) and the characterization of the reaction products ob­
tained during AS catalysis. The results provide strong support 
for a reaction mechanism in which an initial cyclisation of FPP 
to germacryl cation is followed by proton loss from C12 to 
generate 4a.[4]
Results and Discussion
We considered that the introduction of a fluorine atom on C2 
of FPP should lead to a destabilisation of eudesmane cation
germacrene A (4 b). We have therefore studied the AS-cata- 
lyzed reaction of 2-fluorofarnesyldiphosphate (1 b), which was 
prepared by using a modification of a published procedure.1111 
Geranyl acetone was treated with triethyl 2-fluoro-2-phospho- 
noacetate and sodium hydride, followed by DIBAL-H reduction 
of the resulting ester mixture to give 9 and 10 in a ratio of ap­
proximately 1:1 (Scheme 2). Bromination of 10 followed by di­
phosphorylation1121 and purification by reversed-phase HPLC 
gave 1 b in 36% yield over these two steps.
(i)
EtOjC o
) ~ Ff~oet 
OEt .NaH
(i) DIBAL-H
O f W "  (i) LiBr, NEt, MsCI 
(BMBu.N^PA
1b (27%)
Synthesis of 2-fluorofarnesyl-diphosphate (1 b)
9(46%)
10 (49%)
Enzymatic cyclisation of 2-fluorofarnesyl diphosphate
Preparative scale incubation of 1 b with recombinant AS 
(pH 7.5, 25 °C, 48 h) followed by GC mass spectral analysis of 
the pentane-extractable material revealed a single product 
(Figure 1), which showed the molecular mass expected for a 
monofluorinated sesquiterpenoid (m/z 222; Figure 2).
The ]H NMR spectroscopic analysis of compound 4b  at 
room temperature provided a rather poorly resolved spectrum, 
which was similar to the unassigned literature reference spec­
trum of germacrene A.[13] The 19F NMR spectrum of 4 b indicat­
ed two resonances (<5F =  -88.8 and -90.9  ppm) at room tem­
perature. Because of the known flexibility of cyclodecadienes a 
variable temperature NMR study was carried out in [DJtoluene 
between -8 0  and 90 °C, at 10°C intervals. The compound 
proved to be stable over the whole temperature range as evi­
denced by the reversibility of the temperature-dependent 
spectral changes. Significant line sharpening was observed 
both on lowering and increasing the temperature from 25 °C 
(Figure 3). Compound 4 b existed as two resolvable conformers 
at temperatures below 0°C, while at elevated temperatures 
the position of the sharp resonance signals indicated a fast 
equilibrium between the two conformers, which resulted in a 
weighted average of the NMR-resonances. A coalescence tem­
perature of approximately 30 °C was observed.
Variable temperature NMR spectroscopic analysis of 4 b
The COSY and HSQC NMR spectra were obtained both at -6 0  
and 90°C; this made it possible to assign all the ]H resonances 
of 4 b (Table 1). Together with the room temperature HMBC 
during AS catalysis, and hence to the accumulation of 2-fluoro- spectrum these data also allowed us to assign the 13C NMR
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Figure 1. Analysis of the temperature-induced reaction of the pentane ex­
tractable products of 2-fluoroFPP (1 b) utilisation by AS. A) Total ion chroma­
togram (T1Q from the GC analysis of the compound produced by AS from 
1 b at an injection port temperature of 50 °C. B) TIC from the GC analysis of 
the same compound at an injection port temperature of 250 °C. C) TIC from 
the GC analysis of the same compound at an injector port temperature of 
300 °C.
spectrum of this compound. Based on these assignments the 
spectrum of 4 b at room temperature could also be assigned. 
The appearance of signals for the olefinic protons on C12 (<5H =  
4.68 and 4.73 ppm at 25 °C)# which resolved into an AB system 
at low temperature, together with the disappearance of the 
signals for the Cl 2 methyl group and the Cl methylene pro­
tons at 4.42 ppm in FPP are consistent with bond formation 
between Cl and CIO. The double bond was assigned to be be­
tween Cl2 and C11 as opposed to C l3 and Cll based on the 
known stereochemistry of germacrene A formation by AS from 
FPP.141 While all ’H NMR signals of 4b  were dependent on the 
temperature, the existence of two conformers was most obvi-
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Figure 2. Mass spectral analysis of the two isomers produced by thermal re­
arrangement in the GC injector. A) E r  Mass spectrum of the material eluted 
at 26.24 min, which is the presumed 2-fluoro-germacrene A derivative 4b ;
B) E r  mass spectrum of the material eluted at 23.72 min, which is the pre­
sumed p-elemene analogue 7b.
ous from the resonances for the protons on C4, C6 and Cl 4 
(Figure 3). For instance, H6 gave rise to two well-resolved sig­
nals at 5.05 and 5.36 ppm at -6 0  °C, while at high temperature 
only a poorly resolved double doublet was observed at 
5.18 ppm. At low temperature the splitting patterns for the re­
spective C6 protons were different in the two conformers; in 
the predominant conformer a relatively broad doublet was ob­
served while in the minor conformer coupling to both protons 
on C5 was evident. Similarly, the patterns of the H4 resonances 
changed with temperature. One of the two protons leads to a 
complex multiplet at 90 °C; this proton was well resolved at 
low temperature with clear coupling to the geminal proton, 
the vicinal protons on C5 and the fluoro substituent.
Conformational isomerism of the germacrene family of natu­
ral products, in particular the (£,f)-germacranes, has been stud­
ied previously both by NMR spectroscopy and computational­
ly.1141 The ten-membered ring can adopt four distinct conforma­
tions with up-up, down-down (Figure 3), up-down and 
down-up orientations of the methyl groups on C3 and C7.[14]
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Figure 3. The 'H NMR spectra (500 MHz) of 4 b  at —60, 25 and 90°C with assignments shown. Insets show the temperature dependent change in the resonan­
ces for H6, one of the H4 protons and CHj-14. Clearly two conformational isomers exist in a ratio of approximate 3:1 at the lower temperatures (integrals not 
shown), and the signals for the two coalesce at approximately 30 °C. The conformation of the down-down isomer of 4 b is also shown.
Table 1. ’H NMR spectra of 4 b at -60 , 25 and 90°CW
—60 °C major -6 0  °C minor 25 °C 90 °C
CH2-1 1.90-2.07 (m) and 1.90-2.07 (m) and 1.99-2.14 (m) and 1.88-2.02 (m) and
2.33-2.44 (m) 2.33-2.44 (m) 235-2.45 (m) 2.42 CH2-1 (ddd, 2=  3.5,143, 323 Hz)
CHj-4 1.51-1.58 (m) 131-1.58 (m) 133-138 (m) and 1.52-1.60 (m) and
2.95 (ddt, 2=2, 6,12.5 Hz) 3.03 (brq, 2 =  10 Hz) 2.83-3.02 (brm) 2.83-2.90 (dq, 2=  13, 9.5 Hz)
3.00-3.06 (m)
CHj-5 2.02-2.14 (m) and 2.02-2.14 (m) and 2.11-114 (m) and 2.12-2.17 (m) and
2.25 (ddt, 2=1.5, 5.5, 12 Hz) 235 (ddt, 2=  13, 53 ,12  Hz) 232-230 (brm) 234-2.26 (m)
CH-6 536 (brd, 2=12.5 Hz) 5.05 (t, 2= 8  Hz) 5.02-5.10 (brs) and 5.18 (m)
535-5.32 (brm)
CHj-8 2.02-2.14 (m) 2.02-2.14 (m) 111-114 (m) 2.12-2.17 (m)
CH2-9 131-1.58 (m) and 131-1.58 (m) and 1.53-138 (m) and 132-1.60 (m) and
1.90-2.07 (m) 1.90-2.07 (m) 1.99-2.14 (m) 1.88-2.02 (m)
CH-10 2.02-2.14 (m) 2.02-2.14 (m) 111-2.14 (m) 2.12-2.17 (m)
CHj-12 pseudo AB system pseudo AB system 4.68 (brs) and 4.64 (s) and 4.70 (s)
4.70, 4.73, 4.76, 4.78 4.70, 4.73, 4.76, 4.78 4.73 (s)
CHj-13 1.67 (s) 1.79 (s) 1.62 (s) 1.62 (s)
CH3-14 1.60 (s) 1.62 (s) 1.67 (br) 1.66 (s)
CHj-15 1.26 (d, 2„f =  3 Hz) 138 (d, 2^ =  3 Hz) 132 (d, 2^ =  3 Hz) 136 (d, 2Hf =  23 Hz)
[a] All resonances are <5H (500 MHz, [DJtoluene) in ppm. Entries are chemical-shift range followed by multiplicity in parentheses and coupling constants. 
Some proton resonances overlapped; no distinction was made in the chemical-shift range quoted for these protons.
These conformations are interconvertible by rotation of each 
of the double bonds through the ring and inversion of the C9- 
C10 unit, the conformation of which is largely determined by 
the exocyclic subsistent on C10, which favours a pseudo-equa­
torial orientation. For (-f)-hedycaryol ((10/?)-11-hydroxy-germa- 
crene A) the up-up configuration predominated at all temper­
atures according to NMR studies (75% at -30°C).t15] It is rea­
sonable to suggest that the down-down orientation of the
methyl groups is the dominant orientation in 4 b since AS pro­
duces (-)-germacrene A;[161 hence, the isopropylidene group 
will predominantly adopt the pseudoequatorial configuration. 
Analysis of the relative intensities of the resonances for the 
proton on C6 in the — 60 °C ’H NMR spectrum indicates that 
the ratio between the major and minor conformer of 4 b was 
3.22:1; this is similar to what had been observed for (+)-hedy- 
caryol.
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Thermal rearrangement of 4 b
Germacrene A is known to undergo a Cope rearrangement to 
generate p-elemene (7a).[131 It was partly because of the tem­
perature induced Cope rearrangement in GC-MS experiments 
that 4a  was first identified as a minor product of FPP turnover 
by AS.[5] To further characterize compound 4 b, GC-MS analysis 
was performed with varying injector temperatures but under 
otherwise identical conditions (Figure 1). Germacrene A is 
known to undergo significant Cope rearrangement when the 
injector temperature is set to 200°C.[S1 In contrast, thermal rear­
rangement of 4 b was not observed at this temperature. How­
ever, at 250 °C a small amount of rearranged product was ob­
served and at 300 °C thermal rearrangement of 4 b was domi­
nant (Figure 1); furthermore, high-resolution mass spectrome­
try indicated that the two compounds had an identical ele­
mental composition (C^H^F). As had been observed for 4 b 
the mass to charge ratio for the parent ion of 7 b was 222 
(Figure 2). The fragmentation patterns of both compounds 
were indicative of a loss of CH3 (m /z -15) and HF (m/z -20) as 
well as loss of both CH3 and HF (m/z -35). The parent molecu­
lar ion of 4 b was more intense than that of the presumed 
fluoro-(3-elemene (7b); this was most likely as a consequence 
of facilitated loss of hydrogen fluoride from 7 b to generate a 
conjugated diene compared to elimination of HF from 4 b.
The presence of the fluoro-substituent in 4 b appears to 
slow the Cope rearrangement compared to 4a. The effects of 
fluorine substituents on six electron electrocylic processes is 
unclear since steric and electronic effects often compete, 
which leads to unpredictable effects on the reaction kinetics/171 
hence a rationalization of the reduced reactivity of 4b  is diffi­
cult.
Conclusions
In summary, the work described here shows that 2-fluorofarne- 
syl-diphosphate (1 b) is a substrate of aristolochene synthase 
and is converted exclusively to 2-fluorogermacrene A (4b). This 
result provides strong support that germacrene A is generated 
as an on-path reaction product of the conversion of 1 a to aris­
tolochene (6). If germacrene A was produced in a minor, but 
separate pathway by AS, more than one product would be ex­
pected from the incubation with 2-fluoro-FPP. The observation 
that germacrene A does not act as a substrate for AS is most 
likely the consequence of its very poor solubility in aqueous 
solvents.
The effectiveness of the fluoro analogue of germacrene A in 
blocking the second cyclisation step is most likely a conse­
quence of the inductive effect of this highly electronegative 
group on the C2=C3 double bond and the destabilising effect 
on the positive charge on C3 in eudesmane cation. This effect 
leads to an increase in the height of the energy barrier of the 
step following 4 b formation. It has been shown previously 
that vinyl-fluoro groups reduce the rate of solvolysis of fluoro 
terpenoid methanesulfonates/18-201 Interestingly, the 2-fluoro 
substituent of FPP did not prevent the first cyclisation step 
that leads to 2-fluorogermacrene A in the present case despite
evidence from mutational studies that this process occurs in a 
stepwise fashion through farnesyl cation/21-231 Either the allylic 
stabilisation in farnesyl cation is sufficient to push the reaction 
to the decadiene-ring system or the results obtained with the 
mutants do not apply to the wild-type enzyme and the cyclisa­
tion of FPP to germacrene A is indeed a concerted process in 
which cyclisation and diphosphate expulsion occur concomi­
tantly. This would be in agreement with the observation that 
cyclisation of FPP occurs with inversion of configuration on 
C1/241
Clearly, vinyl fluoro analogues of farnesyldiphosphate are 
powerful reagents for studying the mechanism of enzyme-cat­
alysed cyclisations of sesquiterpenoids, which are reactions 
that are inherently difficult to study spectrometrically. A similar 
approach has been used to study the taxadiene synthase-cata­
lysed reaction of geranyl-geranyl-diphosphate.[2S1 Chemical in­
terception could provide a unique opportunity to interrupt 
these multistep polyene cylisation reactions to decipher the 
mechanistic principles used by terpene cyclases to control the 
chemistry of carbocationic processes with exquisite specificity.
Experimental Section
Expression and purification of AS in E. coli: AS was produced in 
E. coli BL21 (DE3) cells that harboured a cDNA for AS under the con­
trol of the T7 promoter. Cells were grown at 37 °C in Luria-Bertani 
(LB) medium with ampicillin (0.3 mM) until they reached an AM0 of 
0.5. They were induced with isopropyl-{3-D-1-thiogalactopyranoside 
(0.5 mM ), incubated for a further 3 h and harvested by centrifuga­
tion at 8000g for 10 min. Protein was then extracted from the 
inclusion bodies and purified by following the protocol described 
previously.151 The AS sample was pure as judged by SDS gel electro­
phoresis.
(2Z,6£)-2-Fluoro-3,7,11 -trimethyldodeca-2,6,10-trien-1 -ol (10)
and (2£,6£)-2-fluoro-3,7,11 -trimethyldodeca-2,6,10-trien-l-ol (9): 
Triethyl 2-fluoro-2-phosphonoacetate (0.84 cm3, 4.13 mmol) and a 
solution of geranyl acetone (1.02 cm3, 4.54 mmol) in anhydrous 
THF (5 cm3) were sequentially added dropwise to a stirred suspen­
sion of sodium hydride (60% dispersion in mineral oil, 0.10 g, 4.13 
mol) in anhydrous THF (10 cm3), at 0°C under an N2 atmosphere. 
The complete reaction mixture was stirred for 14 h under N2. Water 
(20 cm3) and diethyl ether (20 cm3) were added and the organic 
layer was separated. The aqueous layer was extracted with diethyl 
ether (2x15 cm3). The combined ethereal extracts were washed 
with water (2x10 cm3) and saturated NaCI solution (1x10 cm3), 
dried over anhydrous MgSO* filtered and then concentrated under 
reduced pressure. The resulting ester was a 1:1 mixture of E and 
Z isomers and was reduced without further purification. Diisobu- 
tylaluminum hydride (1.0 m solution in hexanes, 10.33 cm3, 
10.33 mmol) was added dropwise to a stirred solution of the crude 
ester in anhydrous THF (30 cm3) at -7 8  °C, (over 3 min). The reac­
tion mixture was allowed to stir at -78  °C for 1 h, then 0°C for 1 h 
and was then quenched with saturated sodium potassium tartrate 
solution (30 cm3). The resulting mixture was then extracted with di­
ethyl ether (3x20 cm3). The combined organic extracts were dried 
over anhydrous Mg SO* filtered and then concentrated under re­
duced pressure. Purification of the residue by flash-column chro­
matography on silica gel with hexane and ethyl acetate (4:1) as 
eluent gave the Z isomer (0.48 g, 49%) as a colourless oil followed 
by the E isomer (0.46 g, 46%) as a colourless oil.
ChemBioChem 2007, 8, 1819- 1825 © 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.chembiochem.org 1823
C H E M B I O C H E M R. K. Allemann et al.
The Z isomer (10): /?f 0.28 (4:1 hexane-ethyl acetate); HRMS (El+, 
M^ ): found 240.1890, C^H^OF requires 240.1889; (thin film): 
3358.1, 2920.4, 1703.7, 1444.7, 1380.2, 1266.9, 1148.9, 1105.3,
1012.5 cm-’; <5H (500 MHz, C2HCIj): 1.62 (6H, s, 2xCHJ, 1.70 (3H, d, 
= 1.0, C/fj), 1.71 (3 H, d, 4Jhf =  3.48, CH3C=CF), 1.79 (brs, 1 H; 
OH), 1.99-2.14 (8H, m, 2xCH2CH2), 4.19 (2H, dd, VHF = 23.0, 3JHH =
6.0, C/f2OH), 5.09 (2H, m, 2xC=CH); <3C (125 MHz, C2HCIj): 13.48 (d, 
3Jct =  9.0, CH3C=CF), 15.99 (CH3), 17.67 (CHj), 25.67 (CH3), 26.36 (d, 
AJCF =  4.0, CH2CH2C=CF), 26.62 (CH2), 31.71 (d, 3Jcf =  5.00, CH2CH2C= 
CF), 39.67 (CH2), 57.67 (d, l/c: =  31.0, C=CFCH2OH), 115.74 (d, 2JCf =  
14, CH3C=CFCH2), 123.00 (C=CH), 124.14 (C=CH), 131.52 (C^ CH), 
136.52 (C=CH), 152.57 (d, ’^  =  242.50, CH3C=CF); df (283 MHz,
C2HC\J: -119.5 (t, 3Jhf =  23.0); m/z (El+) 240.2 (2%, [MD, 69.1
(100%), 81.1 (20%).
The E isomer (9): Rf 020 (4:1 hexane-ethyl acetate); HRMS (El+ M+): 
found 240.1897, CuH^OF requires 240.1889; (thin film):
3349.0, 2931.5, 2361.3, 1703.1, 1667.2, 1450.6, 1380.5, 1270.8,
1238.0, 1158.9, 1105.5, 1012.8, 910.9 cm-1; dH (500 MHz, C^CIj):
1.62 (6H, s, 2xCHj), 1.70 (3H, d, 4JHF = 2.5, CH3C=CF), 1.70 (3H, s, 
CHj), 1.82 (1 H, b, OH), 1.98-2.15 (8H, m, 2xCH2CH2), 4.23 (2H, dd, 
3JHf =  22.5, 3Jm =  5.5, CH2OH), 5.11 (2H, m, 2xC=CH); <5C (125 MHz, 
C2HC\J: 15.37 (d, 3JC =  5.0, CH3C=CF), 16.0 (CHj), 17.7 (CHj), 25.7 
(CHj), 25.9 (d, aJcf — 1 -25, CH2CH2C=CF), 26.7 (CH2), 29.8 (d, %  =  
625, CH2CH2C=CF), 39.7 (CH2), 58.0 (d, 2JCf = 32.5, CH2OH), 116.0 (d, 
2Jcf =  16.25, CH3CCFCH2), 123.5 (C=CH), 124.3 (C=CH), 131.4 (C=CH), 
135.7 (C=CH), 151.79 (d, ^  = 240, CH3C=CF); 6r (283 MHz, C^ HCI,): 
121.13 (t, 37hf =  22.5); m/z (El+) 240.2 (4%, [M]^ ), 69.1 (100%), 81.1 
(35%).
Tris-ammonium-(2Z/6£)-2-fluoro-3,7,11 -trimethyldodeca-2,6,10- 
trien-1-yl diphosphate (1b): A stirred solution of alcohol 10 
(022 g, 0.92 mmol) and triethylamine (0.26 cm3, 1.84 mmol) in an­
hydrous THF (10 cm3) was cooled to —45°C; MsCI (0.09 cm3, 
120 mmol) was then added. The resulting milky mixture was 
stirred at -45  °C for 45 min, then a solution of LiBr (0.35 g, 
3.68 mmol) in THF (5 cm3) was added at -45  °C, by using a needle. 
The suspension was allowed to warm to 0°C and stirred for 1 h, 
after which time the reaction was judged complete by TLC analy­
sis. Cold water (10 cm3) and hexane (10 cm3) were added. The two 
layers were separated, and the aqueous layer was extracted with 
hexane (2x10 cm3). The pooled organic layers were washed with 
saturated NaHC03 solution (10 cm3) and saturated NaCI solution 
(10 cm3), and then dried over anhydrous NaS04 and filtered. Con­
centration of the solvent under reduced pressure gave the re­
quired bromide as a light yellow oil that was used without further 
purification. Freshly recrystallized tris(tetra-n-butylammonium) hy­
drogen diphosphate (1.80 g, 2.00 mmol), which was prepared by 
the method of Poulter, was added to a stirred solution of the bro­
mide in anhydrous acetonitrile (10 cm3) under N2.t121 The complete 
reaction mixture was stirred for 2 h. Solvent was then removed 
under reduced pressure and the resulting residue was dissolved in 
1:49 (v/v) isopropyl alcohol and 25 mM ammonium hydrogencar- 
bonate solution (2 cm3; ion-exchange buffer). The pale yellow solu­
tion was slowly passed through a column that contained 30 equiv 
of DOWEX 50W-X8 (100-200 mesh) cation-exchange resin that had 
been pre-equilibrated with two-column volumes of ion-exchange 
buffer. The column was eluted with two-column volumes of ion-ex­
change buffer at a flow rate of one-column volume per 15 min. 
The clear, light yellow eluent was freeze dried to yield a fluffy 
yellow solid, which was purified by reverse phase HPLC (150x 
21.2 mm Phenomenex LunaC-18 column, eluted under isocratic 
conditions with 10% B for 20 min, a linear gradient to 60% B over 
25 min, then a linear gradient to 100% B over 5 min and finally 
with 100% B for 10 min; solvent B: CH3CN; solvent A: 25 mM
NH4HC03 in water, flow rate 5.0 cm3 min-1, detection at 220 nm) to 
give title compound as a white solid (0.15 g, 36%); HPLC fR 
36.99 min; purity 96.33% by analytical HPLC; HRMS (El- , [/W-H]-): 
found 399.1135, C,5H260 7FP2 requires 399.1143; (KBr disc): 
2963.4, 1701.8, 1494.4, 1455.4, 1411.8, 1204.0, 1164.6, 1122.1, 
1091.9, 1034.7, 908.7, 825.9, 723.3, 595.4, 552.7 cm"1; <5H (500 MHz, 
2H20): 1.47 (3 H, s, CH^ , 1.48 (3H, s, CH3), 1.54 (3H, s, CH3), 1.59 
(3H, d, 4-/hf =  2.5, CH3C=CF), 1.86-2.01 (8H, m, 2CH2CH2), 4.42 (2H, 
dd, 3Jhf =  24.0,3JHP =  6.0, C=CFCH2OP), 5.02 (1 H, t, 3Jm =  7.0, C=CH), 
5.06 (1 H, m, C=CH); <3C (125 MHz, 2H20): 4.82 (d, ^  =  5.0, CH3C= 
CF), 15.33 (CHJ, 17.06 (CHj), 24.98 (CH,), 25.33 (CH2), 26.04 (CH2), 
29.38 (d, 3Jcf — 6.0, CH2CH2C=CF), 39.04 (CH2), 60.54 (dd, l/CF = 31.25, 
2JC? =  5.00, C=CFCH2OP), 119.33 (d, ^  =  14.0, CH3C=CFCH2), 123.92 
(C=CH), 124.44 (C=CH), 132.82 (C=CH), 136.62 (C=CH), 149.25 (dd, 
'Jcf — 237.5, %>=9.0, CH3C=CFCH2OP); df (283 MHz, 2H20): -120.23 
(t, % r =  24.0); dP (121 MHz, 2H20): -6.29 (d, l/pp =  21.0), 10.50 (d, 
3J p p =  1.0); MS (ES“) m /z 399.2 (15%, [M-H^D, 74.9 (100%,), 198.8 
(40%).
Incubation of 2-fluoro farnesyl pyrophosphate (1 b) with AS: Ar-
istolochene synthase solution (3.60 cm3, 638 pM) was diluted with 
buffer consisting of 20 mM tris-HCI, 5 mM p-mercaptoethanol, 
5 mM MgCI2 and 15% (v/v) glycerol, pH 7.5 (to 33.5 cm3). The assay 
solution was gently mixed as 1 b (30.0 mg, 0.067 mmol) and pen- 
tane (2 cm3) were added sequentially. After incubation for 48 h at 
25 °C, the olefin products were extracted with pentane (3x80 cm3). 
The pooled pentane extracts were concentrated under a nitrogen 
stream until about 5 cm3 of solvent remained. This solution was 
passed through a short pad of silica gel overlayed with anhydrous 
MgS04. The pentane was concentrated under reduced pressure to 
yield a single product as judged by GC-MS analysis (4.0 mg, 27%); 
GC-MS fR 26.24 min. GC-MS was performed by using a Hewlett 
Packard 6890 GC fitted with a J&W scientific DB-5MS column 
(30 mx0.25 mm internal diameter) and a Micromass GCT Premiere 
that detected in the range m /z 50-800 in El+ mode by scanning 
once a second with a scan time of 0.9 s. Injections were performed 
in split mode (split ratio 5:1) at 50 °C. Chromatograms were begun 
with an oven temperature of 50°C, this was raised at 4 0Cmin_1 for 
25 min (up to 150°C) and then at 20oCmin_1 for 5 min (250°C 
final temperature).
HRMS (El+): found 222.1785, C^H^F requires 222.1784. Compound 
4b displayed conformational isomerism which complicated the in­
terpretation of its NMR spectra. Consequently, variable temperature 
NMR experiments were performed. The ^  NMR data are reported 
in Table 1. The 13C NMR spectrum could not be observed directly 
due to the small quantity of material isolated and reduction of line 
intensity due to the conformational isomerism, but could be indi­
rectly observed and interpreted through the cross peaks observed 
in the various 2D spectra. <5C (125 MHz, [DJtoluene, 25 °C): 14.7 (C- 
14), 19.5 (C-13 and C-15), 25.1 (C-5), 27.5 (C-4), 33.3 (C-9), 33.8 (C- 
8), 34.1 (C-1), 45.4 (C-10), 108.9 (C-12), 112.0 (C-3), 128.2 (C-7), 137.1 
(C-6), 149.6 (C-11), 154.5, 156.7 (d, C-2); df (283 MHz, [DJtoluene, 
-60°C) -89.2 (major conformer) and -91.8 (minor); <5F (283 MHz, 
[DJtoluene, 25 °C) —88.8 (major conformer) and —91.3 (minor); 
m /z (ED 222.2 (12%, [Afl+), 207.2 (19%, [M-CHJ+), 202.2 (10%, 
[M—HFD, 187.2 (18%, [M-HF-CH3D ,  179.1 (5%), 165.1 (11%),
159.1 (18%), 145.1 (22%), 131.0 (20%), 121.1 (21%), 107.1 (29%),
93.1 (50%), 79.1 (48%), 68.1 (100%), 65.0 (21 %), 53.0 (50%).
Thermal rearrangement of 4b: The pentane extractable products 
obtained from incubation of 1 b with AS were diluted to approxi­
mately 1 mgmL"1 in hexane and 2 mm3 of this solution was inject­
ed onto the GC-MS column by using the conditions described 
above, except the injector temperature was varied from 50 to
18 2 4  www.chembiochem.org © 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim ChemBioChem 2007, 8, 1819- 1825
Aristolochene Synthase-Catalyzed Reaction of 2F-FPP FULL PAPERS
300 °C in 50 °C steps for each run. The peak at fR 26.24 min re­
mained unchanged. At temperatures 250-300 °C a second peak ap­
peared with tR 23.72 min (Figure 1); HRMS (El+): found 222.1792, 
C15H23F requires 222.1784; m/z (ED 222.2 (2%, [M]+), 207.2 (5%, 
[M-CHjD, 202.2 (10%, [M—HF]+), 187.2 (50%, [M-HF-CHjD,
173.1 (10%), 159.1 (38%), 145.1 (60%), 133.1 (25%), 131.1 (40%),
119.1 (98%), 105.1 (60%), 91.1 (100%), 77.0 (55%), 67.1 (50%), 53.0 
(35%).
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Competitive inhibition of aristolochene synthase by phenyl-substituted 
farnesyl diphosphates: evidence of active site plasticityf
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Analogues of farnesyl diphosphate (FPP, 1) containing phenyl substituents in place of methyl groups 
have been prepared in syntheses that feature use of a Suzuki-Miyaura reaction as a key step. These 
analogues were found not to act as substrates of the sesquiterpene cyclase aristolochene synthase from 
Penicillium roqueforti (AS). However, they were potent competitive inhibitors of AS with A",-values 
ranging from 0.8 to 1.2 pM. These results indicate that the diphosphate group contributes the largest 
part to the binding of the substrate to AS and that the active sites of terpene synthases are sufficiently 
flexible to accommodate even substrate analogues with large substituents suggesting a potential way for 
the generation of non-natural terpenoids. Molecular mechanics simulations of the enzyme bound 
inhibitors suggested that small changes in orientations of active site residues and subtle alterations of 
the conformation of the backbones of the inhibitors are sufficient to accommodate the 
phenyl-famesyl-diphosphates.
Introduction
Terpenoids are the largest group of natural products with 
immense diversity in their structure and function. 1 There has 
been significant interest in terpenoids as antifungal, antibacterial 
and anticancer agents for the treatment of human disease with 
multibillion-dollar sales worldwide. Despite their enormous struc-
School o f Chemistry, Main Building, Cardiff University, Park Place, Cardiff, 
CF10 3AT, UK. E-mail: allemannrk@cardiff.ac.uk; Fax: +44 2920874030 
t Electronic supplementary information (ESI) available: General experi­
mental procedures and protocols for diphosphorylation of target alcohols. 
Enzyme preparation, purification and kinetic characterisation of inhibitors 
as well as plots of [/] versus apparent K M for FPP turnover by AS in the 
presence of 19, 29, and 36. See DOI: 10.1039/b713301b
tural variety, all terpenes are derived from simple linear precursors 
such as geranyl diphosphate (GPP), farnesyl diphosphate (FPP), 
and geranyl geranyl diphosphate (GGPP). Cyclisation of GPP to 
monoterpenes, FPP to sesquiterpenes and GGPP to diterpenes is 
accomplished by terpene synthases. These enzymes, many of which 
share the mainly a-helical class I terpene fold, serve as high fidelity 
templates that subtly channel conformation and stereochemistry 
during the cyclisation reactions and are key to the generation of the 
wide diversity in structure and stereochemistry found in terpenoids 
(Fig. 1). They bind their respective substrates together with the 
obligatory Mg2+-cofactor, catalyse the loss of the diphosphate 
group and chaperone the reaction intermediates along complex 
reaction pathways; often with exquisite specificity. Terpene syn­
thases catalyse highly regio- and stereospecific cyclisations, hydride
OPjOe1 r HO'"
(+)-artstok>chene 2
parthenolidc 7 O
Fig. 1 Structure of FPP (1) and some examples of the complexity of natural products derived from it. The parent sesquiterpenes such as 2, 4, 6 and 8 
may be further transformed by downstream metabolic processes into a diverse set of sesquiterpenoids such as PR toxin (3), artemisinin (5), parthenolide 
(7), and gossypol (9).
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and methyl transfers as well as deprotonation reactions while at 
the same time excluding solvent from the active site to prevent 
premature quenching by water of the extremely reactive cationic 
reaction intermediates. The majority of the characterised terpene 
synthases form only one or a few products; however, there are some 
enzymes that form a variety of products from a single substrate. 
The 5-selinene and y-humulene synathases from Abies grcutdis (the 
grand fir) produce 34 and 52 sesquiterpenes, respectively. 2 ,3
Clearly the exact arrangement of the amino acid residues in 
the active site of individual terpene cyclases within a common 
protein fold is crucial for the outcome of the reaction. Site 
directed replacement of amino acids in and around the active 
site of several terpene synthases has indicated that the product 
distribution can often be altered . 4 - 1 3  While these experiments 
indicated the high adaptability of these enzymes, the products 
generated by the mutant enzymes were always known natural 
terpenoids. However, the plasticity of terpene synthases suggests 
that they have the potential for the generation of novel “unnatural” 
terpenes from unnatural prenyl-diphosphate analogues. While 
biosynthetic restrictions imply that all prenyl-diphosphates carry 
methyl substituents only, a synthetic approach to analogues of the 
substituents of terpene cyclases currently allows the introduction 
of a wide variety of substituents.
To test whether the active sites of terpene synthases can 
accommodate alternate substrates we report here syntheses of 
the FPP analogues containing phenyl substituents in place of the 
methyl groups on C3 and Cl 1 (Scheme 1). While (2£,6£,10£)-3, 
7-dimethyl-ll-phenyldodeca-2,6,10-trien-l-yl diphosphate (19), 
(2£,6£,10Z)-3,7-dimethyl-1 l-phenyldodeca-2,6,10-trien-l-yl di­
phosphate (29) and (2Z,6£)-7,1 l-dimethyl-3-phenyldodeca-2, 
6,10-trien-l-yl diphosphate (36) were not converted to products 
by AS from Penicillium roqueforti, all three FPP analogues acted 
as potent competitive inhibitors indicating that they bound to 
the active site of this sesquiterpene cyclase in a fashion similar to 
the natural substrate, thereby highlighting the enormous plasticity 
of these enzymes and their potential for the production of novel 
terpenoid analogues that might have superior properties for many 
applications including the treatment of human disease.
^^COaEt
Rm  = CHj, Ph
Scheme 1
Results
In order to explore the plasticity of terpene cyclases and to in­
vestigate their potential for the synthesis of non-natural terpenoid 
analogues from modified prenyl diphosphates, we have synthesised 
three FPP analogues in which the methyl groups on C3 and Cl 1 
were replaced by phenyl substituents. The general structure of 
these analogues is shown in Scheme 1 along with the retrosynthetic
disconnection used here. Previous syntheses of analogues of 
famesol concentrated on modification of the Cl 5 methyl group1 4 -1 8  
and to some extent the C1419 with little attention to the C 1 2  and 
C13 methyl groups of FPP. These syntheses have largely used the 
elegant and robust chain extension methodology of Weiler and 
Sum as a key step. 2 0  For the syntheses of the compounds required 
here, a synthesis allowing changes to all the methyl groups of FPP 
was required and it seemed that a disconnection that exploits the 
oligomeric nature of FPP would be both appropriate and efficient. 
Hence two series of monomers were envisaged with one group 
being composed of 1,3-dienes representing the C-terminal end of 
the farnesyl group and the other set comprising various £-crotonyl 
iodides. The key forward reaction to connect these two monomers 
would involve transformation of the terminal alkenyl group with 
a hindered borane such as 9-BBN followed by Suzuki-Miyaura 
coupling with the appropriate iodide. 2 1 -2 5
Synthesis of E- and Z -l 1-phenyl farnesyl diphosphate analogues
Both of these compounds were prepared using novel Suzuki- 
Miyaura coupling methodology. The synthesis of the £-11-phenyl 
FPP analogue 19 is shown in Scheme 2. The C-terminal 1,3-diene, 
compound 12b, was prepared from acetophenone 10 in four steps. 
Homer-Emmons modification using triethyl phosphonoacetate 
and sodium hydride followed by DIBAL-H reduction yielded 
the £-cinnamyl alcohol 11, then oxidation using PCC and then 
a Wittig reaction using methyltriphenylphosphonium bromide 
gave the required £-phenyl diene 12b. This compound was then 
hydroborated using crystalline 9-BBN and immediately coupled 
to iodide 13 using PdCl2dppf as catalyst, triphenylarsine as co­
ligand and aqueous sodium hydroxide as base. 2 4 The £-phenyl- 
geranyl ester product 14 was isolated in 59% yield under these 
conditions. Ester 14 was then homologated to a new 1,3-diene 
derivative 16b in a very similar manner to the preparation of 
12b and a second Suzuki coupling to iodide 13 under identical 
conditions gave the farnesyl ester analogue 17 in 54% yield for the 
coupling step. Ester 17 was then transformed into the diphosphate 
19 by DIBAL-H reduction, bromination of the resulting alcohol 
and diphosphorylation using the methodology of Poulter et al.26
Preparation of the Z -11-phenyl FPP analogue was achieved 
in much the same fashion (Scheme 3). Preparation of the initial 
Z-l,3-diene 23b was a little more complex because Homer- 
Emmons or Wittig modification of acetophenone 10 will only 
yield a small amount of the Z-ester 21. It was therefore made 
by Suzuki-Miyaura coupling of phenylboronic acid to Z-crotonyl 
iodide 20, which was an intermediate in the preparation of 13.27 
Hence treatment of 20 with phenylboronic acid in the presence of 
Pd(OAc)2, triphenylarsine and K3P 0 4 in toluene at 90 °C yielded 
ester 21 in 44% yield after chromatography. 28 This ester was then 
transformed into the 1,3-diene 23b and then to the Z-l 1-phenyl 
FPP analogue 29 using almost identical chemistry as used for the 
preparation of 19. The two crucial Suzuki-Miyaura coupling steps 
took place in approximately 40% yield in each case.
Synthesis of 3-phenyl farnesyl diphosphate 36
For the synthesis of 36 the chain extension methodology of Weiler 
and Sum was found most effective (Scheme 4) . 2 0 Hence geraniol 
30 was transformed into geranyl bromide and then treated with
3288 | Org. Biomol. Chem., 2007,5, 3287-3298 This journal is © The Royal Society of Chemistry 2007
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Scbeme 2 Synthesis of the E-\ 1-phenylfamesyl diphosphate derivative 19. Reagents and conditions: (i) triethylphosphonoacetate, NaH, DME, 61%; 
(ii) DIBAL-H, THF, -78 °C, %%; (iii) PCC, CH2C12, 56%; (iv) CH3PPh3Br, n-BuLi, THF, 94%; (v) 9-BBN, THF then 13, PdCl2dppf, NaOH, AsPh3, 
THF, 50 °C, 59%; (vi) TPAP, NMO, CH3CN, 89%; (vii) CH3PPh3Br, n-BuLi, THF, 81%; (viii) 9-BBN, THF then 13, PdCl2dppf, NaOH, AsPh3, THF, 
50 °C, 54%; (ix) DIBAL-H, THF, -78 °C, 86%; (x) NEt3, MsCl, -45 °C then LiBr, (xi) (Bu4N)3HP207, CH3CN then cation exchange BiuNVNH/, 
31%.
00. (ii)
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Scheme 3 Synthesis of Z-l 1-phenylfamesyl diphosphate 29. Reagents and conditions: (i) PhB(OH)2, Pd(OAc)2, AsPh3, K3P04, toluene, 90 °C, 44%;
(ii) DIBAL-H, THF, -78 °C, 99%; (iii) oxalyl chloride, DMSO, CH2C12 -78 °C then NEt3, 88%; (iv) CH3PPh3Br, n-BuLi, THF, 76%; (v) 9-BBN, THF 
then 13, PdCl2dppf, NaOH, AsPh3, THF, 50 °C, 41%; (vi) DIBAL-H, THF. -78 °C, 91%; (vii) TPAP, NMO, CH3CN, 87%; (viii) CH3PPh3Br, n-BuLi, 
THF, 86%; (ix) 9-BBN, THF then 13, PdCl2dppf, NaOH, AsPh3, THF, 50 °C, 40%; (x) DIBAL-H, THF, -78 °C, 77%; (xi) NEt3, MsCl, -45 °C then 
LiBr; (xii) (Bu4N)3HP207, CH3CN then cation exchange Bu4NVNH4+, 36%.
the dienolate 31 derived from ethyl acetoacetate2 0 giving the (3- 
ketoester 32 in 92% yield. This was then treated with triflic 
anhydride and KHMDS at —78 °C in THF to give the Z-enol 
triflate compound 33 in 51% yield. 16 This compound underwent a 
Suzuki-Miyaura cross-coupling reaction with phenylboronic acid 
to give 34 in 6 6 % yield. Derivatisation of this compound to the 
diphosphate analogue 36 was achieved in the usual manner. 26
Studies of the kinetics of AS-catalysis in the presence of 19, 29 
and 36
To test whether the active site of terpene synthases could accom­
modate the size increases resulting from the replacement of a 
methyl with a phenyl group, the farnesyl diphosphate analogues 
19, 29 and 36 were tested as substrates for and as inhibitors of
This journal is © The Royal Society of Chemistry 2007 Org. Biomol. Chem., 2007,5, 3287-3298 | 3289
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Scheme 4 Synthesis of 3-phenylfamesyl diphosphate 36. Reagents and conditions: (i) NEt3, MsCl, THF, —45 °C then LiBr, then 31,92%; (ii) KHMDS, 
(CFjS0:):0, THF, -78 °C, 51%; (iii) PhB(OH),, AsPh3, Pd(OAc)2, A&O, THF, A, 66%; (iv) DIBAL-H, THF, -78 °C, 85%; (v) NEt3, MsCl, -45 °C 
then LiBr, (vi) (Bu,N)3HP207, CH3CN then cation exchange BiuNVNH,*, 31%.
aristolochene synthase. AS is a Mg*+ dependent sesquiterpene 
cyclase that catalyses the conversion of FPP to (+)-aristolochene
(2 ), which in the fungus is further transformed to produce a family 
of toxins that includes PR toxin (3) (Fig. I ) . 2 9 -3 1  The catalytic 
mechanism for the formation of 2 in the active site of AS has been 
studied extensively by classical substrate labelling studies as well 
as by analysing the reaction products generated from substrate 
analogues and by enzyme mutants. 9 - 1 1 ,3 2 ,3 3 The reaction proceeds 
through the intermediate eudesmane cation (38), the positive 
charge of which is stabilised through interaction with the indole 
ring of Trp 334 of AS. Hydride and methyl shifts followed by site- 
specific deprotonation generate the bicyclic product (Scheme 5).
2 38
Scheme 5 Proposed catalytic mechanism of AS from P. roqueforti.
The phenyl-FPPs 19, 29 and 36 were incubated at a concentra­
tion of 200 pM with 100 nM aristolochene synthase at pH 7.5 in 
the presence of the essential cofactor Mg2+ at 25 °C. The reaction 
rate for the conversion of 5 pM FPP was proportional to the con­
centration of AS at this concentration of enzyme. 5 ,11 Incubations 
were overlayed with pentane in order to extract potential products 
and to minimise product inhibition that is often observed with 
these enzymes due to the hydrophobic nature of the terpenoid 
products. The organic phase was concentrated carefully and the 
reaction products analysed by GC-MS. While the production of 
aristolochene from FPP was manifest by the strong GC signal 
and by its mass spectrum after only 16 hours, even prolonged 
incubation with 19, 29 and 36 of up to 7 days did not indicate 
the formation of any products as judged by GC-MS analysis 
suggesting that these compounds were not substrates of AS.
Each compound was examined as an inhibitor of AS using a 
radiolabelled assay. Initially, IC 50 values were determined with 
FPP concentrations maintained at 1 pM (close to the AfM of
Fpp) s.2 9  The concentrations of the phenyl-FPP analogues were 
varied between 1 mM and 1 nM. 19,29 and 36 acted as inhibitors 
of AS with IC50 values ranging from 1-5 pM. Therefore full K, 
determinations were performed in order to examine the mode 
of inhibition of these compounds. The Michaelis constant of 
FPP was determined both in the presence and absence of each 
inhibitor at various concentrations by use of a non-linear fit.} 
Double reciprocal plots for each set of fitted data indicated that the 
compounds were all reversible competitive inhibitors of AS (Fig. 2) 
and hence bound to the enzyme’s active site in a way similar to that 
of the natural substrate. The -values were determined as 0.8 ±  
0.2,1.2 ±  0.2 and 1.2 ±  0.1 pM for 19,29, and 36, respectively (see 
ESIf). No time dependent inactivation of the enzyme was observed 
when each inhibitor was preincubated with enzyme prior to the 
assay indicating that the inhibition was reversible in all three cases.
Molecular mechanics simulations of inhibitor-bound AS
Each of the FPP-analogues 19, 29 and 36 are characterised by 
the replacement of a methyl group by the much bulkier phenyl 
substituent. Despite the high structural similarities observed in 
sesquiterpene synthases, that suggest that these enzymes have 
evolved to facilitate subtle conformational changes of their 
common substrate through the positional reorganisation of only 
a limited number of active site residues, the observation that 
the phenyl-substituted famesyl-diphosphates acted as potent 
competitive inhibitors of AS was somewhat surprising.
Each inhibitor was therefore docked to the active site of AS 
using the existing molecular model of 1 bound to AS34 as a 
starting point. Energy minimisations of the docked structures were 
performed using the MMFF94 forcefield. 35 Amino acids within
6.5 A of the inhibitor molecule were allowed to move while the co­
ordinates of all other residues were fixed. Each inhibitor appeared 
to fit well into the active site of AS and only minor reorganisations 
of active site residues were necessary to avoid steric clashes through 
the introduction of the bulky phenyl substituents (Fig. 3). In
JData were fitted using Systat Sigmaplot 10.0, 2007. Sigmaplot for 
Windows Version 10.0, Build 10.0.0.54, 2006, Systat Software Inc. 1735, 
Technology Drive, Ste 430, San Jose, CA 95110, USA. Molecular 
Operating Environment (MOE 2004.03) Chemical Computing Group, 
Inc., 1255 University St. Suite 1600, Montreal, Quebec, Canada. H3B 
3 x 3 .
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Fig. 2 Double reciprocal plots of initial rates versus the concentration of 
substrate for AS catalysed turnover of FPP in the presence of 19,29 and 36 
are shown on panels a, b and c for increasing concentrations of inhibitor 
(0 pM (•), 1 pM (A), 2 pM (♦) and 3 pM (■)). Intersection of the lines 
on the y-axis indicate that each compound is a competitive inhibitor of 
AS. All assays were carried out at 37 °C and pH 7.5.
addition, some rearrangements of the inhibitors' prenyl-chains 
were observed relative to the conformation calculated for FPP. In 
the E -11-phenyl FPP analogue (19) an alteration in the orientation 
of the C7-C11 portion of the prenyl chain and a movement of 
the diphosphate group towards the Tyr 92 residue of AS was 
observed. This was accompanied by an approximate 90° rotation 
of the phenyl ring of Phe 112 and minor rotations of the rings of 
Phe 178 and Tyr 92. The indole ring of Trp 334 moved slightly 
away from the bound substrate analogue. The phenyl ring of 19 
and that of Phe 178 appear to be in reasonably close proximity in 
this simulation.
The Z-l 1 -phenyl FPP analogue (29) showed an entirely different 
set of movements. In this instance Trp 334 did not move at all. 
Most interestingly, there appears to be a possible J t-J i stacking 
arrangement between the phenyl ring of 29 and Phe 112 aided 
by a substantial movement of the side chain of Phe 112. In this 
case the overall fold of the prenyl chain was very similar to that 
observed for the substrate with a more modest movement of the 
diphosphate group relative to that observed for 19. Again Phe 178 
and Tyr 92 show small rotations upon binding of the analogue 
relative to their positions adopted upon binding of FPP.
The simulation of the binding of 36 indicated that the binding 
of this compound to FPP requires the least amount of active site
W334
W334
Fig. 3 Sketches from molecular mechanics simulations of the active sites 
of AS complexed with (2£,6£,10£)-3,7-dimethyl-1 l-phenyldodeca-2,6, 
10-trien-l-yl diphosphate (19) (a), (2£,6£, 10Z)-3,7-dimethyl-11-phenyl- 
dodeca-2,6,10-trien-l-yl diphosphate (29) (b) and (2Z,6£)-7,11-dimethyl- 
3-phenyldodeca-2,6,10-trien-l-yl diphosphate (36) (c). The substrate and 
the inhibitors as well as key amino acid residues are shown in gold for the 
original structure and in blue for the energy minimised structures of the 
inhibitor complexes of AS.
movement for the compounds in this study. Trp 334, Phe 178 and 
Tyr 92 displayed only minor rearrangements; the phenyl ring of 
Phe 178 was rotated by approximately 45° relative to its position in 
the substrate complex. The overall fold of the prenyl chain in the 
inhibitor complex was similar to that observed for the substrate 
with the exception of the C4-C7 portion of the chain where the 
apex of the phenyl group of 36 adopts an almost identical position 
to that of C3 of FPP, thereby forcing the C4-C7 chain downwards 
(Fig. 3) to accommodate the rest of the bulky phenyl residue in 
the active site.
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Discussion
Three analogues of farnesyl diphosphate have been prepared 
using novel methodology that involves a Suzuki-Miyaura 
cross-coupling reaction as a key step in the synthesis. These 
coupling reactions proceed in moderate to good yield. It should be 
possible to use this technology to prepare combinatorial libraries 
of FPP analogues in the future. Some members of such libraries 
may act as substrates for AS and other terpene cyclases thereby 
opening up the possibility of short economical routes to complex, 
synthetic unnatural analogues of terpenoids.
While the replacement of the methyl groups on C ll and C3 
of FPP with phenyl substituents did not produce substrates for 
AS, compounds 19, 29 and 36 proved to be potent competitive 
inhibitors of AS that acted in a reversible fashion. The most 
potent of these inhibitors was the E-\ 1-phenyl-FPP analogue 
19 with a Ki of 0.8 pM, which is comparable to the K M of 
the natural substrate5,9 and to the inhibitory constant of 12,13- 
difluoro-FPP.36 Given the relatively size neutral substitutions in 
12,13-difluoro-FPP, the tight binding of the phenyl substituted 
FPP analogues to AS clearly indicate the remarkable plasticity of 
this enzyme’s active site. Furthermore, farnesyl thiodiphosphate, 
an analogue of FPP where the oxygen attached directly to the 
farnesyl chain was replaced by a sulfur, was a much more 
weakly bound inhibitor of this enzyme (AT, =  10 pM) (Beyer 
and Allemann, unpublished). Replacing the oxygen with sulfur 
in the diphosphate group clearly reduces the binding energy more 
significantly than a change from a methyl to a phenyl group in 
the prenyl chain. The majority of the binding energy seems to 
stem from the interaction of the charged diphosphate group to the 
Mg2+ binding site while the interaction of the aliphatic chain with 
the hydrophobic pocket of the active site contributes a smaller 
amount.
Analysis of the X-ray crystal structure of AS indicates that the 
indole ring of Trp 334 is positioned close to C3 of FPP.7,34 The 
GC-MS analysis of the sesquiterpenes produced by mutants of AS 
in which this residue was replaced by non aromatic amino acids 
indicated that the indole ring was involved in the stabilisation 
of the positive charge build up on C3 during formation of the 
eudesmane cation (38).7 The tight binding of 36, where the methyl 
group on C3 was replaced with a phenyl substitutent was therefore 
most interesting. No steric clash between the two aromatic groups 
appeared to prevent tight binding of the inhibitor. The precise 
geometry of binding of these compounds in the active site of 
AS is currently being studied by X-ray crystallography of the 
inhibitor complexes. However, our molecular modelling studies 
of AS bound to the 19, 29 and 36 suggest possible binding modes 
for these competitive inhibitors. AS appears to be sufficiently 
flexible to accommodate the extra bulk of the phenyl groups 
in the active site. The reorganisation of the active site residues, 
which is accompanied by alteration of the conformation of the 
prenyl chain, does however lead to loss of catalytic activity. 
This may be a consequence of changes in the position of the 
diphosphate group in each simulation thereby preventing the 
initial diphosphate loss and hence cyclisation of FPR In addition, 
the active site conformation of the prenyl chain has been shown 
to be critical for AS catalysis6'36 and the rearrangement of the 
substrate analogue necessary to accommodate the phenyl ring, 
may lead to an unreactive conformation.
The results described here show that the active site geometry of 
terpene synthases is sufficiently flexible to accommodate substrate 
analogues even when these carry large pendant groups. The 
plasticity of the terpene cyclases appears not only to provide 
the framework for the combinatorial production of many natural 
terpenoids through subtle alterations in the composition of the 
active site during evolution but may also allow modifications of 
the active site residues by site directed or random mutagenesis 
in vitro or in vivo for the production of functional enzymes that 
convert FPP analogues to unnatural “terpenoids”.
Experimental
For general experimental procedures, final synthesis of diphos­
phates, enzyme preparation and purification and kinetic charac­
terisation of inhibitors see ESI.f
(£)-3-Phenylbut-2-en-l-ol ( l l)37
To a stirred solution of sodium hydride (4.40 g, 110 mmol) 
in anhydrous DME (200 cm3) at room temperature under N2, 
triethyl phosphonoacetate (21.8 cm3, 110 mmol) and a solution 
of acetophenone (11.7 cm3, 100 mmol) in anhydrous DME were 
sequentially added, dropwise. After 3 h, water (50 cm3) was added 
and the organic layer was separated. The aqueous layer was 
extracted with diethyl ether (3 x 50 cm3). The combined organic 
phases were washed with brine (50 cm3), dried over MgS04, 
filtered and then concentrated under reduced pressure to give the 
intermediate ester as a pale yellow oil (11.6 g, 61%); TLC R( 0.39 
(hexane-EtOAc =  9:1); HRMS (ES+, [M + H]+) found 191.1067, 
C,2H150 2 requires 191.1067; vmax(thin film)/cnr‘ 2980.1, 1713.0,
1628.4, 1576.4, 1494.0, 1446.0, 1365.9, 1343.8, 1272.6, 1171.3,
1044.1, 872.4, 766.9 and 694.9; <5H (500 MHz, C2HC13) 1.23 (3 H, 
t, J  7.5, C i/3CH20), 2.50 (3 H, d, J  1.5, CH3CPh), 4.13 (2 H, q, 
J  7.5, CH3C //20), 6.05 (1 H, q, J  1.5, PhC=CH) and 7.27-7.40 
(5 H, m, Ar-H); Sc (125 MHz, C2HC13) 14.4 (CH3CH20), 18.0 
(CH3C=CH), 59.8 (CH3CH20), 117.2 (PhC=CH), 126.3, 128.4 
and 129.0 (Ar-CH), 142.3 and 155.5 (quaternary C) and 166.9 
(C=0); m /z  (ES+) 191.1 (100%, [M + H]+).
The ester (9.08 g, 47.8 mmol) was dissolved in anhydrous 
THF (50 cm3) and cooled to —78 °C (acetone-dry ice bath). To 
this stirred solution, under N2, was added diisobutylaluminium 
hydride (1.0 M solution in hexanes, 152 cm3, 152 mmol) dropwise 
over 10 min. This solution was stirred for 2 h at —78 °C then 
allowed to warm to 0 °C. Saturated potassium sodium tartrate 
solution (50 cm3) and diethyl ether (50 cm3) were added. The 
mixture was stirred at room temperature for another 30 min, and 
the organic layer was separated. The aqueous layer was extracted 
with diethyl ether (2 x 50 cm3). The combined ethereal extracts 
were washed with brine (150 cm3), dried over MgS04, filtered and 
then concentrated under reduced pressure. Purification by flash 
chromatography on silica gel with hexane and ethyl acetate (2 : 
1) gave 11 as a fight yellow oil (6.7 g, 96%); R{ 0.27 (hexane- 
EtOAc =  2 :1 ) ;  HRMS: (EI+, M+) found 148.0890, C10H12O 
requires 148.0888; vmM(thin film)/cm-‘ 3347.2, 2922.2, 2597.9,
1493.8, 1444.5, 1379.9, 1003.0, 758.1 and 696.1; dH (500 MHz, 
C2HC13) 2.11 (3 H, s, C //3CPh), 4.40 (2 H, d, J  6.5, C //2OH),
6.01 (1 H, t, J  6.5, PhC=CH) and 7.28-7.45 (5 H, m, Ar-H); 
5C (125 MHz, C2HC13) 16.1 (CH3CPh), 60.0 (CH2OH), 126.5
3292 | Org. Biomol. Chem., 2007,5, 3287-3298 This journal is © The Royal Society of Chemistry 2007
(PhC=CH), 125.8,127.3 and 128.3 (Ar-CH) and 137.8 and 142.9 
(quaternary C); m /z  (EI+) 148.1 (13%, M+) and 115.1 (100).
(ZT)-3-Phenylbut-2-enal (12a)
Pyridinium chlorochromate (12.3 g, 56.0 mmol) was suspended in 
anhydrous CH2C12 (50 cm3) then a solution of 11 (6.7 g, 45 mmol) 
in CH2C12 (50 cm3) was added in one portion to the stirred 
suspension. After 4 h, dry diethyl ether (100 cm3) was added and 
the supernatant liquid was decanted from the resulting black gum. 
The insoluble residue was washed with diethyl ether (100 cm3) and 
became a black granular solid. The organic phases were combined, 
washed with brine (300 cm3), dried over MgS04, filtered and then 
concentrated under reduced pressure to give 12a as a yellow oil 
(3.7 g, 56%); Rt 0.37 (hexane-EtOAc =  4 :1); HRMS: (EI+, M+) 
found: 146.0730, C10H 10O requires 146.0732; vmal(thin film)/cm-1
1722.2,1659.7,1446.2,1377.3,1248.1,1144.5,865.5 and 758.6; <5H 
(500 MHz, C2HC13) 1.94 (3 H, d, J  1.0, C tf3CPh), 6.41 (1 H, dq, 
J  7.5, J  1.0, PhC=CH), 7.10-7.18 (5 H, m, Ar-H) and 10.05 (1 H, 
d, J  7.5, CHO); dc (125 MHz, C2HC13) 15.5 (CH3CPh), 127.4 
(PhC=CH), 126.2, 128.5 and 129.5 (Ar-CH), 140.8 and 155.8 
(quaternary C) and 189.8 (CHO). m /z  (EI+) 146.1 (46%, M+) and
145.1 (100).
(E)-Penta-2,4-dien-2-ylbenzene (12b)
A stirred suspension of methyltriphenylphosphonium bromide 
(7.61 g, 21.3 mmol) in anhydrous THF (50 cm3) was cooled to 
—78 °C then n-BuLi (2.5 M, 8.52 cm3, 21.3 mmol) was added 
dropwise under argon. The reaction mixture was allowed to warm 
to 0 °C giving a clear deep yellow solution. After stirring at 
0 °C for 30 min, the aldehyde 12a (1.83 g, 12.6 mmol) was 
added dropwise and the complete reaction mixture was stirred for 
16 h whilst slowly warming to room temperature. Water (20 cm3) 
and diethyl ether (20 cm3) were added and the organic layer was 
separated. The aqueous layer was extracted with diethyl ether (2 x 
15 cm3). The combined ethereal extracts were washed with water 
(2 x 20 cm3) and brine (20 cm3), dried over MgS04, filtered and 
then concentrated under reduced pressure. Purification by flash 
chromatography on silica gel with hexane and ethyl acetate (9 : 
1) as eluent gave 12b as a light yellow oil (1.70 g, 94%); R{ 0.57 
(hexane-EtOAc =  19 : 1); HRMS: (EI+, M+) found 144.0938, 
CuH12 requires 144.0939; vmai(thin film)/cm_1 3029.5, 2923.2,
1803.9, 1627.6, 1594.2, 1493.3, 1445.8, 1380.1, 1175.1, 1027.4,
985.3, 903.6, 759.8 and 694.8; «5H (400 MHz, C2HC13) 2.09 (3 H, s, 
C tf3CPh), 5.10 (1 H, d, J  10.0, CHCH=CH(ra„ //fiI), 5.22 (1 H, d, J
17.0, CHCH=C//,ra„H t.iI), 6.37 (1 H, d, J 11.0, CtfCH=CH2), 6.68 
(1 H, dt, J  17.0, J  10.5, C H Ci/=CH 2) and 7.14-7.26 (5 H, m, Ar-
H);<5C (100 MHz, C2HC13) 16.1 (CH3CPh), 117.7 (CHCH=CH2),
127.8 (CHCH=CH2), 125.7, 127.2 and 128.3 (Ar-CH), 133.6 
(CHCH=CH2) and 136.8 and 143.0 (quaternary C); m /z  (EI+)
144.1 (35%, M+) and 129.1 (100, [M -  CH3]+).
(2£,6E)-Ethyl 3-methyl-7-phenylocta-2,6-dienoate (14)
A mixture of 12b (1.45 g, 9.92 mmol) and 9-BBN (3.63 g,
14.9 mmol) dissolved in anhydrous THF (50 cm3) was stirred at 
room temperature under N2 until all the starting material had 
been consumed as judged by TLC (approx. 2 h). The iodide 
1327 (2.38 g, 9.92 mmol), triphenylarsine (0.30 g, 0.99 mmol),
PdCl2dppf (0.37 g, 0.45 mmol) and aqueous NaOH (6.0 M. 
9.92 cm3, 39.7 mmol) were added in quick succession, the complete 
solution was then stirred at 50 °C for 15 h. After cooling to 
room temperature, aqueous hydrogen peroxide solution (30%, 
15 cm3) was carefully added and the solution was stirred for a 
further 30 min. Water (30 cm3) and diethyl ether (30 cm3) were 
added, and the organic layer was separated. The aqueous layer was 
extracted with diethyl ether (2 x 25 cm3). The combined ethereal 
extracts were washed with water (2 x 20 cm3) and brine (20 cm3), 
dried over MgS04, filtered and then concentrated under reduced 
pressure. Purification by flash chromatography on silica gel with 
hexane and ethyl acetate gave 14 as a light yellow oil (1.51 g, 
59%); R{ 0.27 (hexane-EtOAc =  19 : 1); HRMS: (ES+, [M + 
NH4]+) found 276.1959, C17H26N 0 2 requires 276.1958; vmax(thin 
film)/cm-‘ 2978.8,2930.2,1714.9,1647.6,1493.8,1444.3,1381.4,
1327.6, 1272.3, 1222.8, 1146.1, 1098.9, 1049.6, 864.4, 757.9 and 
696.4; SH (500 MHz, C2HC13) 1.20 (3 H, t, J  7.0, C tf3CH20), 1.96 
(3 H, d, J  1.0, C tf3C=CHC02Et), 2.13 (3 H, d, J  1.0, C i/3CPh), 
2.19-2.32 (4 H, m, C H 2CH2), 4.07 (2 H, q, J  7.0, CH3C //20), 
5.64 (2 H, m, 2 x C=CH) and 7.13-7.30 (5 H, m, Ar-H); dc 
(125 MHz, C2HC13) 14.4(CH3CH20), 15.9(CH3C=CHCO), 18.9 
(CH3CPh), 26.8 and 40.6 (CH2CH2), 59.6 (CH3CH20), 115.9 
(C=CHCO), 126.66 (PhC=CH), 125.7, 126.73 and 128.2 (Ar- 
CH), 135.8, 144.7, 159.3 (quaternary C) and 166.9 (C=0); m /z  
(CI+) 276.2 (100%, [M + NH4]+).
(2£,6£>3-Methyl-7-phenylocta-2,6-dlen-l -ol (15)
To a stirred solution of 14 (1.46 g, 5.67 mmol) in anhydrous 
THF (60 cm3) at —78 °C (acetone-dry ice bath) was added 
diisobutylaluminium hydride (1.0 M solution in hexanes, 13.6 cm3,
13.6 mmol) dropwise. The resulting mixture was stirred at —78 °C 
for 2 h and then allowed to warm to 0 °C at which time 
the reaction was judged complete by TLC analysis. Saturated 
potassium sodium tartrate solution (50 cm3) and diethyl ether 
(50 cm3) were added. The mixture was stirred at room temperature 
for another 30 min, and the organic layer was separated. The 
aqueous layer was extracted with diethyl ether (2 x 30 cm3). 
The combined ethereal extracts were washed with brine (30 cm3), 
dried over MgS04, filtered and then concentrated under reduced 
pressure. Purification by flash chromatography on silica gel with 
hexane and ethyl acetate (2:1) as eluent gave 15 as a light yellow oil 
(1.2 g, 96%); R{ 0.27 (hexane-EtOAc =  2:1); HRMS: (ES+, [M + 
NH4]+) found 234.1851, C15H24NO requires 234.1852; vmM(thin 
film)/cm-‘ 3363.0,2923.4,1493.3,1444.0, 999.4, 756.3 and 695.8; 
dH (500 MHz, C2HC13) 1.65 (3 H, s, C //3C=CHCH2OH), 1.96 
(3 H, d, J  0.9, CH3CPh), 2.09-2.29 (4 H, m, C H 2CH2), 4.09 (2 H, 
d, J  10.0, C H 2OH), 5.40 (1 H, tq, J  10.0, J  1.5, C/7CH2OH), 
5.68 (1H, tq, J  7.0, J  1.5, C//CH2CH2) and 7.13-7.31 (5 H, 
m, Ar-H); Sc (125 MHz, C2HC13) 15.9 (CH3C=CHCH2OH),
16.4 (CH3CPh), 27.1 and 39.2 (CH2CH2), 59.4 (CH2OH), 123.7 
(CHCH2OH), 127.7 (PhC=CH), 125.6,126.6 and 128.2 (Ar-CH) 
and 135.0, 139.4, 143.9 (quaternary C); m /z  (CI+) 234.2 (100%, 
[M + NH4]+).
(2£,6£)-3-Methyl-7-phenylocta-2,6-dienal (16a)
A mixture of 15 (0.98 g, 4.52 mmol), JV-methylmorpholine-iV- 
oxide (074 g, 6.33 mmol) and freshly activated powdered 4 A
This journal is © The Royal Society of Chemistry 2007 Org. Biomol. Chem., 2007,5, 3287-3298 | 3293
molecular sieves (0.35 g) in anhydrous acetonitrile (35 cm3) 
was stirred for 10 min whereupon tetra-n-propylammonium 
perruthenate (81 mg, 0.23 mmol) was added. The reaction became 
warm and was then stirred at room temperature for 16 h. The 
mixture was filtered through a short pad of Celite® and the 
solvent was concentrated under reduced pressure. Purification 
by flash chromatography on silica gel with hexane and ethyl 
acetate (4 : 1) as eluent gave 16a as a light yellow oil (0.86 g, 
89%); Rs 0.33 (hexane-EtOAc =  4 : 1); HRMS: (EI+, M+) found 
214.1350, C15Hi80  requires 214.1352; v^^thin film)/cm_1 1672.0,
1493.5, 1443.9, 1193.1, 1124.0, 757.7 and 696.2; dH (500 MHz; 
C62H6) 1.62 (3 H, d, J  1.1, C tf3C=CHCHO), 1.92 (3 H, d, J  1.0, 
CH, CPh), 1.86-2.10 (4 H, m, C H 2C H 2), 5.64 (1 H, tq, J  7.0, J  1.0, 
C=C//CH2CH2), 5.95 (1 H, dq, J  7.5, J  1.0, CtfCHO), 7.21-7.44 
(5 H, m, Ar-H) and 9.98 (1 H, d, J  7.5, CHO); Sc (125 MHz; 
C62H6) 15.7 (CH3CPh), 16.7 (CH3C=CHCHO), 26.3 and 39.8 
(CH2CH2), 126.3 (PhC=CH), 127.5 (CHCHO), 125.8,127.0 and
128.4 (Ar-CH), 136.0, 143.8 and 160.9 (quaternary C) and 189.6 
(CHO); m /z  (CI+) 232.2 (100%, [M + NR,]+).
(2£,7 £^-8-Phenyl-4-methyl-nona-1,3,7-triene (16b)
This compound was prepared from 16a in a manner identical 
to that for the 12b; purification by flash chromatography using 
hexane and ethyl acetate (9 : 1) as eluent gave 16b as a light 
yellow oil (0.68 g, 81%); R{ 0.68 (hexane-EtOAc =  9:1); HRMS: 
(EP, M+) found 212.1559, C^H^ requires 212.1560; vmai(thin 
film)/cm_1 2919.4, 1649.7, 1597.7, 1493.5, 1443.8, 1379.7, 987.8,
896.6, 756.3 and 695.3; <5H (500 MHz, C2HC13) 1.73 (3 H, s, 
C tf3C=CHCH=CH2), 1.92 (3 H, s, C //3CPh), 2.11-2.29 (4 H, m, 
CH 2CH2), 4.92 (1 H, d, J  10.0, CH=CHCHlraBJi / fiJ), 5.02 (1 H, dd, 
J 17.0, J 1.5, CH=C/7,rauHcit), 5.68 (1 H, t, /  7.0, C=Ci/CH2CH2), 
5.82 (1 H, d, J  11.0, C/7CH=CH2), 6.52 (1 H, dt, J  17.0, J
10.5, C/7=CH2) and 7.12-7.30 (5 H, m, Ar-H); <5C (125 MHz, 
C2HC13) 15.9 (CH3CPh), 16.8 (CH3C=CHCH2CH2), 27.3 and
39.6 (CH2CH2), 114.9 (CH=CH2), 125.8 (CHCH=CH2), 127.8 
(PhC=CH), 125.7, 126.6 and 128.2 (Ar-CH), 133.4 (CH=CH2) 
and 135.0,139.1 and 143.9 (quaternary C); m/z (CP) 213.1 (100%, 
[M + H]+).
(2£,6£,10£)-Ethyl-3,7-dimethyl-ll-phenyldodeca-
2,6,10-trienoate (17)
This compound was prepared from 16b in a manner identical to 
that for the ester 14; purification by flash chromatography using 
hexane and ethyl acetate (25 : 1) as eluent gave 17 as a light yellow 
oil (0.56 g, 54%); R( 0.32 (hexane-EtOAc =  25 : 1); HRMS (ES+, 
[M + H]+) found 327.2320, C22H310 2 requires 327.2319; vmai(thin 
film)/cm-‘ 2928.8, 1714.9, 1647.2, 1444.1,1381.4, 1221.1,1143.0,
757.1 and 695.9; SH (500 MHz, C2HC13) 1.21 (3 H, t, J  6.5, 
C tf3CH20), 1.50, 1.58 and 1.96 (3 x 3 H, s, 3 x C tf3C=CH), 
2.02-2.24 (8H, m, 2 x C H 2C H 2), 4.07 (2 H, q, J  6.5, CH3C tf20),
5.08 and 5.67 (2 H, m, 2 x C=C77CH2CH2), 5.60 (1 H, d, J  1.0, 
C //C 02Et) and 7.13-7.30 (5 H, m, Ar-H); Sc (125 MHz, C2HC13) 
14.4(CH3CH20), 15.8,16.1 and 18.9 (3 x CH3C=CH), 26.0,27.4,
39.4 and 41.0(2 x CH2CH2),59.5(CH3CH20), 115.6(CHC02Et),
123.3 and 128.1 (C=CH), 125.6,127.0 and 128.2 (Ar-CH), 131.6, 
135.8,144.0 and 159.8 (quaternary C) and 166.9(C=0); m/z(CP)
344.3 (100%, [M + NH4]+), 327.3 (65, [M + H]+).
(ZfjbEjlO^-SJ-Dimethyl-l l-phenyldodeca-2,6,10-trien-l-ol (18)
This compound was prepared from 17 in a manner identical to 
that for the alcohol 15; purification by flash chromatography 
using hexane and ethyl acetate (2 : 1) as eluent gave 18 as a light 
yellow oil (0.41 g, 86%); R{ 0.31 (hexane-EtOAc =  2:1); HRMS 
(EP, M+) found 284.2141, C20H2gO requires 284.2140; vmai(thin 
film)/cm_1 3321.5, 2921.0, 1666.9, 1597.7,1493.7, 1444.1, 1381.1,
1000.4,846.3,756.6 and 696.1;<5H (500 MHz, C2HC13) 1.57 (3 H,s, 
CiT3C=CH), 1.60 (3 H, s, C i/3C=CHCH2OH), 1.96 (3 H, d, J  1.0, 
PhCC//3), 1.97-2.25 (8 H, m, 2 x CH 2C H 2), 4.04 (2 H, d, J  7.0, 
C //2OH), 5.08 (1 H, dt, J  7.0, J  1.0, CH3C=C/7), 5.33 (1 H, m, 
C=Ci7CH2OH), 5.68 (1 H, dt, J  7.0, J  1.5, PhC=CH) and 7.12-
7.30 (5 H, m, Ar-H); Sc (125 MHz, C2HC13) 15.8, 16.1 and 16.3 
(3 x CH3), 26.3,27.4,39.4 and 39.5 (2 x CH2CH2), 59.4 (CH2OH),
123.4 (CHCH2OH), 124.3 (CH3C=CH) and 128.2 (PhC=CH),
125.6,126.5 and 128.2 (Ar-CH) and 134.6,135.0,139.7 and 144.0 
(quaternary C); m /z  (EI+) 284.2 (1%, M+), 131.1 (100), 266.2 (2, 
[M -  H20 ]+).
(Z)-Ethyl 3-phenylbut-2-enoate (21 )27’2*
To a stirred solution of the iodide 20 (7.20 g, 30.0 mmol) in 
anhydrous toluene (100 cm3) under N2 was added palladium(ii) 
acetate (0.34 g, 1.50 mmol), triphenylarsine (0.79 g, 3.00 mmol), 
tripotassium orthophosphate (19.1 g, 90.0 mmol) and phenyl­
boronic acid (5.49 g, 45.0 mmol). The complete reaction mixture 
was then stirred at 90 °C for 6 h. Water (50 cm3) and diethyl 
ether (50 cm3) were added, and the organic layer was separated. 
The aqueous layer was extracted with diethyl ether (2 x 30 cm3). 
The combined ethereal extracts were washed with water (2 x 
30 cm3) and brine (30 cm3), dried over MgS04, filtered and 
then concentrated under reduced pressure. Purification by flash 
chromatography on silica gel with hexane and ethyl acetate (9:1) 
as eluent gave 21 as a light yellow oil (2.49 g, 44%); R{ 0.30 (hexane- 
EtOAc =  9:1); HRMS (ES+, [M + H]+) found 191.1067, C12H150 2 
requires 191.1067; v,^ (thin film)/cm_1 2979.6, 1725.4, 1639.5,
1492.5, 1442.6, 1374.8, 1277.2, 1230.2, 1162.1, 1095.6, 1076.6,
1047.3, 867.6, 768.4 and 698.1 c n r1; ^  (500 MHz, C2HC13) 1.14 
(3 H, t, J  7.5, C/73CH20), 2.23 (3 H, d, J  1.5, C tf3CPh), 4.05 (2 H, 
q, J  7.5, CH3C tf zO), 6.05 (1 H, q, J  1.5, PhC=Cif) and 7.26-7.42 
(5 H, m, Ar-H); Sc (125 MHz, C2HC13) 14.0 (CH3CH20), 27.2 
(CH3CPh), 59.8 (CH3CH20), 117.8 (PhC=CH), 126.9,127.8 and
127.9 (Ar-CH), 140.9 and 155.4 (quaternary C) and 165.9 (C=0); 
m /z  (CP) 208.1 (100%, [M + NH4]+) and 191.0 (35%, [M + H]+).
(Z)-3-Phenylbut-2-ene-l-ol (22)
This compound was prepared from 21 in a manner identical to 
that for the alcohol 15; purification by flash chromatography using 
hexane and ethyl acetate (2:1) as eluent gave 22 as a colourless oil 
(4.12 g, 99%); R{ 0.26 (hexane-EtOAc =  2:1); HRMS (CP, [M + 
NH4]+) found 166.1229, C10H16NO requires 166.1226; vmax (thin 
film)/cm-‘ 3331.7, 3055.2, 2969.9, 1656.1, 1600.0, 1493.6, 1434.8,
1376.0, 1246.4, 1065.2, 1002.0, 764.1 and 700.8; SH (500 MHz, 
C2HC13) 1.46 (1 H, b, OH), 2.02 (3 H, d, J 1.0, C /f3CPh), 3.99 (2 H, 
dd, J  7.0, J 1.0, C //2OH), 5.64 (1 H, tq, J  7.0, J 1.5, PhC=C/7) and 
7.09-7.28 (5 H, m, Ar-H);<5c (125 MHz, C2HC13) 25.4 (CH3CPh),
60.3 (CH2OH), 126.1 (PhC=CH), 127.2, 127.8 and 128.2
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(Ar-CH), 140.3 and 140.8 (quaternary C); m /z  (CI+) 166.1 (20%, 
[M + NH4]+), 148.1 (50, M+) and 131.0 (100, [M -  OH]+).
(Z)-3-Pbenylbut-2-ene-1 -al (23a)
To a stirred solution of oxalyl chloride (2.69 cm3, 31.3 mmol) 
in anhydrous CH2C12 (80 cm3) at —78 °C under N2, was added 
anhydrous dimethylsulfoxide (4.44 cm3, 62.6 mmol). The reaction 
mixture was stirred for 5 min then a solution of 22 (3.85 g,
26.1 mmol) in CH;C12 was added over 5 min. Stirring was 
continued at —78 °C for an additional 15 min. Triethylamine 
(18.2 cm3, 130 mmol) was added and the reaction mixture was 
stirred for 5 min and then allowed to warm to room temperature. 
Water (50 cm3) was then added, and the organic layer was 
separated. The aqueous layer was extracted with CH2C12 (2 x 
30 cm3). The combined organic extracts were washed with water 
(2 x 30 cm3) and brine (30 cm3), dried over MgS04, filtered and 
then concentrated under reduced pressure. Purification by flash 
chromatography on silica gel with hexane and ethyl acetate (2 :
1) as eluent gave 23a as a light yellow oil (3.36 g, 88%); R{ 0.48 
(hexane-EtOAc =  2:1); HRMS (ES+, [M -  H]+) found 145.0645, 
C10H9O requires 145.0648; vm„ (thin film)/cm-1 2357.8, 1668.3,
1614.1, 1433.3, 1388.2, 1136.6, 767.0 and 701.5; <5H (500 MHz, 
C2HC13) 1.81 (3 H, s, C //3CPh), 6.09 (1 H, d, J  8.0, PhC=Ctf), 
6.95-7.13 (5 H, m, Ar-H) and 9.71 (1 H, dd, J  8.0, J  3.5, CHO); 
dc (125 MHz, C2HC13) 25.6 (CH3CPh), 128.3, 128.4 and 128.7 
(Ar-CH), 129.4 (PhC=CH), 138.5 and 160.1 (quaternary C) and
191.6 (CHO); m /z  (CP) 164.1 (95%, [M + NH,]+), 161.1 (100%) 
and 146.1 (30%, M+).
(Z)-4-Phenyl-penta-l,3-diene (23b)
This compound was prepared from 23a in a manner identical 
to that for the diene 12b; purification by flash chromatography 
using hexane and ethyl acetate (9 : 1) as eluent gave 23b as a 
light yellow oil (1.80 g, 76%); R { 0.63 (hexane-EtOAc = 9:1) ;  
HRMS (EP, M*) found 144.0938, CnH12 requires 144.0939; vm„ 
(thin film)/cm-‘ 3080.3, 2960.4, 2856.8, 1805.6, 1636.2, 1601.6,
1492.1, 1433.6, 1414.1, 1375.3, 1024.7, 995.6, 898.4, 766.1 and 
700.2; <5h (400 MHz, C2HC13) 2.04 (3 H, s, C i/3CPh), 4.86 
(1 H, d, J  10.0, CHCH=CHIra„ /f ciJ), 5.08 (1 H, d, J  17.0, 
CHCH=Ci/,„MJH£.iJ), 6.06 (1 H, d, J  11.0, C/7CH=CH2), 6.32 
(1 H, dt, J  17.0, J  10.5, CHC77=CH2) and 7.14-7.28 (5 H, m, Ar-
H);<5C (100 MHz, C2HC13) 25.5 (CH3CPh), 116.1 (CHCH=CH2),
127.9 (CHCH=CH2), 127.1, 128.1 and 128.3 (Ar-CH), 134.6 
(CHCH=CH2) and 139.5 and 141.5 (quaternary C); m /z  (EI+)
144.1 (35%, M+), 129.1 (100, [M -  CH3]+).
(2£,6Z)-Ethyl 3-methyl-7-phenylocta-2,6-dienoate (24)
This compound was prepared from 23b in a manner identical 
to that for the ester 14; the crude product was purified by flash 
chromatography using hexane and ethyl acetate (9 :1) as eluent to 
give 24 as a light yellow oil (1.33 g, 41%); R{ 0.35 (hexane-EtOAc = 
9 : 1); HRMS (ES+, [M + H]+) found 259.1691, C17H230 2 requires 
259.1693; vmai (thin film)/cm-L 2975.8, 2359.6, 1715.0, 1647.3,
1493.4,1442.0,1367.2,1221.8,1146.1,1099.6,1052.2,865.4,763.2 
and 701.0; SH (500 MHz, C2HC13) 1.18 (3 H, t, J  7.0, C tf3CH20),
1.95 (3 H, s, C tf3C=CHC02Et), 1.98 (3 H, d, J  1.0, C tf3CPh),
2.07 (4 H, m, CH 2CH2), 4.07 (2 H, q, J  7.0, CH3C7720), 5.32 (1 H,
m, C =Ci/CH 2CH2), 5.52 (1 H, d, J  0.5, C =C tf C 02Et) and 7.07-
7.30 (5 H, m, Ar-H);<5c (125 MHz, C2HC13) 14.4 (CH3CH20), 18.7 
(CH3CPh), 25.7 (CH3C=CHC02Et), 26.9 and 41.2 (CH2CH2),
59.5 (CH3CH20), 115.7 (C=CHC02Et), 125.8 (PhC=CH), 126.6,
127.9 and 128.2 (Ar-CH), 137.5, 141.8 and 159.4 (quaternary C) 
and 166.9 (C=0); m /z  (CP) 276.2 (100%, [M + NH4]+), 259.2 (95, 
[M + H]+).
(2£,6Z)-3-Methyl-7-phenylocta-2,6-dien-l-ol (25)
This compound was prepared from 24 in a manner identical to 
that for the alcohol 15; purification by flash chromatography on 
silica gel using hexane and ethyl acetate (2 : 1) as eluent gave 25 
fight yellow oil (0.816 g, 91%); Rs 0.31 (hexane-EtOAc =  2 : 1); 
HRMS (ES+, [M + NH4]+) found 234.1850, C15H24NO requires 
234.1852; vmax (thin film)/cm-‘ 3335.5, 2965.2, 2914.6, 1667.9,
1492.8, 1436.1, 1376.6, 999.9, 763.1 and 700.1; <5H (500 MHz, 
C2HC13) 1.22 (1 H, b, OH), 1.50 (3 H, s, C tf3C=CHCH2OH),
1.95 (3 H, d, J  1.0, C i/3CPh), 1.97-2.04 (4 H, m, C H 2CH2), 4.04 
(2 H, d, J  7.0, C i/2OH), 5.28 (1 H, dt, J  7.0, J 1.0, C=C//CH2OH), 
5.36 (1 H, dt, J  7.0, J  1.5, C=CtfCH2CH2) and 7.10-7.28 (5 H, 
m, Ar-H); Sc (125 MHz, C2HC13) 16.2 (CH3C=CHCH2OH),
25.6 (CH3CPh), 27.3 and 39.8 (CH2CH2), 59.4 (CH2OH), 123.5 
(C=CHCH2OH), 126.8 (PhC=CH), 126.5, 127.9 and 128.1 (Ar- 
CH) and 136.6, 139.5 and 142.1 (quaternary C); m /z  (CP) 234.2 
(100%, [M + NH4]+), 216.2 (80, M+), 199.1 (40, [M -  OH]+).
(IZTjb-Z^-S-Methyl^-phenylocta-ljb-dienal (26a)
This compound was prepared from 25 in a manner identical to 
that for the compound 16a; purification by flash chromatography 
using hexane and ethyl acetate (2:1) as eluent to gave 26a as a fight 
yellow oil (0.86 g, 87%); R{ 0.45 (hexane-EtOAc =  2:1);  HRMS 
(EP, M+) found 214.1352, C15H180  requires 214.1358; vm„ (thin 
film)/cm-‘ 2912.7, 2851.7, 2360.2, 1672.8, 1630.3, 1492.6, 1439.9,
1379.2, 1193.2, 1124.0, 1025.8, 831.0, 764.1, 702.0 and 668.1; SH 
(500 MHz, C2HC13) 1.49 (3 H, d, J  1.0, C i/3C=CHCHO), 1.85-
2.08 (4 H, m, C H 2C H 2), 2.03 (3 H, d, J  1.0, C H ,CPh), 5.30 
(1 H, td, J  7.0, J  1.0, C=C//CH2CH2), 5.85 (1 H, dd, J  8.0, J
1.0, C=C//CHO), 7.17-7.29 (5 H, m, Ar-H) and 9.91 (1 H, d, J
8.0, CHO); Sc (125 MHz, C2HC13) 16.4 (CH3C=CHCHO), 25.5 
(CH3CPh), 26.7 and 40.4 (CH2CH2), 126.0 (PhC=CH), 127.6 
(CH=CHO), 126.9, 127.9 and 128.3 (Ar-CH), 137.6, 141.8 and
160.8 (quaternary C) and 189.6 (CHO); m /z  (EP) 214.1 (2%, M+),
131.1 (100).
(3£,7Z)-4-Methyl-8-phenyl-nona-l,3,7-triene (26b)
This compound was prepared from 26a in a manner identical to 
that for the diene 12b; purification by flash chromatography using 
hexane and ethyl acetate (2 :1) as eluent gave 26b as a fight yellow 
oil (0.48 g, 86%); R{ 0.62 (hexane-EtOAc =  9:1);  HRMS (ES+, 
[M + H]+) found 212.1569, Ci6H20 requires 212.1565; vmM(thin 
film)/cm-‘ 2964.8,2358.3, 1649.8, 1598.9,1493.0, 1436.5, 1378.1,
985.7, 896.9, 761.8 and 700.0; SH (500 MHz, C2HC13) 1.70 (3 H, s, 
C //3C=CHCH=CH2), 2.07 (3 H, s, C tf3CPh), 2.08-2.17 (4 H, 
m, CH 2CH2), 5.00 (1 H, dd, J  10.0, J  1.5, CH=Ci7^H(raBI), 5.10 
(1 H, dd, J  17.0, J  2.0, CH=CHci!//,raM), 5.46 (1 H, td, J  7.0, J
1.5, C=Ci/CH 2CH2), 5.83 (1 H, dd, J  11.0, J  0.5, CtfCH=CH2), 
6.59 (1 H, dt, J  17.0, J  10.5, CHCtf=CH2) and 7.21-7.39 (5 H,
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m, Ar-H); Sc (125 MHz, C2HC13) 16.6 (CH3C=CHCH2), 25.6 
(CHjCPh), 27.4 and 40.1 (CH2CH2), 114.7 (CHCH=CH2), 125.6 
(CHCH=CH2), 126.9 (PhC=CH), 126.5, 128.0 and 128.2 (Ar- 
CH), 133.4 (CH=CH2) and 136.6, 139.1 and 142.1 (quaternary 
C); m /z  (EP) 212.2 (5%, M+), 131.1 (100) and 91.1 (40).
(2E,6E, 10Z)-Ethyl-3,7-<limethyl-l 1 -phenyldodeca-
2,6,10-trienoate (27)
This compound was prepared from 26b in a manner identical to 
that for the ester 14; purification by flash chromatography using 
hexane and ethyl acetate (19 : 1) gave 27 as a light yellow oil 
(0.29 g, 40%); R{ 0.33 (hexane-EtOAc =  19 : 1); HRMS (ES+, 
[M + H]+) found 327.2318, C22H310 2 requires 327.2319; (thin 
film)/cm-' 2926.3,1715.4,1647.5,1442.7,1366.5,1221.5,1144.3,
1053.9, 865.3, 762.0 and 700.5; dH (500 MHz, C2HC13) 1.20 (3 H, 
t, J  7.0, OCH2C tf3), 1.43 (3 H, s, C tf3C=CH), 1.95 (3 H, d, J  1.0, 
C //3C=CH), 2.08 (3 H, d, J  1.0, C tf3C=CHC02Et), 1.91-2.11 
(8 H, m, 2 x C H 2CH 2), 4.06 (2 H, q, J  7.0, OCi72CH3), 4.97 (1 H, 
b, C= CHCU2CH2), 5.35 (1 H, dt, /  7.0, J  1.0, C=CtfCH2CH2), 
5.58 (1 H, s, C = C //C 02Et) and 7.09-7.30 (5 H, m, Ar-H); <5C 
(125 MHz, C2HC13) 14.4 (OCH2CH3), 16.0 (CH3C=CH), 18.9 
(CH3C=CH C02Et), 25.6 (CH3C=CH), 26.0, 27.5, 39.9 and 41.0 
(2 x CH2CH2), 59.5 (OCH2CH3), 115.6 (C=CHC02Et), 123.1 
and 127.2 (2 x C=CHCH2CH2), 126.4,127.6 and 128.0 (Ar-CH),
135.7, 136.2, 142.1 and 159.9 (quaternary C) and 166.9 (C=0); 
m /z  (CP) 344.3 (100%, [M + NH4]+) and 327.3 (50, [M + H]+).
(2E,6E, 10Z)-3,7-Dimethyl-11 -phenyldodeca-2,6,10-trien-1 -ol (28)
This compound was prepared in a manner identical to that for 
the alcohol 15; purification by flash chromatography using hexane 
and ethyl acetate (2 : 1) as eluent gave 28 as a light yellow oil 
(0.12 g, 77%); Rr 0.26 (hexane-EtOAc =  2:1); HRMS (ES+, [M + 
NH4]+) found 302.2477, C^H^NO requires 302.2478; vm„ (thin 
film)/cm-‘ 3344.4, 2919.3, 1666.0, 1597.4,1493.4, 1443.8,1381.2,
998.9, 756.6 and 696.0; <5H (500 MHz, C2HC13) 1.23 (1 H, b, OH), 
1.43 (3 H, s, C H ,C=CH), 1.60 (3 H, s, C i/3C=CH), 1.95 (3 H, 
d, J  1.0, C //3C=CH), 1.91-2.06 (8 H, m, 2 x CH2CH2), 4.07 
(2 H, d, J  7.0, CHjOH), 4.99 (1 H, td, J  7.0, J  1.0, C=CH), 
5.33 (2 H, m, 2 x C=CH) and 7.10-7.30 (5 H, m, Ar-H); Sc 
(125 MHz, C2HC13) 16.0,16.3 and 25.6 (3 x CH3), 26.3,21.6, 39.5 
and 40.0 (2 x CH2CH2), 59.4 (CH2OH), 123.3, 124.0 and 127.3 
(3 x C=CH), 126.4, 128.0 and 128.0 (Ar-CH) and 135.0, 136.1,
139.8 and 142.2 (quaternary C); m /z  (CP) 302.3 (100%, [M + 
NH4]+), 284.3 (55, M+).
(£)-EthyI 7,ll-dimethyI-3-oxododeca-6,10-dienoate (32)20,3®
To a stirred solution of geraniol (2.60 cm3 g, 15.0 mmol) and 
triethylamine (4.20 cm3, 30.0 mmol) in anhydrous THF (100 cm3) 
at —45 °C under N2 was added methanesulfonyl chloride (1.50 cm3,
19.5 mmol). The resulting milky mixture was stirred at —45 °C for 
45 min then a solution of lithium bromide (5.20 g, 60.0 mmol) in 
THF (10 cm3) was added via a cannula at —45 °C. The suspension 
was allowed to warm to 0 °C and stirred for an additional 1 h before 
cold water (30 cm3) and hexane (30 cm3) were added to quench 
the reaction. The two layers were separated, and the aqueous layer 
was extracted with hexane (2 x 20 cm3). The combined organic 
layers were washed with saturated NaHC03 solution (20 cm3) and
then brine (20 cm3), dried over Na2S04 and filtered. Concentration 
of the solvent gave the intermediate bromide as a light yellow oil, 
which was used without further purification.
To a stirred suspension of NaH (60% dispersion in mineral 
oil, 1.20 g, 49.5 mmol) in anhydrous THF (100 cm3) was added 
ethyl acetoacetate (5.73 cm3, 45.0 mmol) dropwise at 0 °C. After
10 min, n-BuLi (2.2 M, 21.5 cm3, 47.3 mmol) was added slowly 
over 3 min, during which time the colourless solution gradually 
turned yellow. This was stirred for an additional 10 min at 0 °C, 
as a solution of the bromide in THF (5 cm3) was added. The 
clear solution turned to a cloudy yellow suspension. After stirring 
for 30 min at 0 °C, hydrochloric acid (3 M, 10.0 cm3) was added 
followed by water (30 cm3) and diethyl ether (30 cm3) then the 
organic layer was separated. The aqueous layer was extracted with 
diethyl ether (2 x 20 cm3). The combined ethereal extracts were 
washed with water (2 x 20 cm3) and brine (20 cm3), dried over 
MgS04 then filtered and concentrated under reduced pressure. 
Purification by flash chromatography on silica gel with hexane 
and ethyl acetate (4 : 1) as eluent gave 32 as a pale yellow oil 
(3.61 g, 92%); Rs 0.45 (hexane-EtOAc =  2 : 1 ) ;  HRMS (ES+, 
[M + H]+) found 267.1954, C16H270 3 requires 267.1954; vmax (thin 
film)/cm-‘ 2968.0, 2918.6, 1746.5, 1717.2, 1648.9, 1445.8, 1409.9,
1367.4, 1313.3, 1235.8, 1177.2, 1035.9 and 839.8; dH (500 MHz, 
C2HC13) 1.30 (3 H, t, J  7.0, C i/3CH20), 1.61 (3 H, s, C tf3C=CH), 
1.63 (3 H, s, C H ,C= CH), 1.69 (3 H, s, C tf3C=CH), 1.98 (4 H, m, 
(CH3)2C=CHC//2C/72), 2.30 (2 H, q, J  7.5, Ci72CH2C=0), 2.59 
(2 H, t, J  7.5, CH2C //2C=0), 3.45 (2 H, s, COCH2CO), 4.20 (2 H, 
q, J  7.0, OCHjCHj) and 5.09 (2 H, dt, J  1.0, J  7.0, 2 x C=CH); 
Sc (125 MHz, C2HC13) 14.1 (OCH2CH3), 16.0 (CH3C=CH),
17.7 (CH3C=CH), 22.2 (CH2CH2C=0), 25.7 (CH3C=CH),
26.6 and 39.4 ((CH3)2C=CHCH2CH2), 43.1 (CH2CH2CO), 49.4 
(COCH2CO), 61.4 (OCH2CH3), 122.1 and 122.4 (2 x C=CH),
131.5 and 136.8 (quaternary C), 167.3 (ester C =0) and 202.7 
(ketone C=0); m /z  (CP) 284.2 (100%, [M + NH4]+), 267.2 (86, 
[M + H]+).
(1 Z,5F)-1 -{Ethoxycarbonyl)-6,10-dimethylundeca-1,5,9-trien-2-yl 
trifluoromethanesulfonate (33)16
A stirred solution of 32 (546 mg, 2.05 mmol) in anhydrous 
THF (15 cm3) under N2 was cooled to —78 °C then potassium 
bis(trimethylsilyl)amide (0.5 M in THF, 4.93 cm3, 2.46 mmol) was 
added. The resulting mixture was stirred at —78 °C for 30 min. 
Trifluoromethanesulfonic anhydride (414 mm3, 2.46 mmol) was 
added at —78 °C and the solution stirred for 16 h whilst slowly 
warming to room temperature. Diethyl ether (20 cm3) was added 
and the solution was washed with 10% citric acid solution (2 x 
15 cm3) and water (15 cm3). The separated organic layer was dried 
over MgS04 and filtered. Evaporation of the solvent gave a yellow
011 which was purified by flash chromatography on silica gel with 
hexane and ethyl acetate (4 : 1) as eluent to give 33 as light yellow 
oil (0.42 g, 51%); R { 0.41 (hexane-EtOAc =  4 : 1 ) ;  vmax (thin 
film)/cm_1 2975.6,2905.3, 2855.1, 2353.0,1731.9, 1676.1,1427.9,
1209.1, 1141.0, 1037.6, 923.1 and 840.1; dH (500 MHz, C2HC13) 
1.24 (3 H, t, J  7.0, OCH2Ci73), 1.53 (3 H, s, C //3C=CH), 1.54 
(3 H, s, C //3C=CH), 1.61 (3 H, s, Ci73C=CH), 1.91 (4 H, m, 
(CH3)2C=CHCHr2C i/2), 2.20 (2 H, t, J  7.5, C/72CH2C=0), 2.34 
(2 H, t, J  7.5, CH2Ci72C=0), 4.17 (2 H, q, J  7.0, OCtf2CH3), 4.99 
(2 H, t, J  7.0, 2 x C=C//CH2CH2) and 5.67 (1 H, s, O-C=CH);
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Sc (125 MHz, C2HC13) 14.1 (OCH2CH3), 16.1 (CH3C=CH),
17.7 (CH3C=CH), 24.4 (CH2CH2CO), 25.7 (CH3C=CH), 26.5 
and 39.6 ((CH3)2C=CHCH2CH2), 34.6 (CH2CH2C=0), 61.3 
(OCH2CH3), 112.0 (0-C=CH), 120.6 and 123.9 (2 x C=CH),
131.7 and 138.2 (2 x C=CH), 158.5 (CH=COS02CF3) and
162.5 (C=0); SF (283 MHz, C2HC13) -74.6 (s). m /z  (CI+) 398.1 
(2%, M+), 358.0 (80), 314.1 (18), 267.0 (21), 190 (23) and 114 (100).
(2Z,6£)-Ethyl-7,ll-dimethyl-3-phenyldodeca-2,6,10-trienoate
(34)
To a stirred solution of 33 (0.36 g, 0.91 mmol) in anhydrous 
THF (10 cm3) under N2, was added palladium(n) acetate (0.02 g, 
0.09 mmol), triphenylarsine (0.11 g, 0.36 mmol), silver oxide 
(0.42 g, 1.81 mmol) and phenylboronic acid (0.17 g, 1.36 mmol) 
in quick succession. The complete mixture was then heated under 
reflux for 15 h. Water (20 cm3) and diethyl ether (20 cm3) were 
added, and the organic layer was separated. The aqueous layer 
was extracted with diethyl ether (2 x 15 cm3). The combined 
ethereal extracts were washed with water ( 2 x 1 0  cm3) and brine 
(10 cm3), dried over MgS04 filtered and concentrated under 
reduced pressure. Purification by flash chromatography on silica 
gel with hexane and ethyl acetate (9 : 1) as eluent gave 34 as 
a light yellow oil (0.19 g, 66%); Rs 0.35 (hexane-EtOAc =  9 :
1); HRMS (ES+, [M + H]+) found 327.2324, C^Hj.O, requires 
327.2319; v,^ (thin film)/cm-‘ 2975.7, 2926.3, 2361.9, 1727.2,
1638.2, 1442.5, 1377.2, 1276.4, 1223.8, 1159.0, 1042.6, 865.8 and 
698.6; SH (500 MHz, C2HC13) 0.99 (3 H, t, J  7.0, OCH2C tf3), 
1.45 (3 H, s, CH,C=CH), 1.53 (3 H, s, C tf3C=CH), 1.60 
(3 H, s, C i/3C=CH), 1.88 (6 H, m, (CH3)2C=CHCtf2C/72 and 
C/72CH2CPh), 2.40 (2 H, dt, J  1.0, /  8.0, CH2C tf2CPh), 4.90 
(2 H, q, J  7.0, O C//2CH3), 5.01 (2 H, dt, J  1.0, J  7.0, 2 x 
C=CH), 5.81 (1 H, s, C = C //C 02Et) and 7.07 (5 H, m, Ar- 
C H );^  (125 MHz, C2HC13) 14.0 (OCH2 CH3), 16.1 (CH3C=CH),
17.7 (CHjC=CH), 25.7 (CH3C=CH), 25.9, 26.7, 39.7 and 40.5 
(2 x CH2CH2), 59.7 (OCH2CH3), 117.4 (C=CHC02Et), 122.7 
and 124.2 (2 x C=CHCH2CH2), 127.2, 127.5 and 127.8 (Ar-CH) 
and 131.4,136.3,140.2,159.3 and 166.1 (quaternary C); m /z  (CI+)
344.4 (53%, [M + NH4]+) and 327.4 (100, [M + H]+).
(2Z,6£)-7,1 l-Dimethyl-3-phenyldodeca-2,6,10-trien-l-ol (35)
This compound was prepared from 34 in a manner identical to 
that for the alcohol 15; purification by flash chromatography on 
silica gel using hexane and ethyl acetate (2 : 1) as eluent gave 35 as 
a light yellow oil (0.11 g, 85%); Rt 0.38 (hexane-EtOAc =  2 : 1); 
HRMS (EI+, M+) found 284.2147, C20H28O requires 284.2140; vmax 
(thin film)/cm-‘ 3355.5, 2965.4, 2922.2, 2855.4, 1650.6, 1491.7,
1442.2, 1379.7, 1080.3, 1005.6, 830.9 and 769.8; <5H (500 MHz, 
C2HC13) 1.42 (1 H, b, CH2Oi/), 1.54 (3 H, s, C //3C=CH), 1.59 
(3 H, s, C i/3C=CH), 1.71 (3 H, s, C tf3C=CH), 1.97 (6 H, m , 
(CH3)2C=CHCtf2C tf2 and C/72CH2CPh), 2.44 (2 H, t, J  7.5, 
CH2C/72CPh), 4.07 (2 H, d, J  7.0, C tf2OH), 5.11 (2 H, m, 2 x 
C=CH), 5.72 (1 H, t, J  7.0, C=C77CH2OH) and 7.15 (5 H, m, Ar- 
CH); Sc (125 MHz, C2HC13) 16.0 (CH3), 17.7 (CH3), 25.7 (CH3),
26.5, 26.7, 39.0 and 39.7 (2 x CH2CH2), 60.3 (CH2OH), 123.5 
and 124.4(2 x C=CH), 125.7 (C=CHCH2OH), 127.1,128.1 and
128.2 (Ar-CH) and 131.3, 135.5, 140.0 and 144.6 (quaternary C); 
m /z  (EI+) 284.2 (10%, M+) and 266.2 (100, [M -  H2Q]+).
Molecular mechanics simulations
The X-ray crystal structure of AS from P. roqueforti containing 
a docked FPP molecule (PDB 1FIP) was used as the starting 
structure.34 For each docking experiment, the FPP substrate was 
converted to the relevant substrate analogue 19, 29 and 36, 
respectively, using the molecule builder module of the software 
package MOE.§ Hydrogen atoms were added to both the protein 
and FPP automatically using the software. The inhibitor and 
all amino acid residues containing heavy atoms within 6.5 A of 
the inhibitor were selected as the key active site atoms and the 
MMFF94 molecular mechanics forcefield was applied to these 
atoms only.35 The energy of the system was minimised and the 
resulting coordinates used to generate Fig. 3.
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The universal sesquiterpene 
precursor, farnesyl diphosphate (FPP), is 
cyclized in a Mg2+-dependent reaction 
catalyzed by the tetrameric aristolochene 
synthase from Aspergillus terreus to form 
the bicyclic hydrocarbon aristolochene and 
a pyrophosphate anion (PP;) coproduct 
The 2.1 A resolution crystal structure 
determined from crystals soaked with FPP 
reveals the binding of intact FPP to 
monomers A-C, and the binding of PP; and 
Mg2+B to monomer D. The 1.89 A 
resolution structure of the complex with 2- 
fluorofarnesyl diphosphate (2F-FPP) 
reveals 2F-FPP binding to all subunits of 
the tetramer, with Mg2+B accompanying 
the binding of this analogue only in 
monomer D. All monomers adopt open 
active site conformations in these 
complexes, but slight structural changes in 
monomers C and D of each complex reflect 
the very initial stages of a conformational 
transition to the closed state. Finally, the 
2.4 A resolution structure of the complex 
with 12,13-difluorofarnesyl diphosphate 
(DF-FPP) reveals the binding of intact DF- 
FPP to monomers A-C in the open 
conformation, and the binding of PPj, 
Mg2+ b ,  and Mg2+c to monomer D in a
.: 215-573-2201; E-mail: chris@sas.upenn.edu
predominantly closed conformation. Taken 
together, these structures provide 12 
independent "snapshots" of substrate or 
product complexes that suggest a possible 
sequence for metal ion binding and 
conformational changes required for 
catalysis.
Farnesyl diphosphate (FPP)2, a 
flexible 15-carbon isoprenoid, is the universal 
precursor o f more than 300 different cyclic 
sesquiterpenes found in numerous plants, 
bacteria, and fungi (1, 2). The cyclization of 
FPP is catalyzed by a sesquiterpene cyclase 
that utilizes a trinuclear magnesium cluster to 
trigger the departure o f the pyrophosphate 
(PPi) leaving group, thereby forming an 
allylic carbocation that typically reacts with 
one o f the remaining jt bonds o f the substrate 
(3-7). The remarkable diversity of 
sesquiterpene structure and stereochemistry is 
the consequence o f precise control exerted by 
the cyclase over the conformations o f the 
flexible substrate and carbocation 
intermediates in the cyclization cascade.
Aristolochene synthase from A. 
terreus is a sesquiterpene cyclase that 
catalyzes the cyclization o f FPP to form 
aristolochene (Figure la), the parent 
hydrocarbon of a large group of fungal toxins
Copyright 2008 by The American Society for Biochemistry and Molecular Biology, Inc.
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such as gigantenone, PR-toxin, and 
bipolaroxin (8). In contrast to aristolochene 
synthase from P. roqueforti, which generates 
aristolochene predominantly (>90%) but also 
small amounts o f germacrene A and 
valencene (9, 10), aristolochene synthase 
from A. terreus generates aristolochene 
exclusively (9). Each cyclase adopts the 
common a-helical fold o f a class I terpenoid 
cyclase and contains two conserved metal 
binding motifs: the “aspartate-rich” motif
D90DLLE that coordinates to Mg2+A and 
Mg2+c, and the “NSE/DTE” motif 
N219DIYSYEKE that chelates Mg2+B 
(boldface residues are metal ligands) (11). X- 
ray crystallographic studies show that the 
binding o f Mg2+3-PPi stabilizes the active site 
in a closed conformation that is completely 
sequestered from bulk solvent (Figure lb) 
(11). In addition to multiple metal 
coordination interactions, the PPi anion 
accepts hydrogen bonds from conserved 
residues R175, K226, R314, and Y315 when 
bound to the closed conformation (Figure lc). 
It is likely that the diphosphate group of FPP 
makes identical metal coordination and 
hydrogen bond interactions in the Michaelis 
complex, i.e., the complex between the 
enzyme and the productively bound substrate 
that immediately precedes the initiation of the 
cyclization cascade.
Substrate conformation is a crucial 
determinant o f  the biosynthetic outcome of 
the terpenoid cyclase reaction. The active site 
of aristolochene synthase from A. terreus 
serves as a high-fidelity template that fixes 
FPP in a single, productive conformation in 
the Michaelis complex -  otherwise, aberrant 
cyclization products would result. To study 
the conformational control o f FPP in the 
active site o f  aristolochene synthase from A. 
terreus, we now report the structures of 
crystalline complexes with the intact 
substrates FPP and 2-fluorofamesyl 
diphosphate (2F-FPP) (12), and the inhibitor 
12,13-difluorofamesyl diphosphate (DF-FPP) 
(13). Differences observed in active site 
conformations and substrate conformations
appear to be linked to differences in metal 
binding, analysis o f which suggests a possible 
sequence for metal ion binding and 
conformational changes required for 
catalysis.
MATERIAL AND METHODS 
Enzyme incubations with 2F-FPP 
and DF-FPP in solution. The syntheses of 
2F-FPP and DF-FPP have been reported (12- 
14) and an additional synthesis o f 2F-FPP is 
outlined in the Supporting Information. 
Recombinant A. terreus aristolochene 
synthase was expressed in Escherichia coli 
BL21(DE3)pLysS and purified as previously 
described (11, 15). Analysis o f the products 
generated by enzyme incubation with 2F-FPP 
was performed using gas chromatography 
and mass spectroscopy (GC-MS) using a 
similar procedure as previously described for 
the reaction with substrate FPP (11).
Briefly, a 4 mL solution o f 500 nM 
aristolochene synthase, 20 mM Hepes (pH 
7.6), 10% glycerol, 5 mM MgCl2 , and 5 mM 
(3-mercaptoethanol was incubated with 50 -  
100 pM 2F-FPP or DF-FPP and overlaid with 
HPLC-grade w-pentane (Fisher P399-1) in a 
glass centrifuge tube at 30 °C for about 30 h. 
After the initial 10 h incubation, 500 nM 
enzyme and 50 pM 2F-FPP or DF-FPP were 
added twice into the aqueous reaction layer at 
6 h intervals. Reaction products were 
extracted with HPLC-grade w-pentane and the 
organic extract was passed through a 3 cm 
230-400 mesh silica gel column. The purified 
extract was concentrated on an ice-water 
mixture under reduced pressure until the 
volume was decreased to about 50 pL. The 
resulting concentrate was analyzed using a 
Hewlett-Packard 6890 gas chromatograph 
coupled to a 5973 mass selective detector and 
equipped with an HP-5MS capillary column 
(0.25 mm i.d. x 30 m with 0.25 pm film) 
(Agilent Technologies). Typically, a 2 pL 
sample was injected in splitless mode into the 
GS-MS. The oven temperature was at 35 °C 
for 1 min, then raised to 230 °C at the rate o f 
5 °C/min, followed by a 20 °C/min increase
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to 280 °C. The temperature was maintained at 
280 °C for 20 min.
Crystal structure determinations o f  
enzyme complexes with FPP, 2F-FPP, and 
DF-FPP. Recombinant A. terreus 
aristolochene synthase was crystallized by the 
hanging drop vapor diffusion method at 4°C 
as previously described (11). The structures 
o f complexes with substrate FPP and 
substrate analogues 2F-FPP and DF-FPP 
were determined by soaking crystals o f the 
unliganded enzyme for 20-24 hours in a 
buffer solution containing 100 mM Tris-HCl 
(pH 8.4), 18% PEG 6000, 0.5 M NaCl, 1 mM 
MgCl2, and 2  mM substrate or substrate 
analogue. X-ray diffraction data were 
collected from crystals o f each complex at the 
Brookhaven National Synchrotron Light 
Source and processed using HKL (16) or 
Mosflm (17). Crystals were isomorphous 
with those o f the unliganded enzyme (space 
group P2U a = 61.2 A, b = 147.2 A, c = 83.7 
A, j3 = 97.9°, with four molecules in the 
asymmetric unit (11)). Iterative rounds of 
refinement and model adjustment for each 
complex were performed using CNS and O, 
respectively (18, 19). Individual B-factors 
were refined in each complex.
The N-termini M l-SI2, C-termini 
V318-D320, and loop segments S231-G239 
were disordered in all monomers o f each 
structure. Additionally, loop segments F46- 
P47 and R160-T161 were disordered in 
monomer D of the FPP complex, loop 
segment L286-E287 was disordered in 
monomer C o f the 2F-FPP complex, and loop 
segments N45-N48, K54-F55, and Y95-S97, 
were disordered in monomer D of the DF- 
FPP complex. Disordered residues were 
excluded from the final model of each 
complex. The exclusion o f 111/1280 residues 
from each tetramer (8.7% of the scattering 
matter) likely contributed to the somewhat 
higher than expected R and Rfree values 
recorded in Table 1. Continuous electron 
density peaks adjacent to 5, 3, and 2 cysteine 
residues, respectively, were modeled as 
disulfide-linked BME molecules in the FPP,
2F-FPP, and DF-FPP complexes. Data 
collection and refinement statistics for each 
complex are recorded in Table 1. Figures 
were generated using the program Pymol 
(20).
RESULTS
Reactivity o f  fluorinated substrates. 
Aristolochene synthase from A. terreus 
generates (+)-aristolochene as its sole product 
from reaction with substrate FPP (9). 
However, following incubation with 2F-FPP 
in solution, two products are identified in a 
95:5 ratio by GS-MS (Figure 2). The 
chemical ionization (Cl) mass spectrum of 
the major peak eluting at 25.1 min 
corresponds to a fluorinated sesquiterpene 
(C15H23F) with m/z = 2 2 2  (data not shown). 
This result is consistent with the generation 
of 2-fluorogermacrene A, as observed after 
incubating aristolochene synthase from P. 
roqueforti with 2F-FPP (12). The small peak 
at 23.37 min has a chemical ionization 
spectrum indicative o f a non-fluorinated 
sesquiterpene (C15H24) with M-l = 204 (data 
not shown); this is presumed to be a 
degradation product. A control experiment 
conducted in the absence o f enzyme indicates 
that 2F-FPP itself does not react to yield any 
extractable products based on GC-MS 
analysis.
Incubation o f A. terreus aristolochene 
synthase with DF-FPP for 30 h using the 
approach described above for 2F-FPP does 
not generate any pentane-extractable products 
based on GC-MS analysis. This is consistent 
with the lack o f activity with DF-FPP 
reported for aristolochene synthase from P. 
roqueforti, against which DF-FPP is a 
reversible competitive inhibitor with Ki = 0 . 8  
pM (13).
Crystal structure o f the complex with 
FPP. The structure o f tetrameric 
aristolochene synthase determined from 
crystals soaked in a buffer solution containing 
FPP reveals that monomers A-D adopt open
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active site conformations similar to those o f 
the unliganded enzyme (11). Intact FPP 
molecules with partially similar folded 
conformations bind in the active site clefts o f  
monomers A, B, and C (Figures 3a and 3b), 
while Mg2+B-PPi binds in the active site cleft 
of monomer D (Figure 3c). The r.m.s. 
deviations o f 295 Ca atoms in monomers A 
and B with the corresponding monomers in 
the unliganded enzyme are 0.28 A and 0.26 
A, respectively, indicating that these 
monomers remain in predominantly open 
conformations. However, some slight
structural changes are observed in monomers 
C and D that reflect the very initial stages o f a 
transition to the closed conformation: helices 
C l, D, and D1 and loops A-Cl and D -D l 
shift slightly toward their expected positions 
in the closed conformation of monomer C, 
and helices Cl and H do likewise in 
monomer D (for reference, the locations of 
these structural elements are indicated in 
Figure lb). Accordingly, the r.m.s.
deviations with the unliganded enzyme are 
larger for these monomers: 0.59 A for 295 
Ca atoms in monomer C, and 0.51 A for 290 
Ca atoms in monomer D. Even so, the active 
sites o f monomers C and D remain in 
predominantly open, solvent-exposed 
conformations.
In each o f monomers A, B, and C, 
the terminal diphosphate group o f FPP 
accepts hydrogen bonds from R314 and 
Y315, and the terminal isoprenoid group of 
FPP is nestled between F87 and FI53. The 
conformation o f the middle isoprenoid 
moiety o f FPP in monomer B is flipped, 
however, compared to that observed in 
monomers A and C, both o f which have the 
predicted relative and absolute orientation of 
the C3 and C7 methyl groups (Figure 3b). 
Notably, none o f the observed FPP 
conformations correspond to that required for 
the formation o f germacrene A (the first 
intermediate in aristolochene biosynthesis), 
since the electrophilic Cl atom is positioned 
~ 6  A away from the C10-C11 n bond and is 
not properly oriented for the C1-C10 bond
forming step. The binding of FPP to 
monomers A, B, and C thus may provide 
“snapshots” o f possible substrate binding 
conformations in the open active site prior to 
metal ion binding and active site closure.
The active site cleft o f monomer D 
contains only the Mg2+B-PPi complex (Figure 
3c). Notably, only monomer D appears to be 
capable o f achieving the closed conformation 
required for catalysis in complex with Mg2+3- 
PPi (11). While aristolochene synthase from 
A. terreus is a dimer in solution (11), the 
assembly o f two dimers to form the tetramer 
observed in the crystal structure may hinder 
the conformational transition from the open, 
inactive state to the closed, active state, 
thereby accounting for the attenuation o f  
catalytic activity with increasing protein 
concentrations (9). Additionally, catalytically 
required conformational changes may be 
hindered in monomers A-C due to crystal 
lattice contacts. In monomer D, the observed 
single-metal ion complex Mg2+B-PPi is 
presumably a remnant o f the FPP cyclization 
reaction catalyzed by this monomer in the 
crystal. This structure represents the first 
observation o f product PPi binding to the 
predominantly open active site conformation 
of a wild-type terpenoid cyclase.
Since the orientation o f PPi bound in 
the presence o f Mg2+B in monomer D differs 
from the orientations of the FPP diphosphate 
groups in monomers A-C (Figure 3d), Mg2+B 
coordination interactions are presumed to 
play an important role in orienting the 
substrate diphosphate group and PPi anion. 
Superposition o f the Mg2+B-PPi complex in 
the open active site conformation and the 
Mg2+3-PPi complex in the closed active site 
conformation reveals a similar binding mode 
for the Mg2+B-PPi moiety (Figure 3d). Thus, 
it appears that Mg2+B is the key metal ion 
governing the proper binding orientation of 
PPi. Hydrogen bond interactions with R314 
and Y 315 also orient the binding o f PPi.
Interestingly, although R175, K181, 
and K226 donate hydrogen bonds to PPi in 
the Mg2+3-PPi complex in the closed active
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site conformation (Figure lc) (11), these 
residues do not interact with the diphosphate 
groups o f PPi or FPP in the open active site 
conformation. The binding of PPi to the open 
conformation o f monomer D may provide a 
“snapshot” o f a possible complex just prior to 
product release at the conclusion of the 
cyclization cascade.
Crystal structure o f the complex with 
2F-FPP. Despite the evidence for catalytic 
activity with 2F-FPP in solution (Figure 2), 
the crystal structure o f the aristolochene 
synthase tetramer complexed with 2F-FPP 
reveals the binding o f intact 2F-FPP to all 
four monomers with open active site 
conformations. As observed in the FPP 
complex, slight structural changes are 
observed in monomers C and D that appear to 
reflect the very initial stages of a transition to 
the closed conformation. The r.m.s. 
deviations with the unliganded enzyme are 
0.26 A, 0.29 A, 0.57 A, and 0.52 A for 
monomers A, B, C, and D, respectively.
Electron density corresponding to the 
diphosphate group of 2F-FPP is well defined 
in monomers A and D (Figure 4a) but 
ambiguous in monomers B and C (data not 
shown). Only one metal ion, Mg2+B, is bound 
in this complex, and it binds only to the 
enzyme-substrate complex in monomer D. 
Here, the substrate diphosphate group 
chelates Mg2+B and accepts hydrogen bonds 
from R314, Y315, and K226. The position 
and orientation o f the diphosphate group of 
2F-FPP is roughly comparable to that of PPi 
in the Mg2+B-PPi complex (Figure 4b). 
Strikingly, comparison o f the metal-free and 
metal-bound conformations o f 2F-FPP in 
monomers A and D, respectively, reveals a 
significant Mg2+B-dependent reorientation of 
the substrate (Figure 4c). Thus, it appears 
that Mg2+B is the key metal ion governing the 
proper binding orientation o f the substrate 
diphosphate group.
In each monomer, the fluorine atom 
o f 2F-FPP accepts a hydrogen bond from 
K181. As observed for FPP, the terminal 
isoprenoid group o f 2F-FPP is nestled
between residues F87 and FI53, but the 2F- 
FPP molecules adopt somewhat varying 
folded conformations in each monomer. 
Since none o f the observed 2F-FPP 
conformations in monomers A-D are 
consistent with that required for Cl-CIO bond 
formation in the first step o f catalysis, the 
observed binding conformations o f 2F-FPP in 
the presence or absence o f Mg2+B suggest that 
additional metal ion binding and active site 
closure are necessary to chaperone the 
substrate into a cyclization-competent 
conformation. Regardless, the complexes o f  
2F-FPP with monomers A -D  provide 
additional “snapshots” o f possible substrate 
binding modes to the open active site 
conformation prior to and subsequent to the 
binding o f Mg2+B.
Crystal structure o f  the complex with 
DF-FPP. The crystal structure of 
aristolochene synthase complexed with DF- 
FPP reveals the binding o f the intact substrate 
analogue to the open active site 
conformations o f monomers A, B, and C; the 
r.m.s. deviations with the unliganded enzyme 
are 0.30 A, 0.31 A, and 0.58 A, respectively. 
A representative electron density map o f DF- 
FPP bound to monomer B is shown in Figure 
5a. No metal ions accompany DF-FPP 
binding, and the observed isoprenoid and 
diphosphate conformations are somewhat 
variable, suggesting some degree o f disorder 
(Figure 5b). The binding o f DF-FPP to 
monomers A-C provides additional 
"snapshots" o f substrate binding 
conformations that, in the absence o f metal 
ion binding and full active site closure, are 
not cyclization-competent.
In contrast, monomer D adopts a 
predominantly closed conformation and 
contains a PPi anion complexed with Mg2+B 
and Mg2+c (Figure 5c). There is no residual 
electron density in the active site to indicate 
that an intact DF-FPP molecule is present but 
disordered. A key conformational change 
evident in this structure is that the aspartate- 
rich and NSE metal ion binding motifs on 
helices D and H, respectively, are brought
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closer together in order to accommodate the 
binding of the binuclear magnesium cluster. 
Reflecting this significant conformational 
change, the r.m.s. deviation of 278 Ca atoms 
with the unliganded structure is 0.83 A.
Although the incubation o f DF-FPP 
with the A. terreus enzyme (data not shown) 
or the P. roqueforti enzyme (13) yields no 
observable products, it is possible that a slow 
reaction with this substrate analogue occurs 
over the time course o f the X-ray 
crystallographic experiment to yield the 
observed PPi product. Notably, the 061 and 
062 atoms o f D90 coordinate to Mg2+c with 
bidentate geometry, whereas in the complex 
o f aristolochene synthase with Mg2+3-PPi, 
D90 coordinates to both Mg2+A and Mg2+C 
with syn-syn bidentate geometry (i.e., D90 
061 coordinates to Mg2+A and D90 062  
coordinates to Mg2+C) (11). Some, but not all, 
hydrogen bond interactions observed in the 
Mg2+3-PPi cluster (11) are observed in the 
Mg2+B-Mg2+c-PPi complex: R314 and Y315 
donate hydrogen bonds to PPi but K226 is 
characterized by poor electron density and 
appears to be somewhat disordered, and R175 
is too far from PPi (5.7 A) to be considered a 
formal hydrogen bond donor.
Importantly, this structure reveals 
that only 2 Mg2+ ions are needed to stabilize 
the predominantly closed active site 
conformation. Specifically, the binding of 
Mg2+c to the FPP/PPi-Mg2+B complex appears 
to be the key molecular event that triggers the 
conformational transition o f the active site 
from the open state to the closed state. The 
binding o f Mg2+A to complete the trinuclear 
magnesium cluster also completes these 
conformational transitions such that the r.m.s. 
deviation o f 295 Ca atoms between open and 
closed conformations is 1.5 A.
DISCUSSION
The three crystal structures reported 
herein contain 12 independent structures o f A. 
terreus aristolochene synthase monomers that 
illuminate an unprecedented array o f binding
interactions: 9 examples of substrate binding 
in the absence o f Mg2+ to the open active site 
conformation; 1 example o f substrate binding 
to the open active site conformation in the 
presence o f one metal ion, Mg2+B; 1 example 
o f PPi binding to the open active site 
conformation in the presence o f one metal 
ion, Mg2+B; and 1 example o f PPi binding to 
the predominantly closed active site 
conformation in the presence o f two metal 
ions, Mg2+B and Mg2+C. Along with the 
structure o f PPi binding to the closed active 
site conformation in the presence o f all three 
metal ions, Mg2+A, Mg2+B, and Mg2+C (11), 
these structures suggest a possible sequence 
for metal ion binding and conformational 
changes required for catalysis.
Substrate Conformation. The 
observed conformations o f intact FPP, 2F- 
FPP, and DF-FPP are not cyclization- 
competent due to the fact that they are bound 
to the open active site conformation. This is 
a direct consequence o f incomplete metal 
binding, since a complete trinuclear 
magnesium cluster is required to stabilize the 
fully closed active site conformation. It is 
only in the closed conformation that the 
active site is sequestered from bulk solvent, 
thereby forming a protected environment in 
which reactive carbocation intermediates can 
be formed without the risk of premature 
quenching by solvent.
Interestingly, most o f the crystal 
structures reported to date o f class I terpenoid 
cyclases complexed with isoprenoid substrate 
analogues similarly reveal isoprenoid 
conformations that are not catalytically 
competent (21-23). As with aristolochene 
synthase, this often appears to be a 
consequence o f incomplete or compromised 
metal binding, e.g., as observed in the 
complex o f 5-epi aristolochene synthase with 
trifluorofamesyl diphosphate (22). However, 
isoprenoid conformations that are not 
cyclization-competent are occasionally 
observed in monoterpene cyclase active sites 
with closed conformations stabilized by 
complete trinuclear magnesium clusters. For
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example, the binding of 3-aza-2,3- 
dihydrogeranyl diphosphate and 3 Mg2+ ions 
to bomyl diphosphate synthase triggers active 
site closure, and the position, orientation, and 
intermolecular contacts o f the analogue 
diphosphate group are nearly identical to 
those observed in the Mg2+3-PPi complex 
(21). Even so, the conformation o f the 
substrate analogue is inconsistent with that 
required for cyclization. More recently, 
cocrystallization o f limonene synthase with 
2-fluorogeranyl diphosphate yields the 
structure o f the complex with 2-fluoro-(3<S')- 
linalyl diphosphate, a catalytic intermediate, 
bound with an extended conformation that is 
not cyclization-competent; in contrast, 
cocrystallization with racemic 2-fluorolinalyl 
diphosphate yields the helical, cyclization- 
competent isoprenoid conformation (23). 
This suggests the possibility that 
isomerization o f geranyl diphosphate to 
linalyl diphosphate does not require a 
cyclization-competent substrate conformation 
-  such a conformation could instead be 
achieved after formation o f the linalyl 
diphosphate intermediate.
Metal Binding. Analyses o f enzyme- 
substrate and enzyme-PPi complexes reported 
herein and comparisons with the structure of 
the enzyme-Mg2+3-PPi complex reported 
previously (11) lead to a proposed model for 
substrate and metal binding (Figure 6). First, 
hydrogen bond donors R314 and Y315 would 
govern the initial molecular recognition of the 
FPP diphosphate group, perhaps concurrently 
with binding o f the Mg2+B ion by the 
NSE/DTE motif. Coordination to Mg2+B 
would reorient the substrate diphosphate 
group, as exemplified by the Mg2+B- 
dependent reorientation o f the 2F-FPP 
diphosphate group shown in Figure 4c. Since 
it is only Mg2+B that is chelated by three 
protein residues, it is reasonable to 
hypothesize that this is the first o f the three 
metal ions to bind (its binding site is largely 
pre-organized). Some slight conformational 
changes reflecting the very initial stages of 
active site closure may be triggered by Mg2+B
and/or substrate binding, e.g., as observed in 
monomers C and D of the FPP/PPi and 2F- 
FPP complexes.
Subsequently, the binding o f Mg2+c 
by both D90 and the substrate diphosphate 
group would trigger more substantial 
conformational changes leading to active site 
closure, as illustrated by the Mg2+B-Mg2+c-PPi 
complex in Figure 5c. Finally, the binding of 
Mg2+A would complete the formation o f the 
trinuclear metal ion cluster, causing Mg2+C to 
shift such that D90 would coordinate to both 
Mg2+A and Mg2+c with syn-syn bidentate 
geometry.
The formation o f a complete 
trinuclear magnesium cluster would complete 
conformational changes required for full 
active site closure. In the closed 
conformation, substrate diphosphate metal 
ion coordination interactions and hydrogen 
bond interactions with R175, K226, R314, 
and Y 315 would be fully formed, as observed 
in the Mg2+3-PP, complex (Figure lc) (11). 
Upon achieving a cyclization-competent 
substrate conformation in the closed active 
site, with the three negative charges o f the 
diphosphate leaving group fully neutralized, 
substrate ionization (24, 25) and cyclization 
would be initiated.
At the conclusion o f the cyclization 
cascade, we suggest that metal ion 
dissociation and the transition to the open 
active site conformation occurs in reverse 
sequence: Mg2+A would dissociate first, but 
Mg2+B and Mg2+C would stabilize the active 
site conformation in a predominantly closed 
state, e.g., as observed in the Mg2+B-Mg2+c- 
PPi complex in Figure 5c. The subsequent 
dissociation o f Mg2+C would then facilitate 
the transition to an open active site 
conformation with the release o f product 
aristolochene, and the release o f Mg2+B-PPi 
would conclude the catalytic sequence.
Additional support for the proposed 
role o f metal binding in the conformational 
transition o f the terpenoid synthase active site 
derives from site-directed mutagenesis 
studies o f another fungal sesquiterpene
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cyclase, trichodiene synthase, related to 
aristolochene synthase by only 15% amino 
acid sequence identity. The r.m.s. deviation 
of 349 Ca atoms between unliganded and 
Mg2+3-PPi complexed wild-type trichodiene 
synthase is 1.4 A (26). In contrast, D100E 
trichodiene synthase is defective in Mg2+c 
binding and does not achieve a fully closed 
active site conformation in its complex with 
Mg2+A, Mg2+B, and PPt; the r.m.s. deviation of 
354 Ca atoms between the unliganded and 
liganded enzymes is only 0.44 A (27). 
Therefore, Mg2+c must play a critical role in 
triggering the structural transition o f the 
trichodiene synthase active site from the open 
to the closed conformation, just as Mg2+c is 
proposed to play a critical role in triggering 
the structural transition o f the aristolochene 
synthase active site from the open to the 
closed conformation.
In accord with the metal binding 
behavior observed with aristolochene 
synthase and trichodiene synthase, we 
conclude that the metal binding sequence 
summarized in Figure 6 suggests specific 
functions for the three metal ions in terpenoid 
cyclase-catalyzed ionization-cyclization 
reactions: Mg2+B governs initial enzyme- 
substrate association; Mg2+c triggers the 
conformational transition o f the active site 
from the open state to a predominantly closed
state in which metal ion binding motifs on 
helices D and H are brought closer together; 
and Mg2+A completes the trinuclear 
magnesium cluster and thereby completes the 
conformational transition to the closed state 
and initiates the cyclization cascade. Future 
studies o f site-specific mutants in the metal 
binding site o f aristolochene synthase and 
other terpenoid cyclases will allow us to test 
this model o f metal ion function.
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Figure Legends
Figure 1. Aristolochene synthase reaction, (a) Cyclization of farnesyl diphosphate (FPP) to form 
aristolochene (OPP = diphosphate, PPi = pyrophosphate), (b) Superposition of monomer D of 
unliganded aristolochene synthase in the open conformation (red), the closed conformation in the 
Mg2+3-PPi complex (green) (11), and the FPP/PPi complex (blue). The binding o f Mg2+3-PPi triggers 
significant conformational changes in helices G1 and H and loops F-G l and A -C l. Additionally, 
the N-terminal portion o f the H -a l loop is incorporated into an extension of helix H; helices C l, D, 
DI, F, G l, H, and I shift inward, and the H -a l loop (S231 -  G239), disordered in the unliganded 
enzyme, becomes ordered and caps the active site. In the FPP complex (blue), helices C l, H and 
loops A -C l and H -a l shift slightly toward their expected positions in the closed conformation, 
reflecting the very initial stages o f a transition from the open active site conformation to the closed 
active site conformation, (c) Aristolochene synthase-Mg2+3-PPi complex (11); PP, metal 
coordination and hydrogen bond interactions are shown as red dotted lines.
Figure 2. Enzyme incubation with 2F-FPP. Gas chromatogram of the pentane-extractable 
product from the incubation o f aristolochene synthase with 2F-FPP. The chemical ionization (Cl) 
mass spectrum o f the compound eluting at 25.10 min is consistent with a fluorinated sesquiterpene 
with m/z = 222. The compound eluting at 23.37 min exhibits M-l = 204 and is presumed to be a 
nonfluorinated degradation product.
Figure 3. Stereoview of FPP binding, (a) Simulated annealing omit map of FPP in monomer A 
contoured at 3.0a; enzyme-substrate hydrogen bond interactions are indicated by red dotted lines,
(b) Superposition o f FPP molecules from monomers A (blue), B (green), and C (magenta). For 
clarity, only the protein atoms of monomer B are shown, (c) Simulated annealing omit maps o f the 
PPi anion (blue) and Mg2+B (red) in monomer D contoured at 3 a. Water molecules appear as red 
spheres and hydrogen bond interactions with PPi are indicated by red dotted lines, (d) Superposition 
of the “NS E/DTE” motifs of monomers A (yellow) and D (green) in the FPP/PPi complex, and 
monomer D in the Mg2+3-PPi complexed structure (11) (blue), in which the enzyme active site 
adopts the closed conformation. Note that the Mg2+B-PPi orientation is similar regardless o f whether 
PPi is complexed with Mg2+3 or only Mg2+B; moreover, the orientation of the FPP diphosphate group 
in the absence o f Mg2+ ions differs significantly from that o f metal-coordinated PPi. Metal 
coordination interactions are indicated by dashed lines; water molecules are omitted for clarity.
Figure 4. Stereoview of 2F-FPP binding, (a) Simulated annealing omit maps o f 2F-FPP (blue) and 
Mg2+B (red) in monomer D contoured at 3.1a. Water molecules appear as red spheres and enzyme- 
substrate hydrogen bond interactions are indicated by red dotted lines, (b) Superposition o f the 
NSE/DTE motifs o f monomer D (yellow) in the 2F-FPP complex, and monomer D in the Mg2+B-PPi 
complex (green) shown in Figure 3 c. The interaction o f the 2F-FPP diphosphate group with Mg2+B 
is roughly similar to that observed for PPi. Metal coordination interactions are indicated by dashed 
lines; water molecules are omitted for clarity, (c) Superposition o f 2F-FPP bound to monomer A 
(red) and monomer D (blue) illustrates the Mg2+B-triggered reorientation o f the substrate 
diphosphate group (for clarity, only the protein atoms o f monomer D are shown).
Figure 5. Stereoview of DF-FPP binding, (a) Simulated annealing omit map of DF-FPP bound to 
monomer B of aristolochene synthase contoured at 3.0a. Water molecules appear as red spheres and 
a hydrogen bond between a diphosphate oxygen atom and R314 is indicated by a red dotted line, (b) 
Superposition o f DF-FPP molecules from monomers A (blue), B (green), and C (red), indicating
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some degree o f disordered binding. For clarity, only the protein atoms of monomer A are shown.
(c) Simulated annealing omit maps (contoured at 3 a) of the PPi anion (blue) and Mg2+B and Mg2+c 
(red) in monomer D. Water molecules appear as red spheres; enzyme-PPi metal coordination and 
hydrogen bond interactions are indicated by red dotted lines.
Figure 6. Proposed metal ion binding sequence for catalysis. Model for metal ion binding, 
conformational transitions between open and closed conformations, and catalysis by aristolochene 
synthase based on the "snapshots" o f metal ion, substrate, and product PPi binding provided by the 
crystal structures reported herein.
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Table 1: Data Collection and Refinement Statistics
Complex FPP 2F-FPP DF-FPP
Resolution (A) 50 .00-2 .10 61 .08 -1 .89 56 .3 0 -2 .4
Unique reflections 80431 104421 57488
Completeness (%) (outer shell) 93.7 (93.5) 88.2 (77.9) 99.6 (99.8)
I/a(I) overall (outer shell) 11.2(2.1) 12.3 (3.2) 14.3 (4.4)
Rfflerge(outer shell)8 0.099 (0.586) 0.073 (0.502) 0.095 (0.649)
Protein atoms (N)h 9558 9571 9494
Solvent (N)h 303 524 245
BME/glycerol atoms (N)h 20 12 14
Magnesium ions (N)b 1 1 2
Chloride ions (N)b 1 0 1
Substrate atoms (N)h 72 100 78
PPi atoms (N)b 9 0 9
Rcryst (outer shell)c 0.239(0.314) 0.224 (0.270) 0.241 (0.333)
Rfree (outer shell)0 0.277 (0.350) 0.264 (0.320) 0.290 (0.387)
R.m.s. deviations
Bonds (A) 0.007 0.013 0.006
Angles (°) 1.1 1.6 1.1
Dihedral angles (°) 18.8 20.0 18.9
Improper dihedral angles (°) 0.8 1.1 1.7
Ramachandran statistics (%)d
Allowed 91.8 93.8 90.7
Additionally allowed 7.7 5.5 8.3
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Generously allowed 0.5 0.7 1.1
a Emerge= 2|/, - (/,)|/Z/„ where Ij is the observed intensity for reflection i and (I,) is the average intensity 
calculated for reflection / from replicate data. 
b Per asymmetric unit.
CR = '2 ||F0| - |/rc||/2|7r0|> where R and RfTee are calculated using the working and test reflection sets, respectively 
(the test reflection set is excluded from refinement); | F01 and | Fc | are the observed and calculated structure 
factor amplitudes, respectively. 
d Calculated with PROCHECK (28).
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